{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "dbe37428",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "80876dff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>phase</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>study_design</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>status</th>\n",
       "      <th>gender</th>\n",
       "      <th>location</th>\n",
       "      <th>start_date</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>masking</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00000102</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>Congenital Adrenal Hyperplasia</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NIH</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>ALL</td>\n",
       "      <td>South Carolina</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DOUBLE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00000104</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lead Poisoning</td>\n",
       "      <td>PROCEDURE</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Minnesota</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00000105</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>BIOLOGICAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>112.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Minnesota</td>\n",
       "      <td>2002-07-31</td>\n",
       "      <td>2012-03-31</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00000106</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Rheumatic Diseases</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>NIH</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Wisconsin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00000107</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Heart Defects, Congenital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NIH</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Vermont</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id          phase                       condition  \\\n",
       "0  NCT00000102  PHASE1/PHASE2  Congenital Adrenal Hyperplasia   \n",
       "1  NCT00000104            NaN                  Lead Poisoning   \n",
       "2  NCT00000105            NaN                          Cancer   \n",
       "3  NCT00000106            NaN              Rheumatic Diseases   \n",
       "4  NCT00000107            NaN       Heart Defects, Congenital   \n",
       "\n",
       "  intervention_type study_design sponsor_type  enrollment enrollment_type  \\\n",
       "0              DRUG          NaN          NIH         NaN             NaN   \n",
       "1         PROCEDURE          NaN          FED         NaN             NaN   \n",
       "2        BIOLOGICAL          NaN        OTHER       112.0          ACTUAL   \n",
       "3            DEVICE   RANDOMIZED          NIH         NaN             NaN   \n",
       "4               NaN          NaN          NIH         NaN             NaN   \n",
       "\n",
       "       status  gender        location  start_date completion_date masking  \n",
       "0   COMPLETED     ALL  South Carolina         NaN             NaN  DOUBLE  \n",
       "1   COMPLETED  FEMALE       Minnesota         NaN             NaN     NaN  \n",
       "2  TERMINATED     ALL       Minnesota  2002-07-31      2012-03-31     NaN  \n",
       "3     UNKNOWN     ALL       Wisconsin         NaN             NaN     NaN  \n",
       "4   COMPLETED     ALL         Vermont         NaN             NaN     NaN  "
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"unique_trial_data.csv\")\n",
    "df.head() # Loading the Raw Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "73ddb167",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop('nct_id', axis=1) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "44917a34",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_55345/898100831.py:1: FutureWarning: A value is trying to be set on a copy of a DataFrame or Series through chained assignment using an inplace method.\n",
      "The behavior will change in pandas 3.0. This inplace method will never work because the intermediate object on which we are setting values always behaves as a copy.\n",
      "\n",
      "For example, when doing 'df[col].method(value, inplace=True)', try using 'df.method({col: value}, inplace=True)' or df[col] = df[col].method(value) instead, to perform the operation inplace on the original object.\n",
      "\n",
      "\n",
      "  df['study_design'].fillna('UNKNOWN', inplace=True)\n"
     ]
    }
   ],
   "source": [
    "df['study_design'].fillna('UNKNOWN', inplace=True) # Replace NaN values with 'UNKNOWN'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "12e74f29",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "study_design\n",
       "RANDOMIZED        154593\n",
       "UNKNOWN           118006\n",
       "NON_RANDOMIZED     27401\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['study_design'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "087eb6b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.dropna(subset=['phase'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "afdc5553",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 142095 entries, 0 to 299998\n",
      "Data columns (total 13 columns):\n",
      " #   Column             Non-Null Count   Dtype  \n",
      "---  ------             --------------   -----  \n",
      " 0   phase              142095 non-null  object \n",
      " 1   condition          142095 non-null  object \n",
      " 2   intervention_type  142095 non-null  object \n",
      " 3   study_design       142095 non-null  object \n",
      " 4   sponsor_type       142095 non-null  object \n",
      " 5   enrollment         139148 non-null  float64\n",
      " 6   enrollment_type    132310 non-null  object \n",
      " 7   status             142095 non-null  object \n",
      " 8   gender             142009 non-null  object \n",
      " 9   location           91340 non-null   object \n",
      " 10  start_date         140052 non-null  object \n",
      " 11  completion_date    133327 non-null  object \n",
      " 12  masking            137863 non-null  object \n",
      "dtypes: float64(1), object(12)\n",
      "memory usage: 15.2+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "94ade8af",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df[df['status'].isin(['COMPLETED', 'TERMINATED', 'WITHDRAWN'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "3991ecbd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "status\n",
       "COMPLETED     100970\n",
       "TERMINATED     15325\n",
       "WITHDRAWN       5221\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "93bba513",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.dropna(subset=['masking'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "d386c261",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.dropna(subset=['gender'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "11a2df30",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['start_date'] = pd.to_datetime(df['start_date'], errors='coerce')\n",
    "df['completion_date'] = pd.to_datetime(df['completion_date'], errors='coerce')\n",
    "df['duration'] = (df['completion_date'] - df['start_date']).dt.days\n",
    "df.drop(columns=['start_date', 'completion_date'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "id": "b6532ae2",
   "metadata": {},
   "outputs": [],
   "source": [
    "mean_enrollment = df['enrollment'].mean()\n",
    "mean_duration = df['duration'].mean()\n",
    "\n",
    "# Find rows where enrollment is NaN\n",
    "enrollment_na_mask = df['enrollment'].isna()\n",
    "\n",
    "# Fill enrollment NaNs with mean\n",
    "df.loc[enrollment_na_mask, 'enrollment'] = mean_enrollment\n",
    "\n",
    "# Overwrite enrollment_type to 'ESTIMATED' where enrollment was replaced\n",
    "df.loc[enrollment_na_mask, 'enrollment_type'] = 'ESTIMATED'\n",
    "\n",
    "# Fill duration NaNs with mean\n",
    "df['duration'] = df['duration'].fillna(mean_duration)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "7068f6fe",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['location'] = df['location'].fillna(\"other\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "1f46cf9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 117741 entries, 0 to 299998\n",
      "Data columns (total 12 columns):\n",
      " #   Column             Non-Null Count   Dtype  \n",
      "---  ------             --------------   -----  \n",
      " 0   phase              117741 non-null  object \n",
      " 1   condition          117741 non-null  object \n",
      " 2   intervention_type  117741 non-null  object \n",
      " 3   study_design       117741 non-null  object \n",
      " 4   sponsor_type       117741 non-null  object \n",
      " 5   enrollment         117741 non-null  float64\n",
      " 6   enrollment_type    112711 non-null  object \n",
      " 7   status             117741 non-null  object \n",
      " 8   gender             117741 non-null  object \n",
      " 9   location           117741 non-null  object \n",
      " 10  masking            117741 non-null  object \n",
      " 11  duration           117741 non-null  float64\n",
      "dtypes: float64(2), object(10)\n",
      "memory usage: 11.7+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "a732043a",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.loc[df['status']=='WITHDRAWN', 'status'] = 'TERMINATED'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "id": "4ac2b103",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"For_EDA.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "c8c2f9ed",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "status\n",
       "COMPLETED     97525\n",
       "TERMINATED    20216\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "7d0fee0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.preprocessing import LabelEncoder\n",
    "\n",
    "# Create a copy of df to store encoded data\n",
    "df_encoded = df.copy()\n",
    "\n",
    "# Columns to encode (excluding 'status', 'enrollment', and 'duration')\n",
    "cols_to_encode = [col for col in df.columns if col not in ['status', 'enrollment', 'duration']]\n",
    "\n",
    "# Store label encoders for each column\n",
    "label_encoders = {}\n",
    "\n",
    "for col in cols_to_encode:\n",
    "    le = LabelEncoder()\n",
    "    df_encoded[col] = le.fit_transform(df_encoded[col].astype(str))\n",
    "    label_encoders[col] = le"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_55345/3628498710.py:1: FutureWarning: A value is trying to be set on a copy of a DataFrame or Series through chained assignment using an inplace method.\n",
      "The behavior will change in pandas 3.0. This inplace method will never work because the intermediate object on which we are setting values always behaves as a copy.\n",
      "\n",
      "For example, when doing 'df[col].method(value, inplace=True)', try using 'df.method({col: value}, inplace=True)' or df[col] = df[col].method(value) instead, to perform the operation inplace on the original object.\n",
      "\n",
      "\n",
      "  df_encoded['status'].replace({'COMPLETED': 0, 'TERMINATED': 1}, inplace=True)\n",
      "/tmp/ipykernel_55345/3628498710.py:1: FutureWarning: Downcasting behavior in `replace` is deprecated and will be removed in a future version. To retain the old behavior, explicitly call `result.infer_objects(copy=False)`. To opt-in to the future behavior, set `pd.set_option('future.no_silent_downcasting', True)`\n",
      "  df_encoded['status'].replace({'COMPLETED': 0, 'TERMINATED': 1}, inplace=True)\n"
     ]
    }
   ],
   "source": [
    "df_encoded['status'].replace({'COMPLETED': 0, 'TERMINATED': 1}, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "fe808bc4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 117741 entries, 0 to 299998\n",
      "Data columns (total 12 columns):\n",
      " #   Column             Non-Null Count   Dtype  \n",
      "---  ------             --------------   -----  \n",
      " 0   phase              117741 non-null  int64  \n",
      " 1   condition          117741 non-null  int64  \n",
      " 2   intervention_type  117741 non-null  int64  \n",
      " 3   study_design       117741 non-null  int64  \n",
      " 4   sponsor_type       117741 non-null  int64  \n",
      " 5   enrollment         117741 non-null  float64\n",
      " 6   enrollment_type    117741 non-null  int64  \n",
      " 7   status             117741 non-null  int64  \n",
      " 8   gender             117741 non-null  int64  \n",
      " 9   location           117741 non-null  int64  \n",
      " 10  masking            117741 non-null  int64  \n",
      " 11  duration           117741 non-null  float64\n",
      "dtypes: float64(2), int64(10)\n",
      "memory usage: 11.7 MB\n"
     ]
    }
   ],
   "source": [
    "df_encoded.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_encoded.to_csv(\"Encoded_without_sampling.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "status\n",
       "0    97525\n",
       "1    20216\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_encoded['status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "fe1c9211",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.utils import resample\n",
    "\n",
    "# Separate majority and minority classes\n",
    "df_majority = df_encoded[df_encoded['status'] == 0]\n",
    "df_minority = df_encoded[df_encoded['status'] == 1]\n",
    "\n",
    "# Undersample majority class to 50000 samples\n",
    "df_majority_undersampled = resample(\n",
    "    df_majority,\n",
    "    replace=False,\n",
    "    n_samples=50000,\n",
    "    random_state=42\n",
    ")\n",
    "\n",
    "# Oversample minority class to 50000 samples\n",
    "df_minority_oversampled = resample(\n",
    "    df_minority,\n",
    "    replace=True,\n",
    "    n_samples=50000,\n",
    "    random_state=42\n",
    ")\n",
    "\n",
    "# Combine undersampled majority and oversampled minority\n",
    "df_balanced_sampled = pd.concat([df_majority_undersampled, df_minority_oversampled], ignore_index=True)\n",
    "\n",
    "# Shuffle the resulting dataframe\n",
    "df_balanced_sampled = df_balanced_sampled.sample(frac=1, random_state=42).reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "status\n",
       "1    50000\n",
       "0    50000\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_balanced_sampled['status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_balanced_sampled.to_csv(\"Encoded_sampled.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "8e0ad09c",
   "metadata": {},
   "outputs": [],
   "source": [
    "completed_sample = df[df['status'] == 'COMPLETED'].sample(n=20000, random_state=42)\n",
    "\n",
    "terminated_all = df[df['status'] == 'TERMINATED']\n",
    "withdrawn_all = df[df['status'] == 'WITHDRAWN']\n",
    "\n",
    "df_balanced = pd.concat([completed_sample, terminated_all, withdrawn_all], ignore_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "67c646fe",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_balanced['final_status'] = np.where(df_balanced['status'] == 'COMPLETED', 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "8e51674d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_balanced = df_balanced.drop('status', axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "b220cf25",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 40216 entries, 0 to 40215\n",
      "Data columns (total 12 columns):\n",
      " #   Column             Non-Null Count  Dtype  \n",
      "---  ------             --------------  -----  \n",
      " 0   phase              40216 non-null  object \n",
      " 1   condition          40216 non-null  object \n",
      " 2   intervention_type  40216 non-null  object \n",
      " 3   study_design       40216 non-null  object \n",
      " 4   sponsor_type       40216 non-null  object \n",
      " 5   enrollment         40216 non-null  float64\n",
      " 6   enrollment_type    38792 non-null  object \n",
      " 7   gender             40216 non-null  object \n",
      " 8   location           40216 non-null  object \n",
      " 9   masking            40216 non-null  object \n",
      " 10  duration           40216 non-null  float64\n",
      " 11  final_status       40216 non-null  int64  \n",
      "dtypes: float64(2), int64(1), object(9)\n",
      "memory usage: 3.7+ MB\n"
     ]
    }
   ],
   "source": [
    "df_balanced.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "c5e87d85",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mapping for column 'phase':\n",
      "  EARLY_PHASE1: 0\n",
      "  PHASE1: 1\n",
      "  PHASE1/PHASE2: 2\n",
      "  PHASE2: 3\n",
      "  PHASE2/PHASE3: 4\n",
      "  PHASE3: 5\n",
      "  PHASE4: 6\n",
      "\n",
      "Mapping for column 'condition':\n",
      "  \"Wet\" Age-Related Macular Degeneration: 0\n",
      "  - HIV: 1\n",
      "  - Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy): 2\n",
      "  11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),: 3\n",
      "  15q Duplication Syndrome: 4\n",
      "  2009 H1N1 Influenza: 5\n",
      "  22q11.2 Deletion Syndrome: 6\n",
      "  2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer: 7\n",
      "  3rd Line GIST: 8\n",
      "  50 % Reduction of Delayed Gastric Emptying: 9\n",
      "  714leukemia: 10\n",
      "  A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response: 11\n",
      "  ABSORPTION: 12\n",
      "  ACE Inhibitor Induced Angioedema: 13\n",
      "  ACE Inhibitor-associated Angioedema: 14\n",
      "  ACL - Anterior Cruciate Ligament Rupture: 15\n",
      "  ACL Repair: 16\n",
      "  ACL Surgery: 17\n",
      "  ACOS (Fixed Airflow Obstruction and Elevated Eosinophils): 18\n",
      "  ACUTE LEUKEMIA: 19\n",
      "  ACUTE MYELOGENOUS LEUKEMIA: 20\n",
      "  ADHD: 21\n",
      "  AIDS: 22\n",
      "  AIDS Dementia Complex: 23\n",
      "  AIDS Related Lymphoma: 24\n",
      "  AIDS Vaccines: 25\n",
      "  AIDS-Related Hodgkin Lymphoma: 26\n",
      "  AIDS-related Dementia Complex: 27\n",
      "  AIDS-related Diffuse Large Cell Lymphoma: 28\n",
      "  AIDS-related Kaposi Sarcoma: 29\n",
      "  AIDS-related Kaposi's Sarcoma: 30\n",
      "  AIDS-related Lymphoma: 31\n",
      "  AIDS-related Peripheral/Systemic Lymphoma: 32\n",
      "  AIS: 33\n",
      "  AL Amyloidosis: 34\n",
      "  ALK Fusion Protein Expression: 35\n",
      "  ALK Gene Mutation: 36\n",
      "  ALK Gene Translocation: 37\n",
      "  ALK or ROS1-positive NSCLC: 38\n",
      "  ALK+ Anaplastic Large Cell Lymphoma: 39\n",
      "  ALK-positive Advanced NSCLC: 40\n",
      "  ALK-positive Non-small Cell Lung Cancer: 41\n",
      "  ALK-positive Non-small Cell Lung Cancer (NSCLC): 42\n",
      "  ALL: 43\n",
      "  ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: 44\n",
      "  ALPS: 45\n",
      "  ALS: 46\n",
      "  ALS (Amyotrophic Lateral Sclerosis): 47\n",
      "  ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation: 48\n",
      "  AMD: 49\n",
      "  AMI: 50\n",
      "  AML: 51\n",
      "  AML - Acute Myeloid Leukemia: 52\n",
      "  AML Including AML de Novo and AML Secondary to MDS: 53\n",
      "  AML and High Risk MDS: 54\n",
      "  AML, Adult: 55\n",
      "  ANCA + Vasculitides Relapsing Either Under Corticosteroid: 56\n",
      "  ANCA Associated Systemic Vasculitis Including Wegener's: 57\n",
      "  ANCA-Associated Vasculitis: 58\n",
      "  ANCA-associated Vasculitides: 59\n",
      "  ANCA-associated Vasculitis: 60\n",
      "  ANTICALCULUS EFFICACY OF PYROPHOSPHATE IN HEAVY CALCULUS FORMERS: 61\n",
      "  ANTIPHOSPHOLIPID SYNDROME: 62\n",
      "  AOD Use, Abuse, and Dependence: 63\n",
      "  ARDS: 64\n",
      "  AS: 65\n",
      "  ASA Class I/II Patients Scheduled for Surgery Under General Anesthesia: 66\n",
      "  ASCVD: 67\n",
      "  ASTHMA: 68\n",
      "  ATM Gene Mutation: 69\n",
      "  ATRIAL FIBRILLATION: 70\n",
      "  ATRIAL FLUTTER: 71\n",
      "  ATTR-PN: 72\n",
      "  AV Fistula: 73\n",
      "  Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome: 74\n",
      "  Abdominal Abscess: 75\n",
      "  Abdominal Aortic Aneurysm: 76\n",
      "  Abdominal Aortic Aneurysm (AAA): 77\n",
      "  Abdominal Aortic Aneurysm Uncomplicated: 78\n",
      "  Abdominal Aortic Aneurysms: 79\n",
      "  Abdominal Body Contouring Surgery: 80\n",
      "  Abdominal Cancer: 81\n",
      "  Abdominal Discomfort: 82\n",
      "  Abdominal Hysterectomy (& Wertheim): 83\n",
      "  Abdominal Injuries: 84\n",
      "  Abdominal Injury: 85\n",
      "  Abdominal Neuroblastoma: 86\n",
      "  Abdominal Obesity: 87\n",
      "  Abdominal Obesity Metabolic Syndrome: 88\n",
      "  Abdominal Pain: 89\n",
      "  Abdominal Pain Upper: 90\n",
      "  Abdominal Surgery: 91\n",
      "  Abdominal Surgery Patients: 92\n",
      "  Abdominoplasty: 93\n",
      "  Ablation of Atrial Fibrillation: 94\n",
      "  Abnormal Respiratory Airway Resistance: 95\n",
      "  Abnormal Uterine Bleeding, Unspecified: 96\n",
      "  Abnormal Vaginal Flora: 97\n",
      "  Abortion: 98\n",
      "  Abortion Failure: 99\n",
      "  Abortion Second Trimester: 100\n",
      "  Abortion Seekers: 101\n",
      "  Abortion, Habitual: 102\n",
      "  Abortion, Induced: 103\n",
      "  Abortion, Legal: 104\n",
      "  Abortion, Missed: 105\n",
      "  Abortion, Second Trimester: 106\n",
      "  Abscess: 107\n",
      "  Abscess, Intra-Abdominal: 108\n",
      "  Abscesses: 109\n",
      "  Absolute Bioavailability: 110\n",
      "  Abuse Potential: 111\n",
      "  Abuse Potential Study: 112\n",
      "  Abuse of Anabolic Steroids: 113\n",
      "  Abuse, Drug: 114\n",
      "  Accelerated Phase Chronic Myelogenous Leukemia: 115\n",
      "  Accelerated Phase Chronic Myelogenous Leukemia (CML): 116\n",
      "  Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive: 117\n",
      "  Accelerated Phase of Disease: 118\n",
      "  Accelerating the Epithelialization of Split Thickness Skin Graft: 119\n",
      "  Accidental Fall From Bed: 120\n",
      "  Accidental Falls: 121\n",
      "  Accidents, Traffic: 122\n",
      "  Acellular Pertussis: 123\n",
      "  Acetaminophen Exposure: 124\n",
      "  Acetaminophen Overdose: 125\n",
      "  Acetaminophen Toxicity: 126\n",
      "  Achalasia: 127\n",
      "  Achilles Pain: 128\n",
      "  Achilles Tendinopathy: 129\n",
      "  Achromatopsia: 130\n",
      "  Acid Base Imbalance: 131\n",
      "  Acid Reflux: 132\n",
      "  Acid Sphingomyelinase Deficiency: 133\n",
      "  Acidosis, Renal Tubular: 134\n",
      "  Acinar Cell Adenocarcinoma of the Pancreas: 135\n",
      "  Acne: 136\n",
      "  Acne Keloidalis Nuchae: 137\n",
      "  Acne Scarring of the Face: 138\n",
      "  Acne Scars: 139\n",
      "  Acne Vulgaris: 140\n",
      "  Acneiform Rash: 141\n",
      "  Acquired Bleeding Disorder: 142\n",
      "  Acquired Brain Injury: 143\n",
      "  Acquired Deformities of Toe: 144\n",
      "  Acquired Esotropia: 145\n",
      "  Acquired Immune Deficiency Syndrome: 146\n",
      "  Acquired Immune Deficiency Syndrome (AIDS): 147\n",
      "  Acquired Immunodeficiency Syndrome: 148\n",
      "  Acquired Thrombotic Thrombocytopenic Purpura: 149\n",
      "  Acquired Tracheo-esophageal Fistula: 150\n",
      "  Acral Lentiginous Malignant Melanoma: 151\n",
      "  Acral Lentiginous Melanoma: 152\n",
      "  Acromegaly: 153\n",
      "  Actinic Cheilitis: 154\n",
      "  Actinic Keratoses: 155\n",
      "  Actinic Keratosis: 156\n",
      "  Actinic Keratosis (AK): 157\n",
      "  Activated PI3K-delta Syndrome: 158\n",
      "  Activated PI3Kdelta Syndrome (APDS); PASLI Disease: 159\n",
      "  Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis: 160\n",
      "  Active Chronic Graft Versus Host Disease: 161\n",
      "  Active Dermatomyositis: 162\n",
      "  Active Emergence From General Anesthesia: 163\n",
      "  Active Melanoma Brain Metastases: 164\n",
      "  Active Rheumatoid Arthritis: 165\n",
      "  Active Rheumatoid Arthritis; Rheumatoid Arthritis: 166\n",
      "  Active Systemic: 167\n",
      "  Active Systemic Lupus Erythematosus: 168\n",
      "  Active Ulcerative Colitis: 169\n",
      "  Acupuncture, Ear: 170\n",
      "  Acute ACE-induced Angioedema: 171\n",
      "  Acute Adenoviral Conjunctivitis: 172\n",
      "  Acute Agitated Patients: 173\n",
      "  Acute Agitation: 174\n",
      "  Acute Agitation, Behavioural Emergency: 175\n",
      "  Acute Alcoholic Hepatitis: 176\n",
      "  Acute Anterior Wall Myocardial Infarction: 177\n",
      "  Acute Antibody-Mediated Rejection (AMR): 178\n",
      "  Acute Appendicitis: 179\n",
      "  Acute Asthma: 180\n",
      "  Acute Bacterial Conjunctivitis: 181\n",
      "  Acute Bacterial Sinusitis: 182\n",
      "  Acute Bacterial Skin and Skin Structure Infections: 183\n",
      "  Acute Bilineal Leukemia: 184\n",
      "  Acute Biphenotypic Leukemia: 185\n",
      "  Acute Bipolar Mania: 186\n",
      "  Acute Bronchiolitis: 187\n",
      "  Acute Bronchitis: 188\n",
      "  Acute Cardiac Dysfunction: 189\n",
      "  Acute Cardiogenic Pulmonary Edema: 190\n",
      "  Acute Cellular Graft Rejection: 191\n",
      "  Acute Cerebrovascular Accident: 192\n",
      "  Acute Cervical Spinal Cord Injury: 193\n",
      "  Acute Chest Syndrome: 194\n",
      "  Acute Coronary Syndrome: 195\n",
      "  Acute Coronary Syndrome (ACS): 196\n",
      "  Acute Coronary Syndromes: 197\n",
      "  Acute Cough: 198\n",
      "  Acute Decompensated Heart Failure: 199\n",
      "  Acute Decompensated Heart Failure; Renal Dysfunction: 200\n",
      "  Acute Demylelinating Optic Neuritis: 201\n",
      "  Acute Dental Pain: 202\n",
      "  Acute Depression: 203\n",
      "  Acute Depressive Episode: 204\n",
      "  Acute Diarrhea: 205\n",
      "  Acute Diarrhoea: 206\n",
      "  Acute Diverticulitis: 207\n",
      "  Acute Ebola Virus Disease: 208\n",
      "  Acute Exacerbation of Chronic Bronchitis: 209\n",
      "  Acute Exacerbation of Remitting Relapsing Multiple Sclerosis: 210\n",
      "  Acute Falciparum Malaria: 211\n",
      "  Acute Fungal Otitis Externa: 212\n",
      "  Acute GVHD: 213\n",
      "  Acute Gastritis: 214\n",
      "  Acute Gastroenteritis: 215\n",
      "  Acute Gastrointestinal Graft vs Host Disease: 216\n",
      "  Acute Gout: 217\n",
      "  Acute Gouty Arthritis: 218\n",
      "  Acute Graft Versus Host Disease: 219\n",
      "  Acute Graft-Versus-Host Disease: 220\n",
      "  Acute Graft-versus-Host Disease: 221\n",
      "  Acute Graft-versus-host Disease: 222\n",
      "  Acute GvHD: 223\n",
      "  Acute HIV Infection: 224\n",
      "  Acute Heart Failure: 225\n",
      "  Acute Heart Failure (AHF): 226\n",
      "  Acute Hepatitis A: 227\n",
      "  Acute Herpes Zoster: 228\n",
      "  Acute Hypoxemic Respiratory Failure: 229\n",
      "  Acute Illness: 230\n",
      "  Acute Infection of Total Knee Replacement: 231\n",
      "  Acute Intermittent Porphyria: 232\n",
      "  Acute Intermittent Porphyria (AIP): 233\n",
      "  Acute Interstitial Nephritis: 234\n",
      "  Acute Ischaemic Middle Cerebral Artery Stroke: 235\n",
      "  Acute Ischaemic Stroke: 236\n",
      "  Acute Ischemic Stroke: 237\n",
      "  Acute Kidney Failure: 238\n",
      "  Acute Kidney Injury: 239\n",
      "  Acute Leukaemia: 240\n",
      "  Acute Leukemia: 241\n",
      "  Acute Leukemia (Category): 242\n",
      "  Acute Leukemia in Remission: 243\n",
      "  Acute Leukemia of Ambiguous Lineage: 244\n",
      "  Acute Leukemias of Ambiguous Lineage: 245\n",
      "  Acute Limb Ischemia: 246\n",
      "  Acute Liver Failure: 247\n",
      "  Acute Low Back Pain: 248\n",
      "  Acute Lower Respiratory Illness: 249\n",
      "  Acute Lumbago: 250\n",
      "  Acute Lung Injury: 251\n",
      "  Acute Lymphoblastic Leukaemia: 252\n",
      "  Acute Lymphoblastic Leukaemias (ALL): 253\n",
      "  Acute Lymphoblastic Leukemia: 254\n",
      "  Acute Lymphoblastic Leukemia (ALL): 255\n",
      "  Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL): 256\n",
      "  Acute Lymphoblastic Leukemia in Complete Remission: 257\n",
      "  Acute Lymphoblastic Leukemia in Remission: 258\n",
      "  Acute Lymphoblastic Leukemia, Adult B-Cell: 259\n",
      "  Acute Lymphoblastic Leukemia, in Relapse: 260\n",
      "  Acute Lymphocytic Leukaemia: 261\n",
      "  Acute Lymphocytic Leukemia: 262\n",
      "  Acute Lymphoid Leukemia: 263\n",
      "  Acute Lymphoid Leukemia (ALL): 264\n",
      "  Acute Lymphoid Leukemia Relapse: 265\n",
      "  Acute Mania: 266\n",
      "  Acute Migraine: 267\n",
      "  Acute Migraine With or Without Aura: 268\n",
      "  Acute Migraine With or Without Aura in Adolescents: 269\n",
      "  Acute Moderate to Severe Pain: 270\n",
      "  Acute Mountain Sickness: 271\n",
      "  Acute Muscle Pain: 272\n",
      "  Acute Myeloblastic Leukemia: 273\n",
      "  Acute Myelocytic Leukemia: 274\n",
      "  Acute Myelogenous Leukemia: 275\n",
      "  Acute Myelogenous Leukemia (AML): 276\n",
      "  Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors: 277\n",
      "  Acute Myelogenous Leukemia in Relapse: 278\n",
      "  Acute Myeloid Leukaemia: 279\n",
      "  Acute Myeloid Leukemia: 280\n",
      "  Acute Myeloid Leukemia (AML): 281\n",
      "  Acute Myeloid Leukemia (AML) Relapse: 282\n",
      "  Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults: 283\n",
      "  Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome: 284\n",
      "  Acute Myeloid Leukemia NOS: 285\n",
      "  Acute Myeloid Leukemia Post Cytotoxic Therapy: 286\n",
      "  Acute Myeloid Leukemia With FLT3/ITD Mutation: 287\n",
      "  Acute Myeloid Leukemia With Gene Mutations: 288\n",
      "  Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome: 289\n",
      "  Acute Myeloid Leukemia and Myelodysplastic Syndrome: 290\n",
      "  Acute Myeloid Leukemia in Remission: 291\n",
      "  Acute Myeloid Leukemia, Relapsed, Adult: 292\n",
      "  Acute Myeloid Leukemia, in Relapse: 293\n",
      "  Acute Myocardial Infarction: 294\n",
      "  Acute Myocardial Infarction (AMI): 295\n",
      "  Acute Myocardial Infarctus: 296\n",
      "  Acute Necrotizing Pancreatitis: 297\n",
      "  Acute Non-ST Elevation Myocardial Infarction: 298\n",
      "  Acute Noninfectious Posterior, Intermediate, or Pan Uveitis: 299\n",
      "  Acute Optic Neuritis: 300\n",
      "  Acute Otitis Externa: 301\n",
      "  Acute Otitis Media: 302\n",
      "  Acute Pain: 303\n",
      "  Acute Pain (Flare) Associated With Osteoarthritis (OA) of the Knee: 304\n",
      "  Acute Pain Due to Trauma: 305\n",
      "  Acute Pain From Ankle Sprain or Strain: 306\n",
      "  Acute Pain Management: 307\n",
      "  Acute Pain, Postoperative: 308\n",
      "  Acute Pancreatitis: 309\n",
      "  Acute Patella Tendon Rupture: 310\n",
      "  Acute Pericarditis: 311\n",
      "  Acute Phonotrauma: 312\n",
      "  Acute Porphyrias: 313\n",
      "  Acute Post-thoracotomy Pain: 314\n",
      "  Acute Postoperative Pain: 315\n",
      "  Acute Promyelocytic Leukemia: 316\n",
      "  Acute Pulmonary Edema: 317\n",
      "  Acute Pyelonephritis: 318\n",
      "  Acute Recurrent Pancreatitis: 319\n",
      "  Acute Rejection: 320\n",
      "  Acute Renal Failure: 321\n",
      "  Acute Respiratory Distress: 322\n",
      "  Acute Respiratory Distress Syndrome: 323\n",
      "  Acute Respiratory Distress Syndrome (ARDS): 324\n",
      "  Acute Respiratory Failure: 325\n",
      "  Acute Respiratory Failure With Hypoxia: 326\n",
      "  Acute Respiratory Infection: 327\n",
      "  Acute Respiratory Viral Infections: 328\n",
      "  Acute Rhinosinusitis: 329\n",
      "  Acute Ruptures of the Anterior Cruciate Ligament: 330\n",
      "  Acute ST Segment Elevation Myocardial Infarction: 331\n",
      "  Acute ST-elevation Myocardial Infarction: 332\n",
      "  Acute Schizophrenia: 333\n",
      "  Acute Spinal Cord Injury: 334\n",
      "  Acute Spinal Cord Injury.: 335\n",
      "  Acute Stress Reaction: 336\n",
      "  Acute Stroke: 337\n",
      "  Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery: 338\n",
      "  Acute Uncomplicated Pyelonephritis: 339\n",
      "  Acute Undifferentiated Leukemia: 340\n",
      "  Acute Upper Gastrointestinal Bleeding: 341\n",
      "  Acute Urticaria: 342\n",
      "  Acute Variceal Haemorrhage: 343\n",
      "  Acute on Chronic Hepatic Failure: 344\n",
      "  Acute, Non-traumatic Subarachnoid Hemorrhage: 345\n",
      "  Acute, Perforated Appendicitis: 346\n",
      "  Acute-On-Chronic Liver Failure: 347\n",
      "  Acute-onset Herpes Zoster Pain: 348\n",
      "  Addiction: 349\n",
      "  Addison Disease: 350\n",
      "  Addison's Disease: 351\n",
      "  Adenocarcinoma: 352\n",
      "  Adenocarcinoma Pancreas: 353\n",
      "  Adenocarcinoma of Colon: 354\n",
      "  Adenocarcinoma of Colon Recurrent: 355\n",
      "  Adenocarcinoma of Head of Pancreas: 356\n",
      "  Adenocarcinoma of Lung: 357\n",
      "  Adenocarcinoma of Lung Stage IIIB: 358\n",
      "  Adenocarcinoma of Pancreas: 359\n",
      "  Adenocarcinoma of Stomach or Esophagogastric Junction: 360\n",
      "  Adenocarcinoma of Unknown Primary: 361\n",
      "  Adenocarcinoma of the Bladder: 362\n",
      "  Adenocarcinoma of the Cervix: 363\n",
      "  Adenocarcinoma of the Colon: 364\n",
      "  Adenocarcinoma of the Endometrium: 365\n",
      "  Adenocarcinoma of the Esophagogastric Junction: 366\n",
      "  Adenocarcinoma of the Esophagus: 367\n",
      "  Adenocarcinoma of the Extrahepatic Bile Duct: 368\n",
      "  Adenocarcinoma of the Gallbladder: 369\n",
      "  Adenocarcinoma of the Gastroesophageal Junction: 370\n",
      "  Adenocarcinoma of the Lung: 371\n",
      "  Adenocarcinoma of the Pancreas: 372\n",
      "  Adenocarcinoma of the Prostate: 373\n",
      "  Adenocarcinoma of the Rectum: 374\n",
      "  Adenocarcinoma of the Stomach: 375\n",
      "  Adenocarcinoma,Stomach: 376\n",
      "  Adenocarcinomas of the Esophagogastric Junction: 377\n",
      "  Adenoid Cystic Carcinoma: 378\n",
      "  Adenoma: 379\n",
      "  Adenoma, Pleomorphic: 380\n",
      "  Adenomatous Polyp: 381\n",
      "  Adenomatous Polyposis Coli: 382\n",
      "  Adenomatous Polyps: 383\n",
      "  Adenomyosis: 384\n",
      "  Adenosine Deaminase Deficiency: 385\n",
      "  Adenosquamous Cell Lung Cancer: 386\n",
      "  Adenotonsillar Hypertrophy: 387\n",
      "  Adenotonsillectomy: 388\n",
      "  Adenoviral Conjunctivitis: 389\n",
      "  Adenoviral Infection: 390\n",
      "  Adenovirus: 391\n",
      "  Adenovirus Infection: 392\n",
      "  Adenylosuccinate Lyase Deficiency: 393\n",
      "  Adherence: 394\n",
      "  Adherence, Medication: 395\n",
      "  Adhesion Formation After Primary Cesarean Delivery: 396\n",
      "  Adhesions: 397\n",
      "  Adhesive Capsulitis: 398\n",
      "  Adipose Tissue Atrophy: 399\n",
      "  Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts): 400\n",
      "  Adjustment Disorders: 401\n",
      "  Adjuvant Chemotherapy: 402\n",
      "  Administration Related Reaction: 403\n",
      "  Adolescence: 404\n",
      "  Adolescent Behavior: 405\n",
      "  Adolescent Behaviour: 406\n",
      "  Adolescent Cannabis Use Disorder: 407\n",
      "  Adolescent Idiopathic Scoliosis: 408\n",
      "  Adolescent Problem Behavior at School: 409\n",
      "  Adolescent Schizophrenia: 410\n",
      "  Adrenal Gland Diseases: 411\n",
      "  Adrenal Insufficiency: 412\n",
      "  Adrenal Neoplasia: 413\n",
      "  Adrenal Tumors: 414\n",
      "  Adrenocortical Carcinoma: 415\n",
      "  Adrenoleukodystrophy: 416\n",
      "  Adrenomyeloneuropathy: 417\n",
      "  Adult Acquired Flatfoot: 418\n",
      "  Adult Acute Basophilic Leukemia: 419\n",
      "  Adult Acute Erythroid Leukemia (M6): 420\n",
      "  Adult Acute Lymphoblastic Leukemia in Remission: 421\n",
      "  Adult Acute Lymphocytic Leukemia: 422\n",
      "  Adult Acute Lymphocytic Leukemia T-cell: 423\n",
      "  Adult Acute Megakaryoblastic Leukemia (M7): 424\n",
      "  Adult Acute Minimally Differentiated Myeloid Leukemia (M0): 425\n",
      "  Adult Acute Myeloid Leukemia: 426\n",
      "  Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities: 427\n",
      "  Adult Acute Myeloid Leukemia With Inv(16)(p13;q22): 428\n",
      "  Adult Acute Myeloid Leukemia in Remission: 429\n",
      "  Adult Alveolar Soft Part Sarcoma: 430\n",
      "  Adult Anaplastic Astrocytoma: 431\n",
      "  Adult Anaplastic Oligodendroglioma: 432\n",
      "  Adult Attention-Deficit Hyperactivity Disorder: 433\n",
      "  Adult Attention-deficit Hyperactivity Disorder (ADHD): 434\n",
      "  Adult B Acute Lymphoblastic Leukemia: 435\n",
      "  Adult Brain Glioblastoma: 436\n",
      "  Adult Brain Tumor: 437\n",
      "  Adult Brain Tumors: 438\n",
      "  Adult Central Nervous System Germ Cell Tumor: 439\n",
      "  Adult Cerebral Palsy: 440\n",
      "  Adult Cholangiocarcinoma: 441\n",
      "  Adult Diffuse Large B-Cell Lymphoma: 442\n",
      "  Adult Giant Cell Glioblastoma: 443\n",
      "  Adult Glioblastoma: 444\n",
      "  Adult Grade III Lymphomatoid Granulomatosis: 445\n",
      "  Adult Growth Hormone Deficiency: 446\n",
      "  Adult Growth Hormone Deficiency (AGHD): 447\n",
      "  Adult Hepatocellular Carcinoma: 448\n",
      "  Adult Hodgkin Lymphoma: 449\n",
      "  Adult Intracranial Neoplasm: 450\n",
      "  Adult Liposarcoma: 451\n",
      "  Adult Liver Carcinoma: 452\n",
      "  Adult Lymphocyte Depletion Hodgkin Lymphoma: 453\n",
      "  Adult Myelodysplastic Syndrome: 454\n",
      "  Adult Nasal Type Extranodal NK/T-cell Lymphoma: 455\n",
      "  Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma: 456\n",
      "  Adult Non-Hodgkin Lymphoma: 457\n",
      "  Adult Patients Scheduled for 3rd Molar Teeth Extractions: 458\n",
      "  Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma: 459\n",
      "  Adult Periodontitis: 460\n",
      "  Adult Primary Cholangiocellular Carcinoma: 461\n",
      "  Adult Primary Hepatocellular Carcinoma: 462\n",
      "  Adult Refractory Complex Partial Seizures: 463\n",
      "  Adult Soft Tissue Sarcoma: 464\n",
      "  Adult Solid Neoplasm: 465\n",
      "  Adult Solid Tumor: 466\n",
      "  Adult Spinal Cord Neoplasm: 467\n",
      "  Adult Spinal Deformity: 468\n",
      "  Adult Synovial Sarcoma: 469\n",
      "  Adult T Cell Leukemia: 470\n",
      "  Adult T-Cell Leukemia and Lymphoma (ATL): 471\n",
      "  Adult-Onset Still´s Disease: 472\n",
      "  Adults With Glioblastoma Multiforma: 473\n",
      "  Advance Care Planning: 474\n",
      "  Advanced Adenocarcinoma of the Colon or Rectum: 475\n",
      "  Advanced Adult Hepatocellular Carcinoma: 476\n",
      "  Advanced Adult Primary Liver Cancer: 477\n",
      "  Advanced Age-related Macular Degeneration: 478\n",
      "  Advanced B-cell Lymphoid Malignancies: 479\n",
      "  Advanced BRAF-mutant Cancers: 480\n",
      "  Advanced BRAFV600 Wild-type Melanoma: 481\n",
      "  Advanced Biliary Tract Cancer: 482\n",
      "  Advanced Bladder Urothelial Carcinoma: 483\n",
      "  Advanced Breast Cancer: 484\n",
      "  Advanced Breast Cancer (Parts 1 and 2): 485\n",
      "  Advanced Breast Carcinoma: 486\n",
      "  Advanced Bulky Malignancies: 487\n",
      "  Advanced Cancer: 488\n",
      "  Advanced Cancer Entities: 489\n",
      "  Advanced Cancer, Various, NOS: 490\n",
      "  Advanced Cancers: 491\n",
      "  Advanced Cancers Associated With Mesothelin Expression: 492\n",
      "  Advanced Carcinoma: 493\n",
      "  Advanced Castrate-resistant Prostate Cancer CRPC: 494\n",
      "  Advanced Cervical Adenocarcinoma: 495\n",
      "  Advanced Cholangiocarcinoma: 496\n",
      "  Advanced Chronic Heart Failure: 497\n",
      "  Advanced Chronic Liver Disease: 498\n",
      "  Advanced Clear Cell Renal Carcinoma: 499\n",
      "  Advanced Clear Cell Renal Cell Carcinoma: 500\n",
      "  Advanced Colorectal Adenomas: 501\n",
      "  Advanced Colorectal Cancer: 502\n",
      "  Advanced Cutaneous Melanoma of the Extremity: 503\n",
      "  Advanced Desmoid Tumor: 504\n",
      "  Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC: 505\n",
      "  Advanced Endometrial Adenocarcinoma, Stage III A, B, C: 506\n",
      "  Advanced Endstage Solid Carcinomas in Adults: 507\n",
      "  Advanced Esophageal Cancers: 508\n",
      "  Advanced Estrogen Receptor Positive HER2- Breast Cancer: 509\n",
      "  Advanced Follicular Lymphoma: 510\n",
      "  Advanced GI Cancer: 511\n",
      "  Advanced Gastric Adenocarcinoma: 512\n",
      "  Advanced Gastric Cancer: 513\n",
      "  Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: 514\n",
      "  Advanced Gastrointestinal (GI) Malignancies: 515\n",
      "  Advanced Gastrointestinal Cancer: 516\n",
      "  Advanced Gastrointestinal Carcinoma: 517\n",
      "  Advanced Gastrointestinal Stromal Tumors: 518\n",
      "  Advanced Glioblastoma: 519\n",
      "  Advanced Gynecological Cancers: 520\n",
      "  Advanced HER2-positive Breast Cancer: 521\n",
      "  Advanced Head and Neck Carcinoma: 522\n",
      "  Advanced Head and Neck Squamous Cell Carcinoma: 523\n",
      "  Advanced Hematologic Malignancies: 524\n",
      "  Advanced Hepatocellular Carcinoma: 525\n",
      "  Advanced Hepatocellular Carcinoma (HCC): 526\n",
      "  Advanced Hepatocellular Carcinoma With c-MET Dysregulation: 527\n",
      "  Advanced Idiopathic Parkinson's Disease: 528\n",
      "  Advanced Illness Patients With Opioid Induced Constipation: 529\n",
      "  Advanced Intra-Ocular Retinoblastoma: 530\n",
      "  Advanced Kidney Cancer: 531\n",
      "  Advanced Liver Cancer: 532\n",
      "  Advanced Lung Cancer: 533\n",
      "  Advanced Malignancies: 534\n",
      "  Advanced Malignancies, Non-small Cell Lung Cancer: 535\n",
      "  Advanced Malignancy: 536\n",
      "  Advanced Malignant Mesothelioma: 537\n",
      "  Advanced Malignant Neoplasm: 538\n",
      "  Advanced Malignant Pleural Mesothelioma: 539\n",
      "  Advanced Malignant Solid Neoplasm: 540\n",
      "  Advanced Malignant Solid Tumors: 541\n",
      "  Advanced Melanoma: 542\n",
      "  Advanced Melanoma and Normal or Impaired: 543\n",
      "  Advanced Metastatic Breast Cancer: 544\n",
      "  Advanced Metastatic Paraganglioma: 545\n",
      "  Advanced NSCLC Patients With T790M: 546\n",
      "  Advanced Non Small Cell Lung Cancer: 547\n",
      "  Advanced Non Small Cell Lung Cancer (NSCLC): 548\n",
      "  Advanced Non-Central Nervous System (CNS) Malignancies: 549\n",
      "  Advanced Non-Clear Cell Kidney Cancer: 550\n",
      "  Advanced Non-Hematologic Malignancies: 551\n",
      "  Advanced Non-Small Cell Lung Cancer: 552\n",
      "  Advanced Non-Small Cell Lung Carcinoma: 553\n",
      "  Advanced Non-small Cell Lung Cancer: 554\n",
      "  Advanced Non-squamous NSCLC: 555\n",
      "  Advanced Non-squamous Non-small-cell Lung Cancer: 556\n",
      "  Advanced Nonhematologic Malignancies: 557\n",
      "  Advanced Nonhematological Malignancies: 558\n",
      "  Advanced Nonhematological Neoplasms: 559\n",
      "  Advanced Ovarian Cancer: 560\n",
      "  Advanced Ovarian Carcinoma: 561\n",
      "  Advanced PD-L1 Positive Malignancies: 562\n",
      "  Advanced Pancreatic Adenocarcinoma: 563\n",
      "  Advanced Pancreatic Cancer: 564\n",
      "  Advanced Pancreatic Neuroendocrine Tumor: 565\n",
      "  Advanced Parkinson's Disease: 566\n",
      "  Advanced Pleural Malignant Mesothelioma: 567\n",
      "  Advanced Primary Liver Cancer: 568\n",
      "  Advanced Prostate Cancer: 569\n",
      "  Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma: 570\n",
      "  Advanced Refractory Solid Tumors: 571\n",
      "  Advanced Renal Cell Carcinoma: 572\n",
      "  Advanced Sarcoma: 573\n",
      "  Advanced Soft Tissue Sarcoma: 574\n",
      "  Advanced Solid Cancer: 575\n",
      "  Advanced Solid Cancers: 576\n",
      "  Advanced Solid Malignancies: 577\n",
      "  Advanced Solid Malignant Tumors: 578\n",
      "  Advanced Solid Metastatic Tumor: 579\n",
      "  Advanced Solid Neoplasm: 580\n",
      "  Advanced Solid Neoplasms: 581\n",
      "  Advanced Solid Tumor: 582\n",
      "  Advanced Solid Tumor Malignancy: 583\n",
      "  Advanced Solid Tumors: 584\n",
      "  Advanced Solid Tumors Cancer: 585\n",
      "  Advanced Solid Tumors With HER2 Abnormalities: 586\n",
      "  Advanced Solid Tumors With and Without Brain Metastases: 587\n",
      "  Advanced Solid Tumors, Excluding Breast Cancer: 588\n",
      "  Advanced Solid Tumours: 589\n",
      "  Advanced Squamous Cell Carcinoma: 590\n",
      "  Advanced Squamous Non-Small Cell Lung Cancer: 591\n",
      "  Advanced Stage Non-small Cell Lung Cancer: 592\n",
      "  Advanced Stage Parkinson's Disease: 593\n",
      "  Advanced Tumor: 594\n",
      "  Advanced Unresectable Pancreatic Cancer: 595\n",
      "  Advanced Unresectable Solid Tumors: 596\n",
      "  Advanced Urothelial Carcinoma: 597\n",
      "  Advanced and Metastatic Breast Cancer: 598\n",
      "  Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma: 599\n",
      "  Advanced and Metastatic Solid Tumor: 600\n",
      "  Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma: 601\n",
      "  Advanced or Metastatic Biliary Tract Cancer: 602\n",
      "  Advanced or Metastatic Breast Cancer: 603\n",
      "  Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct: 604\n",
      "  Advanced or Metastatic ER+ Breast Cancer: 605\n",
      "  Advanced or Metastatic HCC: 606\n",
      "  Advanced or Metastatic Melanoma: 607\n",
      "  Advanced or Metastatic Merkel Cell Carcinoma: 608\n",
      "  Advanced or Metastatic Pancreatic Adenocarcinoma: 609\n",
      "  Advanced or Metastatic Solid Tumor: 610\n",
      "  Advanced or Metastatic Solid Tumors: 611\n",
      "  Advanced or Recurrent Esophageal Squamous Cell Carcinoma: 612\n",
      "  Advanced or Recurrent Solid Tumors: 613\n",
      "  Advanced or Refractory Leukemia: 614\n",
      "  Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma: 615\n",
      "  Advanced or Unresectable Melanoma Progressing After PD1 Blockade: 616\n",
      "  Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers: 617\n",
      "  Advanced/Metastatic Solid Tumors: 618\n",
      "  Advanced/Metastatic Solid Tumors or Lymphomas: 619\n",
      "  Adverse Anesthesia Outcome: 620\n",
      "  Adverse Effect of Antithrombotic Drugs: 621\n",
      "  Adverse Effects: 622\n",
      "  Adverse Reaction to Antiplatelet Agent: 623\n",
      "  Adverse Reaction to Diagnostic Agents and Kits Nos: 624\n",
      "  Adverse Reaction to Other Drugs and Medicines: 625\n",
      "  Affective Disorders, Psychotic: 626\n",
      "  Affective Psychosis, Bipolar: 627\n",
      "  Afibrinogenemia: 628\n",
      "  Agammaglobulinemia: 629\n",
      "  Age Related Macular Degeneration: 630\n",
      "  Age Related Macular Degeneration (AMD): 631\n",
      "  Age-Related Hearing Loss: 632\n",
      "  Age-Related Macular Degeneration: 633\n",
      "  Age-Related Macular Degeneration (AMD): 634\n",
      "  Age-Related Maculopathy: 635\n",
      "  Age-Related Memory Disorders: 636\n",
      "  Age-associated Muscle Loss: 637\n",
      "  Age-related Macular Degeneration: 638\n",
      "  Age-related Macular Degeneration (AMD): 639\n",
      "  Aged: 640\n",
      "  Ageing: 641\n",
      "  Aggression: 642\n",
      "  Aggressive Behavior: 643\n",
      "  Aggressive Lymphoma: 644\n",
      "  Aggressive Periodontitis: 645\n",
      "  Aggressive Periodontitis, Generalized: 646\n",
      "  Aggressive Systemic Mastocytosis: 647\n",
      "  Aging: 648\n",
      "  Aging Frailty: 649\n",
      "  Aging Problems: 650\n",
      "  Agitation: 651\n",
      "  Agitation Associated With Dementia of the Alzheimer's Type: 652\n",
      "  Agitation and Aggression in Alzheimer's Disease: 653\n",
      "  Agitation in Dementia, Including Alzheimer's Disease: 654\n",
      "  Agitation in Patients With Dementia of the Alzheimer's Type: 655\n",
      "  Agitation,Psychomotor: 656\n",
      "  Agoraphobia: 657\n",
      "  Aicardi Goutières Syndrome: 658\n",
      "  Aids, Cdc Group I: 659\n",
      "  Airway Inflammation: 660\n",
      "  Airway Remodeling: 661\n",
      "  Akathisia, Drug-Induced: 662\n",
      "  Alagille Syndrome: 663\n",
      "  Albinism: 664\n",
      "  Alcohol Abuse: 665\n",
      "  Alcohol Abuse, Nervous System: 666\n",
      "  Alcohol Addiction: 667\n",
      "  Alcohol Consumption: 668\n",
      "  Alcohol Craving: 669\n",
      "  Alcohol Dependence: 670\n",
      "  Alcohol Dependence, in Remission: 671\n",
      "  Alcohol Drinking: 672\n",
      "  Alcohol Sensitivity: 673\n",
      "  Alcohol Use: 674\n",
      "  Alcohol Use Disorder: 675\n",
      "  Alcohol Use Disorder (AUD): 676\n",
      "  Alcohol Use Disorders: 677\n",
      "  Alcohol Withdrawal: 678\n",
      "  Alcohol Withdrawal Delirium: 679\n",
      "  Alcohol Withdrawal Syndrome: 680\n",
      "  Alcohol Withdrawal Syndrome(AWS): 681\n",
      "  Alcohol-Related Disorders: 682\n",
      "  Alcohol-induced Cue-craving: 683\n",
      "  Alcoholic Cirrhosis: 684\n",
      "  Alcoholic Hepatitis: 685\n",
      "  Alcoholic Hepatitis (AH): 686\n",
      "  Alcoholic Liver Disease: 687\n",
      "  Alcoholism: 688\n",
      "  Alcoholism,: 689\n",
      "  Alcohols: 690\n",
      "  Alive and Viable Births: 691\n",
      "  Alkaptonuria: 692\n",
      "  All Solid Tumors: 693\n",
      "  All-comer: 694\n",
      "  Allan-Herndon-Dudley Syndrome: 695\n",
      "  Allergen Immunotherapy in Elderly Patients: 696\n",
      "  Allergens: 697\n",
      "  Allergic Asthma: 698\n",
      "  Allergic Asthma Due to Dermatophagoides Farinae: 699\n",
      "  Allergic Bronchopulmonary Aspergillosis: 700\n",
      "  Allergic Conjunctivitis: 701\n",
      "  Allergic Contact Dermatitis: 702\n",
      "  Allergic Reactions: 703\n",
      "  Allergic Rhinitis: 704\n",
      "  Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata: 705\n",
      "  Allergic Rhinitis Due to Dust Mite: 706\n",
      "  Allergic Rhinitis Due to Tree Pollen: 707\n",
      "  Allergic Rhinoconjunctivitis: 708\n",
      "  Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen: 709\n",
      "  Allergies: 710\n",
      "  Allergy: 711\n",
      "  Allergy Dermatophagoides Pteronyssinus: 712\n",
      "  Allergy Induced Asthma: 713\n",
      "  Allergy and Immunology: 714\n",
      "  Allergy to Cat Dander: 715\n",
      "  Allergy to Tree Pollen: 716\n",
      "  Allergy;Food: 717\n",
      "  Allogeneic Haplo-Stem Cell Transplatation (SCT): 718\n",
      "  Allogeneic Hematopoietic Cell Transplantation (HCT): 719\n",
      "  Allogeneic Hematopoietic Stem Cell Transplantation: 720\n",
      "  Allogeneic Hematopoietic Stem Cell Transplantation Recipient: 721\n",
      "  Allogeneic Stem Cell Transplant: 722\n",
      "  Allogeneic Stem Cell Transplantation: 723\n",
      "  Allogeneic Transplantation (Non T-cell Depleted): 724\n",
      "  Allograft Rejection: 725\n",
      "  Alopecia: 726\n",
      "  Alopecia Areata: 727\n",
      "  Alopecia Totalis: 728\n",
      "  Alopecia Totalis/Universalis: 729\n",
      "  Alopecia Universalis (AU): 730\n",
      "  Alpha 1-Antitrypsin Deficiency: 731\n",
      "  Alpha Thalassemia Major: 732\n",
      "  Alpha-1 Antitrypsin Deficiency: 733\n",
      "  Alpha-1-antitrypsin Deficiency: 734\n",
      "  Alpha1-antitrypsin Deficiency: 735\n",
      "  Alport Syndrome: 736\n",
      "  Alström Syndrome: 737\n",
      "  Altered Mental Status: 738\n",
      "  Altitude Sickness: 739\n",
      "  Alveolar Bone Atrophy: 740\n",
      "  Alveolar Bone Loss: 741\n",
      "  Alveolar Bone Loss, Chronic Periodontitis, Lovestatin Gel, Regeneration: 742\n",
      "  Alveolar Childhood Rhabdomyosarcoma: 743\n",
      "  Alveolar Soft Part Sarcoma: 744\n",
      "  Alzheimer Dementia: 745\n",
      "  Alzheimer Disease: 746\n",
      "  Alzheimer Disease (AD): 747\n",
      "  Alzheimer's Dementia: 748\n",
      "  Alzheimer's Disease: 749\n",
      "  Alzheimer's Disease (AD): 750\n",
      "  Alzheimer's Type Dementia: 751\n",
      "  Alzheimers Disease: 752\n",
      "  Alzheimer´s Disease: 753\n",
      "  Amatoxin Poisoning: 754\n",
      "  Amblyopia: 755\n",
      "  Ambulatory IPF: 756\n",
      "  Ambulatory Plastic Surgery: 757\n",
      "  Ambulatory Surgery: 758\n",
      "  Ameliorating Oxidative Stress in Type 1 Diabetes: 759\n",
      "  Amenorrhea: 760\n",
      "  Amino Acid Metabolism, Inborn Errors: 761\n",
      "  Amnesia: 762\n",
      "  Amnestic Mild Cognitive Impairment: 763\n",
      "  Amniotic Problems: 764\n",
      "  Amount of NKTR-118 in Blood: 765\n",
      "  Amphetamine Addiction: 766\n",
      "  Amphetamine Dependence: 767\n",
      "  Amphetamine-Related Disorders: 768\n",
      "  Ampulla of Vater Adenocarcinoma: 769\n",
      "  Amputation: 770\n",
      "  Amputation of Lower Limb: 771\n",
      "  Amputation, Traumatic: 772\n",
      "  Amyloid Beta Protein: 773\n",
      "  Amyloidogenic Transthyretin (ATTR) Amyloidosis: 774\n",
      "  Amyloidosis: 775\n",
      "  Amyloidosis; Heart (Manifestation): 776\n",
      "  Amyloidosis; Systemic: 777\n",
      "  Amyotrophic Lateral Sclerosis: 778\n",
      "  Amyotrophic Lateral Sclerosis (ALS): 779\n",
      "  Anaemia: 780\n",
      "  Anaesthesia: 781\n",
      "  Anaesthetic Induction: 782\n",
      "  Anakinra: 783\n",
      "  Anal Canal Cancer.: 784\n",
      "  Anal Cancer: 785\n",
      "  Anal Chlamydia Infection: 786\n",
      "  Anal Dysplasia: 787\n",
      "  Anal Fissure: 788\n",
      "  Anal Fistula: 789\n",
      "  Anal Fistulas: 790\n",
      "  Analgesia: 791\n",
      "  Analgesia Disorder: 792\n",
      "  Analgesia Duration: 793\n",
      "  Analgesia in Total Knee Arthroplasty: 794\n",
      "  Analgesia, Obstetrical: 795\n",
      "  Analgesia, Postoperative: 796\n",
      "  Analgesic Adverse Reaction: 797\n",
      "  Analgesic Affect: 798\n",
      "  Analgesic Allergy: 799\n",
      "  Analgesic Effects: 800\n",
      "  Anaphylaxis: 801\n",
      "  Anaplastic Astrocytoma: 802\n",
      "  Anaplastic Astrocytomas: 803\n",
      "  Anaplastic Ependymoma: 804\n",
      "  Anaplastic Glioma: 805\n",
      "  Anaplastic Large Cell Lymphoma: 806\n",
      "  Anaplastic Large Cell Lymphoma, ALK-Positive: 807\n",
      "  Anaplastic Large-Cell Lymphoma: 808\n",
      "  Anaplastic Thyroid Cancer: 809\n",
      "  Anaplastic Thyroid Cancers: 810\n",
      "  Anastomotic Leak: 811\n",
      "  Anastomotic Stricture: 812\n",
      "  Anatomic Stage 0 Breast Cancer AJCC v8: 813\n",
      "  Anatomic Stage I Breast Cancer AJCC v8: 814\n",
      "  Anatomic Stage IIB Breast Cancer AJCC v8: 815\n",
      "  Anatomic Stage IV Breast Cancer AJCC v8: 816\n",
      "  Andersen-Tawil Syndrome: 817\n",
      "  Androgen-insensitive Prostate Cancer: 818\n",
      "  Androgenetic Alopecia: 819\n",
      "  Androgens (Deficiency): 820\n",
      "  Anemia: 821\n",
      "  Anemia in Chronic Kidney Disease: 822\n",
      "  Anemia in Chronic Kidney Disease Patients Not on Dialysis: 823\n",
      "  Anemia in Chronic Kidney Disease in Non-dialysis Patients: 824\n",
      "  Anemia in Pre-Dialysis Patients: 825\n",
      "  Anemia of Chronic Disease: 826\n",
      "  Anemia of Chronic Kidney Disease: 827\n",
      "  Anemia of End Stage Renal Disease: 828\n",
      "  Anemia, Aplastic: 829\n",
      "  Anemia, Iron Deficiency: 830\n",
      "  Anemia, Iron-Deficiency: 831\n",
      "  Anemia, Sickle Cell: 832\n",
      "  Anemic, Critically Ill Patients: 833\n",
      "  Anesthesia: 834\n",
      "  Anesthesia Intubation Complication: 835\n",
      "  Anesthesia Recovery Period: 836\n",
      "  Anesthesia, Caudal: 837\n",
      "  Anesthesia, Dental: 838\n",
      "  Anesthesia, Endotracheal: 839\n",
      "  Anesthesia, General: 840\n",
      "  Anesthesia, Local: 841\n",
      "  Anesthesia, Pediatrics, Surgery: 842\n",
      "  Anesthesia, Recovery Period: 843\n",
      "  Anesthesia, Regional: 844\n",
      "  Anesthesia; Adverse Effect, Spinal and Epidural: 845\n",
      "  Anesthesia; Functional: 846\n",
      "  Anesthetic Effectiveness: 847\n",
      "  Anesthetic, Sedative or Analgesic Complications in Labor or Delivery: 848\n",
      "  Anesthetics: 849\n",
      "  Anesthetics, Intravenous: 850\n",
      "  Aneurysm: 851\n",
      "  Aneurysm, Dissecting: 852\n",
      "  Aneurysmal Subarachnoid Hemorrhage: 853\n",
      "  Aneurysms: 854\n",
      "  Anger: 855\n",
      "  Angina: 856\n",
      "  Angina Pectoris: 857\n",
      "  Angina Pectoris, Variant: 858\n",
      "  Angina, Stable: 859\n",
      "  Angina, Unstable: 860\n",
      "  Angiofibroma of Face: 861\n",
      "  Angioid Streaks: 862\n",
      "  Angioimmunoblastic T-cell Lymphoma: 863\n",
      "  Angioneurotic Edema: 864\n",
      "  Angioplasty: 865\n",
      "  Angioplasty, Transluminal, Percutaneous Coronary: 866\n",
      "  Angiosarcoma: 867\n",
      "  Angiosarcomas: 868\n",
      "  Angiotensin Converting Enzyme Inhibitor Induced Angioedema: 869\n",
      "  Angle-closure Glaucoma: 870\n",
      "  Anisometropia: 871\n",
      "  Ankle Fracture in Need of Surgical Fixation: 872\n",
      "  Ankle Fractures: 873\n",
      "  Ankle Injuries: 874\n",
      "  Ankle Sprain: 875\n",
      "  Ankle Sprains: 876\n",
      "  Ankylosing Spondylitis: 877\n",
      "  Ann Arbor Stage I Grade 1 Follicular Lymphoma: 878\n",
      "  Ann Arbor Stage I Mantle Cell Lymphoma: 879\n",
      "  Ann Arbor Stage II Follicular Lymphoma: 880\n",
      "  Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma: 881\n",
      "  Anogenital Human Papilloma Virus Infection: 882\n",
      "  Anogenital Warts: 883\n",
      "  Anorectal Abscess: 884\n",
      "  Anorectal Surgeries: 885\n",
      "  Anorexia: 886\n",
      "  Anorexia Nervosa: 887\n",
      "  Anosmia: 888\n",
      "  Anovulation: 889\n",
      "  Anterior Acute Myocardial Infarction: 890\n",
      "  Anterior Cervical Discectomy and Fusion (ACDF): 891\n",
      "  Anterior Cruciate Ligament: 892\n",
      "  Anterior Cruciate Ligament Injury: 893\n",
      "  Anterior Cruciate Ligament Reconstruction: 894\n",
      "  Anterior Cruciate Ligament Tear: 895\n",
      "  Anterior Ischemic Optic Neuropathy: 896\n",
      "  Anterior Myocardial Infarction: 897\n",
      "  Anterior Urethral Cancer: 898\n",
      "  Anterior Uveitis: 899\n",
      "  Anthrax: 900\n",
      "  Anti Aging: 901\n",
      "  Anti Obesity Agent: 902\n",
      "  Anti-Infective Agents: 903\n",
      "  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: 904\n",
      "  Anti-Xa Activity: 905\n",
      "  Anti-p53 TCR-Gene: 906\n",
      "  Anti-r-HuEpo Associated PRCA Subjects: 907\n",
      "  Antibiotic Associated Diarrhea: 908\n",
      "  Antibiotic Resistant Strain: 909\n",
      "  Antibiotic Side Effect: 910\n",
      "  Antibiotic Therapy: 911\n",
      "  Antibiotic-Associated Diarrhea: 912\n",
      "  Antibiotic-associated Diarrhea: 913\n",
      "  Antibiotic-associated Diarrhoea: 914\n",
      "  Antibiotics: 915\n",
      "  Antibody Mediated Rejection: 916\n",
      "  Antibody-mediated Rejection: 917\n",
      "  Anticoagulant Reversal: 918\n",
      "  Anticoagulant Therapy: 919\n",
      "  Anticoagulants: 920\n",
      "  Anticoagulants and Bleeding Disorders: 921\n",
      "  Anticoagulation in Pregnancy: 922\n",
      "  Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents: 923\n",
      "  Antimicrobial Agent: 924\n",
      "  Antimicrobial Effect: 925\n",
      "  Antimicrobial Prophylaxis: 926\n",
      "  Antineoplastic Chemotherapy Induced Anemia: 927\n",
      "  Antiphospholipid (aPL)-Positive: 928\n",
      "  Antiphospholipid Syndrome: 929\n",
      "  Antiphospholipid Syndrome in Pregnancy: 930\n",
      "  Antiplatelet Drugs: 931\n",
      "  Antipsychotics Weight Gain: 932\n",
      "  Antithrombin Deficiency Type 2: 933\n",
      "  Antithrombin III Deficiency: 934\n",
      "  Antithrombotic: 935\n",
      "  Antitrypsin Deficiency Liver Disease: 936\n",
      "  Antiviral Treatment of Chronic Hepatitis B: 937\n",
      "  Anus Neoplasms: 938\n",
      "  Anxiety: 939\n",
      "  Anxiety Disorder: 940\n",
      "  Anxiety Disorder Social: 941\n",
      "  Anxiety Disorder of Adolescence: 942\n",
      "  Anxiety Disorders: 943\n",
      "  Anxiety State: 944\n",
      "  Anxiety in Those Patients With Anorexia Nervosa: 945\n",
      "  Anxiety/Depression in Cardiological Unit: 946\n",
      "  Anxious Major Depressive Disorder: 947\n",
      "  Any Cancer: 948\n",
      "  Any Cancer Diagnosis: 949\n",
      "  Any Condition Requiring Vulvar Biopsy: 950\n",
      "  Any Solid Tumor or Lymphoma: 951\n",
      "  Aortic Aneurysm: 952\n",
      "  Aortic Aneurysm, Abdominal: 953\n",
      "  Aortic Aneurysm, Thoracic: 954\n",
      "  Aortic Blood Pressure: 955\n",
      "  Aortic Disease: 956\n",
      "  Aortic Disorders: 957\n",
      "  Aortic Dissection: 958\n",
      "  Aortic Stenosis: 959\n",
      "  Aortic Stenosis and Lipoprotein(a) Levels: 960\n",
      "  Aortic Stenosis, Non-rheumatic: 961\n",
      "  Aortic Valve Disease: 962\n",
      "  Aortic Valve Replacement: 963\n",
      "  Aortic Valve Stenosis: 964\n",
      "  Aortocoronary Bypass: 965\n",
      "  Apathy: 966\n",
      "  Aphakia: 967\n",
      "  Aphasia: 968\n",
      "  Aphasia Following Cerebral Infarction: 969\n",
      "  Aphthous Stomatitis: 970\n",
      "  Aphtous Ulcers: 971\n",
      "  Apical Ballooning Syndrome: 972\n",
      "  Apical Periodontitis: 973\n",
      "  Aplasia With Expected Thrombocytopenia: 974\n",
      "  Aplastic Anaemia: 975\n",
      "  Aplastic Anemia: 976\n",
      "  Apnea: 977\n",
      "  Apnea of Prematurity: 978\n",
      "  Apophysitis; Juvenile: 979\n",
      "  Apoptotic DNA Damage: 980\n",
      "  Apparent Mineralocorticoid Excess (AME): 981\n",
      "  Appendicitis: 982\n",
      "  Appendicitis Acute: 983\n",
      "  Appendicitis Perforated: 984\n",
      "  Appendix Cancer: 985\n",
      "  Appetitive Aggression: 986\n",
      "  Arachnidism: 987\n",
      "  Arachnoiditis: 988\n",
      "  Argatroban, Rt-PA: 989\n",
      "  Argininosuccinate Synthetase Deficient: 990\n",
      "  Arm Spasticity: 991\n",
      "  Arnold-Chiari Malformation: 992\n",
      "  Arrhythmia: 993\n",
      "  Arrhythmia, Cardiac: 994\n",
      "  Arrhythmia, Sinus: 995\n",
      "  Arrhythmias: 996\n",
      "  Arrhythmias, Cardiac: 997\n",
      "  Arrythmias: 998\n",
      "  Arterial Dysfunction: 999\n",
      "  Arterial Hypertension: 1000\n",
      "  Arterial Inflammation: 1001\n",
      "  Arterial Ischemic Stroke: 1002\n",
      "  Arterial Ischemic Stroke (AIS) in Children: 1003\n",
      "  Arterial Obstructive Diseases: 1004\n",
      "  Arterial Occlusive Disease: 1005\n",
      "  Arterial Occlusive Diseases: 1006\n",
      "  Arteriosclerosis: 1007\n",
      "  Arteriosclerosis of Coronary Artery Bypass Graft: 1008\n",
      "  Arteriovenous Access Fistula Stenosis: 1009\n",
      "  Arteriovenous Access Grafts or Extra-anatomic and Infra-inguinal Grafts: 1010\n",
      "  Arteriovenous Fistula: 1011\n",
      "  Arteriovenous Graft: 1012\n",
      "  Arteriovenous Malformations: 1013\n",
      "  Arteriovenous Malformations, Cerebral: 1014\n",
      "  Arthralgia: 1015\n",
      "  Arthritic Knee Pain: 1016\n",
      "  Arthritis: 1017\n",
      "  Arthritis Knee: 1018\n",
      "  Arthritis Multiple Joint: 1019\n",
      "  Arthritis of Hip: 1020\n",
      "  Arthritis, Degenerative: 1021\n",
      "  Arthritis, Juvenile: 1022\n",
      "  Arthritis, Juvenile Rheumatoid: 1023\n",
      "  Arthritis, Psoriatic: 1024\n",
      "  Arthritis, Reactive: 1025\n",
      "  Arthritis, Rheumatoid: 1026\n",
      "  Arthroplasty: 1027\n",
      "  Arthroplasty, Knee Replacement: 1028\n",
      "  Arthroplasty, Replacement, Hip: 1029\n",
      "  Arthroplasty, Replacement, Knee: 1030\n",
      "  Arthroscopic Medial Meniscectomy: 1031\n",
      "  Arthroscopic Meniscus Surgery: 1032\n",
      "  Arthroscopic Shoulder Surgery: 1033\n",
      "  Arthroscopy: 1034\n",
      "  Arthrosis: 1035\n",
      "  Articular Cartilage: 1036\n",
      "  Articular Cartilage Defects in the Knee Joint: 1037\n",
      "  Articular Cartilage Disorder: 1038\n",
      "  Articular Cartilage Disorder of Knee: 1039\n",
      "  Articular Cartilage Injury: 1040\n",
      "  Articular Cartilage Lesion of Knee: 1041\n",
      "  Articular Cartilage Lesion of the Femoral Condyle: 1042\n",
      "  Ascites: 1043\n",
      "  Aseptic Hip Necrosis: 1044\n",
      "  Aseptic Loosening of the Hip Prosthesis: 1045\n",
      "  Asherman Syndrome: 1046\n",
      "  Asherman's Syndrome: 1047\n",
      "  Aspergillosis: 1048\n",
      "  Aspergillosis/Blood: 1049\n",
      "  Aspiration of Gastric Contents: 1050\n",
      "  Assess Pharmacokinetics of Ketorolac Tromethamine Intranasal and Assess Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine: 1051\n",
      "  Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.: 1052\n",
      "  Assess the Effect of Green Tea on Diabetes: 1053\n",
      "  Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.: 1054\n",
      "  Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL: 1055\n",
      "  Assess the Periprocedural Myocardial Necrosis: 1056\n",
      "  Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women: 1057\n",
      "  Assisted Reproductive Technology: 1058\n",
      "  Asthenia: 1059\n",
      "  Asthma: 1060\n",
      "  Asthma Atopic: 1061\n",
      "  Asthma Chronic: 1062\n",
      "  Asthma in Children: 1063\n",
      "  Asthma in the Elderly: 1064\n",
      "  Asthma, Allergic: 1065\n",
      "  Asthma, Bronchial: 1066\n",
      "  Asthma, Exercise-Induced: 1067\n",
      "  Asthma, Exercise-induced: 1068\n",
      "  Asthma; Status: 1069\n",
      "  Asthmatic: 1070\n",
      "  Astigmatism: 1071\n",
      "  Astrocytic Tumors: 1072\n",
      "  Astrocytoma: 1073\n",
      "  Astrocytomas: 1074\n",
      "  Asymptomatic Amyloid-positive: 1075\n",
      "  Asymptomatic Bacteriuria: 1076\n",
      "  Asymptomatic Chronic HCV Carriers: 1077\n",
      "  Asymptomatic Hyperuricemia: 1078\n",
      "  Asymptomatic Myeloma: 1079\n",
      "  Asymptomatic Parasitemia In Pregnancy: 1080\n",
      "  Asymptotic Venous Thrombosis: 1081\n",
      "  Ataxia Telangiectasia: 1082\n",
      "  Ataxia-Telangiectasia: 1083\n",
      "  Atherosclerosis: 1084\n",
      "  Atherosclerotic Cardiovascular Disease: 1085\n",
      "  Atherosclerotic Coronary Artery Disease: 1086\n",
      "  Atherosclerotic Coronary Vascular Disease: 1087\n",
      "  Atherosclerotic Lesion(s): 1088\n",
      "  Atherothrombosis: 1089\n",
      "  Atherothrombotic Diseases: 1090\n",
      "  Athletic Performance: 1091\n",
      "  Atopic Asthma: 1092\n",
      "  Atopic Dermatitis: 1093\n",
      "  Atopic Dermatitis (AD): 1094\n",
      "  Atopic Dermatitis Eczema: 1095\n",
      "  Atrial Fibrillation: 1096\n",
      "  Atrial Fibrillation or Atrial Flutter: 1097\n",
      "  Atrial Fibrillation or Flutter: 1098\n",
      "  Atrial Fibrillation or Pulmonary Embolism: 1099\n",
      "  Atrial Flutter: 1100\n",
      "  Atrial High Rate Episodes: 1101\n",
      "  Atrial Septal Defect: 1102\n",
      "  Atrioventricular Block: 1103\n",
      "  Atrophic Vaginitis: 1104\n",
      "  Atrophic Vaginitis Due to Menopause: 1105\n",
      "  Atrophy: 1106\n",
      "  Atrophy of Vagina: 1107\n",
      "  Atrophy, Muscular: 1108\n",
      "  Attention Bias Modification Treatment (ABMT): 1109\n",
      "  Attention Deficit Disorder: 1110\n",
      "  Attention Deficit Disorder With Hyperactivity: 1111\n",
      "  Attention Deficit Disorder With Hyperactivity Disease: 1112\n",
      "  Attention Deficit Hyperactivity Disorder: 1113\n",
      "  Attention Deficit Hyperactivity Disorder (ADHD): 1114\n",
      "  Attention Deficit and Hyperactivity Disorder: 1115\n",
      "  Attention Deficit/Hyperactivity Disorder: 1116\n",
      "  Attention Deficit/Hyperactivity Disorder(ADHD): 1117\n",
      "  Attention-Deficit / Hyperactivity Disorder: 1118\n",
      "  Attention-Deficit Hyperactivity Disorder: 1119\n",
      "  Attention-Deficit Hyperactivity Disorder (ADHD): 1120\n",
      "  Attention-Deficit/Hyperactivity Disorder: 1121\n",
      "  Attention-Deficit/Hyperactivity Disorder (ADHD): 1122\n",
      "  Attention-deficit/Hyperactivity Disorder: 1123\n",
      "  Attenuated Psychosis Syndrome: 1124\n",
      "  Attenuated or Transient Psychosis: 1125\n",
      "  Attitude to Computers: 1126\n",
      "  Atypical Alzheimers Disease: 1127\n",
      "  Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative: 1128\n",
      "  Atypical Depression: 1129\n",
      "  Atypical Ductal Breast Hyperplasia: 1130\n",
      "  Atypical Endometrial Hyperplasia: 1131\n",
      "  Atypical Facial Pain: 1132\n",
      "  Atypical Hemolytic Uremic Syndrome: 1133\n",
      "  Atypical Hemolytic Uremic Syndrome (aHUS): 1134\n",
      "  Atypical Meningioma: 1135\n",
      "  Atypical Nevi: 1136\n",
      "  Auditory Hallucinations in Patients With Schizophrenic Disorders: 1137\n",
      "  Augmentation: 1138\n",
      "  Autism: 1139\n",
      "  Autism Disorder: 1140\n",
      "  Autism Spectrum Disorder: 1141\n",
      "  Autism Spectrum Disorder (ASD): 1142\n",
      "  Autism Spectrum Disorders: 1143\n",
      "  Autistic Disorder: 1144\n",
      "  Autistic Spectrum Disorders: 1145\n",
      "  Autogenous Bone Grafts: 1146\n",
      "  Autoimmune Adrenocortical Failure: 1147\n",
      "  Autoimmune Bullous Dermatose: 1148\n",
      "  Autoimmune Cytopenias: 1149\n",
      "  Autoimmune Disease: 1150\n",
      "  Autoimmune Diseases: 1151\n",
      "  Autoimmune Disorders: 1152\n",
      "  Autoimmune Encephalitis: 1153\n",
      "  Autoimmune Epilepsy: 1154\n",
      "  Autoimmune Hemolytic Anemia: 1155\n",
      "  Autoimmune Hepatitis: 1156\n",
      "  Autoimmune Inner Ear Disease: 1157\n",
      "  Autoimmune Pancytopenia: 1158\n",
      "  Autoimmune Pulmonary Alveolar Proteinosis: 1159\n",
      "  Autoimmune Thrombocytopenic Purpura: 1160\n",
      "  Autonomic Disturbances in Parkinson's Disease: 1161\n",
      "  Autonomic Dysreflexia: 1162\n",
      "  Autonomic Nervous System Diseases: 1163\n",
      "  Autonomic Nervous System Disorders: 1164\n",
      "  Autonomous Hyperfunctioning Thyroid Nodules: 1165\n",
      "  Autosomal Dominant Polycystic Kidney: 1166\n",
      "  Autosomal Dominant Polycystic Kidney Disease: 1167\n",
      "  Autosomal Dominant Polycystic Kidney Disease (ADPKD: 1168\n",
      "  Autosomal Dominant Polycystic Kidney Disease (ADPKD): 1169\n",
      "  Autosomal-dominant Hyper-IgE Syndrome: 1170\n",
      "  Avascular Necrosis: 1171\n",
      "  Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors: 1172\n",
      "  Avian Influenza: 1173\n",
      "  Awake Fiberoptic Intubation: 1174\n",
      "  Axial Spondyloarthritis: 1175\n",
      "  Axillary Drainage Volume After Lymph Node Dissection.: 1176\n",
      "  Axillary Hyperhidrosis: 1177\n",
      "  B Acute Lymphoblastic Leukemia: 1178\n",
      "  B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1: 1179\n",
      "  B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged: 1180\n",
      "  B Cell Lymphoma: 1181\n",
      "  B Cell Non-Hodgkin's Lymphoma: 1182\n",
      "  B Cells-Tumors: 1183\n",
      "  B Thalassemia: 1184\n",
      "  B-Cell Chronic Lymphocytic Leukemia: 1185\n",
      "  B-Cell Leukemia: 1186\n",
      "  B-Cell Lymphoma: 1187\n",
      "  B-Cell Lymphoma Originating in the CNS: 1188\n",
      "  B-Cell Pediatric ALL: 1189\n",
      "  B-Cell Prolymphocytic Leukemia: 1190\n",
      "  B-Precursor ALL: 1191\n",
      "  B-cell Acute Lymphoblastic Leukemia: 1192\n",
      "  B-cell Adult Acute Lymphoblastic Leukemia: 1193\n",
      "  B-cell Childhood Acute Lymphoblastic Leukemia: 1194\n",
      "  B-cell Chronic Lymphocytic Leukemia: 1195\n",
      "  B-cell Chronic Lymphocytic Leukemia (B-CLL): 1196\n",
      "  B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion: 1197\n",
      "  B-cell Lymphoid Leukemia: 1198\n",
      "  B-cell Lymphoma: 1199\n",
      "  B-cell Lymphoma Refractory: 1200\n",
      "  B-cell Lymphomas: 1201\n",
      "  B-cell Malignancies: 1202\n",
      "  B-cell Non Hodgkin Lymphoma: 1203\n",
      "  B-cell Non-Hodgkin Lymphoma: 1204\n",
      "  BACTERIAL VAGINOSIS: 1205\n",
      "  BCC: 1206\n",
      "  BCG Infection: 1207\n",
      "  BIPOLAR I DISORDER: 1208\n",
      "  BK Polyomavirus: 1209\n",
      "  BK Virus (Nephropathy): 1210\n",
      "  BK Virus Infection: 1211\n",
      "  BK Virus Nephropathy: 1212\n",
      "  BK Virus Nephropathy After Kidney Transplantation: 1213\n",
      "  BPH: 1214\n",
      "  BRAF Gene Mutation: 1215\n",
      "  BRAF V600E Mutation Present: 1216\n",
      "  BRAF V600E-mutant Metastatic Colorectal Cancer: 1217\n",
      "  BRAFV600 Mutation: 1218\n",
      "  BRAFV600E Melanoma Patients: 1219\n",
      "  BRCA1 Gene Mutation: 1220\n",
      "  BRCA1 Hereditary Breast and Ovarian Cancer Syndrome: 1221\n",
      "  BREAST CANCER: 1222\n",
      "  BRONCHIECTASIS: 1223\n",
      "  Bacillus Anthracis (Anthrax): 1224\n",
      "  Back Pain: 1225\n",
      "  Back Pain Lower Back: 1226\n",
      "  Back Pain Lower Back Chronic: 1227\n",
      "  Back Pain Without Radiation: 1228\n",
      "  Bacteraemia: 1229\n",
      "  Bacteraemia Post Debridement: 1230\n",
      "  Bacteremia: 1231\n",
      "  Bacteremia Due to Staphylococcus Aureus: 1232\n",
      "  Bacteria Infection: 1233\n",
      "  Bacteria Microflora Reduction: 1234\n",
      "  Bacterial Conjunctivitis: 1235\n",
      "  Bacterial Infection: 1236\n",
      "  Bacterial Infections: 1237\n",
      "  Bacterial Infections and Mycoses: 1238\n",
      "  Bacterial Meningitis: 1239\n",
      "  Bacterial Pneumonia: 1240\n",
      "  Bacterial Sepsis: 1241\n",
      "  Bacterial Vaginosis: 1242\n",
      "  Bacterial Vaginosis (BV): 1243\n",
      "  Bacteriuria: 1244\n",
      "  Baker's Cyst: 1245\n",
      "  Balance Problems: 1246\n",
      "  Bandages: 1247\n",
      "  Bardet Biedl Syndrome (BBS): 1248\n",
      "  Bardet-Biedl Syndrome: 1249\n",
      "  Bariatric Patients: 1250\n",
      "  Bariatric Surgery: 1251\n",
      "  Bariatric Surgery Candidate: 1252\n",
      "  Barrett Esophagus: 1253\n",
      "  Barrett Metaplasia: 1254\n",
      "  Barrett Oesophagus: 1255\n",
      "  Barrett's Esophagus: 1256\n",
      "  Barretts Esophagus: 1257\n",
      "  Barth Syndrome: 1258\n",
      "  Basal Cell Carcinoma: 1259\n",
      "  Basal Cell Carcinoma of the Skin: 1260\n",
      "  Basal Cell Carcinomas: 1261\n",
      "  Basal Cell Nevus Syndrome: 1262\n",
      "  Base-of-thumb Osteoarthritis: 1263\n",
      "  Becker Muscular Dystrophy: 1264\n",
      "  Bee Venom Allergy: 1265\n",
      "  Behavior: 1266\n",
      "  Behavior Therapy: 1267\n",
      "  Behavior and Behavior Mechanisms: 1268\n",
      "  Behavioral Manifestations of Lesch-Nyhan Disease: 1269\n",
      "  Behcet Disease: 1270\n",
      "  Behcet Syndrome: 1271\n",
      "  Behcet's Disease Uveitis: 1272\n",
      "  Behcet's Syndrome: 1273\n",
      "  Behcet's Uveitis: 1274\n",
      "  Behçet Disease: 1275\n",
      "  Bell Palsy: 1276\n",
      "  Benign Headache: 1277\n",
      "  Benign Neoplasms, Brain: 1278\n",
      "  Benign Nontoxic and Toxic Goiter: 1279\n",
      "  Benign Prostate Hyperplasia: 1280\n",
      "  Benign Prostatic Hyperplasia: 1281\n",
      "  Benign Prostatic Hyperplasia (BPH): 1282\n",
      "  Benign Prostatic Hypertrophy: 1283\n",
      "  Benign Prostatic Hypertrophy (BPH): 1284\n",
      "  Benign Vascular Periocular Lesions: 1285\n",
      "  Benzodiazepine Dependence: 1286\n",
      "  Bereavement: 1287\n",
      "  Berylliosis: 1288\n",
      "  Beta Thalassemia Major: 1289\n",
      "  Beta-Thalassemia: 1290\n",
      "  Bifurcation Coronary Disease: 1291\n",
      "  Bilateral Cochlear Aplasia: 1292\n",
      "  Bile Acid Malabsorption: 1293\n",
      "  Bile Duct Adenocarcinoma: 1294\n",
      "  Bile Duct Diseases: 1295\n",
      "  Bile Duct Neoplasm: 1296\n",
      "  Biliary Atresia: 1297\n",
      "  Biliary Cancer: 1298\n",
      "  Biliary Cirrhosis, Primary: 1299\n",
      "  Biliary Tract Cancer: 1300\n",
      "  Biliary Tract Cancer (BTC): 1301\n",
      "  Biliary Tract Carcinoma: 1302\n",
      "  Biliary Tract Neoplasms: 1303\n",
      "  Binge Eating: 1304\n",
      "  Binge Eating Disorder: 1305\n",
      "  Binge-Eating Disorder: 1306\n",
      "  Bio-Equivalency of 2 Treatment Schedules in HD Patients: 1307\n",
      "  Bio-equivalence Study: 1308\n",
      "  Bioavailability: 1309\n",
      "  Bioavailability Heathy Volunteers: 1310\n",
      "  Bioavailability Study on Healthy Volunteers: 1311\n",
      "  Bioavailability and AUC: 1312\n",
      "  Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy: 1313\n",
      "  Bioequivalence: 1314\n",
      "  Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch: 1315\n",
      "  Bioequivalence Study: 1316\n",
      "  Bioequivalence in Healthy Subjects: 1317\n",
      "  Bioequivalence of Two Azilsartan Formulations: 1318\n",
      "  Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin: 1319\n",
      "  Bioequivalency: 1320\n",
      "  Biological Availability: 1321\n",
      "  Bipolar: 1322\n",
      "  Bipolar 1 Disorder: 1323\n",
      "  Bipolar Affective Disorder: 1324\n",
      "  Bipolar Depression: 1325\n",
      "  Bipolar Disorder: 1326\n",
      "  Bipolar Disorder I: 1327\n",
      "  Bipolar Disorder I or II: 1328\n",
      "  Bipolar Disorder, Mania: 1329\n",
      "  Bipolar Disorders: 1330\n",
      "  Bipolar I Depression: 1331\n",
      "  Bipolar I Disorder: 1332\n",
      "  Bipolar I or II Depression and Alcohol Abuse or Dependence: 1333\n",
      "  Bipolar II Disorder, Most Recent Episode Major Depressive: 1334\n",
      "  Bipolar Type II Disorder: 1335\n",
      "  Bipolar Youth Treated With Second-generation Antipsychotics: 1336\n",
      "  Birch Pollen Allergy: 1337\n",
      "  Birch Pollen-Related Rhinoconjunctivitis: 1338\n",
      "  Birth Weight: 1339\n",
      "  Bladder Adenocarcinoma: 1340\n",
      "  Bladder Cancer: 1341\n",
      "  Bladder Cancer TNM Staging Primary Tumor (T) T2: 1342\n",
      "  Bladder Carcinoma: 1343\n",
      "  Bladder Exstrophy: 1344\n",
      "  Bladder Neoplasm: 1345\n",
      "  Bladder Neoplasms: 1346\n",
      "  Bladder Outlet Obstruction: 1347\n",
      "  Bladder Pain Syndrome: 1348\n",
      "  Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive: 1349\n",
      "  Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML): 1350\n",
      "  Blastic Phase Chronic Myelogenous Leukemia: 1351\n",
      "  Blastic Plasmacytoid Dendritic Cell Neoplasm: 1352\n",
      "  Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 1353\n",
      "  Blastomycosis: 1354\n",
      "  Blasts Under 15 Percent of Bone Marrow Nucleated Cells: 1355\n",
      "  Bleeding: 1356\n",
      "  Bleeding Gastric Varices: 1357\n",
      "  Blepharitis: 1358\n",
      "  Blepharoconjunctivitis: 1359\n",
      "  Blepharokeratoconjunctivitis: 1360\n",
      "  Blepharospasm: 1361\n",
      "  Blindness: 1362\n",
      "  Blocked Ventricular Shunts: 1363\n",
      "  Blood And Marrow Transplantation: 1364\n",
      "  Blood Brain Barrier Defect: 1365\n",
      "  Blood Cancer: 1366\n",
      "  Blood Coagulation Disorder: 1367\n",
      "  Blood Coagulation Disorders: 1368\n",
      "  Blood Donors: 1369\n",
      "  Blood Glucose, Postprandial: 1370\n",
      "  Blood Loss: 1371\n",
      "  Blood Loss Anemia: 1372\n",
      "  Blood Loss During Vaginal Hysterectomy: 1373\n",
      "  Blood Loss Following Open Femur Fracture Surgery: 1374\n",
      "  Blood Loss in Myomectomy: 1375\n",
      "  Blood Loss, Surgical: 1376\n",
      "  Blood Pressure: 1377\n",
      "  Blood Pressure in Pregnancy: 1378\n",
      "  Blood Pressure, High: 1379\n",
      "  Blood Sugar (Glucose) Control: 1380\n",
      "  Blood Transfusion Complication: 1381\n",
      "  Bloodstream Infection: 1382\n",
      "  Bloodstream Infections: 1383\n",
      "  Body Dysmorphic Disorder: 1384\n",
      "  Body Temperature Changes: 1385\n",
      "  Body Weight Changes: 1386\n",
      "  Bone Atrophy: 1387\n",
      "  Bone Cancer: 1388\n",
      "  Bone Cysts: 1389\n",
      "  Bone Demineralization: 1390\n",
      "  Bone Demineralization Lesions in the Injured Marrow: 1391\n",
      "  Bone Diseases: 1392\n",
      "  Bone Diseases, Metabolic: 1393\n",
      "  Bone Fractures: 1394\n",
      "  Bone Gain: 1395\n",
      "  Bone Giant Cell Tumor: 1396\n",
      "  Bone Infection: 1397\n",
      "  Bone Ingrowth: 1398\n",
      "  Bone Loss: 1399\n",
      "  Bone Marrow Disease: 1400\n",
      "  Bone Marrow Edema: 1401\n",
      "  Bone Marrow Suppression: 1402\n",
      "  Bone Marrow Transplantation: 1403\n",
      "  Bone Metabolism: 1404\n",
      "  Bone Metastases: 1405\n",
      "  Bone Neoplasms: 1406\n",
      "  Bone Resorption: 1407\n",
      "  Bone and Joint Infection: 1408\n",
      "  Borderline Ovarian Serous Tumor: 1409\n",
      "  Borderline Personality Disorder: 1410\n",
      "  Borderline Resectable Pancreatic Cancer: 1411\n",
      "  Botulism: 1412\n",
      "  Bowel Cleansing Quality: 1413\n",
      "  Bowel Diseases, Inflammatory: 1414\n",
      "  Bowel Dysfunction: 1415\n",
      "  Bowel Obstruction: 1416\n",
      "  Bowel Preparation: 1417\n",
      "  Bowel Preparation Quality: 1418\n",
      "  Bowel Preparation Solutions: 1419\n",
      "  Bowel Preparation for Colonoscopy: 1420\n",
      "  Bowen's Disease: 1421\n",
      "  Brachial Plexus Block: 1422\n",
      "  Bradycardia: 1423\n",
      "  Brain: 1424\n",
      "  Brain Cancer: 1425\n",
      "  Brain Concussion: 1426\n",
      "  Brain Dead Organ Donors: 1427\n",
      "  Brain Death: 1428\n",
      "  Brain Distribution of [11C]AZ12807110 and AZD5213: 1429\n",
      "  Brain Edema: 1430\n",
      "  Brain Fibrillarab Levels: 1431\n",
      "  Brain Function: 1432\n",
      "  Brain Injuries: 1433\n",
      "  Brain Injuries, Traumatic: 1434\n",
      "  Brain Injury: 1435\n",
      "  Brain Ischemia: 1436\n",
      "  Brain Metastases: 1437\n",
      "  Brain Metastases From Non-small Cell Lung Cancer (NSCLC): 1438\n",
      "  Brain Metastases, Adult: 1439\n",
      "  Brain Metastasis: 1440\n",
      "  Brain Neoplasm: 1441\n",
      "  Brain Neoplasms: 1442\n",
      "  Brain Neoplasms, Malignant: 1443\n",
      "  Brain Stem Gliomas: 1444\n",
      "  Brain Stem Neoplasms: 1445\n",
      "  Brain Tumor: 1446\n",
      "  Brain Tumor, Pediatric, Brainstem Glioma: 1447\n",
      "  Brain Tumor, Recurrent: 1448\n",
      "  Brain Tumors: 1449\n",
      "  Brain Tumors With Ill-defined Margins: 1450\n",
      "  Brain Tumour: 1451\n",
      "  Brain and Central Nervous System Tumors: 1452\n",
      "  Brainstem Glioma: 1453\n",
      "  Branch Retinal Vein Occlusion: 1454\n",
      "  Branch Retinal Vein Occlusion with Macular Edema: 1455\n",
      "  Breakthrough Nausea and Vomiting: 1456\n",
      "  Breakthrough Pain: 1457\n",
      "  Breast Abnormalities: 1458\n",
      "  Breast Adenocarcinoma: 1459\n",
      "  Breast Atypical Ductal Hyperplasia: 1460\n",
      "  Breast Cancer: 1461\n",
      "  Breast Cancer - Female: 1462\n",
      "  Breast Cancer Ductal Infiltrating Metastatic: 1463\n",
      "  Breast Cancer Female: 1464\n",
      "  Breast Cancer Invasive Nos: 1465\n",
      "  Breast Cancer Metastatic: 1466\n",
      "  Breast Cancer Metastatic to the Liver: 1467\n",
      "  Breast Cancer Screening: 1468\n",
      "  Breast Cancer Stage IIIA: 1469\n",
      "  Breast Cancer Stage IV: 1470\n",
      "  Breast Cancer Triple Negative: 1471\n",
      "  Breast Cancer With Bone Metastasis: 1472\n",
      "  Breast Cancer With Brain Metastasis: 1473\n",
      "  Breast Cancer With Chronic Lymphedema: 1474\n",
      "  Breast Cancer, PI3K, Alpelisib: 1475\n",
      "  Breast Cancer, Preneoplastic Conditions, BRCA: 1476\n",
      "  Breast Cancer.: 1477\n",
      "  Breast Carcinoma: 1478\n",
      "  Breast Carcinoma Metastatic in the Bone: 1479\n",
      "  Breast Carcinoma Metastatic in the Brain: 1480\n",
      "  Breast Diseases: 1481\n",
      "  Breast Feeding: 1482\n",
      "  Breast Fibroadenoma: 1483\n",
      "  Breast Inflammatory Carcinoma: 1484\n",
      "  Breast Neoplasm: 1485\n",
      "  Breast Neoplasm Female: 1486\n",
      "  Breast Neoplasms: 1487\n",
      "  Breast Pain: 1488\n",
      "  Breast Reconstruction: 1489\n",
      "  Breast Surgery: 1490\n",
      "  Breast Tumour: 1491\n",
      "  Breastcancer: 1492\n",
      "  Breastfeeding: 1493\n",
      "  Breathing: 1494\n",
      "  Breech Presentation: 1495\n",
      "  Brenner Tumor: 1496\n",
      "  Bronchial Alveolar; Tumor: 1497\n",
      "  Bronchial Asthma: 1498\n",
      "  Bronchial Neoplasms: 1499\n",
      "  Bronchiectasis: 1500\n",
      "  Bronchiectasis Adult: 1501\n",
      "  Bronchiectasis With Acute Exacerbation: 1502\n",
      "  Bronchiolitis: 1503\n",
      "  Bronchiolitis Obliterans: 1504\n",
      "  Bronchiolitis, Viral: 1505\n",
      "  Bronchitis, COPD: 1506\n",
      "  Bronchitis, Chronic: 1507\n",
      "  Bronchopulmonary Dysplasia: 1508\n",
      "  Bronchopulmonary Dysplasia (BPD): 1509\n",
      "  Bronchoscopy: 1510\n",
      "  Bronchospasm: 1511\n",
      "  Bronchospasm; Bronchiolitis: 1512\n",
      "  Brow Ptosis: 1513\n",
      "  Brown Adipose Tissue: 1514\n",
      "  Brugada Syndrome: 1515\n",
      "  Bruises: 1516\n",
      "  Bruxism: 1517\n",
      "  Bulimia: 1518\n",
      "  Bulimia Nervosa: 1519\n",
      "  Bullous Pemphigoid: 1520\n",
      "  Buprenorphine: 1521\n",
      "  Burkitt Lymphoma: 1522\n",
      "  Burkitt's Lymphoma: 1523\n",
      "  Burn: 1524\n",
      "  Burn Any Degree Involving 20-29 Percent of Body Surface: 1525\n",
      "  Burn Injury: 1526\n",
      "  Burn Pain: 1527\n",
      "  Burn Patients: 1528\n",
      "  Burn, Partial Thickness: 1529\n",
      "  Burning Mouth Syndrome: 1530\n",
      "  Burns: 1531\n",
      "  Bursitis: 1532\n",
      "  Busulfan Pharmacokinetic Analysis: 1533\n",
      "  C.Delivery; Surgery (Previous), Gynecological: 1534\n",
      "  C.Surgical Procedure: 1535\n",
      "  C.Surgical Procedure; Cardiac: 1536\n",
      "  C.Surgical Procedure; Vascular (Peripheral): 1537\n",
      "  C3 Glomerulonephritis: 1538\n",
      "  CABG: 1539\n",
      "  CANCER: 1540\n",
      "  CANCER,NOS: 1541\n",
      "  CCND1 Positive: 1542\n",
      "  CD19 Positive: 1543\n",
      "  CD19 Positive Non-Hodgkin Lymphoma: 1544\n",
      "  CD20 Positive B Cell Non-Hodgkin's Lymphoma: 1545\n",
      "  CD20 Positive Diffuse Large B-cell Lymphoma: 1546\n",
      "  CD20+ Follicular Lymphoma: 1547\n",
      "  CD20-Positive Large B-Cell Lymphoma: 1548\n",
      "  CD20-positive Non-Hodgkin Lymphoma: 1549\n",
      "  CD22 Positive: 1550\n",
      "  CD22+ Relapsed/Refractory B-ALL: 1551\n",
      "  CD30-Positive Neoplastic Cells Present: 1552\n",
      "  CD30-positive Lymphoma: 1553\n",
      "  CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma: 1554\n",
      "  CDKN2A-p16 Positive: 1555\n",
      "  CHRONIC LYMPHOCYTIC B-LEUKEMIA: 1556\n",
      "  CHRONIC MYELOGENOUS LEUKEMIA: 1557\n",
      "  CHRONIC OBSTRUCTIVE PULMONARY DISEASE: 1558\n",
      "  CKD: 1559\n",
      "  CKd Patients With Stage 3 and 4: 1560\n",
      "  CLL: 1561\n",
      "  CML: 1562\n",
      "  CMT1A: 1563\n",
      "  CMV: 1564\n",
      "  CMV Disease: 1565\n",
      "  CMV Infection: 1566\n",
      "  CMV Infections: 1567\n",
      "  CMV Reactivation: 1568\n",
      "  CNS: 1569\n",
      "  CNS 2a: 1570\n",
      "  CNS Tumor: 1571\n",
      "  COL6A3 Positive: 1572\n",
      "  COMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBO: 1573\n",
      "  COPD: 1574\n",
      "  COPD (Chronic Obstructive Pulmonary Disease): 1575\n",
      "  COPD Exacerbation: 1576\n",
      "  COPD Method Evaluation: 1577\n",
      "  CORONARY DISEASE: 1578\n",
      "  CRC (Colorectal Cancer): 1579\n",
      "  CREST Syndrome: 1580\n",
      "  CROHN'S DISEASE: 1581\n",
      "  CSF Leak: 1582\n",
      "  CTLA4 Haploinsufficency: 1583\n",
      "  CYP2C19 Genotypes: 1584\n",
      "  CYP2C19 Polymorphism: 1585\n",
      "  CYSTOID MACULAR EDEMA: 1586\n",
      "  Cachexia: 1587\n",
      "  Cachexia; Cancer: 1588\n",
      "  Caesarean: 1589\n",
      "  Caesarean Section: 1590\n",
      "  Caesarian Section: 1591\n",
      "  Caffeine: 1592\n",
      "  Calcinosis Cutis: 1593\n",
      "  Calciphylaxis: 1594\n",
      "  Calcium Deficiency: 1595\n",
      "  Calcium Phosphate Kidney Stones: 1596\n",
      "  Calcium Pyrophosphate Deposition Disease: 1597\n",
      "  Calcium and Vitamin D Deficiencies: 1598\n",
      "  Canavan Disease: 1599\n",
      "  Cancer: 1600\n",
      "  Cancer - Acute Myeloid Leukemia: 1601\n",
      "  Cancer - Ovarian: 1602\n",
      "  Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma: 1603\n",
      "  Cancer Cachexia: 1604\n",
      "  Cancer Pain: 1605\n",
      "  Cancer Pains: 1606\n",
      "  Cancer Prostate: 1607\n",
      "  Cancer Recurrence: 1608\n",
      "  Cancer Related Fatigue: 1609\n",
      "  Cancer Survivor: 1610\n",
      "  Cancer Survivors: 1611\n",
      "  Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate: 1612\n",
      "  Cancer of Bone: 1613\n",
      "  Cancer of Brain and Nervous System: 1614\n",
      "  Cancer of Breast: 1615\n",
      "  Cancer of Cervix: 1616\n",
      "  Cancer of Colon: 1617\n",
      "  Cancer of Head and Neck: 1618\n",
      "  Cancer of Larynx: 1619\n",
      "  Cancer of Liver: 1620\n",
      "  Cancer of Ovary: 1621\n",
      "  Cancer of Pancreas: 1622\n",
      "  Cancer of Prostate: 1623\n",
      "  Cancer of Rectum: 1624\n",
      "  Cancer of Skin: 1625\n",
      "  Cancer of Stomach: 1626\n",
      "  Cancer of the Bile Duct: 1627\n",
      "  Cancer of the Breast: 1628\n",
      "  Cancer of the Cervix: 1629\n",
      "  Cancer of the Gastrointestinal Tract: 1630\n",
      "  Cancer of the Head and Neck: 1631\n",
      "  Cancer of the Liver: 1632\n",
      "  Cancer of the PROSTATE: 1633\n",
      "  Cancer of the Pancreas: 1634\n",
      "  Cancer of the Pancreatic Head: 1635\n",
      "  Cancer of the Pharynx: 1636\n",
      "  Cancer of the Prostate: 1637\n",
      "  Cancer,: 1638\n",
      "  Cancer, Advanced: 1639\n",
      "  Cancer, Breast: 1640\n",
      "  Cancer, Malignant Tumors: 1641\n",
      "  Cancer, Metastatic: 1642\n",
      "  Cancer, Neoplasms, Tumors: 1643\n",
      "  Cancer, Ovarian: 1644\n",
      "  Cancer, Prostate: 1645\n",
      "  Cancer-related Fatigue: 1646\n",
      "  Cancer-related Malnutrition: 1647\n",
      "  Cancer-related Problem/Condition: 1648\n",
      "  Cancer: Breakthrough Pain: 1649\n",
      "  Cancer: Solid Tumors: 1650\n",
      "  Cancers of the Head and Neck: 1651\n",
      "  Cancers, Pain: 1652\n",
      "  Candida Sepsis: 1653\n",
      "  Candida Vulvovaginitis: 1654\n",
      "  Candidaemia: 1655\n",
      "  Candidemia: 1656\n",
      "  Candidiasis: 1657\n",
      "  Candidiasis Vulvaginitis: 1658\n",
      "  Candidiasis, Chronic Mucocutaneous: 1659\n",
      "  Candidiasis, Invasive: 1660\n",
      "  Candidiasis, Oral: 1661\n",
      "  Cannabidiol Pharmacokinetics: 1662\n",
      "  Cannabis: 1663\n",
      "  Cannabis Dependence: 1664\n",
      "  Cannabis Use: 1665\n",
      "  Cannabis Use Disorder: 1666\n",
      "  Cannabis-use Disorders: 1667\n",
      "  Capillary Malformations: 1668\n",
      "  Capsaicin Evoked Pain: 1669\n",
      "  Carbon Monoxide Poisoning: 1670\n",
      "  Carcinoid: 1671\n",
      "  Carcinoid Syndrome: 1672\n",
      "  Carcinoid Tumor: 1673\n",
      "  Carcinoid Tumors: 1674\n",
      "  Carcinologic Ear, Nose, and Throat (ENT) Surgery: 1675\n",
      "  Carcinoma: 1676\n",
      "  Carcinoma Breast Stage IV: 1677\n",
      "  Carcinoma Prostate: 1678\n",
      "  Carcinoma Transitional Cell: 1679\n",
      "  Carcinoma in Situ: 1680\n",
      "  Carcinoma in Situ of Bladder: 1681\n",
      "  Carcinoma of Anal Canal: 1682\n",
      "  Carcinoma of Esophagus: 1683\n",
      "  Carcinoma of Unknown Primary: 1684\n",
      "  Carcinoma of the Appendix: 1685\n",
      "  Carcinoma of the Head and Neck: 1686\n",
      "  Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors: 1687\n",
      "  Carcinoma, Advanced Metastatic: 1688\n",
      "  Carcinoma, Basal Cell: 1689\n",
      "  Carcinoma, Breast: 1690\n",
      "  Carcinoma, Ductal, Breast: 1691\n",
      "  Carcinoma, Hepatocellular: 1692\n",
      "  Carcinoma, Islet Cell: 1693\n",
      "  Carcinoma, Large Cell: 1694\n",
      "  Carcinoma, Metastatic Breast: 1695\n",
      "  Carcinoma, Midline: 1696\n",
      "  Carcinoma, Neuroendocrine: 1697\n",
      "  Carcinoma, Non Small Cell Lung: 1698\n",
      "  Carcinoma, Non-Small -Cell Lung: 1699\n",
      "  Carcinoma, Non-Small Cell Lung: 1700\n",
      "  Carcinoma, Non-Small-Cell Lung: 1701\n",
      "  Carcinoma, Non-Small-Cell Lung (NSCLC): 1702\n",
      "  Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive: 1703\n",
      "  Carcinoma, Non-Small-Cell-Lung: 1704\n",
      "  Carcinoma, Non-small Cell Lung: 1705\n",
      "  Carcinoma, Non-small-cell Lung: 1706\n",
      "  Carcinoma, Pancreatic Ductal: 1707\n",
      "  Carcinoma, Renal Cell: 1708\n",
      "  Carcinoma, Small Cell: 1709\n",
      "  Carcinoma, Small Cell Lung: 1710\n",
      "  Carcinoma, Squamous: 1711\n",
      "  Carcinoma, Squamous Cell: 1712\n",
      "  Carcinoma, Squamous Cell of Head and Neck: 1713\n",
      "  Carcinoma, Transitional Cell: 1714\n",
      "  Carcinoma, Unspecified Site: 1715\n",
      "  Cardiac AL Amyloidosis: 1716\n",
      "  Cardiac Allograft Vasculopathy: 1717\n",
      "  Cardiac Amyloidosis: 1718\n",
      "  Cardiac Arrest: 1719\n",
      "  Cardiac Arrest During and/or Resulting From A Procedure: 1720\n",
      "  Cardiac Arrhythmia: 1721\n",
      "  Cardiac Arrhythmias: 1722\n",
      "  Cardiac Arrythmias: 1723\n",
      "  Cardiac Cachexia: 1724\n",
      "  Cardiac Diagnostic Procedure: 1725\n",
      "  Cardiac Disease: 1726\n",
      "  Cardiac Edema: 1727\n",
      "  Cardiac Failure: 1728\n",
      "  Cardiac Failure Aggravated: 1729\n",
      "  Cardiac Fibrosis: 1730\n",
      "  Cardiac Function: 1731\n",
      "  Cardiac Hypertrophy: 1732\n",
      "  Cardiac Magnetic Resonance Imaging: 1733\n",
      "  Cardiac Output: 1734\n",
      "  Cardiac Output, Low: 1735\n",
      "  Cardiac Remodeling: 1736\n",
      "  Cardiac Repolarization: 1737\n",
      "  Cardiac Resynchronization Therapy: 1738\n",
      "  Cardiac Sarcoidosis: 1739\n",
      "  Cardiac Steatosis: 1740\n",
      "  Cardiac Surgery: 1741\n",
      "  Cardiac Surgery With Cardiopulmonary Bypass: 1742\n",
      "  Cardiac Surgery-CABG: 1743\n",
      "  Cardiac Surgical Procedures: 1744\n",
      "  Cardiac Toxicity: 1745\n",
      "  Cardiac Transplant Disorder: 1746\n",
      "  Cardiac Transplantation: 1747\n",
      "  Cardio-pulmonary Function: 1748\n",
      "  Cardiogenic Shock: 1749\n",
      "  Cardiomegaly: 1750\n",
      "  Cardiomyopathy: 1751\n",
      "  Cardiomyopathy Due to Drug: 1752\n",
      "  Cardiomyopathy, Dilated: 1753\n",
      "  Cardiomyopathy, Hypertrophic: 1754\n",
      "  Cardiopulmonary Arrest: 1755\n",
      "  Cardiopulmonary Bypass: 1756\n",
      "  Cardiorenal Syndrome: 1757\n",
      "  Cardiothoracic Surgery: 1758\n",
      "  Cardiotoxicity: 1759\n",
      "  Cardiovascular Abnormalities: 1760\n",
      "  Cardiovascular Complications: 1761\n",
      "  Cardiovascular Disease: 1762\n",
      "  Cardiovascular Disease Risk Factors: 1763\n",
      "  Cardiovascular Diseases: 1764\n",
      "  Cardiovascular Events: 1765\n",
      "  Cardiovascular Function: 1766\n",
      "  Cardiovascular Health: 1767\n",
      "  Caregivers: 1768\n",
      "  Carotid Artery Disease: 1769\n",
      "  Carotid Artery Plaque: 1770\n",
      "  Carotid Artery Stenosis: 1771\n",
      "  Carotid Atherosclerosis: 1772\n",
      "  Carotid Stenosis: 1773\n",
      "  Carpal Tunnel: 1774\n",
      "  Carpal Tunnel Syndrome: 1775\n",
      "  Carpal Tunnel Syndrome (CTS): 1776\n",
      "  Cartilage Defects of the Knee: 1777\n",
      "  Cartilage Diseases: 1778\n",
      "  Cartilage Injury: 1779\n",
      "  Cartilage Injury of Knee: 1780\n",
      "  Castrate Resistant Prostate Cancer: 1781\n",
      "  Castrate Resistant Prostate Cancer (CRPC): 1782\n",
      "  Castrate Resistant Prostate Cancer With Bone Metastasis: 1783\n",
      "  Castrate-Resistant Prostate Cancer: 1784\n",
      "  Castrate-resistant Metastatic Prostate Cancer: 1785\n",
      "  Castrate-resistant Prostate Cancer: 1786\n",
      "  Castrate-resistant Prostate Cancer (CRPC): 1787\n",
      "  Castration Levels of Testosterone: 1788\n",
      "  Castration-Resistant Prostate Carcinoma: 1789\n",
      "  Castration-Sensitive Prostate Carcinoma: 1790\n",
      "  Castration-resistant Prostate Cancer: 1791\n",
      "  Castration-resistant Prostate Cancer, Advanced Breast Cancer: 1792\n",
      "  Cat Allergy: 1793\n",
      "  Cataract: 1794\n",
      "  Cataract Extraction: 1795\n",
      "  Cataract Surgery: 1796\n",
      "  Cataract Surgery Anesthesia: 1797\n",
      "  Cataracts: 1798\n",
      "  Catecholamine-resistant Hypotension (CRH): 1799\n",
      "  Cathartics: 1800\n",
      "  Catheter Occlusion: 1801\n",
      "  Catheter Related Infections: 1802\n",
      "  Catheter-Associated Urinary Tract Infection, Ascorbic Acid: 1803\n",
      "  Catheter-Related Fungal Infections: 1804\n",
      "  Catheter-related Bloodstream Infection (CRBSI) Nos: 1805\n",
      "  Catheter; Infection (Indwelling Catheter): 1806\n",
      "  Catheterization: 1807\n",
      "  Catheterization, Central Venous: 1808\n",
      "  Catheterization, Peripheral: 1809\n",
      "  Caucasian Patients With EGFR Mutation Positive Advanced NSCLC: 1810\n",
      "  Caudal Block: 1811\n",
      "  Causalgia: 1812\n",
      "  Cavernous Angioma, Familial: 1813\n",
      "  Cavities of Teeth: 1814\n",
      "  Cavotricuspid Isthmus Dependent Right Atrial Flutter: 1815\n",
      "  Cedar Pollinosis: 1816\n",
      "  Celiac Disease: 1817\n",
      "  Cellulite: 1818\n",
      "  Cellulite Reduction: 1819\n",
      "  Cellulitis: 1820\n",
      "  Central Abdominal Bulging: 1821\n",
      "  Central Apnea: 1822\n",
      "  Central Arterial Pressure: 1823\n",
      "  Central Giant Cell Granuloma: 1824\n",
      "  Central Nervous System (CNS) Demyelinating Disease: 1825\n",
      "  Central Nervous System (CNS) Metastases: 1826\n",
      "  Central Nervous System Diseases: 1827\n",
      "  Central Nervous System Embryonal Tumor With Rhabdoid Features: 1828\n",
      "  Central Nervous System Lymphoma: 1829\n",
      "  Central Nervous System Neoplasms: 1830\n",
      "  Central Nervous System Sensitization: 1831\n",
      "  Central Nervous System Tumor, Pediatric: 1832\n",
      "  Central Nervous System Tumors: 1833\n",
      "  Central Neuropathic Pain: 1834\n",
      "  Central Precocious Puberty: 1835\n",
      "  Central Precocious Puberty (CPP): 1836\n",
      "  Central Retinal Vein Occlusion: 1837\n",
      "  Central Retinal Vein Occlusion With Macular Edema: 1838\n",
      "  Central Serous Chorioretinopathy: 1839\n",
      "  Central Venous Catheter Related Infections: 1840\n",
      "  Cerebellar Ataxia: 1841\n",
      "  Cerebral Adrenoleukodystrophy: 1842\n",
      "  Cerebral Aneurysm: 1843\n",
      "  Cerebral Atherosclerosis: 1844\n",
      "  Cerebral Cavernous Malformation: 1845\n",
      "  Cerebral Cavernous Malformations: 1846\n",
      "  Cerebral Edema: 1847\n",
      "  Cerebral Embolism: 1848\n",
      "  Cerebral Hemorrhage: 1849\n",
      "  Cerebral Infarction: 1850\n",
      "  Cerebral Ischemia: 1851\n",
      "  Cerebral Lymphoma B Cell Refractory: 1852\n",
      "  Cerebral Palsy: 1853\n",
      "  Cerebral Palsy (CP): 1854\n",
      "  Cerebral Palsy, Dyskinetic: 1855\n",
      "  Cerebral Primitive Tumor With Chirurgical Indication: 1856\n",
      "  Cerebral Small Vessel Diseases: 1857\n",
      "  Cerebral Stroke: 1858\n",
      "  Cerebral Vasospasm: 1859\n",
      "  Cerebrolysin: 1860\n",
      "  Cerebrospinal Fluid Leak: 1861\n",
      "  Cerebrospinal Fluid Pressure Increased: 1862\n",
      "  Cerebrovascular Accident: 1863\n",
      "  Cerebrovascular Accident (CVA): 1864\n",
      "  Cerebrovascular Disorders: 1865\n",
      "  Cervical Adenocarcinoma: 1866\n",
      "  Cervical Cancer: 1867\n",
      "  Cervical Cancer Stage IV: 1868\n",
      "  Cervical Cancers: 1869\n",
      "  Cervical Carcinoma: 1870\n",
      "  Cervical Degenerative Disc Disease: 1871\n",
      "  Cervical Dysplasia: 1872\n",
      "  Cervical Dystonia: 1873\n",
      "  Cervical High Grade Squamous Intraepithelial Lesion: 1874\n",
      "  Cervical Intraepithelial Neoplasia: 1875\n",
      "  Cervical Myelopathy: 1876\n",
      "  Cervical Neoplasia: 1877\n",
      "  Cervical Neoplasms: 1878\n",
      "  Cervical Radiculopathy: 1879\n",
      "  Cervical Ripening: 1880\n",
      "  Cervical Spinal Cord Injury: 1881\n",
      "  Cervical Spondylosis: 1882\n",
      "  Cervical Spondylotic Myelopathy: 1883\n",
      "  Cervical Squamous Cell Carcinoma: 1884\n",
      "  Cervical Squamous Cell Carcinoma In Situ: 1885\n",
      "  Cervix Cancer: 1886\n",
      "  Cervix Neoplasms: 1887\n",
      "  Cervix Uteri--Diseases: 1888\n",
      "  Cesarean Delivery: 1889\n",
      "  Cesarean Section: 1890\n",
      "  Cesarean Section Complications: 1891\n",
      "  Chagas Cardiomyopathy: 1892\n",
      "  Chagas Disease: 1893\n",
      "  Chalazia: 1894\n",
      "  Chalazion: 1895\n",
      "  Charcot Arthropathy: 1896\n",
      "  Charcot-Marie-Tooth Disease: 1897\n",
      "  Cheek Line Depressions: 1898\n",
      "  Chemical Injuries: 1899\n",
      "  Chemical Peel: 1900\n",
      "  Chemo Brain: 1901\n",
      "  Chemo-refractory Melanoma: 1902\n",
      "  Chemotherapeutic Agent Toxicity: 1903\n",
      "  Chemotherapy: 1904\n",
      "  Chemotherapy Induced Anemia: 1905\n",
      "  Chemotherapy Induced Mucositis: 1906\n",
      "  Chemotherapy Induced Nausea Vomiting: 1907\n",
      "  Chemotherapy Induced Nausea and Vomiting: 1908\n",
      "  Chemotherapy Induced Peripheral Neuropathy: 1909\n",
      "  Chemotherapy Induced Thrombocytopenia: 1910\n",
      "  Chemotherapy Patients: 1911\n",
      "  Chemotherapy Symptoms: 1912\n",
      "  Chemotherapy-Induced Myelosuppression: 1913\n",
      "  Chemotherapy-Induced Nausea and Vomiting: 1914\n",
      "  Chemotherapy-Induced Neutropenia: 1915\n",
      "  Chemotherapy-Induced Peripheral Neuropathy: 1916\n",
      "  Chemotherapy-Induced Thrombocytopenia: 1917\n",
      "  Chemotherapy-induced Nausea and Vomiting: 1918\n",
      "  Chemotherapy-induced Nausea and Vomiting (CINV): 1919\n",
      "  Chemotherapy-induced Neutropenia: 1920\n",
      "  Chemotherapy-induced Peripheral Neuropathy: 1921\n",
      "  Chemotherapy-induced Thrombocytopenia: 1922\n",
      "  Chest Pain: 1923\n",
      "  Chest Pain Rule Out Myocardial Infarction: 1924\n",
      "  Chickenpox: 1925\n",
      "  Chikungunya Virus: 1926\n",
      "  Child Abuse: 1927\n",
      "  Child Abuse, Sexual: 1928\n",
      "  Child Behavior: 1929\n",
      "  Child Delivery Using an Elective C- Section: 1930\n",
      "  Child Development: 1931\n",
      "  Child Externalizing Problems: 1932\n",
      "  Child Weight: 1933\n",
      "  Child-Pugh Class A: 1934\n",
      "  Childhood Absence Epilepsy: 1935\n",
      "  Childhood Acute Myeloblastic Leukemia With Maturation (M2): 1936\n",
      "  Childhood Atypical Teratoid/Rhabdoid Tumor: 1937\n",
      "  Childhood Brain Neoplasm: 1938\n",
      "  Childhood Brain Tumor: 1939\n",
      "  Childhood Brain Tumors: 1940\n",
      "  Childhood CNS Primitive Neuroectodermal Tumor: 1941\n",
      "  Childhood Cancer: 1942\n",
      "  Childhood Cancer Survivors: 1943\n",
      "  Childhood Central Nervous System Germ Cell Tumor: 1944\n",
      "  Childhood Choroid Plexus Tumor: 1945\n",
      "  Childhood Chronic Immune Thrombocytopenia: 1946\n",
      "  Childhood Craniopharyngioma: 1947\n",
      "  Childhood Germ Cell Tumor: 1948\n",
      "  Childhood Mortality: 1949\n",
      "  Childhood Myelodysplastic Syndromes: 1950\n",
      "  Childhood Neoplasm: 1951\n",
      "  Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma: 1952\n",
      "  Childhood Obesity: 1953\n",
      "  Childhood Pneumonia: 1954\n",
      "  Childhood Solid Neoplasm: 1955\n",
      "  Childhood Solid Tumor: 1956\n",
      "  Childhood Solid Tumors: 1957\n",
      "  Children: 1958\n",
      "  Children Born With Serious Intra-uterine Growth Retardation: 1959\n",
      "  Children and Adolescent With Type 2 Diabetes: 1960\n",
      "  Children in the Pediatric Intensive Care Unit or General Pediatric Care Unit Requiring a Central Venous Catheter: 1961\n",
      "  Chlamydia Infection: 1962\n",
      "  Chlamydia Trachomatis: 1963\n",
      "  Chlamydia Trachomatis Infection: 1964\n",
      "  Chlamydial Infection: 1965\n",
      "  Choanal Atresia: 1966\n",
      "  Cholangiocarcinoma: 1967\n",
      "  Cholangiocarcinoma Non-resectable: 1968\n",
      "  Cholangiocarcinoma of the Gallbladder: 1969\n",
      "  Cholangitis, Sclerosing: 1970\n",
      "  Cholecystitis: 1971\n",
      "  Cholecystitis, Acute: 1972\n",
      "  Choledocholithiasis: 1973\n",
      "  Cholelithiasis: 1974\n",
      "  Cholera: 1975\n",
      "  Cholera Vaccination: 1976\n",
      "  Cholestasis: 1977\n",
      "  Cholestasis, Intrahepatic: 1978\n",
      "  Cholestasis, Progressive Familial Intrahepatic 3: 1979\n",
      "  Cholesterol Embolism Systemic: 1980\n",
      "  Cholesterol Lowering: 1981\n",
      "  Chondrosarcoma: 1982\n",
      "  Chordoma: 1983\n",
      "  Chorioamnionitis: 1984\n",
      "  Choriocarcinoma: 1985\n",
      "  Chorionic Villi Sampling: 1986\n",
      "  Choroid Neovascularization: 1987\n",
      "  Choroid Plexus Tumors: 1988\n",
      "  Choroidal Melanoma: 1989\n",
      "  Choroidal Neo-Vascular Age-onset Macular Degeneration: 1990\n",
      "  Choroidal Neovascularization: 1991\n",
      "  Choroidal Neovascularization in Angioid Streaks: 1992\n",
      "  Choroideremia: 1993\n",
      "  Chromophobe Renal Cell Carcinoma: 1994\n",
      "  Chronic Abdominal Wall Pain: 1995\n",
      "  Chronic Allergic Conjunctivitis: 1996\n",
      "  Chronic Allograft Dysfunction: 1997\n",
      "  Chronic Allograft Nephropathy: 1998\n",
      "  Chronic Anal Fissure: 1999\n",
      "  Chronic Antibody-mediated Transplant Rejection: 2000\n",
      "  Chronic Aphasia: 2001\n",
      "  Chronic Arsenic Poisoning: 2002\n",
      "  Chronic Arthritis: 2003\n",
      "  Chronic Asthma: 2004\n",
      "  Chronic Atrophic Gastritis: 2005\n",
      "  Chronic B-cell Lymphocytic Leukemia: 2006\n",
      "  Chronic Bacterial Prostatitis: 2007\n",
      "  Chronic Beryllium Disease: 2008\n",
      "  Chronic Bronchitis: 2009\n",
      "  Chronic Cluster Headache: 2010\n",
      "  Chronic Comorbid Conditions: 2011\n",
      "  Chronic Constipation: 2012\n",
      "  Chronic Cough: 2013\n",
      "  Chronic Daily Headache: 2014\n",
      "  Chronic Delta Hepatitis: 2015\n",
      "  Chronic Diabetic Foot Ulcers: 2016\n",
      "  Chronic Disease: 2017\n",
      "  Chronic Dysphagia: 2018\n",
      "  Chronic Exertional Compartment Syndrome: 2019\n",
      "  Chronic Fatigue Syndrome: 2020\n",
      "  Chronic Fatigue With OSA: 2021\n",
      "  Chronic Functional Diarrhea of Unknown Origin: 2022\n",
      "  Chronic Gastritis: 2023\n",
      "  Chronic Gastrointestinal Graft vs Host Disease: 2024\n",
      "  Chronic Genotype 1 Hepatitis C Virus Infection: 2025\n",
      "  Chronic Graft Versus Host Disease: 2026\n",
      "  Chronic Graft Versus Host Disease cGVHD: 2027\n",
      "  Chronic Graft vs. Host Disease: 2028\n",
      "  Chronic Graft-Versus-Host Disease: 2029\n",
      "  Chronic Graft-versus-Host-Disease: 2030\n",
      "  Chronic Graft-versus-host Disease: 2031\n",
      "  Chronic Graft-versus-host-disease: 2032\n",
      "  Chronic Granulomatous Disease: 2033\n",
      "  Chronic Granulomatous Diseases (CGD) and Liver Lesions: 2034\n",
      "  Chronic HCV Infection: 2035\n",
      "  Chronic Hand Dermatitis: 2036\n",
      "  Chronic Hand Eczema: 2037\n",
      "  Chronic Headache: 2038\n",
      "  Chronic Heart Failure: 2039\n",
      "  Chronic Heart Failure (CHF): 2040\n",
      "  Chronic Heart Failure With Reduced Ejection Fraction: 2041\n",
      "  Chronic Heart Failure With Reduced Systolic Function: 2042\n",
      "  Chronic Hepatitis: 2043\n",
      "  Chronic Hepatitis B: 2044\n",
      "  Chronic Hepatitis B Virus Infection: 2045\n",
      "  Chronic Hepatitis C: 2046\n",
      "  Chronic Hepatitis C (CHC): 2047\n",
      "  Chronic Hepatitis C Infection: 2048\n",
      "  Chronic Hepatitis C Virus: 2049\n",
      "  Chronic Hepatitis C Virus (HCV): 2050\n",
      "  Chronic Hepatitis C Virus (HCV) Infection: 2051\n",
      "  Chronic Hepatitis C Virus Genotype 1: 2052\n",
      "  Chronic Hepatitis C Virus Infection: 2053\n",
      "  Chronic Hepatitis C, HCV Genotype 1: 2054\n",
      "  Chronic Hepatitis D Infection: 2055\n",
      "  Chronic Hepatitis b: 2056\n",
      "  Chronic Hepatitis c: 2057\n",
      "  Chronic Hepatitits C: 2058\n",
      "  Chronic Hypersecretions: 2059\n",
      "  Chronic Hypertension: 2060\n",
      "  Chronic Hypertension Complicating Pregnancy (Diagnosis): 2061\n",
      "  Chronic Idiopathic Constipation: 2062\n",
      "  Chronic Idiopathic Thrombocytopenic Purpura: 2063\n",
      "  Chronic Idiopathic Urticaria: 2064\n",
      "  Chronic Immune Thrombocytopenia: 2065\n",
      "  Chronic Inflammation: 2066\n",
      "  Chronic Inflammatory Demyelinating Neuropathy: 2067\n",
      "  Chronic Inflammatory Demyelinating Polyneuropathy: 2068\n",
      "  Chronic Inflammatory Demyelinating Polyradiculoneuropathy: 2069\n",
      "  Chronic Insomnia: 2070\n",
      "  Chronic Interstitial Cystitis: 2071\n",
      "  Chronic Intracranial Subdural Hematoma: 2072\n",
      "  Chronic Intractable Pain: 2073\n",
      "  Chronic Iron Overload Due to Transfusion-dependant Anemias: 2074\n",
      "  Chronic Ischemic Cardiomyopathy: 2075\n",
      "  Chronic Ischemic Heart Disease: 2076\n",
      "  Chronic Ischemic Left Ventricular Dysfunction: 2077\n",
      "  Chronic Ischemic Stroke: 2078\n",
      "  Chronic Kidney Disease: 2079\n",
      "  Chronic Kidney Disease (CKD): 2080\n",
      "  Chronic Kidney Disease (CKD) Stage 5: 2081\n",
      "  Chronic Kidney Disease Requiring Hemodialysis: 2082\n",
      "  Chronic Kidney Disease Stage 3: 2083\n",
      "  Chronic Kidney Disease Stage 3 and 4: 2084\n",
      "  Chronic Kidney Disease, Secondary Hyperparathyroidism: 2085\n",
      "  Chronic Kidney Disease, Unspecified: 2086\n",
      "  Chronic Kidney Diseases: 2087\n",
      "  Chronic Kidney Diseases Stage 5: 2088\n",
      "  Chronic Kidney Failure: 2089\n",
      "  Chronic Left Ventricular Failure: 2090\n",
      "  Chronic Leg Ulcers: 2091\n",
      "  Chronic Liver Disease: 2092\n",
      "  Chronic Low Back Pain: 2093\n",
      "  Chronic Low Back Pain With a Neuropathic Component: 2094\n",
      "  Chronic Lower Back Pain: 2095\n",
      "  Chronic Lung Disease: 2096\n",
      "  Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis: 2097\n",
      "  Chronic Lymphatic Leukemia: 2098\n",
      "  Chronic Lymphocyte Leukemia: 2099\n",
      "  Chronic Lymphocytic Leucemia: 2100\n",
      "  Chronic Lymphocytic Leukaemia: 2101\n",
      "  Chronic Lymphocytic Leukemia: 2102\n",
      "  Chronic Lymphocytic Leukemia (CLL): 2103\n",
      "  Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma.: 2104\n",
      "  Chronic Lymphocytic Leukemia(CLL): 2105\n",
      "  Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: 2106\n",
      "  Chronic Lymphoid Leukemia: 2107\n",
      "  Chronic Male Pelvic Pain Syndrome: 2108\n",
      "  Chronic Migraine: 2109\n",
      "  Chronic Multisymptom Illness in Gulf War Veterans: 2110\n",
      "  Chronic Myeloblastic Leukaemia: 2111\n",
      "  Chronic Myelogenous Leukemia: 2112\n",
      "  Chronic Myelogenous Leukemia - Chronic Phase: 2113\n",
      "  Chronic Myelogenous Leukemia, BCR-ABL1 Positive: 2114\n",
      "  Chronic Myelogenous Leukemia, Ph1-Positive: 2115\n",
      "  Chronic Myelogous Leukemia/Other Leukemia: 2116\n",
      "  Chronic Myeloid Leukemia: 2117\n",
      "  Chronic Myeloid Leukemia (CML): 2118\n",
      "  Chronic Myeloid Leukemia - Chronic Phase: 2119\n",
      "  Chronic Myeloid Leukemia in Chronic Phase: 2120\n",
      "  Chronic Myeloid Leukemia, Blast Crisis: 2121\n",
      "  Chronic Myelomonocytic Leukemia: 2122\n",
      "  Chronic Myeloproliferative Disorders: 2123\n",
      "  Chronic Myocardial Ischemia: 2124\n",
      "  Chronic Neuropathic Pain: 2125\n",
      "  Chronic Non-Malignant Pain: 2126\n",
      "  Chronic Non-specific, Uncomplicated Neck Pain: 2127\n",
      "  Chronic Noncancer Pain: 2128\n",
      "  Chronic Nonhealing Wounds: 2129\n",
      "  Chronic Nonmalignant Pain: 2130\n",
      "  Chronic Nonspecific Low Back Pain: 2131\n",
      "  Chronic Obstructive Airway Disease: 2132\n",
      "  Chronic Obstructive Lung Disease: 2133\n",
      "  Chronic Obstructive Pulmonary: 2134\n",
      "  Chronic Obstructive Pulmonary Disease: 2135\n",
      "  Chronic Obstructive Pulmonary Disease (COPD: 2136\n",
      "  Chronic Obstructive Pulmonary Disease (COPD): 2137\n",
      "  Chronic Obstructive Pulmonary Disease (COPD) With Cachexia: 2138\n",
      "  Chronic Obstructive Pulmonary Disease COPD: 2139\n",
      "  Chronic Obstructive Pulmonary Disease Mild: 2140\n",
      "  Chronic Obstructive Pulmonary Disease Moderate: 2141\n",
      "  Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation: 2142\n",
      "  Chronic Obstructive Pulmonary Diseases: 2143\n",
      "  Chronic Osteoarthritis: 2144\n",
      "  Chronic Pain: 2145\n",
      "  Chronic Pain Due to Trauma: 2146\n",
      "  Chronic Pain Following Thermal Burn Injury: 2147\n",
      "  Chronic Pain Post-Procedural: 2148\n",
      "  Chronic Pancreatitis: 2149\n",
      "  Chronic Pelvic Pain Syndrome: 2150\n",
      "  Chronic Periaortitis: 2151\n",
      "  Chronic Periodontitis: 2152\n",
      "  Chronic Peripheral Neuropathy Pain in Diabetics: 2153\n",
      "  Chronic Peritoneal Dialysis: 2154\n",
      "  Chronic Phase Chronic Myeloid Leukemia: 2155\n",
      "  Chronic Plaque Psoriasis: 2156\n",
      "  Chronic Post Traumatic Headache: 2157\n",
      "  Chronic Post-Traumatic Stress Disorder: 2158\n",
      "  Chronic Posterior Laryngitis (CPL): 2159\n",
      "  Chronic Postoperative Pain: 2160\n",
      "  Chronic Posttraumatic Stress Disorder: 2161\n",
      "  Chronic Prostatitis: 2162\n",
      "  Chronic Prostatitis With Chronic Pelvic Pain Syndrome: 2163\n",
      "  Chronic Pruritus: 2164\n",
      "  Chronic Rejection: 2165\n",
      "  Chronic Renal Disease: 2166\n",
      "  Chronic Renal Failure: 2167\n",
      "  Chronic Renal Failure Related Anemia: 2168\n",
      "  Chronic Renal Impairment: 2169\n",
      "  Chronic Respiratory Failure With Hypoxia: 2170\n",
      "  Chronic Rhinitis: 2171\n",
      "  Chronic Rhinosinusitis: 2172\n",
      "  Chronic Rhinosinusitis (Diagnosis): 2173\n",
      "  Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis: 2174\n",
      "  Chronic Rhinosinusitis Without Nasal Polyps: 2175\n",
      "  Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP): 2176\n",
      "  Chronic Scalp Psoriasis: 2177\n",
      "  Chronic Schizophrenia: 2178\n",
      "  Chronic Sinus Infection: 2179\n",
      "  Chronic Sinusitis: 2180\n",
      "  Chronic Sinusitis With Nasal Polyps and Eosinophilia: 2181\n",
      "  Chronic Sinusitis With or Without Nasal Polyps: 2182\n",
      "  Chronic Spontaneous Urticaria: 2183\n",
      "  Chronic Stable Angina: 2184\n",
      "  Chronic Stable Angina Pectoris: 2185\n",
      "  Chronic Stable Plaque Psoriasis: 2186\n",
      "  Chronic Stress: 2187\n",
      "  Chronic Subdural Hematoma: 2188\n",
      "  Chronic Systolic Heart Failure: 2189\n",
      "  Chronic Thromboembolic Pulmonary Hypertension: 2190\n",
      "  Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 2191\n",
      "  Chronic Tinnitus: 2192\n",
      "  Chronic Total Occlusion: 2193\n",
      "  Chronic Ulcer of Lower Extremity: 2194\n",
      "  Chronic Urticaria: 2195\n",
      "  Chronic Uveitis: 2196\n",
      "  Chronic Vegetative State: 2197\n",
      "  Chronic Venous Disease of Lower Limbs: 2198\n",
      "  Chronic Venous Insufficiency: 2199\n",
      "  Chronic Venous Leg Ulcers: 2200\n",
      "  Chronic Versus Graft Host Disease: 2201\n",
      "  Chronic Viral Hepatitis B Without Delta-agent: 2202\n",
      "  Chronic Wound: 2203\n",
      "  Chronic, Non Malignant Pain: 2204\n",
      "  Chronic-kidney Disease Stage 5D on Stable Hemodialysis: 2205\n",
      "  Churg-Strauss Syndrome: 2206\n",
      "  Cicatrix: 2207\n",
      "  Cigarette Smoker: 2208\n",
      "  Cigarette Smoking: 2209\n",
      "  Cigarette Smoking Toxicity: 2210\n",
      "  Ciliary Body and Choroid Melanoma, Medium/Large Size: 2211\n",
      "  Circadian Rhythm Disorders: 2212\n",
      "  Circulatory Shock: 2213\n",
      "  Circumcision: 2214\n",
      "  Cirrhoses, Liver: 2215\n",
      "  Cirrhosis: 2216\n",
      "  Cirrhosis of Liver: 2217\n",
      "  Cisplatin Induced Hearing Loss: 2218\n",
      "  Classical Hodgkin Lymphoma: 2219\n",
      "  Claudication: 2220\n",
      "  Clavicle Fracture: 2221\n",
      "  Clear Cell Renal Carcinoma: 2222\n",
      "  Clear Cell Renal Cell Carcinoma: 2223\n",
      "  Clear Cell Renal Cell Carcinoma (ccRCC): 2224\n",
      "  Clear Cell Sarcoma: 2225\n",
      "  Clear-cell Metastatic Renal Cell Carcinoma: 2226\n",
      "  Clear-cell Renal Cell Carcinoma: 2227\n",
      "  Cleft Palate: 2228\n",
      "  Clexane is Administered to Healthy Volunteers: 2229\n",
      "  Climacteric Syndrome: 2230\n",
      "  Clinical Competence: 2231\n",
      "  Clinical High Risk for Psychosis: 2232\n",
      "  Clinical Infection: 2233\n",
      "  Clinical Malaria: 2234\n",
      "  Clinical Pharmacology: 2235\n",
      "  Clinical Pharmacology, Healthy Volunteer Study: 2236\n",
      "  Clinical Pregnancy After Single Embryo Transfer: 2237\n",
      "  Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8: 2238\n",
      "  Clinical Trials, Phase I as Topic: 2239\n",
      "  Clinical and Radiographic Success in 24 Months: 2240\n",
      "  Clinically Isolated Syndromes: 2241\n",
      "  Clinically Significant Diabetic Macular Edema: 2242\n",
      "  Clinically Significant Portal Hypertension: 2243\n",
      "  Clomiphene Citrate Resistant Polycystic Ovary Syndrome: 2244\n",
      "  Clopidogrel: 2245\n",
      "  Clopidogrel Resistance: 2246\n",
      "  Closed Fracture of Ankle: 2247\n",
      "  Clostridia Difficile Colitis: 2248\n",
      "  Clostridial Infection: 2249\n",
      "  Clostridium: 2250\n",
      "  Clostridium Difficile: 2251\n",
      "  Clostridium Difficile Colitis: 2252\n",
      "  Clostridium Difficile Diarrhea: 2253\n",
      "  Clostridium Difficile Infection: 2254\n",
      "  Clostridium Difficile Infection Recurrence: 2255\n",
      "  Clostridium Difficile-Associated Diarrhea: 2256\n",
      "  Clostridium Difficile-associated Diarrhea (CDAD): 2257\n",
      "  Clostridium Enterocolitis: 2258\n",
      "  Clostridium Infections: 2259\n",
      "  Clotrimazole: 2260\n",
      "  Cluster Headache: 2261\n",
      "  Cluster Headache - Episodic and Chronic: 2262\n",
      "  Coagulation: 2263\n",
      "  Coagulation; Intravascular: 2264\n",
      "  Coagulopathic Bleeding: 2265\n",
      "  Coagulopathy: 2266\n",
      "  Coarctation of the Aorta: 2267\n",
      "  Cocaine Abuse: 2268\n",
      "  Cocaine Addiction: 2269\n",
      "  Cocaine Dependence: 2270\n",
      "  Cocaine Dependent: 2271\n",
      "  Cocaine Dependent Subjects: 2272\n",
      "  Cocaine Induced Sympathoexciation and Vasoconstriction: 2273\n",
      "  Cocaine Related Disorders: 2274\n",
      "  Cocaine Use: 2275\n",
      "  Cocaine Use Disorder: 2276\n",
      "  Cocaine Use Disorders: 2277\n",
      "  Cocaine-Related Disorders: 2278\n",
      "  Cocaine-related Disorders: 2279\n",
      "  Coccidioidomycosis: 2280\n",
      "  Cochlear Hearing Loss: 2281\n",
      "  Cognition: 2282\n",
      "  Cognition Disorder: 2283\n",
      "  Cognition Disorders: 2284\n",
      "  Cognitive Ability, General: 2285\n",
      "  Cognitive Change: 2286\n",
      "  Cognitive Decline: 2287\n",
      "  Cognitive Deficits: 2288\n",
      "  Cognitive Deficits in Schizophrenia: 2289\n",
      "  Cognitive Dysfunction: 2290\n",
      "  Cognitive Function 1, Social: 2291\n",
      "  Cognitive Impairment: 2292\n",
      "  Cognitive Impairment Associated With Schizophrenia (CIAS): 2293\n",
      "  Cognitive Impairment, Mild: 2294\n",
      "  Cognitive Symptoms: 2295\n",
      "  Cognitive/Functional Effects: 2296\n",
      "  Cognitively Normal Older Adults: 2297\n",
      "  Cold: 2298\n",
      "  Cold Agglutinin Disease: 2299\n",
      "  Cold Contact Urticaria: 2300\n",
      "  Cold Exposure: 2301\n",
      "  Colectomy: 2302\n",
      "  Colic: 2303\n",
      "  Colic, Infantile: 2304\n",
      "  Colitis: 2305\n",
      "  Colitis, Ulcerative: 2306\n",
      "  Collapse of Thoracic Vertebra: 2307\n",
      "  Colo-colonic Anastomoses: 2308\n",
      "  Colo-rectal Cancer: 2309\n",
      "  Colon Adenocarcinoma: 2310\n",
      "  Colon Adenoma: 2311\n",
      "  Colon Adenomas: 2312\n",
      "  Colon Cancer: 2313\n",
      "  Colon Cancer Liver Metastasis: 2314\n",
      "  Colon Cancer Metastatic: 2315\n",
      "  Colon Cancer Prevention: 2316\n",
      "  Colon Cancer, Rectal Cancer: 2317\n",
      "  Colon Carcinoma: 2318\n",
      "  Colon Cleansing for Colonoscopy: 2319\n",
      "  Colon Mucinous Adenocarcinoma: 2320\n",
      "  Colon Polyps: 2321\n",
      "  Colon Preparation: 2322\n",
      "  Colon Rectal Resection: 2323\n",
      "  Colon Tumors: 2324\n",
      "  Colonic Cancer: 2325\n",
      "  Colonic Diverticulosis: 2326\n",
      "  Colonic Inertia: 2327\n",
      "  Colonic Neoplasms: 2328\n",
      "  Colonic Polyps: 2329\n",
      "  Colonization: 2330\n",
      "  Colonoscopy: 2331\n",
      "  Colonoscopy Diagnostic Techniques and Procedures: 2332\n",
      "  Colonoscopy Failure: 2333\n",
      "  Colonoscopy Preparation: 2334\n",
      "  Colonoscopy Procedure: 2335\n",
      "  Colorectal Adenocarcinoma: 2336\n",
      "  Colorectal Adenocarcinoma Metastatic to the Liver: 2337\n",
      "  Colorectal Adenoma: 2338\n",
      "  Colorectal Adenomas: 2339\n",
      "  Colorectal Cancer: 2340\n",
      "  Colorectal Cancer (CRC): 2341\n",
      "  Colorectal Cancer Metastatic: 2342\n",
      "  Colorectal Cancer Screening: 2343\n",
      "  Colorectal Cancer Stage IV: 2344\n",
      "  Colorectal Cancer With Hepatic Metastases: 2345\n",
      "  Colorectal Cancer, Genetics of: 2346\n",
      "  Colorectal Cancer, Metastatic: 2347\n",
      "  Colorectal Carcinoma: 2348\n",
      "  Colorectal Carcinomatosis: 2349\n",
      "  Colorectal Disorders: 2350\n",
      "  Colorectal Liver Metastases: 2351\n",
      "  Colorectal Neoplasm: 2352\n",
      "  Colorectal Neoplasms: 2353\n",
      "  Colorectal Peritoneal Carcinomatosis: 2354\n",
      "  Colorectal Surgery: 2355\n",
      "  Colorectal Tumors: 2356\n",
      "  Colostomy: 2357\n",
      "  Columnar Cell Variant Thyroid Gland Papillary Carcinoma: 2358\n",
      "  Coma: 2359\n",
      "  Combat Posttraumatic Stess Disorder: 2360\n",
      "  Combined Hyperlipidemia: 2361\n",
      "  Combined Immunodeficiencies: 2362\n",
      "  Common Bile Duct Stone: 2363\n",
      "  Common Cold: 2364\n",
      "  Common Variable Immunodeficiency: 2365\n",
      "  Common Wart: 2366\n",
      "  Communication: 2367\n",
      "  Community Acquired Bacterial Pneumonia: 2368\n",
      "  Community Acquired Pneumonia: 2369\n",
      "  Community Acquired Pneumonia, Severe: 2370\n",
      "  Community-Acquired Bacterial Pneumonia: 2371\n",
      "  Community-Acquired Bacterial Pneumonia (CABP): 2372\n",
      "  Community-Acquired Pneumonia: 2373\n",
      "  Community-acquired Bacterial Pneumonia: 2374\n",
      "  Community-acquired Infection: 2375\n",
      "  Community-acquired Pneumonia: 2376\n",
      "  Community-acquired Pneumonia (CAP): 2377\n",
      "  Comparative Bioavailability: 2378\n",
      "  Comparative Bioavailability of Clopidogrel Tablets: 2379\n",
      "  Comparative Multidose Pharmacokinetics: 2380\n",
      "  Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules: 2381\n",
      "  Comparison of the Efficacy of Two Formulations of Epoetin in Patients Undergoing Hemodialysis: 2382\n",
      "  Compartment Syndrome: 2383\n",
      "  Compensated Chronic Hepatitis B: 2384\n",
      "  Compensated Heart Failure: 2385\n",
      "  Complex Anal Fistula: 2386\n",
      "  Complex Partial Seizures: 2387\n",
      "  Complex Perianal Fistula: 2388\n",
      "  Complex Regional Pain Syndrome: 2389\n",
      "  Complex Regional Pain Syndrome (CRPS): 2390\n",
      "  Complex Regional Pain Syndrome Type 1: 2391\n",
      "  Complex Regional Pain Syndrome Type I: 2392\n",
      "  Complex Regional Pain Syndrome, Type 1: 2393\n",
      "  Complex Regional Pain Syndrome, Type I: 2394\n",
      "  Complex Regional Pain Syndromes: 2395\n",
      "  Compliance: 2396\n",
      "  Compliance, Patient: 2397\n",
      "  Complicated Appendicitis: 2398\n",
      "  Complicated Intra-Abdominal Infection: 2399\n",
      "  Complicated Intra-abdominal Infection: 2400\n",
      "  Complicated Parapneumonic Effusion: 2401\n",
      "  Complicated Skin and Skin Structure Infections: 2402\n",
      "  Complicated Skin and Soft Tissue Infection: 2403\n",
      "  Complicated Skin or Skin Structure Infection: 2404\n",
      "  Complicated Urinary Infection: 2405\n",
      "  Complicated Urinary Tract Infection: 2406\n",
      "  Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis: 2407\n",
      "  Complicated Urinary Tract Infections: 2408\n",
      "  Complicated Urinary Tract Infections or Pyelonephritis: 2409\n",
      "  Complication of Catheter: 2410\n",
      "  Complication of Renal Dialysis: 2411\n",
      "  Complication of Surgical Procedure: 2412\n",
      "  Complication of Transplanted Lung: 2413\n",
      "  Complication of Urinary Catheter: 2414\n",
      "  Complications: 2415\n",
      "  Complications of Renal Transplant: 2416\n",
      "  Complications of Transplanted Organs and Tissue: 2417\n",
      "  Complications, Pregnancy: 2418\n",
      "  Complications; Arthroplasty: 2419\n",
      "  Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer: 2420\n",
      "  Complications; Breast Prosthesis, Infection or Inflammation: 2421\n",
      "  Complications; Cesarean Section: 2422\n",
      "  Compulsive Shopping: 2423\n",
      "  Concussion: 2424\n",
      "  Condition Measuring Alkaline Tide and Filling Symptoms' Questionnaire After Abrupt or Gradual Step Down Cessation of PPI: 2425\n",
      "  Conditions in T74.31 or T76.31: 2426\n",
      "  Conduct Disorder: 2427\n",
      "  Conductive Hearing Loss: 2428\n",
      "  Condyloma: 2429\n",
      "  Condylomata Acuminata: 2430\n",
      "  Confirmed Genetic Diagnosis of Prader-Willi Syndrome: 2431\n",
      "  Congenital Adrenal Hyperplasia: 2432\n",
      "  Congenital Bleeding Disorder: 2433\n",
      "  Congenital Central Hypoventilation Syndrome: 2434\n",
      "  Congenital Cystic Adenomatoid Malformation: 2435\n",
      "  Congenital Cytomegalovirus (CMV): 2436\n",
      "  Congenital Cytomegalovirus Infection: 2437\n",
      "  Congenital Diaphragmatic Hernia: 2438\n",
      "  Congenital Diaphragmatic Hernias: 2439\n",
      "  Congenital Heart Defects: 2440\n",
      "  Congenital Heart Disease: 2441\n",
      "  Congenital Heart Disease With Fontan Circulation: 2442\n",
      "  Congenital Heart Diseases: 2443\n",
      "  Congenital Hyperinsulinism: 2444\n",
      "  Congenital Toxoplasmosis: 2445\n",
      "  Congenital or Acquired Limb Deficiency: 2446\n",
      "  Congestive Heart Failure: 2447\n",
      "  Congestive Heart Failure (CHF): 2448\n",
      "  Congestive Heart Failure, Atrial Fibrillation: 2449\n",
      "  Conjunctivitis: 2450\n",
      "  Conjunctivitis, Allergic: 2451\n",
      "  Conjunctivitis, Bacterial: 2452\n",
      "  Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: 2453\n",
      "  Conscious Sedation: 2454\n",
      "  Conscious Sedation Failure During Procedure: 2455\n",
      "  Constipation: 2456\n",
      "  Constipation - Functional: 2457\n",
      "  Constipation Drug Induced: 2458\n",
      "  Constipation Predominant: 2459\n",
      "  Constipation Predominant Irritable Bowel Syndrome: 2460\n",
      "  Constipation and Dyspepsia: 2461\n",
      "  Constipation, Signs and Symptoms, Digestive: 2462\n",
      "  Constipation-Predominant Irritable Bowel Syndrome: 2463\n",
      "  Constipation-predominant IBS (IBS-C): 2464\n",
      "  Constipation-predominant Irritable Bowel Syndrome (IBS-C): 2465\n",
      "  Constrictive Bronchiolitis: 2466\n",
      "  Contact Dermatitis: 2467\n",
      "  Contact Lens: 2468\n",
      "  Contact Lens Discomfort: 2469\n",
      "  Contact Lens Dry Eye: 2470\n",
      "  Contact Ulcer of Vocal Folds: 2471\n",
      "  Contiguous Stage II Adult Diffuse Large Cell Lymphoma: 2472\n",
      "  Contiguous Stage II Mantle Cell Lymphoma: 2473\n",
      "  Continuous Methamphetamine Abuse: 2474\n",
      "  Contraception: 2475\n",
      "  Contraceptive Methods Comparison: 2476\n",
      "  Contraceptive Usage: 2477\n",
      "  Contrast Induced Acute Kidney Injury: 2478\n",
      "  Contrast Induced Kidney Injury.: 2479\n",
      "  Contrast Induced Nephropathy: 2480\n",
      "  Contrast Media: 2481\n",
      "  Contrast Media Allergy: 2482\n",
      "  Contrast Nephropathy: 2483\n",
      "  Contrast-Induced Nephropathy: 2484\n",
      "  Contrast-induced Acute Kidney Injury: 2485\n",
      "  Contribution of Ethanol on Hydroxytyrosol Formation: 2486\n",
      "  Controlled Asthma: 2487\n",
      "  Controlled Hypotension for Nasal Surgeries: 2488\n",
      "  Controlled Ovarian Stimulation: 2489\n",
      "  Conventional Chondrosarcoma: 2490\n",
      "  Coral Snake Bite: 2491\n",
      "  Cord Blood Transplant: 2492\n",
      "  Cord Compression: 2493\n",
      "  Core Binding Factor Acute Myeloid Leukemia (CBF-AML): 2494\n",
      "  Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma: 2495\n",
      "  Corneal Abrasion: 2496\n",
      "  Corneal Astigmatism: 2497\n",
      "  Corneal Disease: 2498\n",
      "  Corneal Diseases: 2499\n",
      "  Corneal Ectasia: 2500\n",
      "  Corneal Health: 2501\n",
      "  Corneal Infiltrates: 2502\n",
      "  Corneal Neovascularization: 2503\n",
      "  Corneal Transplantation: 2504\n",
      "  Corneal Ulcer: 2505\n",
      "  Corneal Ulcers: 2506\n",
      "  Corneal re-Epithelialization: 2507\n",
      "  Coronary Angiograph: 2508\n",
      "  Coronary Arterioscleroses: 2509\n",
      "  Coronary Arteriosclerosis: 2510\n",
      "  Coronary Artery Bypass: 2511\n",
      "  Coronary Artery Bypass Graft: 2512\n",
      "  Coronary Artery Bypass Graft Surgery: 2513\n",
      "  Coronary Artery Bypass Grafting: 2514\n",
      "  Coronary Artery Bypass Grafting Surgery: 2515\n",
      "  Coronary Artery Bypass Surgery: 2516\n",
      "  Coronary Artery Disease: 2517\n",
      "  Coronary Artery Disease (CAD): 2518\n",
      "  Coronary Artery Diseases: 2519\n",
      "  Coronary Artery Dissection, Spontaneous: 2520\n",
      "  Coronary Artery Lesions: 2521\n",
      "  Coronary Artery Stenosis: 2522\n",
      "  Coronary Atherosclerosis: 2523\n",
      "  Coronary Atherosclerosis and Other Heart Disease: 2524\n",
      "  Coronary Bifurcation Lesions: 2525\n",
      "  Coronary Calcification: 2526\n",
      "  Coronary De-novo Stenoses: 2527\n",
      "  Coronary Disease: 2528\n",
      "  Coronary Graft Patency: 2529\n",
      "  Coronary Heart Disease: 2530\n",
      "  Coronary Instent Restenosis: 2531\n",
      "  Coronary Insufficiency: 2532\n",
      "  Coronary Microvascular Dysfunction: 2533\n",
      "  Coronary Occlusion: 2534\n",
      "  Coronary Restenosis: 2535\n",
      "  Coronary Stenosis: 2536\n",
      "  Coronary Stent Occlusion: 2537\n",
      "  Coronary Surgery With Cardiopulmonary Bypass: 2538\n",
      "  Coronary Vasospasm: 2539\n",
      "  Coronary and Peripheral Endothelial Dysfunction: 2540\n",
      "  Coronavirus (SARS-CoV): 2541\n",
      "  Corpus Uteri: 2542\n",
      "  Cortical Spreading Depolarization: 2543\n",
      "  Corticosteroid Refractory Acute Graft vs Host Disease: 2544\n",
      "  Corticotropin Deficiency: 2545\n",
      "  Cosmetic Techniques: 2546\n",
      "  Cough: 2547\n",
      "  Coughing: 2548\n",
      "  Cow's Milk Allergy: 2549\n",
      "  Craniopharyngioma: 2550\n",
      "  Craniosynostosis: 2551\n",
      "  Crestal Bone Loss: 2552\n",
      "  Crigler-Najjar Syndrome: 2553\n",
      "  Crimean-Congo Hemorrhagic Fever: 2554\n",
      "  Critical Care Trial Participation Consent by SDM: 2555\n",
      "  Critical Illness: 2556\n",
      "  Critical Limb Ischemia: 2557\n",
      "  Critical Limb Ischemia (CLI): 2558\n",
      "  Critical Limb Ischemia Due to Buerger's Disease: 2559\n",
      "  Critically Ill: 2560\n",
      "  Critically Ill Patients: 2561\n",
      "  Crohn Disease: 2562\n",
      "  Crohn's Disease: 2563\n",
      "  Crohn's Disease Aggravated: 2564\n",
      "  Crohn's Disease With Perianal Fistulas: 2565\n",
      "  Crohns Disease: 2566\n",
      "  Crohn´s Disease: 2567\n",
      "  Cross Infection: 2568\n",
      "  Croup: 2569\n",
      "  Crow's Feet Lines: 2570\n",
      "  Cryoglobulinemia: 2571\n",
      "  Cryopreservation: 2572\n",
      "  Cryopyrin Associated Periodic Syndrome: 2573\n",
      "  Cryopyrin-Associated Periodic Syndromes (CAPS): 2574\n",
      "  Cryotherapy Effect: 2575\n",
      "  Cryptococcal Infection Disseminated: 2576\n",
      "  Cryptococcal Infections: 2577\n",
      "  Cryptococcal Meningitis: 2578\n",
      "  Cryptococcosis: 2579\n",
      "  Cryptosporidiosis: 2580\n",
      "  Cspine Injury: 2581\n",
      "  Curarization, Postoperative Residual: 2582\n",
      "  Curative Breast Cancer Surgery: 2583\n",
      "  Current Smoker: 2584\n",
      "  Current or Recent History of Atrial Fibrillation: 2585\n",
      "  Cushing Disease: 2586\n",
      "  Cushing Syndrome: 2587\n",
      "  Cushing's Disease: 2588\n",
      "  Cushing's Syndrome: 2589\n",
      "  Cushings Disease: 2590\n",
      "  Cutaneous B-cell Non-Hodgkin Lymphoma: 2591\n",
      "  Cutaneous Hypersensitivity: 2592\n",
      "  Cutaneous Inflammation: 2593\n",
      "  Cutaneous Leishmaniases: 2594\n",
      "  Cutaneous Leishmaniasis: 2595\n",
      "  Cutaneous Lupus: 2596\n",
      "  Cutaneous Lupus Erythematosus: 2597\n",
      "  Cutaneous Lymphoma: 2598\n",
      "  Cutaneous Melanoma: 2599\n",
      "  Cutaneous Metastasis: 2600\n",
      "  Cutaneous Nerves CNS Itch: 2601\n",
      "  Cutaneous Squamous Cell Carcinoma: 2602\n",
      "  Cutaneous Squamous Cell Carcinoma in Situ (CSCCis): 2603\n",
      "  Cutaneous T Cell Lymphoma: 2604\n",
      "  Cutaneous T Cell Lymphomas (CTCL): 2605\n",
      "  Cutaneous T-Cell Lymphoma: 2606\n",
      "  Cutaneous T-Cell Lymphoma (Mycosis Fungoides): 2607\n",
      "  Cutaneous T-Cell Lymphoma/Mycosis Fungoides: 2608\n",
      "  Cutaneous T-Cell Lymphomas: 2609\n",
      "  Cutaneous T-Cell Non-Hodgkin Lymphoma: 2610\n",
      "  Cutaneous T-cell Lymphoma: 2611\n",
      "  Cutaneous T-cell Lymphoma (CTCL): 2612\n",
      "  Cutaneous T-cell Lymphoma Stage I: 2613\n",
      "  Cutaneous or Sub-cutaneous Malignancies: 2614\n",
      "  Cyanotic Congenital Heart Disease: 2615\n",
      "  Cyclic Mastodynia: 2616\n",
      "  Cyst: 2617\n",
      "  Cystic Fibrosis: 2618\n",
      "  Cystic Fibrosis (CF): 2619\n",
      "  Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception: 2620\n",
      "  Cystic Fibrosis Related Bone Disease: 2621\n",
      "  Cystic Fibrosis Related Diabetes: 2622\n",
      "  Cystic Fibrosis With Mild to Moderate Lung Disease: 2623\n",
      "  Cystic Fibrosis With Pulmonary Manifestations: 2624\n",
      "  Cystinosis: 2625\n",
      "  Cystinuria: 2626\n",
      "  Cystitis: 2627\n",
      "  Cystitis, Interstitial: 2628\n",
      "  Cystocele: 2629\n",
      "  Cystoid Macular Edema: 2630\n",
      "  Cystoid Macular Edema Following Cataract Surgery, Bilateral: 2631\n",
      "  Cytochrome P450 CYP3A5 Enzyme Polymorphism: 2632\n",
      "  Cytokines: 2633\n",
      "  Cytomegalovirus: 2634\n",
      "  Cytomegalovirus (CMV): 2635\n",
      "  Cytomegalovirus (CMV) Infection: 2636\n",
      "  Cytomegalovirus Disease: 2637\n",
      "  Cytomegalovirus Infection: 2638\n",
      "  Cytomegalovirus Infections: 2639\n",
      "  Cytomegalovirus Infections, Heart Transplantation: 2640\n",
      "  Cytomegalovirus Positive: 2641\n",
      "  Cytomegalovirus Retinitis: 2642\n",
      "  D Vitamin Deficiency Patients: 2643\n",
      "  DCIS: 2644\n",
      "  DCild Development Disorders, Pervasive: 2645\n",
      "  DDP: 2646\n",
      "  DLBCL: 2647\n",
      "  DS Stage I Plasma Cell Myeloma: 2648\n",
      "  DVT: 2649\n",
      "  DVT - Deep Vein Thrombosis: 2650\n",
      "  Dacryocystorhinostomy: 2651\n",
      "  Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed: 2652\n",
      "  De Novo Kidney Transplant: 2653\n",
      "  De Novo Kidney Transplantation: 2654\n",
      "  De Novo Renal Transplantation: 2655\n",
      "  DeQuervain's Tenosynovitis: 2656\n",
      "  DeQuervains Tenosynovitis: 2657\n",
      "  Deafness: 2658\n",
      "  Death: 2659\n",
      "  Death, Sudden, Cardiac: 2660\n",
      "  Deaths: 2661\n",
      "  Decompensated Cirrhosis: 2662\n",
      "  Decrease Labor Pain: 2663\n",
      "  Dedifferentiated Liposarcoma: 2664\n",
      "  Deep Fibromatosis/Desmoid Tumor: 2665\n",
      "  Deep Full-thickness Burn Injury (Disorder): 2666\n",
      "  Deep Sedation: 2667\n",
      "  Deep Vein Thrombosis: 2668\n",
      "  Deep Vein Thrombosis (DVT): 2669\n",
      "  Deep Vein Thrombosis Leg: 2670\n",
      "  Deep Venous Thrombosis: 2671\n",
      "  Defibrillators, Implantable: 2672\n",
      "  Deficiency; Fibrinogen, Acquired: 2673\n",
      "  Degeneration Disc Intervertebral: 2674\n",
      "  Degenerative Arthritis: 2675\n",
      "  Degenerative Arthritis and Postoperative Pain: 2676\n",
      "  Degenerative Disc Disease: 2677\n",
      "  Degenerative Intervertebral Discs: 2678\n",
      "  Degenerative Joint Disease: 2679\n",
      "  Degenerative Lumbar Spinal Stenosis: 2680\n",
      "  Degenerative Spondylolisthesis or Retrolisthesis: 2681\n",
      "  Dehydration: 2682\n",
      "  Dehydration, Diverting Ileostomy, Loperamide: 2683\n",
      "  Delay in Time to Lactogenesis Stage II: 2684\n",
      "  Delayed Function of Renal Transplant: 2685\n",
      "  Delayed Graft Function: 2686\n",
      "  Delayed Onset Muscle Soreness: 2687\n",
      "  Delayed Onset Muscle Soreness, DOMS: 2688\n",
      "  Delayed Sleep Phase Syndrome: 2689\n",
      "  Delayed Transit Time: 2690\n",
      "  Deliberate Self Harm: 2691\n",
      "  Delirium: 2692\n",
      "  Delirium in Old Age: 2693\n",
      "  Delirium on Emergence: 2694\n",
      "  Delirium, Dementia, Amnestic, Cognitive Disorders: 2695\n",
      "  Delta-9-Tetrahydroncannabinol: 2696\n",
      "  Dementia: 2697\n",
      "  Dementia Alzheimer's Type: 2698\n",
      "  Dementia With Lewy Bodies: 2699\n",
      "  Dementia With Lewy Bodies (DLB): 2700\n",
      "  Dementia With Vitamin B12 Deficiency: 2701\n",
      "  Dementia of Alzheimer's Type: 2702\n",
      "  Dementia, Alzheimer Type: 2703\n",
      "  Dementia, Vascular: 2704\n",
      "  Dementia-related Psychosis: 2705\n",
      "  Demyelinating Disorders: 2706\n",
      "  Demyelinating Sensorimotor Neuropathy: 2707\n",
      "  Dengue: 2708\n",
      "  Dengue Fever: 2709\n",
      "  Dense Deposit Disease: 2710\n",
      "  Dent's Disease: 2711\n",
      "  Dental Anesthesia: 2712\n",
      "  Dental Anxiety: 2713\n",
      "  Dental Cares Under Kalinox's Inhalation: 2714\n",
      "  Dental Caries: 2715\n",
      "  Dental Implantation: 2716\n",
      "  Dental Pain: 2717\n",
      "  Dental Plaque: 2718\n",
      "  Dental Pulp Diseases: 2719\n",
      "  Dental Pulp Regeneration: 2720\n",
      "  Dentin Sensitivity: 2721\n",
      "  Dentinal Hypersensitivity: 2722\n",
      "  Dentine Hypersensitivity: 2723\n",
      "  Denture Stomatitis: 2724\n",
      "  Denutrition: 2725\n",
      "  Depersonalization Disorder: 2726\n",
      "  Depression: 2727\n",
      "  Depression - Major Depressive Disorder: 2728\n",
      "  Depression Bipolar: 2729\n",
      "  Depression Suicidal: 2730\n",
      "  Depression With Prominent Agitation: 2731\n",
      "  Depression in Patients With Bipolar Disorder: 2732\n",
      "  Depression, Anxiety: 2733\n",
      "  Depression, Bipolar: 2734\n",
      "  Depression, Myalgia: 2735\n",
      "  Depression, Postpartum: 2736\n",
      "  Depressive Disorder: 2737\n",
      "  Depressive Disorder and Anxiety Disorders: 2738\n",
      "  Depressive Disorder, Major: 2739\n",
      "  Depressive Disorder, Treatment-Resistant: 2740\n",
      "  Depressive Illness: 2741\n",
      "  Depressive Symptoms: 2742\n",
      "  Depressive Symptoms Post Cardiac Surgery or Post Acute Coronary Syndrome: 2743\n",
      "  Dermal Filler: 2744\n",
      "  Dermatitis: 2745\n",
      "  Dermatitis Herpetiformis: 2746\n",
      "  Dermatitis, Atopic: 2747\n",
      "  Dermatofibrosarcomas of DARIER FERRAND(DFSP): 2748\n",
      "  Dermatologic Complications: 2749\n",
      "  Dermatologic Disorders: 2750\n",
      "  Dermatomycoses: 2751\n",
      "  Dermatomyositis: 2752\n",
      "  Dermatophagoides Farinae Allergy: 2753\n",
      "  Desensitization: 2754\n",
      "  Desmoid Fibromatosis: 2755\n",
      "  Desmoid Tumor: 2756\n",
      "  Desmoid Tumors: 2757\n",
      "  Detectable Prostate Nodules: 2758\n",
      "  Detection Accuracy: 2759\n",
      "  Determine Effect of Vitamin D on Bone Health in Elderly African American Women: 2760\n",
      "  Detrusor Function, Overactive: 2761\n",
      "  Detrusor Muscle Hyperactivity: 2762\n",
      "  Development of Side Effects From Betaxolol: 2763\n",
      "  Developmental Delay: 2764\n",
      "  Developmental Delays: 2765\n",
      "  Dexmedetomidine: 2766\n",
      "  DiGeorge Anomaly: 2767\n",
      "  Diabetes: 2768\n",
      "  Diabetes Complications: 2769\n",
      "  Diabetes Insipidus: 2770\n",
      "  Diabetes Mellitus: 2771\n",
      "  Diabetes Mellitus Non-insulin-dependent: 2772\n",
      "  Diabetes Mellitus Type 1: 2773\n",
      "  Diabetes Mellitus Type 2: 2774\n",
      "  Diabetes Mellitus Type 2 (T2DM): 2775\n",
      "  Diabetes Mellitus Type 2 With Hyperglycemia: 2776\n",
      "  Diabetes Mellitus Type 2, Kidney Disease, Chronic: 2777\n",
      "  Diabetes Mellitus With Periodontal Disease: 2778\n",
      "  Diabetes Mellitus and Heart Failure: 2779\n",
      "  Diabetes Mellitus, Adult Onset: 2780\n",
      "  Diabetes Mellitus, Adult-Onset: 2781\n",
      "  Diabetes Mellitus, Insulin-Dependent: 2782\n",
      "  Diabetes Mellitus, Non-Insulin-Dependent: 2783\n",
      "  Diabetes Mellitus, Type 1: 2784\n",
      "  Diabetes Mellitus, Type 2: 2785\n",
      "  Diabetes Mellitus, Type 2 AND Metformin: 2786\n",
      "  Diabetes Mellitus, Type I: 2787\n",
      "  Diabetes Mellitus, Type II: 2788\n",
      "  Diabetes Mellitus, With Complications: 2789\n",
      "  Diabetes Risk: 2790\n",
      "  Diabetes Type 1: 2791\n",
      "  Diabetes Type 1 or 2 With Diabetic Retinopathy: 2792\n",
      "  Diabetes Type 2: 2793\n",
      "  Diabetes, Autoimmune: 2794\n",
      "  Diabetes, Hyperlipidemia, Mixed Dyslipidemia: 2795\n",
      "  Diabetes, NOS: 2796\n",
      "  Diabetes, Obesity: 2797\n",
      "  Diabetes, Type 1: 2798\n",
      "  Diabetes, Type 2: 2799\n",
      "  Diabetes, Type I: 2800\n",
      "  Diabetic: 2801\n",
      "  Diabetic Foot: 2802\n",
      "  Diabetic Foot Infection: 2803\n",
      "  Diabetic Foot Ulcer: 2804\n",
      "  Diabetic Foot Ulcers: 2805\n",
      "  Diabetic Gastroparesis: 2806\n",
      "  Diabetic Gastropathy: 2807\n",
      "  Diabetic Ketoacidosis: 2808\n",
      "  Diabetic Kidney Disease: 2809\n",
      "  Diabetic Macula Edema: 2810\n",
      "  Diabetic Macular Edema: 2811\n",
      "  Diabetic Macular Edema (DME): 2812\n",
      "  Diabetic Macular Oedema: 2813\n",
      "  Diabetic Nephropathies: 2814\n",
      "  Diabetic Nephropathy: 2815\n",
      "  Diabetic Nephropathy Type 2: 2816\n",
      "  Diabetic Neuralgia: 2817\n",
      "  Diabetic Neuropathic Arthropathy: 2818\n",
      "  Diabetic Neuropathic Pain: 2819\n",
      "  Diabetic Neuropathies: 2820\n",
      "  Diabetic Neuropathy: 2821\n",
      "  Diabetic Neuropathy, Painful: 2822\n",
      "  Diabetic Patients: 2823\n",
      "  Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF: 2824\n",
      "  Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition: 2825\n",
      "  Diabetic Peripheral Neuropathic Pain: 2826\n",
      "  Diabetic Peripheral Neuropathy: 2827\n",
      "  Diabetic Polyneuropathy: 2828\n",
      "  Diabetic Pregnancy: 2829\n",
      "  Diabetic Proliferative Retinopathy: 2830\n",
      "  Diabetic Retinopathy: 2831\n",
      "  Diabetic Ulcer: 2832\n",
      "  Diabetic; Neuropathic, Polyneuropathy (Manifestation): 2833\n",
      "  Diagnoses That Require Stem Cell Transplant: 2834\n",
      "  Diagnosis of Adult Growth Hormone Deficiency (AGDH): 2835\n",
      "  Diagnostic: 2836\n",
      "  Diagnostic Imaging: 2837\n",
      "  Dialysis Access Dysfunction: 2838\n",
      "  Dialysis Catheter Infections: 2839\n",
      "  Diamond Blackfan Anemia: 2840\n",
      "  Diaper Rash: 2841\n",
      "  Diaphragmatic Hernia: 2842\n",
      "  Diarrhea: 2843\n",
      "  Diarrhea Dominant Irritable Bowel Syndrome: 2844\n",
      "  Diarrhea Predominant Irritable Bowel Syndrome: 2845\n",
      "  Diarrhea Travelers: 2846\n",
      "  Diarrhea, Malnutrition: 2847\n",
      "  Diarrhea- Predominant Irritable Bowel Syndrome: 2848\n",
      "  Diarrhea-predominant Irritable Bowel Syndrome: 2849\n",
      "  Diarrheal Diseases: 2850\n",
      "  Diarrheal Illnesses: 2851\n",
      "  Diarrhoea: 2852\n",
      "  Diarrhoea, Clostridium Difficile: 2853\n",
      "  Diastolic Dysfunction: 2854\n",
      "  Diastolic Heart Failure: 2855\n",
      "  Dientamoebiasis: 2856\n",
      "  Differential Thyroid Cancer: 2857\n",
      "  Differentiated Thyroid Cancer: 2858\n",
      "  Differentiated Thyroid Gland Carcinoma: 2859\n",
      "  Difficult Airway: 2860\n",
      "  Difficult Embryo Transfer: 2861\n",
      "  Difficult-to-access Veins for Intravenous Cannulation: 2862\n",
      "  Diffuse B-Cell Lymphoma: 2863\n",
      "  Diffuse Cutaneous Systemic Sclerosis: 2864\n",
      "  Diffuse Diabetic Macular Edema: 2865\n",
      "  Diffuse Intrinsic Pontine Glioma: 2866\n",
      "  Diffuse Intrinsic Pontine Glioma (DIPG): 2867\n",
      "  Diffuse Large B Cell Lymphoma: 2868\n",
      "  Diffuse Large B Cell Lymphoma CD20 Positive: 2869\n",
      "  Diffuse Large B Cell Non-Hodgkin Lymphoma: 2870\n",
      "  Diffuse Large B-Cell Lymphoma: 2871\n",
      "  Diffuse Large B-Cell Lymphoma (DLBCL): 2872\n",
      "  Diffuse Large B-Cell Lymphoma Refractory: 2873\n",
      "  Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma: 2874\n",
      "  Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: 2875\n",
      "  Diffuse Large B-cell Lymphoma: 2876\n",
      "  Diffuse Large B-cell Lymphoma (DLBCL): 2877\n",
      "  Diffuse Large B-cell Lymphoma Refractory: 2878\n",
      "  Diffuse Large B-cell Lymphoma(DLBCL): 2879\n",
      "  Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma: 2880\n",
      "  Diffuse Large Cell B-lymphoma: 2881\n",
      "  Diffuse Large Cell Lymphoma: 2882\n",
      "  Diffuse, Large B-Cell, Lymphoma: 2883\n",
      "  Diffusive and Convective Clearance: 2884\n",
      "  Digestive Cancer: 2885\n",
      "  Digestive Neuroendocrine Tumors: 2886\n",
      "  Digestive System Disease: 2887\n",
      "  Digestive System Diseases: 2888\n",
      "  Digestive System Disorders: 2889\n",
      "  Digital Ulcers: 2890\n",
      "  Dilated Cardiomyopathy: 2891\n",
      "  Diminished Ovarian Reserve: 2892\n",
      "  Dipeptidyl-Peptidase 4 Inhibitors: 2893\n",
      "  Diphtheria: 2894\n",
      "  Diphtheria-Tetanus-Acellular Pertussis: 2895\n",
      "  Direct Pulp Capping: 2896\n",
      "  Disaster Medicine: 2897\n",
      "  Disc Degeneration: 2898\n",
      "  Disc Degenerative Disease: 2899\n",
      "  Disc Herniation: 2900\n",
      "  Discal Sciatica: 2901\n",
      "  Discogenic Pain: 2902\n",
      "  Discoid Lupus: 2903\n",
      "  Discoid Lupus Erthematosus of the Scalp: 2904\n",
      "  Discoid Lupus Erythematosus: 2905\n",
      "  Disease, Hodgkin: 2906\n",
      "  Disinhibition Syndrome: 2907\n",
      "  Disorder Related to Bone Marrow Transplantation: 2908\n",
      "  Disorder Related to Lung Transplantation: 2909\n",
      "  Disorder Related to Renal Transplantation: 2910\n",
      "  Disorder of Oral Mucous Membrane: 2911\n",
      "  Disorder of Shoulder: 2912\n",
      "  Disorder of Transplanted Kidney: 2913\n",
      "  Disorder of Upper Respiratory System: 2914\n",
      "  Disorder of Vitamin C: 2915\n",
      "  Disorders Associated With Peritoneal Dialysis: 2916\n",
      "  Disruption or Dehiscence of Closure of Sternum or Sternotomy: 2917\n",
      "  Dissection of Thoracic Aorta: 2918\n",
      "  Disseminated Intravascular Coagulation: 2919\n",
      "  Disseminated Intravascular Coagulation (DIC): 2920\n",
      "  Disseminated Neuroblastoma: 2921\n",
      "  Distal (Calf) Deep-vein Thrombosis: 2922\n",
      "  Distal Femur Fractures: 2923\n",
      "  Distal Pancreatectomy: 2924\n",
      "  Distal Radial Buckle Fractures: 2925\n",
      "  Distal Radius Fracture: 2926\n",
      "  Distal Radius Fractures: 2927\n",
      "  Distal Renal Tubular Acidosis: 2928\n",
      "  Distal Subungual Onychomycosis: 2929\n",
      "  Distal Urethral Cancer: 2930\n",
      "  Distress in Caregivers of Cancer Patients: 2931\n",
      "  Diurnal Enuresis: 2932\n",
      "  Diverticular Sigmoïditis: 2933\n",
      "  Diverticulitis: 2934\n",
      "  Does the Vagus Nerve Mediate the Effects of Xenin-25: 2935\n",
      "  Domestic Violence: 2936\n",
      "  Dopamine D2/3 Receptor Availability: 2937\n",
      "  Dose Escalation: Solid Tumors: 2938\n",
      "  Dose Finding Study: 2939\n",
      "  Dosimetry: 2940\n",
      "  Double Cord Blood Transplant: 2941\n",
      "  Double Enterostomy: 2942\n",
      "  Down Syndrome: 2943\n",
      "  Dravet Syndrome: 2944\n",
      "  Drug Abuse: 2945\n",
      "  Drug Action Increased: 2946\n",
      "  Drug Addiction: 2947\n",
      "  Drug Dependence: 2948\n",
      "  Drug Drug Interaction: 2949\n",
      "  Drug Drug Interaction (DDI): 2950\n",
      "  Drug Drug Interactions: 2951\n",
      "  Drug Effect: 2952\n",
      "  Drug Hypersensitivity: 2953\n",
      "  Drug Induced Hyperglycemia: 2954\n",
      "  Drug Induced Liver Injury: 2955\n",
      "  Drug Interaction: 2956\n",
      "  Drug Interaction Potentiation: 2957\n",
      "  Drug Interactions: 2958\n",
      "  Drug Metabolism: 2959\n",
      "  Drug Metabolism, Poor, CYP2D6-RELATED: 2960\n",
      "  Drug Overdose: 2961\n",
      "  Drug Resistant Epilepsy: 2962\n",
      "  Drug Resistant Partial Onset Seizure: 2963\n",
      "  Drug Safety: 2964\n",
      "  Drug Safety and Bioavailability: 2965\n",
      "  Drug Therapy, Combination: 2966\n",
      "  Drug Toxicity: 2967\n",
      "  Drug Toxicity Psychotropic Agents Psychostimulants: 2968\n",
      "  Drug Usage: 2969\n",
      "  Drug Use: 2970\n",
      "  Drug Use Disorders During Pregnancy: 2971\n",
      "  Drug-Induced Acute Liver Injury: 2972\n",
      "  Drug-Induced Liver Injury: 2973\n",
      "  Drug-Induced Nephropathy: 2974\n",
      "  Drug-Related Side Effects and Adverse Reactions: 2975\n",
      "  Drug-Resistant Epilepsy: 2976\n",
      "  Drug-induced Liver Injury,Chronic: 2977\n",
      "  Drug-induced QT Prolongation: 2978\n",
      "  Drug-induced Tardive Dyskinesia: 2979\n",
      "  Drug-withdrawal.: 2980\n",
      "  Drug/Agent Toxicity by Tissue/Organ: 2981\n",
      "  Drugs, Investigational: 2982\n",
      "  Dry AMD: 2983\n",
      "  Dry Age Related Macular Degeneration: 2984\n",
      "  Dry Age-related Macular Degeneration: 2985\n",
      "  Dry Eye: 2986\n",
      "  Dry Eye After LASIK-Laser in Situ Keratomileusis: 2987\n",
      "  Dry Eye Disease: 2988\n",
      "  Dry Eye Disease (DED): 2989\n",
      "  Dry Eye Syndrome: 2990\n",
      "  Dry Eye Syndromes: 2991\n",
      "  Dry Skin: 2992\n",
      "  Dual Diagnosis: 2993\n",
      "  Dual-chamber Pacemaker Placement: 2994\n",
      "  Duchenne Muscular Dystrophy: 2995\n",
      "  Duchenne Muscular Dystrophy (DMD): 2996\n",
      "  Duchenne's Muscular Dystrophy: 2997\n",
      "  Duct Cell Adenocarcinoma of the Pancreas: 2998\n",
      "  Ductal Adenocarcinoma of Pancreas: 2999\n",
      "  Ductal Breast Carcinoma In Situ: 3000\n",
      "  Ductal Breast Carcinoma in Situ: 3001\n",
      "  Ductal Carcinoma: 3002\n",
      "  Ductal Carcinoma in Situ: 3003\n",
      "  Ductus Arteriosis, Patent: 3004\n",
      "  Ductus Arteriosus, Patent: 3005\n",
      "  Dumping Syndrome: 3006\n",
      "  Duodenal Polyposis: 3007\n",
      "  Dupuytren Contracture: 3008\n",
      "  Dupuytren's Contracture: 3009\n",
      "  Dupuytren's Contracture of the Hand (Viking's Disease): 3010\n",
      "  Dupuytren's Disease: 3011\n",
      "  Duration of Pain Relief: 3012\n",
      "  Dwarfism: 3013\n",
      "  Dynapenia: 3014\n",
      "  Dysbiosis: 3015\n",
      "  Dyschesia: 3016\n",
      "  Dysentery, Bacillary: 3017\n",
      "  Dysentery, Shigella: 3018\n",
      "  Dysferlinopathy: 3019\n",
      "  Dysfunctional Central Venous Access Catheters: 3020\n",
      "  Dysfunctional Labor: 3021\n",
      "  Dysfunctional Uterine Bleeding: 3022\n",
      "  Dysfunctional Voiding: 3023\n",
      "  Dysglycemia: 3024\n",
      "  Dyskinesia: 3025\n",
      "  Dyskinesias: 3026\n",
      "  Dyslipidaemia: 3027\n",
      "  Dyslipidemia: 3028\n",
      "  Dyslipidemia (Fredrickson Type Ⅱa): 3029\n",
      "  Dyslipidemia in Patients With Diabetes Mellitus: 3030\n",
      "  Dyslipidemias: 3031\n",
      "  Dysmenorrhea: 3032\n",
      "  Dyspareunia: 3033\n",
      "  Dyspepsia: 3034\n",
      "  Dysphagia: 3035\n",
      "  Dysphagia After Anterior Cervical Decompression and Fusion of the Spine: 3036\n",
      "  Dysphonia: 3037\n",
      "  Dysplasia: 3038\n",
      "  Dysplastic Nevus Syndrome: 3039\n",
      "  Dyspnea: 3040\n",
      "  Dyssocial Behavior: 3041\n",
      "  Dysthymic Disorder: 3042\n",
      "  Dystocia: 3043\n",
      "  Dystonia: 3044\n",
      "  Dystrophia Myotonica 1: 3045\n",
      "  Dystrophic Epidermolysis Bullosa: 3046\n",
      "  Dysuria: 3047\n",
      "  E.Coli Infections: 3048\n",
      "  EBV Lymphomas: 3049\n",
      "  EBV Related Non-Hodgkin's Lymphoma: 3050\n",
      "  EBV-induced Lymphomas: 3051\n",
      "  EC905: 3052\n",
      "  ECG Effects: 3053\n",
      "  EGFR Activating Mutation: 3054\n",
      "  EGFR Exon 19 Deletion Mutation: 3055\n",
      "  EGFR Gene Mutation: 3056\n",
      "  EGFR Mutated EGFR TKI Naive Metastatic NSCLC: 3057\n",
      "  EGFR Positive Solid Tumors: 3058\n",
      "  EGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations: 3059\n",
      "  EGFR-mutated NSCLC (Disorder): 3060\n",
      "  END STAGE RENAL DISEASE: 3061\n",
      "  ENT Surgery: 3062\n",
      "  ER Positive, Her2 Negative Breast Cancer Patients: 3063\n",
      "  ER+ HER2- Advanced Breast Cancer: 3064\n",
      "  ER+ and AR+ Breast Cancer: 3065\n",
      "  ERCP: 3066\n",
      "  ERYTHROCYTOSIS: 3067\n",
      "  ESRD: 3068\n",
      "  Earache: 3069\n",
      "  Early Abortion: 3070\n",
      "  Early Amniotomy, Unfavorable Cervix: 3071\n",
      "  Early Breast Cancer: 3072\n",
      "  Early Breast Cancer (Phase 2): 3073\n",
      "  Early Child Development and Growth: 3074\n",
      "  Early Childhood Caries: 3075\n",
      "  Early Lumbar Disc Degeneration: 3076\n",
      "  Early Neonatal Mortality: 3077\n",
      "  Early Onset Alzheimer Disease: 3078\n",
      "  Early Parkinson Disease: 3079\n",
      "  Early Parkinson Disease (Early PD): 3080\n",
      "  Early Parkinson's Disease: 3081\n",
      "  Early Phase of Severe Sepsis and Septic Shock: 3082\n",
      "  Early Pregnancy Failure: 3083\n",
      "  Early Pregnancy Termination: 3084\n",
      "  Early Rheumatoid Arthritis: 3085\n",
      "  Early Stage Breast Cancer: 3086\n",
      "  Early Stage Esophageal Adenocarcinoma: 3087\n",
      "  Early Stage Non-Small Cell Lung Cancer: 3088\n",
      "  Early Stage Non-small Cell Lung Cancer: 3089\n",
      "  Early Stage Parkinson's Disease: 3090\n",
      "  Early Ventilation Acquired Pneumonia in Brain Injured Patients: 3091\n",
      "  Early-Stage Breast Cancer: 3092\n",
      "  Early-Stage Parkinson's Disease: 3093\n",
      "  Early-stage Parkinson's Disease: 3094\n",
      "  Eating Disorder: 3095\n",
      "  Eating Disorders: 3096\n",
      "  Ebola: 3097\n",
      "  Ebola Hemorrhagic Fever: 3098\n",
      "  Ebola Vaccines: 3099\n",
      "  Ebola Virus: 3100\n",
      "  Ebola Virus Disease: 3101\n",
      "  Ebola Virus Infection: 3102\n",
      "  Ebola Virus Survivor: 3103\n",
      "  Ectasia: 3104\n",
      "  Ectopic ACTH Syndrome: 3105\n",
      "  Ectopic Pregnancy: 3106\n",
      "  Ectropion: 3107\n",
      "  Eczema: 3108\n",
      "  Edema: 3109\n",
      "  Edema Macular: 3110\n",
      "  Edema, Cardiac: 3111\n",
      "  Edematous Fibrosclerotic Panniculopathy (EFP): 3112\n",
      "  Edentulous Alveolar Ridge: 3113\n",
      "  Education: 3114\n",
      "  Educational Course: 3115\n",
      "  Effect of Deep Transcranial Magnetic Stimulation on Memory: 3116\n",
      "  Effect of Drugs: 3117\n",
      "  Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects: 3118\n",
      "  Effect of Orally Administrated Moxaverine on Ocular Blood Flow: 3119\n",
      "  Effect of Sitaxsentan on Airway Remodeling in Severe Asthma: 3120\n",
      "  Effect of Treatment on Bone Mineral Density: 3121\n",
      "  Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality: 3122\n",
      "  Effect on Iron Levels: 3123\n",
      "  Effects of 2 Mu-opiates on Gastrointestinal Transit: 3124\n",
      "  Effects of Chemotherapy: 3125\n",
      "  Effects of High Altitude: 3126\n",
      "  Effects of Sativex on ECG: 3127\n",
      "  Effects of; Anesthesia, in Labor and Delivery: 3128\n",
      "  Efficacy and Safety: 3129\n",
      "  Efficacy and Safety of Xenon Inhalation: 3130\n",
      "  Elderly: 3131\n",
      "  Elderly, Frail: 3132\n",
      "  Elective: 3133\n",
      "  Elective Colorectal Surgery: 3134\n",
      "  Elective Orthopedic Surgery: 3135\n",
      "  Elective Penile Surgeries: 3136\n",
      "  Elective Surgery Requiring Tracheal Intubation Using an Oral Tracheal Tube: 3137\n",
      "  Elective Surgical Procedure: 3138\n",
      "  Elective Thyroidectomy: 3139\n",
      "  Electroencephalographic Neonatal Seizures: 3140\n",
      "  Electromagnetic Fields: 3141\n",
      "  Electronic Prescribing: 3142\n",
      "  Elevated Cardiac Risk: 3143\n",
      "  Elevated High-sensitivity C-Reactive Protein (hsCRP): 3144\n",
      "  Elevated Intraocular Pressure: 3145\n",
      "  Elevated LDL Cholesterol: 3146\n",
      "  Elevated Lipoprotein(a): 3147\n",
      "  Elevated Prostate Specific Antigen: 3148\n",
      "  Embolism and Thrombosis: 3149\n",
      "  Embryo Transfer: 3150\n",
      "  Emergence Agitation: 3151\n",
      "  Emergence of Bacterial Resistance to Antibiotics: 3152\n",
      "  Emergency Department Procedural Sedation: 3153\n",
      "  Emergency Service, Hospital: 3154\n",
      "  Emergent Coronary Procedure: 3155\n",
      "  Emesis: 3156\n",
      "  Emotional Distress: 3157\n",
      "  Emotional Disturbance: 3158\n",
      "  Empaglifozin: 3159\n",
      "  Emphysema: 3160\n",
      "  Empty Nose Syndrome: 3161\n",
      "  Empyema: 3162\n",
      "  Empyema, Pleural: 3163\n",
      "  Enamel Erosion: 3164\n",
      "  Encephalitis: 3165\n",
      "  Encephalitis, Japanese: 3166\n",
      "  Encephalitis, Tick-borne: 3167\n",
      "  Encopresis: 3168\n",
      "  End Stage Heart Disease: 3169\n",
      "  End Stage Kidney Disease: 3170\n",
      "  End Stage Liver Disease: 3171\n",
      "  End Stage Renal Disease: 3172\n",
      "  End Stage Renal Failure: 3173\n",
      "  End-Stage Kidney Disease: 3174\n",
      "  End-Stage Renal Disease: 3175\n",
      "  End-stage Kidney Disease: 3176\n",
      "  End-stage Liver Disease: 3177\n",
      "  End-stage Renal Disease: 3178\n",
      "  End-stage Renal Disease (ESRD): 3179\n",
      "  Endocarditis: 3180\n",
      "  Endocarditis, Bacterial: 3181\n",
      "  Endocrine Dysfunction: 3182\n",
      "  Endocrine System Diseases: 3183\n",
      "  Endodontic Disease: 3184\n",
      "  Endodontic Inflammation: 3185\n",
      "  Endogenous Cushing's Syndrome: 3186\n",
      "  Endometrial Adenocarcinoma: 3187\n",
      "  Endometrial Adenosquamous Carcinoma: 3188\n",
      "  Endometrial Biopsy: 3189\n",
      "  Endometrial Cancer: 3190\n",
      "  Endometrial Cancer Recurrent: 3191\n",
      "  Endometrial Cancers With FGFR2 Mutations: 3192\n",
      "  Endometrial Carcinoma: 3193\n",
      "  Endometrial Clear Cell Adenocarcinoma: 3194\n",
      "  Endometrial Development: 3195\n",
      "  Endometrial Diseases: 3196\n",
      "  Endometrial Hyperplasia: 3197\n",
      "  Endometrial Neoplasms: 3198\n",
      "  Endometrial Preparation: 3199\n",
      "  Endometrial Receptivity: 3200\n",
      "  Endometrial Serous Adenocarcinoma: 3201\n",
      "  Endometriosis: 3202\n",
      "  Endometriosis of the Cul-de-sac: 3203\n",
      "  Endometriosis-related Pain: 3204\n",
      "  Endometritis: 3205\n",
      "  Endophthalmitis: 3206\n",
      "  Endoscopy: 3207\n",
      "  Endothelial Dysfunction: 3208\n",
      "  Endotoxemia: 3209\n",
      "  Endotracheal Intubation: 3210\n",
      "  Endstage Renal Disease: 3211\n",
      "  Enhancing Couples Coping: 3212\n",
      "  Enteral Feeding Intolerance: 3213\n",
      "  Enteral Tube Placement: 3214\n",
      "  Enteric Hyperoxaluria: 3215\n",
      "  Enteric Infections: 3216\n",
      "  Enteritis; Escherichia Coli, Enterotoxigenic: 3217\n",
      "  Enterobacteriaceae Infections: 3218\n",
      "  Enterocolitis: 3219\n",
      "  Enterocolitis, Necrotizing: 3220\n",
      "  Enterocolitis, Pseudomembranous: 3221\n",
      "  Enteropathy: 3222\n",
      "  Enterovirus 71 Human: 3223\n",
      "  Enuresis: 3224\n",
      "  Environmental Carcinogenesis: 3225\n",
      "  EoE: 3226\n",
      "  Eosinophilia: 3227\n",
      "  Eosinophilic Asthma: 3228\n",
      "  Eosinophilic Chronic Rhinosinusitis: 3229\n",
      "  Eosinophilic Esophagitis: 3230\n",
      "  Eosinophilic Esophagitis (EoE): 3231\n",
      "  Eosinophilic Gastroenteritis: 3232\n",
      "  Eosinophilic Pneumonia: 3233\n",
      "  Eosinophils, Asthma: 3234\n",
      "  Ependymoma: 3235\n",
      "  EphA2 Positive Malignant Glioma: 3236\n",
      "  Epicondylitis: 3237\n",
      "  Epicondylitis of the Elbow: 3238\n",
      "  Epidermal Growth Factor Receptor: 3239\n",
      "  Epidermal Growth Factor Receptor (EGFR) Mutations: 3240\n",
      "  Epidermolysis Bullosa: 3241\n",
      "  Epidermolysis Bullosa Dystrophica: 3242\n",
      "  Epidermolysis Bullosa Dystrophica, Recessive: 3243\n",
      "  Epidermolysis Bullosa Simplex: 3244\n",
      "  Epidermolysis Bullosa, Junctional: 3245\n",
      "  Epilepsia Partialis Continua: 3246\n",
      "  Epilepsies, Partial: 3247\n",
      "  Epilepsy: 3248\n",
      "  Epilepsy (Treatment Refractory): 3249\n",
      "  Epilepsy Intractable: 3250\n",
      "  Epilepsy With Partial-onset Seizures: 3251\n",
      "  Epilepsy With Simple or Complex Partial Onset Seizures: 3252\n",
      "  Epilepsy, Complex Partial: 3253\n",
      "  Epilepsy, Cryptogenic: 3254\n",
      "  Epilepsy, Partial: 3255\n",
      "  Epilepsy, Partial Seizures: 3256\n",
      "  Epilepsy, Post-Traumatic: 3257\n",
      "  Epilepsy, Rolandic: 3258\n",
      "  Epilepsy, Tonic-Clonic: 3259\n",
      "  Epilepsy; Paediatric Partial Onset Seizures: 3260\n",
      "  Epileptic Encephalopathy, Childhood-Onset: 3261\n",
      "  Epiphora: 3262\n",
      "  Epiretinal Membrane: 3263\n",
      "  Episiotomy: 3264\n",
      "  Episodic Ataxia Type 2: 3265\n",
      "  Episodic Cluster Headache: 3266\n",
      "  Episodic Tension Type Headache: 3267\n",
      "  Epistaxis: 3268\n",
      "  Epithelial Cancer: 3269\n",
      "  Epithelial Cancer Patients: 3270\n",
      "  Epithelial Defect After Phototherapeutic Keratectomy: 3271\n",
      "  Epithelial Neoplasms, Malignant: 3272\n",
      "  Epithelial Ovarian Cancer: 3273\n",
      "  Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum: 3274\n",
      "  Epithelial Ovarian Carcinoma: 3275\n",
      "  Epithelioid Mesothelioma: 3276\n",
      "  Epstein Barr Virus (EBV) Infection: 3277\n",
      "  Epstein Barr Virus Associated Non Hodgkin's Lymphoma: 3278\n",
      "  Epstein-Barr Virus Infections: 3279\n",
      "  Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma: 3280\n",
      "  Equinovarus; Acquired: 3281\n",
      "  Erdheim-Chester Disease: 3282\n",
      "  Erectile Dysfunction: 3283\n",
      "  Erectile Dysfunction Following Radical Prostatectomy: 3284\n",
      "  Erosive Esophagitis: 3285\n",
      "  Erosive Esophagitis(EE): 3286\n",
      "  Erysipelas: 3287\n",
      "  Erythema: 3288\n",
      "  Erythema Migrans: 3289\n",
      "  Erythematotelangiectatic Rosacea: 3290\n",
      "  Erythrocyte Transfusion: 3291\n",
      "  Erythropoietic Protoporphyria: 3292\n",
      "  Erythropoietic Protoporphyria (EPP): 3293\n",
      "  Escherichia Coli Infections: 3294\n",
      "  Esophageal: 3295\n",
      "  Esophageal Adenocarcinoma: 3296\n",
      "  Esophageal Adenocarcinomas: 3297\n",
      "  Esophageal Atresia: 3298\n",
      "  Esophageal Cancer: 3299\n",
      "  Esophageal Cancer Stage III: 3300\n",
      "  Esophageal Carcinoma: 3301\n",
      "  Esophageal Diseases: 3302\n",
      "  Esophageal Metaplasia: 3303\n",
      "  Esophageal Neoplasm: 3304\n",
      "  Esophageal Neoplasms: 3305\n",
      "  Esophageal Reflux: 3306\n",
      "  Esophageal Squamous Cell Cancer: 3307\n",
      "  Esophageal Squamous Cell Carcinoma: 3308\n",
      "  Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma: 3309\n",
      "  Esophageal Stenosis: 3310\n",
      "  Esophageal Stricture: 3311\n",
      "  Esophageal Strictures: 3312\n",
      "  Esophageal Varices: 3313\n",
      "  Esophagitis: 3314\n",
      "  Esophagogastric Adenocarcinoma: 3315\n",
      "  Esophagogastric Cancer: 3316\n",
      "  Esophagus Cancer: 3317\n",
      "  Essential Arterial Hypertension: 3318\n",
      "  Essential Axillary Hyperhidrosis: 3319\n",
      "  Essential Blepharospasm: 3320\n",
      "  Essential Fatty Acid Deficiency (EFAD): 3321\n",
      "  Essential Hypertension: 3322\n",
      "  Essential Hypertension ( Mild to Moderate): 3323\n",
      "  Essential Hypertension With Stable Angina and Dyslipidemia: 3324\n",
      "  Essential Hypertension.: 3325\n",
      "  Essential Thrombocythaemia: 3326\n",
      "  Essential Thrombocythemia: 3327\n",
      "  Essential Thrombocythemia (ET): 3328\n",
      "  Essential Tremor: 3329\n",
      "  Established Carotid Atherosclerosis: 3330\n",
      "  Estrogen: 3331\n",
      "  Estrogen Receptor Negative: 3332\n",
      "  Estrogen Receptor Negative Breast Cancer: 3333\n",
      "  Estrogen Receptor Positive: 3334\n",
      "  Estrogen Receptor Positive Breast Cancer: 3335\n",
      "  Estrogen Receptor Positive Tumor: 3336\n",
      "  Estrogen Receptor-negative Breast Cancer: 3337\n",
      "  Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer: 3338\n",
      "  Estrogen Receptor-positive Breast Cancer: 3339\n",
      "  Eustachian Tube Dysfunction: 3340\n",
      "  Evaluating Pharmacokinetics of Intranasal Ketorolac: 3341\n",
      "  Evaluation of Abuse Potential of Sativex: 3342\n",
      "  Evaluation of Expected Bone Loss After Bariatric Surgery: 3343\n",
      "  Evidence of Liver Transplantation: 3344\n",
      "  Ewing Sarcoma: 3345\n",
      "  Ewing's Sarcoma: 3346\n",
      "  Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET): 3347\n",
      "  Ewing's Sarcoma Family of Tumors: 3348\n",
      "  Excessive Daytime Sleepiness: 3349\n",
      "  Exercise: 3350\n",
      "  Exercise Induced Asthma: 3351\n",
      "  Exercise Training: 3352\n",
      "  Exercise Triggered Asthma: 3353\n",
      "  Exercise-induced Bronchoconstriction (EIB): 3354\n",
      "  Exercise-induced Bronchospasm: 3355\n",
      "  Exocrine Pancreatic Insufficiency: 3356\n",
      "  Exocrine Pancreatic Insufficiency (EPI): 3357\n",
      "  Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis: 3358\n",
      "  Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2: 3359\n",
      "  Exocrine Pancreatic Insufficiency: Cystic Fibrosis: 3360\n",
      "  Exostoses, Multiple Hereditary: 3361\n",
      "  Explicit Recall of Intra-operative Events: 3362\n",
      "  Exposure to Ionizing Radiation: 3363\n",
      "  Exposure to Secondhand Smoke in Neonatal Infants: 3364\n",
      "  Extended Ileal Resection Under Laparotomy: 3365\n",
      "  Extensive Decay in Primary Molars: 3366\n",
      "  Extensive Disease: 3367\n",
      "  Extensive Stage Lung Small Cell Carcinoma: 3368\n",
      "  Extensive Stage Small Cell Lung Cancer: 3369\n",
      "  Extensive Stage Small Cell Lung Carcinoma: 3370\n",
      "  Extensive-Stage Small Cell Lung Cancer: 3371\n",
      "  Extensive-stage Small Cell Lung Cancer: 3372\n",
      "  External Cephalic Version: 3373\n",
      "  Extra-Adrenal Paraganglioma: 3374\n",
      "  Extracorporeal Circulation: 3375\n",
      "  Extracorporeal Membrane Oxygenation: 3376\n",
      "  Extracorporeal Membrane Oxygenation Complication: 3377\n",
      "  Extragonadal Germ Cell Tumor: 3378\n",
      "  Extrahepatic Bile Duct Cancer: 3379\n",
      "  Extraintestinal Pathogenic Escherichia Coli Prevention: 3380\n",
      "  Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue: 3381\n",
      "  Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: 3382\n",
      "  Extranodal NK-T-CELL LYMPHOMA: 3383\n",
      "  Extranodal NK/T-cell Lymphoma, Nasal Type: 3384\n",
      "  Extranodal Natural Killer/T-Cell Lymphoma: 3385\n",
      "  Extraocular Extension Melanoma: 3386\n",
      "  Extravasation: 3387\n",
      "  Extreme Immaturity: 3388\n",
      "  Exudative Age Related Macular Degeneration: 3389\n",
      "  Exudative Age-Related Macular Degeneration: 3390\n",
      "  Exudative Age-related Macular Degeneration: 3391\n",
      "  Eye Disease: 3392\n",
      "  Eye Diseases: 3393\n",
      "  Eye Infections, Bacterial: 3394\n",
      "  Eye Injuries: 3395\n",
      "  Eyelash Hypotrichosis: 3396\n",
      "  Eyelid Diseases: 3397\n",
      "  Eyelid Laceration: 3398\n",
      "  FANCONI ANEMIA: 3399\n",
      "  FAP: 3400\n",
      "  FED: 3401\n",
      "  FGFR Gene Amplification: 3402\n",
      "  FGFR Inhibition, Pharmacokinetics, Biomarkers: 3403\n",
      "  FLT3 Gene Mutation Negative: 3404\n",
      "  FSGS: 3405\n",
      "  Fabry Disease: 3406\n",
      "  Face Pain: 3407\n",
      "  Face-lift: 3408\n",
      "  Facetogenic Back Pain: 3409\n",
      "  Facial Angiofibroma: 3410\n",
      "  Facial Angiofibromas: 3411\n",
      "  Facial Atrophy Related to Age: 3412\n",
      "  Facial Bones Fracture: 3413\n",
      "  Facial Pain: 3414\n",
      "  Facial Paresis: 3415\n",
      "  Facial Rhytides: 3416\n",
      "  Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality: 3417\n",
      "  Facial Wrinkles: 3418\n",
      "  Facioscapulohumeral Muscular Dystrophy: 3419\n",
      "  Factor X Deficiency: 3420\n",
      "  Factor XIII Deficiency: 3421\n",
      "  Faecal Incontinence: 3422\n",
      "  Failed Back Surgery Syndrome: 3423\n",
      "  Failed Conscious Sedation During Procedure: 3424\n",
      "  Failed Lumbar Fusion: 3425\n",
      "  Failed Moderate Sedation During Procedure: 3426\n",
      "  Failure to Thrive: 3427\n",
      "  Falciparum Malaria: 3428\n",
      "  Fall From Bed: 3429\n",
      "  Fallopian Tube Adenocarcinoma: 3430\n",
      "  Fallopian Tube Cancer: 3431\n",
      "  Fallopian Tube Carcinoma: 3432\n",
      "  Fallopian Tube Clear Cell Adenocarcinoma: 3433\n",
      "  Fallopian Tube Neoplasms: 3434\n",
      "  Falls: 3435\n",
      "  Familial Adenomatous Polyposis: 3436\n",
      "  Familial Amyloid Polyneuropathy (FAP): 3437\n",
      "  Familial Chylomicronemia Syndrome (FCS): 3438\n",
      "  Familial Chylomicronemia Syndrome (FCS) (HLP Type I): 3439\n",
      "  Familial Cold Autoinflammatory Syndrome (FCAS): 3440\n",
      "  Familial Cold Urticaria: 3441\n",
      "  Familial Hypercholesterolemia: 3442\n",
      "  Familial Hypoalphalipoproteinemia: 3443\n",
      "  Familial Mediterranean Fever: 3444\n",
      "  Familial Partial Lipodystrophy: 3445\n",
      "  Family Caregivers: 3446\n",
      "  Family Planning: 3447\n",
      "  Fanconi Anemia: 3448\n",
      "  Fasciitis, Plantar: 3449\n",
      "  Fast Breathing in Young Infants: 3450\n",
      "  Fasting: 3451\n",
      "  Fat Reduction: 3452\n",
      "  Fatigue: 3453\n",
      "  Fatigue Syndrome, Chronic: 3454\n",
      "  Fatigue in Multiple Sclerosis: 3455\n",
      "  Fatty Acid Oxidation Disorders: 3456\n",
      "  Fatty Liver: 3457\n",
      "  Fear Conditioning: 3458\n",
      "  Fear of Falling: 3459\n",
      "  Feasibility Pilot Study: 3460\n",
      "  Febrile Neutropenia: 3461\n",
      "  Febrile Seizure: 3462\n",
      "  Fecal Analysis: 3463\n",
      "  Fecal Immunochemical Test: 3464\n",
      "  Fecal Incontinence: 3465\n",
      "  Fecal Incontinenece: 3466\n",
      "  Fecal Microflora in the Formula Fed Premature Infant: 3467\n",
      "  Feeding Behaviors: 3468\n",
      "  Feeding Intolerance: 3469\n",
      "  Feeding Tube: 3470\n",
      "  Female Androgenetic Alopecia: 3471\n",
      "  Female Breast Cancer: 3472\n",
      "  Female Breast Carcinoma: 3473\n",
      "  Female Infertility: 3474\n",
      "  Female Infertility Due to Diminished Ovarian Reserve: 3475\n",
      "  Female Pattern Baldness: 3476\n",
      "  Female Puberty: 3477\n",
      "  Female Reproductive Physiology: 3478\n",
      "  Female Sexual Arousal Disorder: 3479\n",
      "  Female Sexual Dysfunction: 3480\n",
      "  Female With Osteoporosis and Chronic Kidney Disease: 3481\n",
      "  Female, Late Life Depression: 3482\n",
      "  Femoral Fractures: 3483\n",
      "  Femoral Neck Fracture: 3484\n",
      "  Femoral Neck Fractures: 3485\n",
      "  Femoroacetabular Impingement: 3486\n",
      "  Femoropopliteal In-Stent Restenosis: 3487\n",
      "  Femoropopliteal Occlusive Disease: 3488\n",
      "  Femur Surgery: 3489\n",
      "  Fertility: 3490\n",
      "  Fertilization: 3491\n",
      "  Fetal Alcohol Syndrome: 3492\n",
      "  Fetal Congenital Abnormalities: 3493\n",
      "  Fetal Death: 3494\n",
      "  Fetal Growth Restriction: 3495\n",
      "  Fetal Growth Retardation: 3496\n",
      "  Fetal Membranes, Premature Rupture: 3497\n",
      "  Fetal Testing: 3498\n",
      "  Fetus or Newborn Affected by Condition of Umbilical Cord: 3499\n",
      "  Fever: 3500\n",
      "  Fever, Sweats, and Hot Flashes: 3501\n",
      "  Fibrillation, Atrial: 3502\n",
      "  Fibrinogen Deficiency: 3503\n",
      "  Fibrocystic Disease of Breast: 3504\n",
      "  Fibrodysplasia Ossificans Progressiva: 3505\n",
      "  Fibroid: 3506\n",
      "  Fibroid Uterus: 3507\n",
      "  Fibroids: 3508\n",
      "  Fibrolamellar Hepatocellular Carcinoma: 3509\n",
      "  Fibromuscular Dysplasia of Arteries: 3510\n",
      "  Fibromyalgia: 3511\n",
      "  Fibromyalgia Pain: 3512\n",
      "  Fibromyalgia Syndrome: 3513\n",
      "  Fibromyalgia, Primary: 3514\n",
      "  Fibrosis: 3515\n",
      "  Fibrovascular Pigment Epithelial Detachment: 3516\n",
      "  Fighting Behavior: 3517\n",
      "  Filariasis: 3518\n",
      "  First Child Delivery With Epidural: 3519\n",
      "  First Episode Psychosis: 3520\n",
      "  First Episode Schizophrenia: 3521\n",
      "  First Line Metastatic Breast Cancer: 3522\n",
      "  First Time Dual Chamber Pacemaker Implantation: 3523\n",
      "  Fistula Stenosis: 3524\n",
      "  Fistula in Ano: 3525\n",
      "  Flank Pain: 3526\n",
      "  Flexible Bronchoscopy: 3527\n",
      "  Flu: 3528\n",
      "  Flu, Human: 3529\n",
      "  Fluid Balance of ICU Patients: 3530\n",
      "  Fluid Inteligence: 3531\n",
      "  Fluid Loss: 3532\n",
      "  Fluid Overload: 3533\n",
      "  Focal Dystonia: 3534\n",
      "  Focal Epilepsy: 3535\n",
      "  Focal Segmental Glomerulosclerosis: 3536\n",
      "  Focal Segmental Glomerulosclerosis (FSGS): 3537\n",
      "  Focus is Determination of the Role of SNO-Hb in Forearm Blood Flow Regulation: 3538\n",
      "  Focus of Study is STEMI: 3539\n",
      "  Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms: 3540\n",
      "  Focus of Study: Pharmacokinetics Analysis, in Vivo Dissolution Studies: 3541\n",
      "  Focus of Study: Radiolabel Recovery and Survival of RBCs: 3542\n",
      "  Focus of the Study: DNA Damage Due to Medical Diagnostic X-ray: 3543\n",
      "  Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD: 3544\n",
      "  Focus: Prevent Preterm Delivery: 3545\n",
      "  Focus: Surgical Smoke During Laparoscopic Surgery: 3546\n",
      "  Follicular Low Grade Non-Hodgkin's Lymphoma: 3547\n",
      "  Follicular Lymphoma: 3548\n",
      "  Follicular Lymphoma (FL): 3549\n",
      "  Follicular Lymphoma Patients (Phase IB): 3550\n",
      "  Follicular Lymphoma, Mantle Cell Lymphoma: 3551\n",
      "  Follicular Non-Hodgkin's Lymphoma: 3552\n",
      "  Fontan Procedure: 3553\n",
      "  Food Allergy: 3554\n",
      "  Food Effect: 3555\n",
      "  Food Hypersensitivity: 3556\n",
      "  Food Intake: 3557\n",
      "  Food Preferences: 3558\n",
      "  Food-drug Interaction: 3559\n",
      "  Foot Deformities, Acquired: 3560\n",
      "  Foot Surgery: 3561\n",
      "  Foot Ulcer: 3562\n",
      "  Foot Ulcer, Diabetic: 3563\n",
      "  For Donors: 3564\n",
      "  Forearm Fracture: 3565\n",
      "  Forearm Surgeries: 3566\n",
      "  Forehead Rhytides: 3567\n",
      "  Foreign Body Left During Endoscopic Examination: 3568\n",
      "  Foreign-Body Reaction: 3569\n",
      "  Fracture: 3570\n",
      "  Fracture Healing: 3571\n",
      "  Fracture of Foot: 3572\n",
      "  Fracture of Lower Limb: 3573\n",
      "  Fracture, Closed, Comminuted, Healing: 3574\n",
      "  Fracture, Ununited: 3575\n",
      "  Fractures: 3576\n",
      "  Fractures, Comminuted: 3577\n",
      "  Fractures, Open: 3578\n",
      "  Fragile X Syndrome: 3579\n",
      "  Fragile X Syndrome (FXS): 3580\n",
      "  Frail Elderly: 3581\n",
      "  Frail Elderly Inpatient: 3582\n",
      "  Frailty: 3583\n",
      "  Freeze Dried Plasma in Healthy Volunteers: 3584\n",
      "  Frequent Heartburn: 3585\n",
      "  Frequent Relapsing Nephrotic Syndrome: 3586\n",
      "  Friedreich Ataxia: 3587\n",
      "  Friedreich's Ataxia: 3588\n",
      "  Frontotemporal Dementia: 3589\n",
      "  Frontotemporal Lobar Degeneration: 3590\n",
      "  Fuchs' Endothelial Dystrophy: 3591\n",
      "  Full-thickness Skin Loss Due to Burn, Unspecified Site: 3592\n",
      "  Fulminant Hepatic Failure: 3593\n",
      "  Functioanl Dyspepsia: 3594\n",
      "  Function of Renal Transplant: 3595\n",
      "  Functional Abdominal Pain: 3596\n",
      "  Functional Constipation: 3597\n",
      "  Functional Constipation in Children Ages 6-17 Years: 3598\n",
      "  Functional Dyspepsia: 3599\n",
      "  Functional Gastrointestinal Disorder: 3600\n",
      "  Functional Gastrointestinal Disorders: 3601\n",
      "  Functional Iron Deficiency: 3602\n",
      "  Functional Limitation: 3603\n",
      "  Functional Pancreatic Neuroendocrine Tumor: 3604\n",
      "  Functional Popliteal Artery Entrapment Syndrome: 3605\n",
      "  Fungal Infection: 3606\n",
      "  Fungal Infections: 3607\n",
      "  Fungal Keratitis: 3608\n",
      "  Fungemia: 3609\n",
      "  Furcation Defects: 3610\n",
      "  Fusion of Spine, Lumbar Region: 3611\n",
      "  G(M2) Ganglioside: 3612\n",
      "  GD2 Positive Glioma: 3613\n",
      "  GERD: 3614\n",
      "  GI Adenocarcinoma: 3615\n",
      "  GI Patients on Oxaliplatin Containing Regimen: 3616\n",
      "  GIARDIASIS: 3617\n",
      "  GIST: 3618\n",
      "  GM1 Gangliosidoses: 3619\n",
      "  GNA11 Mutation-positive Metastatic Melanoma: 3620\n",
      "  GPC3 Positive Hepatocellular Carcinoma: 3621\n",
      "  GTP Cyclohydrolase Deficiency: 3622\n",
      "  GVHD (Acute or Chronic): 3623\n",
      "  GYN Disorders: 3624\n",
      "  Gait Disorder, Sensorimotor: 3625\n",
      "  Gait Disorders: 3626\n",
      "  Gait Disorders, Neurologic: 3627\n",
      "  Gait Disturbance in Multiple Sclerosis Patients: 3628\n",
      "  Gait or Balance Disorder Problems: 3629\n",
      "  Gale: 3630\n",
      "  Gallbladder Disease: 3631\n",
      "  Gallstones: 3632\n",
      "  Gambling: 3633\n",
      "  Gambling Disorder: 3634\n",
      "  Ganglion Cysts: 3635\n",
      "  Ganglioneuroblastoma: 3636\n",
      "  Gangliosidoses GM2: 3637\n",
      "  Gangliosidoses, GM2: 3638\n",
      "  Gastric Acid: 3639\n",
      "  Gastric Acid-related Diseases: 3640\n",
      "  Gastric Adenocarcinoma: 3641\n",
      "  Gastric Adenocarcinoma With Peritoneal Carcinomatosis: 3642\n",
      "  Gastric Bypass: 3643\n",
      "  Gastric Bypass Status: 3644\n",
      "  Gastric Cancer: 3645\n",
      "  Gastric Cancer Stage IV: 3646\n",
      "  Gastric Carcinoma: 3647\n",
      "  Gastric Carcinoma Stage IV: 3648\n",
      "  Gastric Dysplasia: 3649\n",
      "  Gastric Influenza: 3650\n",
      "  Gastric Motility Disorder: 3651\n",
      "  Gastric Neoplasm: 3652\n",
      "  Gastric Neoplasms: 3653\n",
      "  Gastric Polyp: 3654\n",
      "  Gastric Retention: 3655\n",
      "  Gastric Ulcer: 3656\n",
      "  Gastric Ulcer Induced by Antiplatelet Agent: 3657\n",
      "  Gastric Ulcers: 3658\n",
      "  Gastric pH Control: 3659\n",
      "  Gastrin-Producing Neuroendocrine Tumor: 3660\n",
      "  Gastrinoma: 3661\n",
      "  Gastritis: 3662\n",
      "  Gastritis Acute: 3663\n",
      "  Gastritis, Atrophic: 3664\n",
      "  Gastro Intestinal Stromal Tumor: 3665\n",
      "  Gastro-Esophageal Junction Adenocarcinoma: 3666\n",
      "  Gastro-Intestinal Cancer: 3667\n",
      "  Gastro-Intestinal Stromal Tumour: 3668\n",
      "  Gastro-Oesophageal Reflux Disease: 3669\n",
      "  Gastro-entero-pancreatic Neuroendocrine Tumors: 3670\n",
      "  Gastro-enteropancreatic Neuroendocrine Tumor: 3671\n",
      "  Gastro-esophageal Reflux Disease (GERD): 3672\n",
      "  Gastro-intestinal Neuroendocrine Tumors: 3673\n",
      "  Gastro-intestinal Stromal Tumours: 3674\n",
      "  Gastro-oesophageal Junction Cancer: 3675\n",
      "  Gastro-oesophageal Reflux: 3676\n",
      "  GastroEsophageal Cancer: 3677\n",
      "  Gastroduodenal Erosions: 3678\n",
      "  Gastroduodenal Ulcer: 3679\n",
      "  Gastroenteritis: 3680\n",
      "  Gastroenteritis Escherichia Coli: 3681\n",
      "  Gastroenteritis Norovirus: 3682\n",
      "  Gastroenterology: 3683\n",
      "  Gastroenteropancreatic Neuroendocrine Tumor: 3684\n",
      "  Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System: 3685\n",
      "  Gastroenteropancreatic Neuroendocrine Tumors: 3686\n",
      "  Gastroesophageal Adenocarcinoma: 3687\n",
      "  Gastroesophageal Cancer: 3688\n",
      "  Gastroesophageal Junction Adenocarcinoma: 3689\n",
      "  Gastroesophageal Reflux: 3690\n",
      "  Gastroesophageal Reflux Disease: 3691\n",
      "  Gastroesophageal Reflux Disease (GERD): 3692\n",
      "  Gastrointestinal Bleeding: 3693\n",
      "  Gastrointestinal Bleeding of Unknown Origin: 3694\n",
      "  Gastrointestinal Bleedings: 3695\n",
      "  Gastrointestinal Cancer: 3696\n",
      "  Gastrointestinal Cancer Metastatic: 3697\n",
      "  Gastrointestinal Carcinoid Tumor: 3698\n",
      "  Gastrointestinal Diseases: 3699\n",
      "  Gastrointestinal Disorders in Parkinson's Disease: 3700\n",
      "  Gastrointestinal Dysfunction: 3701\n",
      "  Gastrointestinal Dysmotility: 3702\n",
      "  Gastrointestinal Endoscopy: 3703\n",
      "  Gastrointestinal Hemorrhage: 3704\n",
      "  Gastrointestinal Motility: 3705\n",
      "  Gastrointestinal Motility Disorder: 3706\n",
      "  Gastrointestinal Mucositis: 3707\n",
      "  Gastrointestinal Neoplasms: 3708\n",
      "  Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies: 3709\n",
      "  Gastrointestinal Stromal Tumor: 3710\n",
      "  Gastrointestinal Stromal Tumor (GIST): 3711\n",
      "  Gastrointestinal Stromal Tumors: 3712\n",
      "  Gastrointestinal Stromal Tumour (GIST): 3713\n",
      "  Gastrointestinal Symptoms: 3714\n",
      "  Gastrointestinal Tumors: 3715\n",
      "  Gastrointestinal Ulcer Haemorrhage: 3716\n",
      "  Gastrointestinal and Gynecologic Malignancies: 3717\n",
      "  Gastroparesis: 3718\n",
      "  Gastroschisis: 3719\n",
      "  Gaucher Disease: 3720\n",
      "  Gaucher Disease Type 1: 3721\n",
      "  Gaucher Disease Type I: 3722\n",
      "  Gaucher Disease, Type 1: 3723\n",
      "  General Anesthesia: 3724\n",
      "  Generalised Anxiety Disorder: 3725\n",
      "  Generalized Anxiety Disease: 3726\n",
      "  Generalized Anxiety Disorder: 3727\n",
      "  Generalized Anxiety Disorder (GAD): 3728\n",
      "  Generalized Anxious Disorders: 3729\n",
      "  Generalized Convulsive Epilepsy: 3730\n",
      "  Generalized Epilepsy: 3731\n",
      "  Generalized Myasthenia Gravis: 3732\n",
      "  Generalized Social Phobia: 3733\n",
      "  Genetic Diseases: 3734\n",
      "  Genetic Disorder: 3735\n",
      "  Genetic Disorders: 3736\n",
      "  Genetic Risk for Alzheimer's Disease: 3737\n",
      "  Genetic Sucrase-Isomaltase Deficiency: 3738\n",
      "  Genital Diseases, Female: 3739\n",
      "  Genital Herpes: 3740\n",
      "  Genital Herpes Simplex Type 2: 3741\n",
      "  Genital Lichen Planus: 3742\n",
      "  Genital Neoplasms, Male: 3743\n",
      "  Genital Warts: 3744\n",
      "  Genitourinary Abnormality: 3745\n",
      "  Genitourinary Disease: 3746\n",
      "  Genotype Guided(HNF4a): 3747\n",
      "  Genotype-related Drug Metabolism: 3748\n",
      "  Gentle Colonoscopy: 3749\n",
      "  Geographic Atrophy: 3750\n",
      "  Germ Cell Neoplasms: 3751\n",
      "  Germ Cell Tumor: 3752\n",
      "  Germ Cell Tumors: 3753\n",
      "  Germline BRCA1/2 Mutations and: 3754\n",
      "  Gestational Diabetes: 3755\n",
      "  Gestational Diabetes Mellitus: 3756\n",
      "  Gestational Diabetes Mellitus in Pregnancy: 3757\n",
      "  Gestational Diabetes Mellitus, Class A2: 3758\n",
      "  Gestational Trophoblastic Neoplasia: 3759\n",
      "  Gestational Trophoblastic Tumor: 3760\n",
      "  Giant Cell Arteritis: 3761\n",
      "  Giant Cell Glioblastoma: 3762\n",
      "  Giant Cell Tumor of Bone: 3763\n",
      "  Giant Cell Tumors of Bone: 3764\n",
      "  Giant Lymph Node Hyperplasia: 3765\n",
      "  Gilles de la Tourette Syndrome: 3766\n",
      "  Gingival Diseases: 3767\n",
      "  Gingival Hyperpigmentaion: 3768\n",
      "  Gingival Recession: 3769\n",
      "  Gingivitis: 3770\n",
      "  Glabellar Frown Lines: 3771\n",
      "  Glabellar Lines: 3772\n",
      "  Glabellar Rhytides: 3773\n",
      "  Glaucoma: 3774\n",
      "  Glaucoma Open-Angle Primary: 3775\n",
      "  Glaucoma Patients and Healthy Controls: 3776\n",
      "  Glaucoma and Ocular Hypertension: 3777\n",
      "  Glaucoma, Angle-Closure: 3778\n",
      "  Glaucoma, Open Angle: 3779\n",
      "  Glaucoma, Open-Angle: 3780\n",
      "  Glaucoma, Open-Angle [C11.525.381.407]: 3781\n",
      "  Glaucoma, Primary Open Angle: 3782\n",
      "  Glaucomatous Neuropathy: 3783\n",
      "  Glenohumeral Arthritis: 3784\n",
      "  Glenohumeral Osteoarthritis: 3785\n",
      "  Glioblastoma: 3786\n",
      "  Glioblastoma (GBM): 3787\n",
      "  Glioblastoma Multiform (Grade IV Astrocytoma): 3788\n",
      "  Glioblastoma Multiforme: 3789\n",
      "  Glioblastoma Multiforme (GBM): 3790\n",
      "  Glioblastoma Multiforme (WHO Grade IV): 3791\n",
      "  Glioblastoma Multiforme of the Brain: 3792\n",
      "  Glioblastoma Multiforme, Adult: 3793\n",
      "  Glioblastoma or Malignant Glioma: 3794\n",
      "  Glioblastoma, Adult: 3795\n",
      "  Glioma: 3796\n",
      "  Glioma of Brain: 3797\n",
      "  Glioma, Malignant: 3798\n",
      "  Gliomas: 3799\n",
      "  Gliosarcoma: 3800\n",
      "  Glistenings: 3801\n",
      "  Glomerulonephritis: 3802\n",
      "  Glomerulonephritis, IGA: 3803\n",
      "  Glomerulonephritis, Membranous: 3804\n",
      "  Glomerulosclerosis, Focal Segmental: 3805\n",
      "  Glucocorticoids Toxicity: 3806\n",
      "  Glucocorticosteroid Refractory Acute GVHD: 3807\n",
      "  Glucose Blood: 3808\n",
      "  Glucose Homeostasis: 3809\n",
      "  Glucose Intolerance: 3810\n",
      "  Glucose Metabolism Disorders: 3811\n",
      "  Glucose Tolerance: 3812\n",
      "  Glucose Transporter Type 1 Deficiency Syndrome: 3813\n",
      "  Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS): 3814\n",
      "  Gluten Sensitivity: 3815\n",
      "  Glycemic Control: 3816\n",
      "  Glycogen Storage Disease Type II: 3817\n",
      "  Glycogen Synthase Kinase 3: 3818\n",
      "  Goal Directed Fluid Therapy: 3819\n",
      "  Goiter: 3820\n",
      "  Gonadotroph Adenomas: 3821\n",
      "  Gonadotropin Deficiency: 3822\n",
      "  Gonorrhea: 3823\n",
      "  Gonorrhoea: 3824\n",
      "  Gout: 3825\n",
      "  Gout Attack: 3826\n",
      "  Gout and Asymptomatic Hyperuricemia: 3827\n",
      "  Gouty Arthritis: 3828\n",
      "  Grade 1 Follicular Lymphoma: 3829\n",
      "  Grade 3/4 Neutropenia: 3830\n",
      "  Grade IV Astrocytoma: 3831\n",
      "  Graft -Versus-host-disease: 3832\n",
      "  Graft Dysfunction: 3833\n",
      "  Graft Failure: 3834\n",
      "  Graft Pancreatitis: 3835\n",
      "  Graft Rejection: 3836\n",
      "  Graft Versus Host Disease: 3837\n",
      "  Graft Vs Host Disease: 3838\n",
      "  Graft vs Host Disease: 3839\n",
      "  Graft-Versus-Host Disease: 3840\n",
      "  Graft-versus-Host Disease: 3841\n",
      "  Graft-versus-host Disease: 3842\n",
      "  Graft-versus-host Disease Prevention: 3843\n",
      "  Graft-vs-Host Disease: 3844\n",
      "  Graft-vs-host Disease: 3845\n",
      "  Grafting: 3846\n",
      "  Gram Negative Meningitis: 3847\n",
      "  Gram-Negative Bacterial Infections: 3848\n",
      "  Gram-Positive Bacterial Infections: 3849\n",
      "  Gram-positive Bacterial Infections: 3850\n",
      "  Gram-positive, Skin Infections: 3851\n",
      "  Granulomatosis With Polyangiitis: 3852\n",
      "  Granulomatosis With Polyangiitis (GPA): 3853\n",
      "  Granulomatosis With Polyangiitis (Wegener's Granulomatosis): 3854\n",
      "  Granulomatosis With Polyangiitis (Wegener's) (GPA): 3855\n",
      "  Granulomatous Colitis: 3856\n",
      "  Granulomatous Disease, Chronic, X-linked, Variant: 3857\n",
      "  Granulomatous and Lymphocytic Interstitial Lung Disease: 3858\n",
      "  Granulosa Cell Tumour of the Ovary: 3859\n",
      "  Grass Pollen Allergy: 3860\n",
      "  Graves Ophthalmopathy: 3861\n",
      "  Graves' Disease: 3862\n",
      "  Graves' Dysthyroid Ophthalmopathy: 3863\n",
      "  Great Saphenous Vein Incompetence: 3864\n",
      "  Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy: 3865\n",
      "  Grief: 3866\n",
      "  Group B Streptococcal Infections: 3867\n",
      "  Group B Streptococcus: 3868\n",
      "  Group B Streptococcus (GBS) Disease: 3869\n",
      "  Growing Vestibular Schwannomas: 3870\n",
      "  Growth: 3871\n",
      "  Growth Disorder: 3872\n",
      "  Growth Disorders: 3873\n",
      "  Growth Failure: 3874\n",
      "  Growth Hormone Deficiency: 3875\n",
      "  Growth Hormone Deficiency (GHD): 3876\n",
      "  Growth Hormone Deficiency, Pediatric: 3877\n",
      "  Growth Hormone Disorder: 3878\n",
      "  Growth Hormone Therapy: 3879\n",
      "  Growth Hormone Treatment: 3880\n",
      "  Growth Hormone-Deficiency: 3881\n",
      "  Growth in Premature Infants: 3882\n",
      "  Guillain-Barré Syndrome: 3883\n",
      "  Gulf War Illness: 3884\n",
      "  Gut Microbiota: 3885\n",
      "  Gynaecomastia: 3886\n",
      "  Gynecologic Cancer: 3887\n",
      "  Gynecologic Diseases: 3888\n",
      "  Gynecologic Laparoscopic Surgery: 3889\n",
      "  Gynecologic Malignancies: 3890\n",
      "  Gynecologic Neoplasms: 3891\n",
      "  Gynecologic Surgical Procedures: 3892\n",
      "  Gynecological Infection: 3893\n",
      "  H. Pylori Infection: 3894\n",
      "  H.Pylori Infection: 3895\n",
      "  H1N1 Influenza: 3896\n",
      "  H7N9 Influenza: 3897\n",
      "  H7N9 Influenza Vaccine: 3898\n",
      "  HBV: 3899\n",
      "  HBe Negative Chronic Hepatitis B: 3900\n",
      "  HBeAg-negative Chronic Hepatitis B: 3901\n",
      "  HBeAg-positive Chronic Hepatitis B: 3902\n",
      "  HBsAg-positive Renal Allograft Recipients: 3903\n",
      "  HCC: 3904\n",
      "  HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin: 3905\n",
      "  HCMV Infection: 3906\n",
      "  HCV: 3907\n",
      "  HCV HIV: 3908\n",
      "  HCV Infection: 3909\n",
      "  HCV Negative Status: 3910\n",
      "  HCV Recurrence After Liver Transplantation: 3911\n",
      "  HCV-HIV Co-Infection: 3912\n",
      "  HELLP Syndrome: 3913\n",
      "  HEMOGLOBIN SC DISEASE: 3914\n",
      "  HER-2 Gene Amplification: 3915\n",
      "  HER-2 Positive Breast Cancer: 3916\n",
      "  HER-2 Positive Gastric Cancer: 3917\n",
      "  HER-2 Positive Metastatic Breast Cancer: 3918\n",
      "  HER2 Amplified: 3919\n",
      "  HER2 Expressing Breast or Gastric/Stomach Cancers: 3920\n",
      "  HER2 Expressing Solid Tumors: 3921\n",
      "  HER2 Expressing Solid Tumours: 3922\n",
      "  HER2 Gene Mutation: 3923\n",
      "  HER2 Positive Breast Cancer: 3924\n",
      "  HER2 Positive Esophagogastric Cancer: 3925\n",
      "  HER2 Positive Metastatic Breast Cancers: 3926\n",
      "  HER2 Positive Untreated Metastatic Breast Cancer: 3927\n",
      "  HER2-Negative Metastatic Breast Cancer: 3928\n",
      "  HER2-Positive Breast Cancer: 3929\n",
      "  HER2-Positive Early Stage Breast Cancer: 3930\n",
      "  HER2-mutant Non-Small Cell Lung Cancer: 3931\n",
      "  HER2-negative Breast Cancer: 3932\n",
      "  HER2-positive Breast Cancer: 3933\n",
      "  HER2-positive Gastric Cancer Patients With Liver Metastasis: 3934\n",
      "  HER2/Neu Negative: 3935\n",
      "  HER2/Neu Positive: 3936\n",
      "  HIV: 3937\n",
      "  HIV - Human Immunodeficiency Virus: 3938\n",
      "  HIV 1 Infection: 3939\n",
      "  HIV Associated Neurocognitive Disorder (HAND): 3940\n",
      "  HIV Dementia: 3941\n",
      "  HIV Disease: 3942\n",
      "  HIV Enteropathy: 3943\n",
      "  HIV I Infection: 3944\n",
      "  HIV Infection: 3945\n",
      "  HIV Infection Associated Kaposi Disease: 3946\n",
      "  HIV Infections: 3947\n",
      "  HIV Lipodystrophy: 3948\n",
      "  HIV Prevention: 3949\n",
      "  HIV Seropositivity: 3950\n",
      "  HIV in Adults: 3951\n",
      "  HIV-1: 3952\n",
      "  HIV-1 Infection: 3953\n",
      "  HIV-1 Infections: 3954\n",
      "  HIV-1 and HSV-2 Coinfection: 3955\n",
      "  HIV-1-infection: 3956\n",
      "  HIV-2 Infection: 3957\n",
      "  HIV-Associated Lipodystrophy: 3958\n",
      "  HIV-Associated Lipodystrophy Syndrome: 3959\n",
      "  HIV-associated Cognitive Impairment: 3960\n",
      "  HIV-associated Myelopathy: 3961\n",
      "  HIV-associated Neuropathy: 3962\n",
      "  HIV-infection: 3963\n",
      "  HIV-infection/AIDS: 3964\n",
      "  HIV-related Lymphoma: 3965\n",
      "  HIV/AIDS: 3966\n",
      "  HIV/AIDS Treatment: 3967\n",
      "  HIV/HCV Coinfection: 3968\n",
      "  HIV/TB Co-infection: 3969\n",
      "  HLA-A*0201 Positive Cells Present: 3970\n",
      "  HLA-A2 Positive Cells Present: 3971\n",
      "  HNSCC: 3972\n",
      "  HPV: 3973\n",
      "  HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL: 3974\n",
      "  HPV Infections: 3975\n",
      "  HPV-16 +ve Oropharyngeal Carcinoma: 3976\n",
      "  HPV-Associated Cancers: 3977\n",
      "  HPV-Induced Genital Lesions: 3978\n",
      "  HPV-Related Squamous Cell Carcinoma: 3979\n",
      "  HPV16 Associated Cervical Cancer: 3980\n",
      "  HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer: 3981\n",
      "  HRAS Gene Mutation: 3982\n",
      "  HRQOL (Health Related Quality of Life): 3983\n",
      "  HSAN Type IV: 3984\n",
      "  HSIL, High-Grade Squamous Intraepithelial Lesions: 3985\n",
      "  HSV Infection: 3986\n",
      "  HTLV-1 Associated Myelopathy: 3987\n",
      "  HTLV-I-associated Myelopathy: 3988\n",
      "  Habitual Snoring: 3989\n",
      "  Haematological Malignancies: 3990\n",
      "  Haematopoiesis: 3991\n",
      "  Haemodialysis: 3992\n",
      "  Haemophilia A: 3993\n",
      "  Haemophilus Influenza: 3994\n",
      "  Haemophilus Influenzae: 3995\n",
      "  Haemophilus Influenzae (NTHI): 3996\n",
      "  Haemophilus Influenzae Type B Infection: 3997\n",
      "  Haemophilus Influenzae Type b: 3998\n",
      "  Haemophilus Influenzae Type b (Hib) Infection: 3999\n",
      "  Haemostasis: 4000\n",
      "  Hairy Cell Leukemia: 4001\n",
      "  Hallux Abducto Valgus: 4002\n",
      "  Hallux Valgus: 4003\n",
      "  Hamstring Injury: 4004\n",
      "  Hand Dermatoses: 4005\n",
      "  Hand Eczema: 4006\n",
      "  Hand Foot Skin Syndrome: 4007\n",
      "  Hand Fractures: 4008\n",
      "  Hand Injuries: 4009\n",
      "  Hand Laceration: 4010\n",
      "  Hand Osteoarthritis: 4011\n",
      "  Hand, Foot and Mouth Disease: 4012\n",
      "  Hand, Foot and Mouth Disease (HFMD): 4013\n",
      "  Hand-foot Skin Reaction: 4014\n",
      "  Hand-foot Syndrome: 4015\n",
      "  Handling of Auto-injectors: 4016\n",
      "  Hansen's Disease: 4017\n",
      "  Hantaan Virus Disease, Puumala Virus: 4018\n",
      "  Haploidentical Stem Cell Transplantation: 4019\n",
      "  Hay Fever: 4020\n",
      "  Hayfever: 4021\n",
      "  Hazardous Alcohol Consumption: 4022\n",
      "  Hazardous Drinking: 4023\n",
      "  Head And Neck Cancer: 4024\n",
      "  Head Injury: 4025\n",
      "  Head Lice: 4026\n",
      "  Head Lice Infestation: 4027\n",
      "  Head Neck Cancer: 4028\n",
      "  Head Neck Cancer Squamous Cell Metastatic: 4029\n",
      "  Head Trauma: 4030\n",
      "  Head and Neck: 4031\n",
      "  Head and Neck Cancer: 4032\n",
      "  Head and Neck Cancer Squamous Cell Carcinoma: 4033\n",
      "  Head and Neck Carcinoma: 4034\n",
      "  Head and Neck Neoplasms: 4035\n",
      "  Head and Neck Squamous Cell Cancer: 4036\n",
      "  Head and Neck Squamous Cell Carcinoma: 4037\n",
      "  Head and Neck Squamous Cell Carcinoma (HNSCC): 4038\n",
      "  Head and Neck Tumors: 4039\n",
      "  Headache: 4040\n",
      "  Headache (Migraine): 4041\n",
      "  Headache, Migraine: 4042\n",
      "  Headache, Tension-Type: 4043\n",
      "  Headaches: 4044\n",
      "  Headaches Associated With Subarachnoid Hemorrhage (SAH): 4045\n",
      "  Healing of Donor Site: 4046\n",
      "  Health: 4047\n",
      "  Health Behavior: 4048\n",
      "  Health Care: 4049\n",
      "  Health Care Associated Pneumonia: 4050\n",
      "  Health Care Provider Education: 4051\n",
      "  Health Care Quality: 4052\n",
      "  Health Status: 4053\n",
      "  Health-Related Quality of Life: 4054\n",
      "  Healthcare-associated Pneumonia (HCAP): 4055\n",
      "  Healthy: 4056\n",
      "  Healthy Adult Chinese Males: 4057\n",
      "  Healthy Adult Female Participants: 4058\n",
      "  Healthy Adult Immune Response: 4059\n",
      "  Healthy Adult Immune Responses to Vaccine: 4060\n",
      "  Healthy Adult Male: 4061\n",
      "  Healthy Adult Subjects: 4062\n",
      "  Healthy Adult Subjects and Healthy Elderly Subjects: 4063\n",
      "  Healthy Adult Volunteers: 4064\n",
      "  Healthy Adults: 4065\n",
      "  Healthy Adults With Normal BMI: 4066\n",
      "  Healthy Aging: 4067\n",
      "  Healthy Controls: 4068\n",
      "  Healthy Elderly: 4069\n",
      "  Healthy Elderly Volunteers: 4070\n",
      "  Healthy Female Subjects: 4071\n",
      "  Healthy Females: 4072\n",
      "  Healthy Highly Dependant Smokers: 4073\n",
      "  Healthy Human Volunteers: 4074\n",
      "  Healthy Individual: 4075\n",
      "  Healthy Infants: 4076\n",
      "  Healthy Japanese Adult Male: 4077\n",
      "  Healthy Japanese and Caucasian Male Adults: 4078\n",
      "  Healthy Lifestyle: 4079\n",
      "  Healthy Male: 4080\n",
      "  Healthy Male Subjects: 4081\n",
      "  Healthy Male Volunteer: 4082\n",
      "  Healthy Male Volunteers: 4083\n",
      "  Healthy Male and Female Japanese Volunteers: 4084\n",
      "  Healthy Male and Female Volunteers: 4085\n",
      "  Healthy Males: 4086\n",
      "  Healthy Normotensive Volunteers: 4087\n",
      "  Healthy Participants: 4088\n",
      "  Healthy Smokers: 4089\n",
      "  Healthy Stem Cell Donor: 4090\n",
      "  Healthy Subject: 4091\n",
      "  Healthy Subjects: 4092\n",
      "  Healthy Subjects Without Type 1 Diabetes: 4093\n",
      "  Healthy Subjects and Atopic Dermatitis Subjects: 4094\n",
      "  Healthy Symptomatic Menopausal Women: 4095\n",
      "  Healthy Term Babies: 4096\n",
      "  Healthy Term Infants: 4097\n",
      "  Healthy Volunteer: 4098\n",
      "  Healthy Volunteer Smokers: 4099\n",
      "  Healthy Volunteer Study: 4100\n",
      "  Healthy Volunteers: 4101\n",
      "  Healthy Volunteers (HV): 4102\n",
      "  Healthy Volunteers (Meningococcal Infection): 4103\n",
      "  Healthy Volunteers and Glaucoma Patients: 4104\n",
      "  Healthy Women: 4105\n",
      "  Healthy Women of Child Bearing Potential: 4106\n",
      "  Healthy Young Adults: 4107\n",
      "  Healthy or Stable Chronic Illness: 4108\n",
      "  Healthy or Stable Underlying Chronic Medical Condition: 4109\n",
      "  Healthy, Overweight and/or Obese Subjects: 4110\n",
      "  Healthy, no Evidence of Disease: 4111\n",
      "  Healty Male Volunteers: 4112\n",
      "  Hearing Loss: 4113\n",
      "  Hearing Loss, Bilateral: 4114\n",
      "  Hearing Loss, Idiopathic Sudden Sensorineural: 4115\n",
      "  Hearing Loss, Sensorineural: 4116\n",
      "  Hearing Loss, Sudden: 4117\n",
      "  Heart Arrest: 4118\n",
      "  Heart Arrest, Out-Of-Hospital: 4119\n",
      "  Heart Attack: 4120\n",
      "  Heart Catheterization: 4121\n",
      "  Heart Defect, Congenital: 4122\n",
      "  Heart Defects: 4123\n",
      "  Heart Defects, Congenital: 4124\n",
      "  Heart Disease: 4125\n",
      "  Heart Disease End Stage: 4126\n",
      "  Heart Diseases: 4127\n",
      "  Heart Failure: 4128\n",
      "  Heart Failure (HF): 4129\n",
      "  Heart Failure Class II or III: 4130\n",
      "  Heart Failure Congestive: 4131\n",
      "  Heart Failure NYHA Class I: 4132\n",
      "  Heart Failure NYHA Class III: 4133\n",
      "  Heart Failure NYHA Class IV: 4134\n",
      "  Heart Failure With Hyponatremia: 4135\n",
      "  Heart Failure With Normal Ejection Fraction: 4136\n",
      "  Heart Failure With Preserved Ejection Fraction: 4137\n",
      "  Heart Failure With Preserved Ejection Fraction (HFpEF): 4138\n",
      "  Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease: 4139\n",
      "  Heart Failure With Reactive Pulmonary Hypertension: 4140\n",
      "  Heart Failure With Reduced Ejection Fraction: 4141\n",
      "  Heart Failure, Congestive: 4142\n",
      "  Heart Failure, Congestive and Microalbuminuria: 4143\n",
      "  Heart Failure, Diastolic: 4144\n",
      "  Heart Failure, Hyperuricemia: 4145\n",
      "  Heart Failure, Left Sided: 4146\n",
      "  Heart Failure, Reduced Ejection Fraction: 4147\n",
      "  Heart Failure, Systolic: 4148\n",
      "  Heart Failure，Congestive: 4149\n",
      "  Heart Rate: 4150\n",
      "  Heart Rate Control in ICD Patients With Heart Failure: 4151\n",
      "  Heart Septal Defects, Atrial: 4152\n",
      "  Heart Septal Defects, Ventricular: 4153\n",
      "  Heart Transplant: 4154\n",
      "  Heart Transplant Surgery: 4155\n",
      "  Heart Transplantation: 4156\n",
      "  Heart Transplantation, Elevated Resting Heart Rate: 4157\n",
      "  Heart Valve Disease: 4158\n",
      "  Heart Valve Diseases: 4159\n",
      "  Heart and Lung Transplant: 4160\n",
      "  Heart-lung Transplant Rejection: 4161\n",
      "  Heart; Dysfunction Postoperative, Cardiac Surgery: 4162\n",
      "  Heartburn: 4163\n",
      "  Hearth Failure With Reduced Ejection Fraction (HFrEF): 4164\n",
      "  Heat Effect: 4165\n",
      "  Heathy Volunteer: 4166\n",
      "  Heathy Volunteers: 4167\n",
      "  Heavy Drinking: 4168\n",
      "  Heavy Menstrual Bleeding: 4169\n",
      "  Heavy Metal Toxicity: 4170\n",
      "  Heavy Proteinuria: 4171\n",
      "  Helicobacter Infections: 4172\n",
      "  Helicobacter Pylori: 4173\n",
      "  Helicobacter Pylori Gastrointestinal Tract Infection: 4174\n",
      "  Helicobacter Pylori Infected Subjects: 4175\n",
      "  Helicobacter Pylori Infection: 4176\n",
      "  Helminth Infection: 4177\n",
      "  Helminth Infections: 4178\n",
      "  Helminthiasis: 4179\n",
      "  Hemangioblastomas: 4180\n",
      "  Hemangioma: 4181\n",
      "  Hemangioma Liver: 4182\n",
      "  Hemangioma of Infancy: 4183\n",
      "  Hemangioma, Capillary: 4184\n",
      "  Hematologic Disease: 4185\n",
      "  Hematologic Diseases: 4186\n",
      "  Hematologic Disorder: 4187\n",
      "  Hematologic Malignancies: 4188\n",
      "  Hematologic Malignancy: 4189\n",
      "  Hematologic Neoplasms: 4190\n",
      "  Hematologic Tumors: 4191\n",
      "  Hematological Disease: 4192\n",
      "  Hematological Infection: 4193\n",
      "  Hematological Malignancies: 4194\n",
      "  Hematological Malignancy: 4195\n",
      "  Hematological Malignancy (Leukemia- Lymphoma): 4196\n",
      "  Hematological Neoplasms: 4197\n",
      "  Hematoma: 4198\n",
      "  Hematoma Absorption and Neurological Function Recovery: 4199\n",
      "  Hematoma, Subdural, Chronic: 4200\n",
      "  Hematopoetic Stem Cell Transplant: 4201\n",
      "  Hematopoietic Cell Transplantation Recipient: 4202\n",
      "  Hematopoietic Malignancies: 4203\n",
      "  Hematopoietic Neoplasm: 4204\n",
      "  Hematopoietic Stem Cell Transplant: 4205\n",
      "  Hematopoietic Stem Cell Transplantation: 4206\n",
      "  Hematopoietic Stem Cell Transplantation (HSCT): 4207\n",
      "  Hematopoietic Syndrome Due to Acute Radiation Syndrome: 4208\n",
      "  Hematopoietic and Lymphoid Cell Neoplasm: 4209\n",
      "  Hematopoietic/Lymphoid Cancer: 4210\n",
      "  Hematuria: 4211\n",
      "  Hemiplegia: 4212\n",
      "  Hemiplegic Cerebral Palsy: 4213\n",
      "  Hemochromatosis: 4214\n",
      "  Hemodialysis: 4215\n",
      "  Hemodialysis Catheter-related Bacteremia: 4216\n",
      "  Hemodialysis Complication: 4217\n",
      "  Hemodialysis Graft Dysfunction: 4218\n",
      "  Hemodialysis Patients: 4219\n",
      "  Hemodialysis-Induced Symptom: 4220\n",
      "  Hemodynamic: 4221\n",
      "  Hemodynamic Instability: 4222\n",
      "  Hemodynamic Response: 4223\n",
      "  Hemodynamic Stability: 4224\n",
      "  Hemodynamic Stability Post Intubation in Laryngoscopy Surgery: 4225\n",
      "  Hemodynamics: 4226\n",
      "  Hemoglobin SC Disease: 4227\n",
      "  Hemoglobinopathies: 4228\n",
      "  Hemolytic Disease of the Fetus and Newborn: 4229\n",
      "  Hemolytic Disorders: 4230\n",
      "  Hemolytic Uremic Syndrome: 4231\n",
      "  Hemolytic-Uremic Syndrome: 4232\n",
      "  Hemophagocytic Lymphohistiocytosis: 4233\n",
      "  Hemophagocytic Lymphohistiocytosis (HLH): 4234\n",
      "  Hemophagocytic Syndrome (HPS): 4235\n",
      "  Hemophilia: 4236\n",
      "  Hemophilia A: 4237\n",
      "  Hemophilia A With Inhibitor: 4238\n",
      "  Hemophilia A With Inhibitors: 4239\n",
      "  Hemophilia A and B: 4240\n",
      "  Hemophilia A, Congenital: 4241\n",
      "  Hemophilia B: 4242\n",
      "  Hemophilia a: 4243\n",
      "  Hemoptysis: 4244\n",
      "  Hemorrhage: 4245\n",
      "  Hemorrhage; Complicating Delivery: 4246\n",
      "  Hemorrhagic Cystitis: 4247\n",
      "  Hemorrhagic Fever With Renal Syndrome: 4248\n",
      "  Hemorrhagic Fever, Ebola: 4249\n",
      "  Hemorrhagic Shock: 4250\n",
      "  Hemorrhagic Stroke: 4251\n",
      "  Hemorrhoid: 4252\n",
      "  Hemorrhoids: 4253\n",
      "  Hemostasis: 4254\n",
      "  Hemostasis, Surgical: 4255\n",
      "  Hemostatic Disorders: 4256\n",
      "  Hemostatic Techniques: 4257\n",
      "  Heparin: 4258\n",
      "  Heparin Induced Thrombocytopenia (HIT): 4259\n",
      "  Heparin-Induced Thrombocytopenia: 4260\n",
      "  Heparin-induced Thrombocytopenia: 4261\n",
      "  Hepatectomy: 4262\n",
      "  Hepatic Cancer: 4263\n",
      "  Hepatic Carcinoma: 4264\n",
      "  Hepatic Cirrhosis: 4265\n",
      "  Hepatic Encephalopathy: 4266\n",
      "  Hepatic Failure: 4267\n",
      "  Hepatic Impairment: 4268\n",
      "  Hepatic Impairment; Renal Impairment: 4269\n",
      "  Hepatic Insufficiency: 4270\n",
      "  Hepatic Insufficiency & Healthy Subjects: 4271\n",
      "  Hepatic Metastases: 4272\n",
      "  Hepatic Neoplasm Malignant: 4273\n",
      "  Hepatic Neoplasm Malignant Recurrent: 4274\n",
      "  Hepatic Sarcoidosis, Elevated Alkaline Phosphatase: 4275\n",
      "  Hepatic Steatosis: 4276\n",
      "  Hepatic Veno-Occlusive Disease: 4277\n",
      "  Hepatitis: 4278\n",
      "  Hepatitis A: 4279\n",
      "  Hepatitis A Virus: 4280\n",
      "  Hepatitis B: 4281\n",
      "  Hepatitis B Infection: 4282\n",
      "  Hepatitis B Virus: 4283\n",
      "  Hepatitis B Virus (HBV): 4284\n",
      "  Hepatitis B Virus Infection: 4285\n",
      "  Hepatitis B, Chronic: 4286\n",
      "  Hepatitis C: 4287\n",
      "  Hepatitis C Infection: 4288\n",
      "  Hepatitis C Viral Infection: 4289\n",
      "  Hepatitis C Virus: 4290\n",
      "  Hepatitis C Virus (HCV): 4291\n",
      "  Hepatitis C Virus Genotype 4 Infection: 4292\n",
      "  Hepatitis C Virus Genotype-1: 4293\n",
      "  Hepatitis C Virus Infection: 4294\n",
      "  Hepatitis C Virus Infection, Response to Therapy of: 4295\n",
      "  Hepatitis C Virus Recurrence: 4296\n",
      "  Hepatitis C, Chronic: 4297\n",
      "  Hepatitis D: 4298\n",
      "  Hepatitis D, Chronic: 4299\n",
      "  Hepatitis E: 4300\n",
      "  Hepatitis E Infection: 4301\n",
      "  Hepatitis, Alcoholic: 4302\n",
      "  Hepatitis, Autoimmune: 4303\n",
      "  Hepatitis, Chronic: 4304\n",
      "  Hepatitits C: 4305\n",
      "  HepatoCellular Carcinoma: 4306\n",
      "  Hepatobiliary Disease: 4307\n",
      "  Hepatoblastoma: 4308\n",
      "  Hepatocellular Cancer: 4309\n",
      "  Hepatocellular Carcinoma: 4310\n",
      "  Hepatocellular Carcinoma (HCC): 4311\n",
      "  Hepatocellular Carcinoma Non-resectable: 4312\n",
      "  Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: 4313\n",
      "  Hepatocellular Carinoma: 4314\n",
      "  Hepatoma: 4315\n",
      "  Hepatomegaly: 4316\n",
      "  Hepatopulmonary Syndrome: 4317\n",
      "  Hepatorenal Syndrome: 4318\n",
      "  Hepatorenal Syndrome Type 1: 4319\n",
      "  Hepatorenal Syndrome Type I and Type II: 4320\n",
      "  Her2 Amplified Solid Tumors: 4321\n",
      "  Her2 Positive Metastatic Breast Cancer: 4322\n",
      "  Her2-negative Metastatic Breast Cancer: 4323\n",
      "  Her2/Neu Positive Advanced Solid Tumors: 4324\n",
      "  Hereditary Angioedema: 4325\n",
      "  Hereditary Angioedema (HAE): 4326\n",
      "  Hereditary Angioedema Types I and II: 4327\n",
      "  Hereditary Angioedema, HAE: 4328\n",
      "  Hereditary Breast and Ovarian Cancer Syndrome: 4329\n",
      "  Hereditary Hemochromatosis: 4330\n",
      "  Hereditary Hemorrhagic Telangiectasia: 4331\n",
      "  Hereditary Hemorrhagic Telangiectasia (HHT): 4332\n",
      "  Hereditary Inclusion Body Myopathy: 4333\n",
      "  Hereditary Inclusion Body Myopathy (HIBM): 4334\n",
      "  Hereditary Orotic Aciduria: 4335\n",
      "  Hereditary Thrombotic Thrombocytopenic Purpura (TTP): 4336\n",
      "  Hereditary Tyrosinemia, Type I: 4337\n",
      "  Hermanski-Pudlak Syndrome: 4338\n",
      "  Hermansky-Pudlak Syndrome (HPS): 4339\n",
      "  Hernia: 4340\n",
      "  Hernia, Abdominal: 4341\n",
      "  Hernia, Diaphragmatic: 4342\n",
      "  Hernia, Inguinal: 4343\n",
      "  Hernia, Ventral: 4344\n",
      "  Heroin Dependence: 4345\n",
      "  Herpes Genitalis: 4346\n",
      "  Herpes Labialis: 4347\n",
      "  Herpes Simplex: 4348\n",
      "  Herpes Simplex Keratitis: 4349\n",
      "  Herpes Simplex Virus: 4350\n",
      "  Herpes Simplex Virus Infection: 4351\n",
      "  Herpes Simplex Virus Keratitis: 4352\n",
      "  Herpes Zoster: 4353\n",
      "  Herpes Zoster Keratitis: 4354\n",
      "  Herpes Zoster Ophthalmicus: 4355\n",
      "  Herpetic Gingivostomatitis: 4356\n",
      "  Heterogeneous Emphysema: 4357\n",
      "  Heterotopic Ossification: 4358\n",
      "  Heterozygous Familial Hypercholesterolaemia: 4359\n",
      "  Heterozygous Familial Hypercholesterolemia: 4360\n",
      "  Hidradenitis Suppurativa: 4361\n",
      "  High Altitude Pulmonary Edema: 4362\n",
      "  High Blood Pressure: 4363\n",
      "  High Cholesterol: 4364\n",
      "  High Grade Anal Canal Intraepithelial Neoplasia: 4365\n",
      "  High Grade Fallopian Tube Serous Adenocarcinoma: 4366\n",
      "  High Grade Glioma: 4367\n",
      "  High Grade Glioma (III or IV): 4368\n",
      "  High Grade Glioma: Glioblastoma (GBM): 4369\n",
      "  High Grade Gliomas: 4370\n",
      "  High Grade Sarcoma: 4371\n",
      "  High Grade Squamous Intraepithelial Neoplasia: 4372\n",
      "  High Output Stoma: 4373\n",
      "  High Oxidation Stress: 4374\n",
      "  High Risk Cervical Cancer: 4375\n",
      "  High Risk Hematologic Malignancies: 4376\n",
      "  High Risk MC4R Genotype: 4377\n",
      "  High Risk MDS: 4378\n",
      "  High Risk Myelodysplastic Syndrome: 4379\n",
      "  High Risk Neuroblastoma: 4380\n",
      "  High Risk Proliferative Diabetic Retinopathy: 4381\n",
      "  High Risk Prostate Cancer: 4382\n",
      "  High Risk Smoldering Multiple Myeloma: 4383\n",
      "  High Tibia Osteotomy: 4384\n",
      "  High-Frequency Jet Ventilation: 4385\n",
      "  High-Grade Gliomas: 4386\n",
      "  High-Normal Blood Pressure: 4387\n",
      "  High-Risk Acute Myeloid Leukemia: 4388\n",
      "  High-Risk Breast Cancer: 4389\n",
      "  High-Risk Cancer: 4390\n",
      "  High-grade Dysplasia in Barrett Esophagus: 4391\n",
      "  High-grade Glioma: 4392\n",
      "  High-grade Salivary Gland Carcinoma: 4393\n",
      "  High-grade Salivary Gland Mucoepidermoid Carcinoma: 4394\n",
      "  High-risk Diffuse Large B-cell Lymphoma: 4395\n",
      "  High-risk Medulloblastoma: 4396\n",
      "  High-risk Myelodysplastic Syndromes: 4397\n",
      "  High-risk, Non-cardiovascular Surgeries: 4398\n",
      "  Highly Drug-resistant Focal Epilepsy: 4399\n",
      "  Hilar Cholangiocarcinoma: 4400\n",
      "  Hip Arthroplasty: 4401\n",
      "  Hip Arthroplasty Replacement: 4402\n",
      "  Hip Arthroscopy: 4403\n",
      "  Hip Disease: 4404\n",
      "  Hip Dysplasia: 4405\n",
      "  Hip Fracture: 4406\n",
      "  Hip Fracture Surgery: 4407\n",
      "  Hip Fractures: 4408\n",
      "  Hip Fractures Pathologic: 4409\n",
      "  Hip Injuries: 4410\n",
      "  Hip Osteoarthritis: 4411\n",
      "  Hip Surgery: 4412\n",
      "  Hip Surgery Corrective: 4413\n",
      "  Histamine H1 Antagonists, Non-Sedating: 4414\n",
      "  Histamine Responsive Allergy Patients: 4415\n",
      "  Histiocytic Disorders: 4416\n",
      "  Histiocytosis, Langerhans-Cell: 4417\n",
      "  Histiocytosis, Langerhans-cell: 4418\n",
      "  Histologically Confirmed Medulloblastoma: 4419\n",
      "  Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV): 4420\n",
      "  Histologically-proven and Radiologically-confirmed Solid Tumors: 4421\n",
      "  Hiv: 4422\n",
      "  Hodgkin Disease: 4423\n",
      "  Hodgkin Lymphoma: 4424\n",
      "  Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis: 4425\n",
      "  Hodgkin's Disease: 4426\n",
      "  Hodgkin's Lymphoma: 4427\n",
      "  Hodgkin's Lymphoma - Relapsed/Refractory: 4428\n",
      "  Hodgkins Disease: 4429\n",
      "  Hodgkins Lymphoma: 4430\n",
      "  Hodgkin´s Lymphoma: 4431\n",
      "  Home Parenteral Nutrition: 4432\n",
      "  Homeostasis: 4433\n",
      "  Homocystinuria: 4434\n",
      "  Homozygous Familial Hypercholesterolemia: 4435\n",
      "  Homozygous Familial Hypercholesterolemia (HoFH): 4436\n",
      "  Hookworm Infection: 4437\n",
      "  Hookworm Infections: 4438\n",
      "  Hormone Deficiency: 4439\n",
      "  Hormone Refractory Prostate Cancer: 4440\n",
      "  Hormone Refractory Prostate Cancer Disease: 4441\n",
      "  Hormone Replacement Therapy: 4442\n",
      "  Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women: 4443\n",
      "  Hormone-Refractory Prostate Cancer: 4444\n",
      "  Hormone-Resistant Prostate Cancer: 4445\n",
      "  Hormone-Sensitive Breast Cancer: 4446\n",
      "  Hormone-receptor Positive Breast Cancer: 4447\n",
      "  Hormone-refractory Prostate Cancer: 4448\n",
      "  Hormone-resistant Prostate Cancer: 4449\n",
      "  Hormone-sensitive Metastatic Breast Cancer: 4450\n",
      "  Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer: 4451\n",
      "  Hormono-depending Adjuvant Breast Cancer: 4452\n",
      "  Horner Syndrome: 4453\n",
      "  Hospital Acquired Pneumonia in Gurgling Patients: 4454\n",
      "  Hospital-Acquired Bacterial Pneumonia: 4455\n",
      "  Hospital-Acquired Pneumonia: 4456\n",
      "  Hospitalization: 4457\n",
      "  Hospitalized Elderly: 4458\n",
      "  Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days: 4459\n",
      "  Hospitalized Patients: 4460\n",
      "  Hot Flashes: 4461\n",
      "  Hot Flushes: 4462\n",
      "  House Dust Mite Allergy: 4463\n",
      "  Human Epithelial Receptor (HER)-2 Positive Breast Cancer: 4464\n",
      "  Human Experimentation: 4465\n",
      "  Human Herpesvirus 8: 4466\n",
      "  Human Immunodeficiency Virus: 4467\n",
      "  Human Immunodeficiency Virus (HIV): 4468\n",
      "  Human Immunodeficiency Virus (HIV)-1 Infection: 4469\n",
      "  Human Immunodeficiency Virus 1: 4470\n",
      "  Human Immunodeficiency Virus 1 Positive: 4471\n",
      "  Human Immunodeficiency Virus Infection: 4472\n",
      "  Human Immunodeficiency Virus Infections: 4473\n",
      "  Human Immunodeficiency Virus Type 1: 4474\n",
      "  Human Immunodeficiency Virus-1: 4475\n",
      "  Human Immunodeficiency Virus-1 (HIV-1): 4476\n",
      "  Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome: 4477\n",
      "  Human Influenza: 4478\n",
      "  Human Mammary Carcinoma: 4479\n",
      "  Human Papilloma Virus Infection: 4480\n",
      "  Human Papilloma Virus Infection Type 16: 4481\n",
      "  Human Papillomavirus: 4482\n",
      "  Human Papillomavirus (HPV): 4483\n",
      "  Human Papillomavirus Infection: 4484\n",
      "  Human Papillomavirus Infection Leading to Cervical Cancer: 4485\n",
      "  Human Papillomavirus Infections: 4486\n",
      "  Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma: 4487\n",
      "  Human Papillomavirus-16 Positive: 4488\n",
      "  Human Rabies: 4489\n",
      "  Human T-cell Leukemia Virus Type 1 Infection: 4490\n",
      "  Human Volunteers: 4491\n",
      "  Humans: 4492\n",
      "  Humeral Fractures: 4493\n",
      "  Hunger: 4494\n",
      "  Hunter Syndrome: 4495\n",
      "  Huntington Disease: 4496\n",
      "  Huntington's Chorea: 4497\n",
      "  Huntington's Disease: 4498\n",
      "  Hurler Syndrome (MPS I): 4499\n",
      "  Hurler's Syndrome: 4500\n",
      "  Hutchinson-Gilford Progeria Syndrome: 4501\n",
      "  Hyaline Membrane Disease: 4502\n",
      "  Hydration: 4503\n",
      "  Hydrocephalus: 4504\n",
      "  Hygiene: 4505\n",
      "  Hyper-Triglyceridemia: 4506\n",
      "  Hyper-reactive Malarial Splenomegaly: 4507\n",
      "  Hyperactive Delirium: 4508\n",
      "  Hyperalgesia: 4509\n",
      "  Hyperandrogenemia: 4510\n",
      "  Hyperbaric: 4511\n",
      "  Hyperbilirubinemia, Neonatal: 4512\n",
      "  Hypercalciuria: 4513\n",
      "  Hypercatabolic Status Related to Severe Burn: 4514\n",
      "  Hypercholesteremia: 4515\n",
      "  Hypercholesterol: 4516\n",
      "  Hypercholesterolaemia: 4517\n",
      "  Hypercholesterolemia: 4518\n",
      "  Hypercholesterolemia With Type2DM: 4519\n",
      "  Hypercholesterolemia and High Risk for Cardiovascular Events: 4520\n",
      "  Hypercholesterolemia, Familial: 4521\n",
      "  Hyperemesis Gravidarum: 4522\n",
      "  Hyperemia: 4523\n",
      "  Hypereosinophilic Syndrome: 4524\n",
      "  Hypergastrinaemia: 4525\n",
      "  Hyperglycaemia: 4526\n",
      "  Hyperglycemia: 4527\n",
      "  Hyperglycemia Steroid-induced: 4528\n",
      "  Hyperglycemia in Pregnant Diabetic Patients: 4529\n",
      "  Hyperhidrosis: 4530\n",
      "  Hyperhomocysteinemia: 4531\n",
      "  Hyperhydrosis: 4532\n",
      "  Hyperinsulinemia Hypoglycemia: 4533\n",
      "  Hyperinsulinism: 4534\n",
      "  Hyperkalemia: 4535\n",
      "  Hyperkalemic Periodic Paralysis: 4536\n",
      "  Hyperlactatemia: 4537\n",
      "  Hyperlipidemia: 4538\n",
      "  Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events: 4539\n",
      "  Hyperlipidemias: 4540\n",
      "  Hyperlipoproteinemia: 4541\n",
      "  Hyperlipoproteinemia Type II: 4542\n",
      "  Hyperlipoproteinemia Type III: 4543\n",
      "  Hypermobility Syndrome: 4544\n",
      "  Hyperopia: 4545\n",
      "  Hyperoxaluria: 4546\n",
      "  Hyperoxia: 4547\n",
      "  Hyperparathyroidism: 4548\n",
      "  Hyperparathyroidism, Primary: 4549\n",
      "  Hyperparathyroidism, Secondary: 4550\n",
      "  Hyperphagia: 4551\n",
      "  Hyperphosphatemia: 4552\n",
      "  Hyperphosphatemia in Chronic Kidney Disease: 4553\n",
      "  Hyperpigmentation: 4554\n",
      "  Hyperplasia: 4555\n",
      "  Hypersensitivity: 4556\n",
      "  Hypersensitivity Pneumonitis: 4557\n",
      "  Hypersensitivity, Immediate: 4558\n",
      "  Hypersomnia: 4559\n",
      "  Hypertension: 4560\n",
      "  Hypertension Complicated: 4561\n",
      "  Hypertension Pregnancy-induced: 4562\n",
      "  Hypertension Pulmonary Secondary: 4563\n",
      "  Hypertension Resistant to Conventional Therapy: 4564\n",
      "  Hypertension Stage 1: 4565\n",
      "  Hypertension With Dyslipidemia: 4566\n",
      "  Hypertension With Hyperlipidemia: 4567\n",
      "  Hypertension With Metabolic Syndrome: 4568\n",
      "  Hypertension and Coronary Artery Disease: 4569\n",
      "  Hypertension in Pregnancy: 4570\n",
      "  Hypertension in Type 2 Diabetes: 4571\n",
      "  Hypertension,: 4572\n",
      "  Hypertension, Diabetes Mellitus: 4573\n",
      "  Hypertension, Essential: 4574\n",
      "  Hypertension, Hyperlipidemia: 4575\n",
      "  Hypertension, Pregnancy Induced: 4576\n",
      "  Hypertension, Pregnancy-Induced: 4577\n",
      "  Hypertension, Pulmonary: 4578\n",
      "  Hypertension, Resistant to Conventional Therapy: 4579\n",
      "  Hypertension,Essential: 4580\n",
      "  Hypertension,Pulmonary: 4581\n",
      "  Hypertension; Hypertrophy, Left Ventricular: 4582\n",
      "  Hypertensive Leg Ulcer: 4583\n",
      "  Hyperthermia: 4584\n",
      "  Hypertriglyceridemia: 4585\n",
      "  Hypertriglyceridemia in Type 4 Hyperlipidemia: 4586\n",
      "  Hypertrophic Cardiomyopathy: 4587\n",
      "  Hypertrophic Obstructive Cardiomyopathy: 4588\n",
      "  Hypertrophic Scar: 4589\n",
      "  Hypertrophic Scars: 4590\n",
      "  Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery: 4591\n",
      "  Hyperuricemia: 4592\n",
      "  Hypervolemic Hyponatremia: 4593\n",
      "  Hypoactive Delirium: 4594\n",
      "  Hypoactive Sexual Desire Disorder: 4595\n",
      "  Hypoactive Sexual Desire Disorder (HSDD): 4596\n",
      "  Hypoalbuminemia: 4597\n",
      "  Hypocalcemia: 4598\n",
      "  Hypochondriasis: 4599\n",
      "  Hypochondroplasia: 4600\n",
      "  Hypoglycemia: 4601\n",
      "  Hypoglycemia Unawareness: 4602\n",
      "  Hypogonadal Males: 4603\n",
      "  Hypogonadism: 4604\n",
      "  Hypogonadism, Hypogonadotropic: 4605\n",
      "  Hypogonadism, Male: 4606\n",
      "  Hypogonadotrophic Hypogonadism: 4607\n",
      "  Hypogonadotropic Hypogonadism: 4608\n",
      "  Hypokalemia: 4609\n",
      "  Hypokalemic Periodic Paralysis: 4610\n",
      "  Hyponatremia: 4611\n",
      "  Hyponatremia and Extracellular Fluid in Cirrhotic: 4612\n",
      "  Hypoparathyroidism: 4613\n",
      "  Hypoparathyroidism Post-surgical: 4614\n",
      "  Hypophosphatasia: 4615\n",
      "  Hypophosphatasia (HPP): 4616\n",
      "  Hypophosphatemia, Familial: 4617\n",
      "  Hypophosphatemic Rickets, X-Linked Dominant: 4618\n",
      "  Hypoplastic Left Heart Syndrome: 4619\n",
      "  Hypoprothrombinemia: 4620\n",
      "  Hyposalivation: 4621\n",
      "  Hypospadias: 4622\n",
      "  Hypotension: 4623\n",
      "  Hypotension on Induction: 4624\n",
      "  Hypotension, Orthostatic: 4625\n",
      "  Hypotensive Syncope: 4626\n",
      "  Hypothalamic Obesity: 4627\n",
      "  Hypothermia: 4628\n",
      "  Hypothyroidism: 4629\n",
      "  Hypothyroidism Primary: 4630\n",
      "  Hypotonic; Labor: 4631\n",
      "  Hypotrichosis of Eyebrows: 4632\n",
      "  Hypovitaminosis D: 4633\n",
      "  Hypovolemia: 4634\n",
      "  Hypovolemic Shock: 4635\n",
      "  Hypoxia: 4636\n",
      "  Hypoxia, Brain: 4637\n",
      "  Hypoxic Ischaemic Encephalopathy: 4638\n",
      "  Hypoxic Ischemic Encephalopathy: 4639\n",
      "  Hypoxic Pulmonary Vasoconstriction: 4640\n",
      "  Hypoxic Respiratory Failure With Pulmonary Hypertension: 4641\n",
      "  Hypoxic-ischemic Encephalopathy: 4642\n",
      "  Hysterectomy: 4643\n",
      "  Hysteroscopy: 4644\n",
      "  IBD: 4645\n",
      "  IBS-C and IBS With Mixed Bowel Habits: 4646\n",
      "  IBS-D and Functional Dyspepsia: 4647\n",
      "  ICD Indication: 4648\n",
      "  ICU: 4649\n",
      "  ICU Anemia: 4650\n",
      "  ICU Patients: 4651\n",
      "  ICU Sedation: 4652\n",
      "  IDH Family Wildtype: 4653\n",
      "  IDIOPATHIC PARKINSON'S DISEASE: 4654\n",
      "  IFN-Gamma Therapy: 4655\n",
      "  IGA Nephropathy: 4656\n",
      "  III Degree Hemorrhoids: 4657\n",
      "  IMPLANTATION: 4658\n",
      "  INFECTION: 4659\n",
      "  ISCHEMIC CARDIOMYOPATHY: 4660\n",
      "  IUD Insertion: 4661\n",
      "  IUD Insertion Complication: 4662\n",
      "  Iatrogenic Ulcer After ESD: 4663\n",
      "  Ichthyosis: 4664\n",
      "  Ichthyosis Vulgaris: 4665\n",
      "  Idiopathic Axonal Polyneuropathy: 4666\n",
      "  Idiopathic CD4+ T-Lymphocytopenia: 4667\n",
      "  Idiopathic Dilated Cardiomyopathy: 4668\n",
      "  Idiopathic Fecal Incontinence: 4669\n",
      "  Idiopathic Hypersomnia: 4670\n",
      "  Idiopathic Infertility: 4671\n",
      "  Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary: 4672\n",
      "  Idiopathic Intracranial Hypertension: 4673\n",
      "  Idiopathic Membranous Nephropathy: 4674\n",
      "  Idiopathic Parkinson Disease: 4675\n",
      "  Idiopathic Parkinson's Disease: 4676\n",
      "  Idiopathic Peripheral Neuropathy: 4677\n",
      "  Idiopathic Polypoidal Choroidal Vasculopathy: 4678\n",
      "  Idiopathic Pruritus Ani: 4679\n",
      "  Idiopathic Pulmonary Arterial Hypertension: 4680\n",
      "  Idiopathic Pulmonary Arterial Hypertension.: 4681\n",
      "  Idiopathic Pulmonary Fibrosis: 4682\n",
      "  Idiopathic Pulmonary Fibrosis (IPF): 4683\n",
      "  Idiopathic Pulmonary Fibrosis(IPF): 4684\n",
      "  Idiopathic Pulmonary Fibrosis, Acute Fatal Form: 4685\n",
      "  Idiopathic Refractory Scleritis: 4686\n",
      "  Idiopathic Restless Leg Syndrome: 4687\n",
      "  Idiopathic Restless Legs Syndrome: 4688\n",
      "  Idiopathic Short Stature: 4689\n",
      "  Idiopathic Small Fiber Neuropathy: 4690\n",
      "  Idiopathic Thrombocytopenia Purpura: 4691\n",
      "  Idiopathic Thrombocytopenic Purpura: 4692\n",
      "  Idiopathic Thrombocytopenic Purpura (ITP): 4693\n",
      "  Idiopathic Toe Walking: 4694\n",
      "  Idiopathic Triglyceride Deposit Cardiomyovasculopathy: 4695\n",
      "  Idiopathic Venous Thromboembolism: 4696\n",
      "  IgA Nephropathy: 4697\n",
      "  IgA Nephropathy (IgAN): 4698\n",
      "  IgG Deficiency: 4699\n",
      "  Ileostomy - Stoma: 4700\n",
      "  Ileostomy; Complications: 4701\n",
      "  Ileus: 4702\n",
      "  Immediate Dental Implant: 4703\n",
      "  Immune Reconstitution Inflammatory Syndrome: 4704\n",
      "  Immune Response: 4705\n",
      "  Immune Response to DTP-HB-Hib Vaccine: 4706\n",
      "  Immune System: 4707\n",
      "  Immune System Diseases: 4708\n",
      "  Immune System Disorders: 4709\n",
      "  Immune Thrombocytopenia: 4710\n",
      "  Immune Thrombocytopenia (ITP): 4711\n",
      "  Immune Thrombocytopenic Purpura: 4712\n",
      "  Immune Thrombocytopenic Purpura (ITP): 4713\n",
      "  Immune Tolerance: 4714\n",
      "  Immunity: 4715\n",
      "  Immunity, Cellular: 4716\n",
      "  Immunocompromised: 4717\n",
      "  Immunodeficiency: 4718\n",
      "  Immunodeficiency Syndrome: 4719\n",
      "  Immunogenicity: 4720\n",
      "  Immunoglobulin A Nephropathy: 4721\n",
      "  Immunologic Deficiency Syndromes: 4722\n",
      "  Immunologic Desensitization: 4723\n",
      "  Immunoscience: 4724\n",
      "  Immunosenescence: 4725\n",
      "  Immunosuppression: 4726\n",
      "  Immunosuppression After Liver Transplantation: 4727\n",
      "  Immunosuppression For Disease: 4728\n",
      "  Immunosuppression in Solid Organ Transplant: 4729\n",
      "  Immunosuppressive Treatment of Living-donor Renal Transplantation: 4730\n",
      "  Immunotherapy: 4731\n",
      "  Impacted Third Molar Tooth: 4732\n",
      "  Impaired Balance in Elderly: 4733\n",
      "  Impaired Driving: 4734\n",
      "  Impaired Glucose Tolerance: 4735\n",
      "  Impaired Psychomotor Development: 4736\n",
      "  Impaired Synaptic Plasticity: 4737\n",
      "  Impaired Thermoregulation: 4738\n",
      "  Impaired Wound Healing: 4739\n",
      "  Impetigo: 4740\n",
      "  Implant: 4741\n",
      "  Implant Stability With Vitamin D Deficiency: 4742\n",
      "  Implant Therapy: 4743\n",
      "  Impotence: 4744\n",
      "  Improve Healthy Ageing in Seniors; Prevent Disease at Older Age: 4745\n",
      "  In Vitro Fertilization: 4746\n",
      "  In-stent Stenosis of Infrapopliteal Arteries: 4747\n",
      "  InFertility: 4748\n",
      "  Inadequately Controlled Asthma: 4749\n",
      "  Inappropriate ADH Syndrome: 4750\n",
      "  Inappropriate ICD Therapy: 4751\n",
      "  Incidental Gallbladder Carcinoma: 4752\n",
      "  Incisional Pain: 4753\n",
      "  Inclusion Body Myositis: 4754\n",
      "  Incompetence of Nasal Valve: 4755\n",
      "  Incomplete Reversal of Neuromuscular Block: 4756\n",
      "  Incontinence: 4757\n",
      "  Incontinence, Urinary and Urinary Bladder, Overactive: 4758\n",
      "  Increased Intra Ocular Pressure (IOP): 4759\n",
      "  Incurable Platinum Refractory Germ Cell Tumors: 4760\n",
      "  Indication for Surgery of the Posterior Segment Under Locoregional Anaesthesia: 4761\n",
      "  Indication of Blood Gas Analysis by Radial Artery Blood Sampling: 4762\n",
      "  Indigestion: 4763\n",
      "  Individuals Undergoing Cardiac and General Surgery: 4764\n",
      "  Individuals at Risk for Depression: 4765\n",
      "  Indolent B-cell NHL: 4766\n",
      "  Indolent B-cell Non-Hodgkin's Lymphoma: 4767\n",
      "  Indolent Lymphoma: 4768\n",
      "  Indolent Non-Hodgkin Lymphoma: 4769\n",
      "  Indolent Non-Hodgkin's Lymphoma: 4770\n",
      "  Indolent Non-Hodgkin's Lymphomas: 4771\n",
      "  Indolent Plasma Cell Myeloma: 4772\n",
      "  Indolent Systemic Mastocytosis: 4773\n",
      "  Induction of Anesthesia: 4774\n",
      "  Induction of Labor: 4775\n",
      "  Induction of Labor Affected Fetus / Newborn: 4776\n",
      "  Induction of Labour: 4777\n",
      "  Ineffective Esophageal Motility: 4778\n",
      "  Infant Growth: 4779\n",
      "  Infant Immunizations: 4780\n",
      "  Infant Mortality: 4781\n",
      "  Infant Nutrition: 4782\n",
      "  Infant Respiratory Distress Syndrome: 4783\n",
      "  Infant, Newborn: 4784\n",
      "  Infant, Newborn, Diseases: 4785\n",
      "  Infant, Premature: 4786\n",
      "  Infant, Premature, Diseases: 4787\n",
      "  Infant, Preterm: 4788\n",
      "  Infant, Small for Gestational Age: 4789\n",
      "  Infant, Very Low Birth Weight: 4790\n",
      "  Infant,Premature: 4791\n",
      "  Infantile Colic: 4792\n",
      "  Infantile Hemangioma: 4793\n",
      "  Infantile Hemangiomas: 4794\n",
      "  Infantile Neronal Ceroid Lipofuscinosis: 4795\n",
      "  Infantile Neuroaxonal Dystrophy: 4796\n",
      "  Infantile Refsum's Disease: 4797\n",
      "  Infantile Spasm: 4798\n",
      "  Infantile Spasms: 4799\n",
      "  Infantile Spasms (IS): 4800\n",
      "  Infants Growth: 4801\n",
      "  Infarction, Middle Cerebral Artery: 4802\n",
      "  Infected Atopic Dermatitis/Eczema: 4803\n",
      "  Infected Toenails: 4804\n",
      "  Infection: 4805\n",
      "  Infection Due to Resistant Organism: 4806\n",
      "  Infection Prevention: 4807\n",
      "  Infection Prophylaxis: 4808\n",
      "  Infection Secondary to Surgical Procedure: 4809\n",
      "  Infection With Human Papillomavirus: 4810\n",
      "  Infection With Multi-drug Resistant Organisms: 4811\n",
      "  Infection by Trichuris Trichiura: 4812\n",
      "  Infection in Solid Organ Transplant Recipients: 4813\n",
      "  Infection, Human Immunodeficiency Virus: 4814\n",
      "  Infection, Human Immunodeficiency Virus I: 4815\n",
      "  Infection, Viral, Enterovirus: 4816\n",
      "  Infection; Dialysis Catheter: 4817\n",
      "  Infections: 4818\n",
      "  Infections With Soil-Transmitted Helminths (STH): 4819\n",
      "  Infections on: 4820\n",
      "  Infections, Bacterial: 4821\n",
      "  Infections, Human Immunodeficiency Virus and Herpesviridae: 4822\n",
      "  Infections, Intestinal: 4823\n",
      "  Infections, Meningococcal: 4824\n",
      "  Infections, Papillomavirus: 4825\n",
      "  Infections, Pneumococcal: 4826\n",
      "  Infections, Respiratory Tract: 4827\n",
      "  Infections, Rotavirus: 4828\n",
      "  Infections, Staphylococcal: 4829\n",
      "  Infections, Streptococcal: 4830\n",
      "  Infections, Urinary Tract: 4831\n",
      "  Infectious Disease Transmission: 4832\n",
      "  Infectious Diseases: 4833\n",
      "  Infectious Gastroenteritis: 4834\n",
      "  Infectious Mononucleosis: 4835\n",
      "  Infective Endocarditis: 4836\n",
      "  Infertility: 4837\n",
      "  Infertility, Female: 4838\n",
      "  Infiltrating Bladder Urothelial Carcinoma: 4839\n",
      "  Inflammation: 4840\n",
      "  Inflammation Following Ocular Surgery: 4841\n",
      "  Inflammation at Mini-screw Insertion Site: 4842\n",
      "  Inflammatory Acne: 4843\n",
      "  Inflammatory Arthritis: 4844\n",
      "  Inflammatory Bowel Disease: 4845\n",
      "  Inflammatory Bowel Disease (IBD): 4846\n",
      "  Inflammatory Bowel Diseases: 4847\n",
      "  Inflammatory Choroidal Neovascularization: 4848\n",
      "  Inflammatory Macular Edema: 4849\n",
      "  Inflammatory Reaction Due to Ocular Lens Prosthesis: 4850\n",
      "  Inflammatory Response: 4851\n",
      "  Influenza: 4852\n",
      "  Influenza (Pandemic): 4853\n",
      "  Influenza - Type A Strains: 4854\n",
      "  Influenza A: 4855\n",
      "  Influenza A H3N2: 4856\n",
      "  Influenza A Infection: 4857\n",
      "  Influenza A Subtype H5N1 Infection: 4858\n",
      "  Influenza A Subtype H7N7 Infection: 4859\n",
      "  Influenza A Virus: 4860\n",
      "  Influenza A Virus, H1N1 Subtype: 4861\n",
      "  Influenza A Virus, H7N9 Subtype: 4862\n",
      "  Influenza Caused by the Novel Influenza A (H1N1) Virus: 4863\n",
      "  Influenza Disease: 4864\n",
      "  Influenza Infection: 4865\n",
      "  Influenza Prevention: 4866\n",
      "  Influenza Vaccination in Seniors: 4867\n",
      "  Influenza Vaccines: 4868\n",
      "  Influenza Virus: 4869\n",
      "  Influenza Virus Infection: 4870\n",
      "  Influenza Virus Vaccine Adverse Reaction: 4871\n",
      "  Influenza, Avian: 4872\n",
      "  Influenza, Human: 4873\n",
      "  Infra and Juxtarenal Abdominal Aortic Aneurysms: 4874\n",
      "  Inguinal Hernia: 4875\n",
      "  Inguinal Hernias: 4876\n",
      "  Inhalants Craving: 4877\n",
      "  Inhalation Injury: 4878\n",
      "  Inherited Metabolic Diseases: 4879\n",
      "  Inherited Metabolic Disorders IMD: 4880\n",
      "  Inherited Metabolic Storage Diseases: 4881\n",
      "  Inherited Ophthalmic Diseases: 4882\n",
      "  Inhibition on Platelet Aggregation: 4883\n",
      "  Initial Phase of Severe Sepsis and Septic Shock: 4884\n",
      "  Injection Pain: 4885\n",
      "  Injection Site Irritation: 4886\n",
      "  Injuries: 4887\n",
      "  Injuries and Wounds: 4888\n",
      "  Injuries to the Nipple (Fissures and Cracks) Resulting Breastfeeding: 4889\n",
      "  Injury: 4890\n",
      "  Injury Due to Foreign Object Accidentally Left in Body During Surgical Operation: 4891\n",
      "  Injury of Anterior Cruciate Ligament: 4892\n",
      "  Injury of Body of Pancreas: 4893\n",
      "  Injury of Upper Limb: 4894\n",
      "  Innate Immune Response: 4895\n",
      "  Inoperable Early Stage Non-small Cell Lung Cancer: 4896\n",
      "  Inoperable Locally Advanced Breast Cancer: 4897\n",
      "  Inoperable Locally Advanced Non Small Cell Lung Cancer: 4898\n",
      "  Inoperable Locally Advanced or Metastatic Biliary Tract Cancer: 4899\n",
      "  Inoperable Solid Tumors or Lymphomas: 4900\n",
      "  Inoperable œsophageal Cancer: 4901\n",
      "  Insomnia: 4902\n",
      "  Insomnia Disorder: 4903\n",
      "  Insomnia Disorders: 4904\n",
      "  Instantaneous Clearance: 4905\n",
      "  Insufficient Breastmilk Production: 4906\n",
      "  Insular Thyroid Cancer: 4907\n",
      "  Insulin Resistance: 4908\n",
      "  Insulin Resistance Syndrome X: 4909\n",
      "  Insulin Secretion: 4910\n",
      "  Insulin Sensitivity: 4911\n",
      "  Insulin-dependent Diabetes Mellitus: 4912\n",
      "  Insulin-like Growth Factor-1 Deficiency: 4913\n",
      "  Intensive Care (ICU) Myopathy: 4914\n",
      "  Intensive Care Unit: 4915\n",
      "  Intensive Care Unit Syndrome: 4916\n",
      "  Intensive Care Units: 4917\n",
      "  Interaction Drug Food: 4918\n",
      "  Interactive CD-based Education: 4919\n",
      "  Interdigital Tinea Pedis: 4920\n",
      "  Intermediate Risk Prostate Cancer: 4921\n",
      "  Intermittent Claudicants: 4922\n",
      "  Intermittent Claudication: 4923\n",
      "  Intermittent Explosive Disorder: 4924\n",
      "  Intermittent Preventive Treatment: 4925\n",
      "  Intermittent Preventive Treatment In Pregnancy (IPTp): 4926\n",
      "  Internal Carotid Stenosis: 4927\n",
      "  Internal Hemorrhoids: 4928\n",
      "  Interstitial Cystitis: 4929\n",
      "  Interstitial Lung Disease: 4930\n",
      "  Intervertebral Disc Prolapse: 4931\n",
      "  Intestinal Behçet's Disease: 4932\n",
      "  Intestinal Diseases: 4933\n",
      "  Intestinal Diseases, Parasitic: 4934\n",
      "  Intestinal Disorders: 4935\n",
      "  Intestinal Failure: 4936\n",
      "  Intestinal Helminthiasis: 4937\n",
      "  Intestinal Obstruction: 4938\n",
      "  Intestinal Schistosomiasis: 4939\n",
      "  Intimate Partner Violence: 4940\n",
      "  Intra Uterine Growth Retardation: 4941\n",
      "  Intra-Operative Injury - Other: 4942\n",
      "  Intra-abdominal Abscess: 4943\n",
      "  Intra-abdominal Infection: 4944\n",
      "  Intra-abdominal Infections: 4945\n",
      "  Intra-abdominal Perforation: 4946\n",
      "  Intra-uterine Residua: 4947\n",
      "  Intracerebral Aneursym: 4948\n",
      "  Intracerebral Haemorrhage: 4949\n",
      "  Intracerebral Hemorrhage: 4950\n",
      "  Intracerebral Hemorrhage (ICH): 4951\n",
      "  Intracranial Aneurysm: 4952\n",
      "  Intracranial Aneurysms: 4953\n",
      "  Intracranial Arterial Stenosis: 4954\n",
      "  Intracranial Embolism: 4955\n",
      "  Intracranial Hemorrhage: 4956\n",
      "  Intracranial Hemorrhages: 4957\n",
      "  Intracranial Meningioma: 4958\n",
      "  Intracranial Neoplasms: 4959\n",
      "  Intractable Abdominal Pain Secondary to Inoperable Malignancy: 4960\n",
      "  Intractable Pain: 4961\n",
      "  Intradermal Injections: 4962\n",
      "  Intradialytic Hypotension: 4963\n",
      "  Intraductal Papillary Mucinous Neoplasm of the Pancreas: 4964\n",
      "  Intraductal Papillary Mucinous Neoplasms: 4965\n",
      "  Intrahepatic Cholangiocarcinoma: 4966\n",
      "  Intrahepatic Cholestasis Associated With Alcoholic Liver Disease: 4967\n",
      "  Intrahepatic Cholestasis of Pregnancy: 4968\n",
      "  Intrahepatic, Cholestasis: 4969\n",
      "  Intramural Fibroids: 4970\n",
      "  Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia: 4971\n",
      "  Intraocular Lens Associated Postoperative Inflammation: 4972\n",
      "  Intraocular Lens Replacement: 4973\n",
      "  Intraocular Melanoma: 4974\n",
      "  Intraocular Pressure: 4975\n",
      "  Intraocular Retinoblastoma: 4976\n",
      "  Intraoperative Bleeding: 4977\n",
      "  Intraoperative Complications: 4978\n",
      "  Intrauterine Adhesion: 4979\n",
      "  Intrauterine Adhesions: 4980\n",
      "  Intrauterine Device: 4981\n",
      "  Intrauterine Fetal Demise: 4982\n",
      "  Intrauterine Growth Restriction (IUGR): 4983\n",
      "  Intrauterine Insemination: 4984\n",
      "  Intravascular-catheter Colonization: 4985\n",
      "  Intravenous Steroid-Refractory Ulcerative Colitis: 4986\n",
      "  Intraventricular Hemorrhage of Prematurity: 4987\n",
      "  Intravitreous: 4988\n",
      "  Intrinsic Aging of Skin: 4989\n",
      "  Intubation: 4990\n",
      "  Intubation Complication: 4991\n",
      "  Intubation, Endotracheal: 4992\n",
      "  Intubation; Difficult: 4993\n",
      "  Invasive Aspergillosis: 4994\n",
      "  Invasive Bladder Cancer: 4995\n",
      "  Invasive Bladder Cancer Stage IV: 4996\n",
      "  Invasive Breast Cancer: 4997\n",
      "  Invasive Breast Cancer (Stage I-III): 4998\n",
      "  Invasive Breast Carcinoma: 4999\n",
      "  Invasive Candidiasis: 5000\n",
      "  Invasive Cryptococcosis: 5001\n",
      "  Invasive Fungal Infections: 5002\n",
      "  Invasive Group B Streptococcus (GBS) Disease: 5003\n",
      "  Invasive Mucormycosis: 5004\n",
      "  Invasive Pneumococcal Disease: 5005\n",
      "  Invasive Pneumococcal Infections: 5006\n",
      "  Invasive Pulmonary Aspergillosis: 5007\n",
      "  Invasive Thymoma and Thymic Carcinoma: 5008\n",
      "  Inverse Psoriasis: 5009\n",
      "  Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease: 5010\n",
      "  Involutional Osteoporosis: 5011\n",
      "  Iris Melanoma: 5012\n",
      "  Iron Deficiency: 5013\n",
      "  Iron Deficiency Anaemia: 5014\n",
      "  Iron Deficiency Anemia: 5015\n",
      "  Iron Deficiency Anemia (IDA): 5016\n",
      "  Iron Deficiency Anemia Secondary to IBD or Gastric Bypass: 5017\n",
      "  Iron Deficiency Anemia of Pregnancy: 5018\n",
      "  Iron Overload: 5019\n",
      "  Iron Overload Due to Repeated Red Blood Cell Transfusions: 5020\n",
      "  Iron-Deficiency Anemia: 5021\n",
      "  Iron-Refractory Iron-Deficiency Anemia: 5022\n",
      "  Iron-deficiency: 5023\n",
      "  Iron-refractory, Iron-deficiency Anemia (IRIDA): 5024\n",
      "  Irradiation; Adverse Effect: 5025\n",
      "  Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus: 5026\n",
      "  Irreversible Pulpitis: 5027\n",
      "  Irritable Bowel Syndrome: 5028\n",
      "  Irritable Bowel Syndrome (IBS): 5029\n",
      "  Irritable Bowel Syndrome Characterized by Constipation: 5030\n",
      "  Irritable Bowel Syndrome With Constipation: 5031\n",
      "  Irritable Bowel Syndrome With Constipation (IBS-C): 5032\n",
      "  Irritable Bowel Syndrome With Diarrhea: 5033\n",
      "  Irritable Bowel Syndrome With Diarrhoea: 5034\n",
      "  Irritable Bowel Syndrome in Females: 5035\n",
      "  Irritable Colon: 5036\n",
      "  Irritable Mood: 5037\n",
      "  Irvine-Gass Syndrome: 5038\n",
      "  Ischaemic Stroke: 5039\n",
      "  Ischemia: 5040\n",
      "  Ischemia Reperfusion Injury: 5041\n",
      "  Ischemia-Reperfusion Injury: 5042\n",
      "  Ischemia-reperfusion Injury in Liver Transplant: 5043\n",
      "  Ischemic Attack, Transient: 5044\n",
      "  Ischemic Cardiomyopathy: 5045\n",
      "  Ischemic Congestive Heart Failure: 5046\n",
      "  Ischemic Congestive Heart Failure (CHF): 5047\n",
      "  Ischemic Heart Disease: 5048\n",
      "  Ischemic Heart Failure: 5049\n",
      "  Ischemic Optic Neuropathy/Optic Nerve Stroke: 5050\n",
      "  Ischemic Preconditioning: 5051\n",
      "  Ischemic Reperfusion Injury: 5052\n",
      "  Ischemic Stroke: 5053\n",
      "  Ischemic Stroke, Acute: 5054\n",
      "  Ischemic Ventricular Tachycardia: 5055\n",
      "  Ischemic Wound of the Lower Limb: 5056\n",
      "  Islet Cell Transplantation: 5057\n",
      "  Islet Cell Tumor: 5058\n",
      "  Islet Transplantation: 5059\n",
      "  Islets of Langerhans Transplantation: 5060\n",
      "  Isolated Cartilage Injury of the Knee: 5061\n",
      "  Isolated Chemotherapy-induced Thrombocytopenia: 5062\n",
      "  Isolated Systolic Hypertension: 5063\n",
      "  Itch: 5064\n",
      "  Ivermectin: 5065\n",
      "  JOB's Syndrome: 5066\n",
      "  Japanese Encephalitis: 5067\n",
      "  Japanese Healthy Adult Males: 5068\n",
      "  Jaw, Edentulous: 5069\n",
      "  Jaw, Edentulous, Partially: 5070\n",
      "  Jawline Definition: 5071\n",
      "  Joint Instability: 5072\n",
      "  Joint Pain: 5073\n",
      "  Joint Prosthesis: 5074\n",
      "  Jowls: 5075\n",
      "  Junctional Epidermolysis Bullosa: 5076\n",
      "  Juvenile Idiopahtic Arthritis: 5077\n",
      "  Juvenile Idiopathic Arthritis: 5078\n",
      "  Juvenile Idiopathic Arthritis Associated Uveitis: 5079\n",
      "  Juvenile Myelomonocytic Leukemia: 5080\n",
      "  Juvenile Neuronal Ceroid Lipofuscinosis: 5081\n",
      "  Juvenile Rheumatoid Arthritis: 5082\n",
      "  KIDNEY TRANSPLANTATION: 5083\n",
      "  KRAS Gene Mutation: 5084\n",
      "  KRAS Mutant Non-Small Cell Lung Cancer: 5085\n",
      "  KRAS Wild Type: 5086\n",
      "  KRAS and NRAS Wild-type Colorectal Cancer: 5087\n",
      "  Kala Azar: 5088\n",
      "  Kallmann Syndrome: 5089\n",
      "  Kaposi Sarcoma: 5090\n",
      "  Kaposi's Sarcoma: 5091\n",
      "  Kaposiform Hemangioendothelioma: 5092\n",
      "  Kaposiform Hemangioendothelioma (KHE): 5093\n",
      "  Kaposi´s Sarcoma: 5094\n",
      "  Kava on the Metabolism of Nicotine and NNK: 5095\n",
      "  Kawasaki Disease: 5096\n",
      "  Keloid: 5097\n",
      "  Keloid Scar: 5098\n",
      "  Keloid Scar Following Surgery: 5099\n",
      "  Keloid Scars: 5100\n",
      "  Keloids: 5101\n",
      "  Keratitis: 5102\n",
      "  Keratoconjunctivitis Sicca: 5103\n",
      "  Keratoconjunctivitis, Vernal: 5104\n",
      "  Keratoconus: 5105\n",
      "  Keratoconus and Ectasia: 5106\n",
      "  Keratosis Pilaris: 5107\n",
      "  Keratosis Plantaris: 5108\n",
      "  Keratosis, Actinic: 5109\n",
      "  Kidney Calculi: 5110\n",
      "  Kidney Cancer: 5111\n",
      "  Kidney Damage: 5112\n",
      "  Kidney Disease: 5113\n",
      "  Kidney Diseases: 5114\n",
      "  Kidney Dysfunction: 5115\n",
      "  Kidney Failure: 5116\n",
      "  Kidney Failure, Acute: 5117\n",
      "  Kidney Failure, Chronic: 5118\n",
      "  Kidney Failure, Chronic Therapy; Hemodialysis: 5119\n",
      "  Kidney Failure, Kidney Transplant: 5120\n",
      "  Kidney Failures, Acute: 5121\n",
      "  Kidney Graft Dysfunction: 5122\n",
      "  Kidney Injury: 5123\n",
      "  Kidney Injury, Acute: 5124\n",
      "  Kidney Insufficiency: 5125\n",
      "  Kidney Neoplasm: 5126\n",
      "  Kidney Neoplasms: 5127\n",
      "  Kidney Stone: 5128\n",
      "  Kidney Stones: 5129\n",
      "  Kidney Transplant: 5130\n",
      "  Kidney Transplant Failure: 5131\n",
      "  Kidney Transplant Failure and Rejection: 5132\n",
      "  Kidney Transplant Immunosuppression: 5133\n",
      "  Kidney Transplant Infection: 5134\n",
      "  Kidney Transplant Recipients: 5135\n",
      "  Kidney Transplant Rejection: 5136\n",
      "  Kidney Transplant; Complications: 5137\n",
      "  Kidney Transplantation: 5138\n",
      "  Kidney Transplantation (Status Post): 5139\n",
      "  Kidney Transplantation, Mannitol: 5140\n",
      "  Kidney; Complications, Allograft: 5141\n",
      "  Kleptomania: 5142\n",
      "  Klinefelter Syndrome: 5143\n",
      "  Knee Arthritis: 5144\n",
      "  Knee Arthroplasty: 5145\n",
      "  Knee Arthroplasty, Total: 5146\n",
      "  Knee Arthroscopy: 5147\n",
      "  Knee Cartilage Lesion: 5148\n",
      "  Knee Chondral: 5149\n",
      "  Knee Chondral Lesion: 5150\n",
      "  Knee Chondral or Osteochondral Defect: 5151\n",
      "  Knee Injuries: 5152\n",
      "  Knee Injury: 5153\n",
      "  Knee Instability: 5154\n",
      "  Knee Joint Arthritis: 5155\n",
      "  Knee Joint Osteoarthritis: 5156\n",
      "  Knee Osteoarthritis: 5157\n",
      "  Knee Pain: 5158\n",
      "  Knee Pain After Total Knee Arthroplasty: 5159\n",
      "  Knee Pain Chronic: 5160\n",
      "  Knee Prosthesis: 5161\n",
      "  Knee Replacement Arthroplasty: 5162\n",
      "  Knee Replacement Surgery: 5163\n",
      "  Known or Suspected Focal Liver Lesions: 5164\n",
      "  LIVER TRANSPLANTATION: 5165\n",
      "  LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES: 5166\n",
      "  LPL Deficiency: 5167\n",
      "  LPS Challenge, Neutrophils: 5168\n",
      "  LUTS: 5169\n",
      "  LUTS(Lower Urinary Tract Symptoms): 5170\n",
      "  LV Lead: 5171\n",
      "  LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL): 5172\n",
      "  Labor: 5173\n",
      "  Labor Augmentation: 5174\n",
      "  Labor Induction: 5175\n",
      "  Labor Pain: 5176\n",
      "  Labor Stage, First: 5177\n",
      "  Labor, Induced: 5178\n",
      "  Labor, Premature: 5179\n",
      "  Labor; Forced or Induced, Affecting Fetus or Newborn: 5180\n",
      "  Labour: 5181\n",
      "  Labour Dystocia: 5182\n",
      "  Laceration of Skin: 5183\n",
      "  Lacerations: 5184\n",
      "  Lack or Loss Appetite Nonorganic Origin: 5185\n",
      "  Lactation: 5186\n",
      "  Lactic Acidosis: 5187\n",
      "  Lamellar Ichthyosis: 5188\n",
      "  Laminectomy: 5189\n",
      "  Landau-Kleffner Syndrome: 5190\n",
      "  Langerhans Cell Histiocytosis: 5191\n",
      "  Language Development Disorders: 5192\n",
      "  Laparoscopic Cholecystectomy: 5193\n",
      "  Laparoscopic Gynecologic, Abdominal, Other Surgery: 5194\n",
      "  Laparoscopic Myomectomy: 5195\n",
      "  Laparoscopic Orcheopexy: 5196\n",
      "  Laparoscopic Surgery: 5197\n",
      "  Laparoscopic Surgery for Appendicitis: 5198\n",
      "  Laparoscopy: 5199\n",
      "  Laparotomy: 5200\n",
      "  Large Cell Lung Carcinoma: 5201\n",
      "  Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease: 5202\n",
      "  Large Granular Lymphocytic Leukemia: 5203\n",
      "  Large-B-cell Diffuse Lymphoma: 5204\n",
      "  Laryngeal Cancer: 5205\n",
      "  Laryngeal Diseases: 5206\n",
      "  Laryngeal Neoplasms: 5207\n",
      "  Laryngeal Papilloma: 5208\n",
      "  Laryngomalacia: 5209\n",
      "  Laryngopharyngeal Reflux: 5210\n",
      "  Laryngopharyngeal Reflux (LPR): 5211\n",
      "  Laryngospasm: 5212\n",
      "  Larynx: 5213\n",
      "  Larynx Cancer: 5214\n",
      "  Larynx Disease: 5215\n",
      "  Larynx Neoplasms: 5216\n",
      "  Laser Therapy, Low-Level: 5217\n",
      "  Lassa Fever: 5218\n",
      "  Late Acquired Stent Malaposition: 5219\n",
      "  Late Complication From Kidney Transplant: 5220\n",
      "  Late Complication From Skin Graft: 5221\n",
      "  Late Infantile Metachromatic Leukodystrophy: 5222\n",
      "  Late Life Depression: 5223\n",
      "  Late Onset Neonatal Sepsis: 5224\n",
      "  Late-onset Pompe Disease: 5225\n",
      "  Late-onset Sepsis: 5226\n",
      "  Latent Autoimmune Diabetes in Adult (LADA): 5227\n",
      "  Latent Tuberculosis: 5228\n",
      "  Latent Tuberculosis Bacteriology and Histology Unknown: 5229\n",
      "  Latent Tuberculosis Infection: 5230\n",
      "  Lateral Canthal Lines: 5231\n",
      "  Lateral Elbow Tendinopathy: 5232\n",
      "  Lateral Epicondylitis: 5233\n",
      "  Lead Poisoning: 5234\n",
      "  Lead Toxicity: 5235\n",
      "  Leakage: 5236\n",
      "  Lean: 5237\n",
      "  Learning: 5238\n",
      "  Leber's Congenital Amaurosis: 5239\n",
      "  Leber's Hereditary Optic Neuropathy (LHON): 5240\n",
      "  Left Atrial Appendage Occlusion: 5241\n",
      "  Left Ventricular Dysfunction: 5242\n",
      "  Left Ventricular Hypertrophy: 5243\n",
      "  Left Ventricular Insufficiency: 5244\n",
      "  Leg Discrepancy: 5245\n",
      "  Leg Injuries: 5246\n",
      "  Leg Length Inequality: 5247\n",
      "  Leg Ulcer: 5248\n",
      "  Leg Ulcers: 5249\n",
      "  Leigh Syndrome: 5250\n",
      "  Leiomyoma: 5251\n",
      "  Leiomyomas: 5252\n",
      "  Leiomyosarcoma: 5253\n",
      "  Leishmaniasis: 5254\n",
      "  Leishmaniasis, Cutaneous: 5255\n",
      "  Lennox Gastaut Syndrome: 5256\n",
      "  Lennox-Gastaut Syndrome: 5257\n",
      "  Lennox-Gastaut Syndrome (LGS): 5258\n",
      "  Lentigo: 5259\n",
      "  Leptomeningeal Carcinomatosis: 5260\n",
      "  Leptomeningeal Metastasis: 5261\n",
      "  Leptomeningeal Metastasis From Malignant Melanoma: 5262\n",
      "  Leptospirosis: 5263\n",
      "  Lesch-Nyhan Disease: 5264\n",
      "  Lesion: 5265\n",
      "  Leukaemia: 5266\n",
      "  Leukaemia, Lymphocytic, Chronic: 5267\n",
      "  Leukaemia, Myelocytic, Acute: 5268\n",
      "  Leukemia: 5269\n",
      "  Leukemia, Acute: 5270\n",
      "  Leukemia, Acute Lymphoblastic: 5271\n",
      "  Leukemia, Acute Myelogenous: 5272\n",
      "  Leukemia, Acute Myeloid: 5273\n",
      "  Leukemia, Adult T-Cell: 5274\n",
      "  Leukemia, B-Cell: 5275\n",
      "  Leukemia, B-cell: 5276\n",
      "  Leukemia, Chronic Myeloid: 5277\n",
      "  Leukemia, Lymphoblastic, Acute, T-cell: 5278\n",
      "  Leukemia, Lymphocytic: 5279\n",
      "  Leukemia, Lymphocytic, Acute: 5280\n",
      "  Leukemia, Lymphocytic, Chronic: 5281\n",
      "  Leukemia, Lymphocytic, Chronic, B-Cell: 5282\n",
      "  Leukemia, Lymphoma, Chronic Lymphocytic: 5283\n",
      "  Leukemia, Myelocytic, Acute: 5284\n",
      "  Leukemia, Myelocytic, Acute Myelodysplastic Syndromes: 5285\n",
      "  Leukemia, Myelogenous, Acute: 5286\n",
      "  Leukemia, Myelogenous, Chronic, BCR-ABL Positive: 5287\n",
      "  Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive: 5288\n",
      "  Leukemia, Myeloid: 5289\n",
      "  Leukemia, Myeloid, Acute: 5290\n",
      "  Leukemia, Myeloid, Chronic: 5291\n",
      "  Leukemia, Myeloid, Chronic Phase: 5292\n",
      "  Leukemia, Myeloid, Chronic-Phase: 5293\n",
      "  Leukemia, Myeloid, Philadelphia-Positive: 5294\n",
      "  Leukemia, Promyelocytic, Acute: 5295\n",
      "  Leukemias: 5296\n",
      "  Leukocyte Adhesion Defect - Type I: 5297\n",
      "  Levodopa Induced Dyskinesia in Patients With Parkinson's Disease: 5298\n",
      "  Levodopa-induced Dyskinesia: 5299\n",
      "  Lewy Body Dementia: 5300\n",
      "  Lewy Body Disease: 5301\n",
      "  Li-Fraumeni Syndrome: 5302\n",
      "  Libido: 5303\n",
      "  Lice Infestations: 5304\n",
      "  Lichen Planus: 5305\n",
      "  Life Stress: 5306\n",
      "  Life Threatening Diseases: 5307\n",
      "  Light Chain Deposition Disease: 5308\n",
      "  Limb Defects: 5309\n",
      "  Limb Deformity: 5310\n",
      "  Limb Girdle Muscular Dystrophy: 5311\n",
      "  Limb Girdle Muscular Dystrophy Type 2C: 5312\n",
      "  Limb Ischemia: 5313\n",
      "  Limb-Girdle Muscular Dystrophy: 5314\n",
      "  Limb-Girdle Muscular Dystrophy, Type 2D: 5315\n",
      "  Limbal Insufficiency: 5316\n",
      "  Limbal Stem Cell Deficiency: 5317\n",
      "  Linear or Emi-linear Incisions: 5318\n",
      "  Lipid Lowering, Vascular Inflammation: 5319\n",
      "  Lipid Metabolism Disorders: 5320\n",
      "  Lipid Metabolism, Inborn Errors: 5321\n",
      "  Lipidemia: 5322\n",
      "  Lipoatrophy: 5323\n",
      "  Lipodystrophy: 5324\n",
      "  Lipoma: 5325\n",
      "  Lipoprotein Lipase Deficiency, Familial: 5326\n",
      "  Lipoprotein Metabolism: 5327\n",
      "  Liposarcoma: 5328\n",
      "  Listen to Vodcast: 5329\n",
      "  Liver Abscess: 5330\n",
      "  Liver Biopsy: 5331\n",
      "  Liver Cancer: 5332\n",
      "  Liver Carcinoma: 5333\n",
      "  Liver Cirrhoses: 5334\n",
      "  Liver Cirrhosis: 5335\n",
      "  Liver Cirrhosis, Biliary: 5336\n",
      "  Liver Disease: 5337\n",
      "  Liver Diseases: 5338\n",
      "  Liver Dysfunction: 5339\n",
      "  Liver Failure: 5340\n",
      "  Liver Failure Acute: 5341\n",
      "  Liver Fibrosis: 5342\n",
      "  Liver Fibrosis Due to Chronic Hepatitis B Infection: 5343\n",
      "  Liver Fibrosis Due to NASH: 5344\n",
      "  Liver Function After Partial Liver Resection: 5345\n",
      "  Liver Iron Overload: 5346\n",
      "  Liver Metastases: 5347\n",
      "  Liver Metastasis: 5348\n",
      "  Liver Neoplasms: 5349\n",
      "  Liver Resection: 5350\n",
      "  Liver Transplant: 5351\n",
      "  Liver Transplant Recipient: 5352\n",
      "  Liver Transplant Rejection: 5353\n",
      "  Liver Transplantation: 5354\n",
      "  Liver Tumor: 5355\n",
      "  Liver Tumors: 5356\n",
      "  Liver Tumors Not Resectable in One Surgical Procedure: 5357\n",
      "  Liver Tumour: 5358\n",
      "  Living Donor Kidney Transplants Patients: 5359\n",
      "  Living Donor Liver Transplantation: 5360\n",
      "  Living-Donor Kidney Transplant: 5361\n",
      "  Local Anesthesia: 5362\n",
      "  Local Anesthetic: 5363\n",
      "  Local Anesthetic Effectiveness: 5364\n",
      "  Local Anesthetics: 5365\n",
      "  Local Pain: 5366\n",
      "  Local Tumor Spread: 5367\n",
      "  Localized Cutaneous Leishmaniasis: 5368\n",
      "  Localized Resectable Neuroblastoma: 5369\n",
      "  Localized Squamous Cell Carcinoma of the Esophagus: 5370\n",
      "  Localized Transitional Cell Cancer of the Renal Pelvis and Ureter: 5371\n",
      "  Locally Advanced Breast Cancer: 5372\n",
      "  Locally Advanced Breast Cancer and Large Operable Breast Cancer: 5373\n",
      "  Locally Advanced Cancer: 5374\n",
      "  Locally Advanced Cancer in the Anal Region: 5375\n",
      "  Locally Advanced Cervical Cancer: 5376\n",
      "  Locally Advanced Digestive System Neuroendocrine Carcinoma: 5377\n",
      "  Locally Advanced Esophageal or GE Junction Cancer: 5378\n",
      "  Locally Advanced Gastric Carcinoma: 5379\n",
      "  Locally Advanced HER2-negative Breast Cancer: 5380\n",
      "  Locally Advanced HER2-positive Breast Cancer: 5381\n",
      "  Locally Advanced Head and Neck Squamous Cell Carcinoma: 5382\n",
      "  Locally Advanced Lung Cancer; Metastatic Lung Cancer: 5383\n",
      "  Locally Advanced Lung Carcinoma: 5384\n",
      "  Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma: 5385\n",
      "  Locally Advanced Malignant Neoplasm: 5386\n",
      "  Locally Advanced Metastatic BRAF Mutant Melanoma: 5387\n",
      "  Locally Advanced Non Small Cell Lung Cancer (NSCLC): 5388\n",
      "  Locally Advanced Non-Small Cell Lung Cancer: 5389\n",
      "  Locally Advanced Non-small Cell Lung Cancer: 5390\n",
      "  Locally Advanced Pancreatic Adenocarcinoma: 5391\n",
      "  Locally Advanced Pancreatic Cancer: 5392\n",
      "  Locally Advanced Papillary Renal Cell Carcinoma: 5393\n",
      "  Locally Advanced Rectal Adenocarcinoma: 5394\n",
      "  Locally Advanced Rectal Cancer: 5395\n",
      "  Locally Advanced Rectal Carcinoma: 5396\n",
      "  Locally Advanced Renal Cell Carcinoma: 5397\n",
      "  Locally Advanced Resectable Oral Cavity Squamous Cell Cancer: 5398\n",
      "  Locally Advanced Sarcoma: 5399\n",
      "  Locally Advanced Solid Tumor: 5400\n",
      "  Locally Advanced Solid Tumors: 5401\n",
      "  Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): 5402\n",
      "  Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer: 5403\n",
      "  Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN): 5404\n",
      "  Locally Advanced Squamous Non-Small Cell Lung Cancer: 5405\n",
      "  Locally Advanced Tumors: 5406\n",
      "  Locally Advanced Unresectable Gastric Adenocarcinoma: 5407\n",
      "  Locally Advanced Unresectable Gastric Cancer: 5408\n",
      "  Locally Advanced or Metastatic Breast Cancer: 5409\n",
      "  Locally Advanced or Metastatic EGFR T790M+ NSCLC: 5410\n",
      "  Locally Advanced or Metastatic Melanoma: 5411\n",
      "  Locally Advanced or Metastatic Non Small Cell Lung Cancer: 5412\n",
      "  Locally Advanced or Metastatic Solid Tumor: 5413\n",
      "  Locally Advanced or Metastatic Solid Tumors: 5414\n",
      "  Locally Advanced or Metastatic Urothelial Cell Carcinoma: 5415\n",
      "  Locally Advanced or Metastatic and Unresectable HCC: 5416\n",
      "  Locally Advanced, Metastatic Solid Tumors: 5417\n",
      "  Locally Metastatic Malignant Neoplasm: 5418\n",
      "  Locally Recurrent Breast Cancer: 5419\n",
      "  Locally Recurrent or Metastatic Breast Cancer: 5420\n",
      "  Loco-regional Esophageal Cancer: 5421\n",
      "  Loiasis: 5422\n",
      "  Long Bone Non-Union: 5423\n",
      "  Long QT Syndrome Type 3: 5424\n",
      "  Long-Term Oral Anticoagulated Patients: 5425\n",
      "  Long-chain Fatty Acid Transport Deficiency: 5426\n",
      "  Long-term Oral Anticoagulant Therapy: 5427\n",
      "  Low Back Pain: 5428\n",
      "  Low Back Pain, Recurrent: 5429\n",
      "  Low Birth Weight Infant: 5430\n",
      "  Low Cardiac Output Syndrome: 5431\n",
      "  Low Gelsolin: 5432\n",
      "  Low Grade B Cell Lymphoma: 5433\n",
      "  Low Grade Glioma: 5434\n",
      "  Low Grade Glioma (LGG), High Grade Glioma (HGG): 5435\n",
      "  Low Ovarian Reserve: 5436\n",
      "  Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors: 5437\n",
      "  Low Risk Prostate Cancer: 5438\n",
      "  Low Risk of Preterm Delivery: 5439\n",
      "  Low Serum Lipid Levels: 5440\n",
      "  Low T3 Syndrome: 5441\n",
      "  Low Testosterone: 5442\n",
      "  Low and Int 1-risk Myelodysplastic Syndrome: 5443\n",
      "  Low-Grade Astrocytoma, Nos: 5444\n",
      "  Low-Grade Glioma: 5445\n",
      "  Low-Grade Lymphoma: 5446\n",
      "  Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma: 5447\n",
      "  Low-grade B Cell Non-Hodgkin's Lymphoma: 5448\n",
      "  Low-grade Glioma: 5449\n",
      "  Low-grade Serous Ovarian Cancer: 5450\n",
      "  Low-risk Papillary Thyroid Cancer: 5451\n",
      "  Lower Abdominal Surgery: 5452\n",
      "  Lower Back Pain: 5453\n",
      "  Lower Extremity Fractures.: 5454\n",
      "  Lower Extremity Ischemia: 5455\n",
      "  Lower Extremity Surgery: 5456\n",
      "  Lower Limb Injuries: 5457\n",
      "  Lower Limb Ischemia: 5458\n",
      "  Lower Urinary Tract Discomfort: 5459\n",
      "  Lower Urinary Tract Symptoms: 5460\n",
      "  Lumbar Degenerative Disc Disease: 5461\n",
      "  Lumbar Disc Herniation: 5462\n",
      "  Lumbar Herniated Disc: 5463\n",
      "  Lumbar Herniated Intervertebral Disc: 5464\n",
      "  Lumbar Radiculopathy: 5465\n",
      "  Lumbar Spinal Stenosis: 5466\n",
      "  Lumbar Spine Degeneration: 5467\n",
      "  Lumbar Spine Fusion: 5468\n",
      "  Lumbar Spine Injury: 5469\n",
      "  Lumbar Spine Surgery: 5470\n",
      "  Lumbosacral Radiculopathy: 5471\n",
      "  Lung Adenocarcinoma: 5472\n",
      "  Lung Cancer: 5473\n",
      "  Lung Cancer - Non Small Cell: 5474\n",
      "  Lung Cancer Metastatic: 5475\n",
      "  Lung Cancer Non-small Cell Stage IV: 5476\n",
      "  Lung Cancer Screening: 5477\n",
      "  Lung Cancer Squamous Cell: 5478\n",
      "  Lung Cancer in Normal and Malignant Tumors: 5479\n",
      "  Lung Cancer, Non-Small Cell: 5480\n",
      "  Lung Cancer, Nonsmall Cell: 5481\n",
      "  Lung Cancer, Nonsmall Cell, Stage I: 5482\n",
      "  Lung Cancer, Small Cell: 5483\n",
      "  Lung Carcinoma: 5484\n",
      "  Lung Carcinoma Metastatic in the Brain: 5485\n",
      "  Lung Disease: 5486\n",
      "  Lung Disease Airways: 5487\n",
      "  Lung Disease, Interstitial: 5488\n",
      "  Lung Diseases: 5489\n",
      "  Lung Diseases, Interstitial: 5490\n",
      "  Lung Diseases, Obstructive: 5491\n",
      "  Lung Infection: 5492\n",
      "  Lung Injury, Acute: 5493\n",
      "  Lung Injury, Acute (ALI): 5494\n",
      "  Lung Injury, Acute and Respiratory Distress Syndrome, Adult: 5495\n",
      "  Lung Neoplasm: 5496\n",
      "  Lung Neoplasm Malignant: 5497\n",
      "  Lung Neoplasms: 5498\n",
      "  Lung Neoplasms, Non-Small Cell Lung Cancer: 5499\n",
      "  Lung Non-Squamous Non-Small Cell Carcinoma: 5500\n",
      "  Lung Resection: 5501\n",
      "  Lung Squamous Cell Carcinoma Stage IV: 5502\n",
      "  Lung Structure Determination: 5503\n",
      "  Lung Transplant: 5504\n",
      "  Lung Transplant Rejection: 5505\n",
      "  Lung Transplantation: 5506\n",
      "  Lung Tumors: 5507\n",
      "  Lung and Heart-lung Transplantation: 5508\n",
      "  Lung and Pleural Malignancies: 5509\n",
      "  Lung; Disease, Fibroid (Chronic): 5510\n",
      "  Lungcancer: 5511\n",
      "  Lupus: 5512\n",
      "  Lupus Erythematosus: 5513\n",
      "  Lupus Erythematosus, Cutaneous: 5514\n",
      "  Lupus Erythematosus, Systemic: 5515\n",
      "  Lupus Membranous Nephropathy: 5516\n",
      "  Lupus Nephritis: 5517\n",
      "  Luteal Hormone Supplementation in In-vitro Fertilization: 5518\n",
      "  Luteal Phase Defect: 5519\n",
      "  Lyme Disease: 5520\n",
      "  Lyme Neuroborreliosis: 5521\n",
      "  Lymphangioleiomyomatosis: 5522\n",
      "  Lymphangioma: 5523\n",
      "  Lymphatic Diseases: 5524\n",
      "  Lymphatic Filariasis: 5525\n",
      "  Lymphatic Malformations: 5526\n",
      "  Lymphedema: 5527\n",
      "  Lymphoblastic Leukemia: 5528\n",
      "  Lymphoblastic Leukemia, Acute: 5529\n",
      "  Lymphocele: 5530\n",
      "  Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia: 5531\n",
      "  Lymphocytic Colitis: 5532\n",
      "  Lymphocytic Leukemia: 5533\n",
      "  Lymphocytic Leukemia, Chronic: 5534\n",
      "  Lymphoid Hematological Malignancies: 5535\n",
      "  Lymphoid Malignancies: 5536\n",
      "  Lymphoid Malignancy: 5537\n",
      "  Lymphoma: 5538\n",
      "  Lymphoma of Mucosa-Associated Lymphoid Tissue: 5539\n",
      "  Lymphoma, B Cell: 5540\n",
      "  Lymphoma, B-Cell: 5541\n",
      "  Lymphoma, B-Cell, Marginal Zone: 5542\n",
      "  Lymphoma, B-cell: 5543"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "  Lymphoma, Diffuse Large-Cell B-cell: 5544\n",
      "  Lymphoma, Extranodal NK-T-Cell: 5545\n",
      "  Lymphoma, Follicular: 5546\n",
      "  Lymphoma, Large B-Cell, Diffuse: 5547\n",
      "  Lymphoma, Large Cell, Diffuse: 5548\n",
      "  Lymphoma, Large-Cell: 5549\n",
      "  Lymphoma, Large-Cell, Diffuse: 5550\n",
      "  Lymphoma, Large-Cell, Ki-1: 5551\n",
      "  Lymphoma, Low-Grade: 5552\n",
      "  Lymphoma, Lymphoblastic: 5553\n",
      "  Lymphoma, Malignant: 5554\n",
      "  Lymphoma, Mantle Cell: 5555\n",
      "  Lymphoma, Mantle-Cell: 5556\n",
      "  Lymphoma, Mucosa-Associated Lymphoid Tissue: 5557\n",
      "  Lymphoma, Non-Hodgkin: 5558\n",
      "  Lymphoma, Non-Hodgkin's: 5559\n",
      "  Lymphoma, Non-Hodgkin's, Adult: 5560\n",
      "  Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic: 5561\n",
      "  Lymphoma, Non-Hodgkins: 5562\n",
      "  Lymphoma, Small Cleaved-Cell, Follicular: 5563\n",
      "  Lymphoma, Small Lymphocytic: 5564\n",
      "  Lymphoma, T-Cell: 5565\n",
      "  Lymphoma, T-Cell, Cutaneous: 5566\n",
      "  Lymphoma, T-Cell, Peripheral: 5567\n",
      "  Lymphomas: 5568\n",
      "  Lymphomas Non-Hodgkin's B-Cell: 5569\n",
      "  Lymphopenia: 5570\n",
      "  Lymphoproliferative Disorder: 5571\n",
      "  Lymphoproliferative Disorders: 5572\n",
      "  Lymphoproliferative Malignancies: 5573\n",
      "  Lymphorrhea: 5574\n",
      "  Lysosomal Acid Lipase Deficiency: 5575\n",
      "  Lysosomal Storage Diseases: 5576\n",
      "  MAB: 5577\n",
      "  MBL-Deficient: 5578\n",
      "  MCL Tear: 5579\n",
      "  MDD: 5580\n",
      "  MDS: 5581\n",
      "  MDS (Myelodysplastic Syndrome): 5582\n",
      "  MELAS Syndrome: 5583\n",
      "  MEMBRANOUS NEPHROPATHY: 5584\n",
      "  MERS (Middle East Respiratory Syndrome): 5585\n",
      "  MET Positive: 5586\n",
      "  METASTATIC BREAST CANCER: 5587\n",
      "  MPA: 5588\n",
      "  MPN (Myeloproliferative Neoplasms): 5589\n",
      "  MPS I: 5590\n",
      "  MPS III B: 5591\n",
      "  MPS IV A: 5592\n",
      "  MRSA: 5593\n",
      "  MRSA - Methicillin Resistant Staphylococcus Aureus Infection: 5594\n",
      "  MRSA Colonization: 5595\n",
      "  MS Patient With Relpasing Remitting Attacks: 5596\n",
      "  MSCs: 5597\n",
      "  MSI: 5598\n",
      "  MULTIPLE SCLEROSIS: 5599\n",
      "  MV(Mitral Valve) Repair: 5600\n",
      "  MYOPATHY: 5601\n",
      "  Macrophage Activation Syndrome: 5602\n",
      "  Macular Degeneration: 5603\n",
      "  Macular Edema: 5604\n",
      "  Macular Edema Following Cataract Surgery: 5605\n",
      "  Macular Edema Secondary to Central Retinal Vein Occlusion: 5606\n",
      "  Macular Edema, Cystoid: 5607\n",
      "  Macular Edema, Diabetic: 5608\n",
      "  Macular Hole: 5609\n",
      "  Macular Telangiectasia: 5610\n",
      "  Macular Telangiectasia Type 2: 5611\n",
      "  Macular Thickening: 5612\n",
      "  Maculopathy, Age-Related: 5613\n",
      "  Madarosis: 5614\n",
      "  Magnesium Sulphate: 5615\n",
      "  Magnetic Resonance Imaging: 5616\n",
      "  Maintenance Kidney Transplant: 5617\n",
      "  Maintenance Liver Transplant Patients With New Onset Diabetes: 5618\n",
      "  Major Abdominal Operation: 5619\n",
      "  Major Coronary Event: 5620\n",
      "  Major Cutaneous Abscess: 5621\n",
      "  Major Depression: 5622\n",
      "  Major Depression With Psychotic Features: 5623\n",
      "  Major Depressive Disorder: 5624\n",
      "  Major Depressive Disorder (MDD): 5625\n",
      "  Major Depressive Disorder Patients: 5626\n",
      "  Major Depressive Disorder With Mixed Features: 5627\n",
      "  Major Depressive Disorder With Panic Attacks: 5628\n",
      "  Major Depressive Disorder With Psychotic Features: 5629\n",
      "  Major Depressive Disorder and Irritability: 5630\n",
      "  Major Depressive Disorder in Pregnancy: 5631\n",
      "  Major Depressive Disorder, Healthy Volunteer: 5632\n",
      "  Major Depressive Disorder, Recurrent: 5633\n",
      "  Major Depressive Disorders: 5634\n",
      "  Major Depressive Episode: 5635\n",
      "  Major Liver Resection: 5636\n",
      "  Major Trauma: 5637\n",
      "  Major hæmorrhage: 5638\n",
      "  Malaria: 5639\n",
      "  Malaria Prophylaxis: 5640\n",
      "  Malaria in Pregnancy: 5641\n",
      "  Malaria in Pregnant HIV + Patients: 5642\n",
      "  Malaria, Antepartum: 5643\n",
      "  Malaria, Falciparum: 5644\n",
      "  Malaria, Vivax: 5645\n",
      "  Malaria,Falciparum: 5646\n",
      "  Male Breast Cancer: 5647\n",
      "  Male Breast Carcinoma: 5648\n",
      "  Male Erectile Dysfunction: 5649\n",
      "  Male Hypogonadism: 5650\n",
      "  Male Infertility: 5651\n",
      "  Male Oligoasthenospermia: 5652\n",
      "  Male Osteoporosis: 5653\n",
      "  Male Pattern Hair Loss: 5654\n",
      "  Male Subjects With Type II Diabetes (T2DM): 5655\n",
      "  Males: 5656\n",
      "  Malignancies: 5657\n",
      "  Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor: 5658\n",
      "  Malignancy: 5659\n",
      "  Malignant Ascites: 5660\n",
      "  Malignant Carcinoid Syndrome: 5661\n",
      "  Malignant Chest Wall Neoplasm: 5662\n",
      "  Malignant Childhood Neoplasm: 5663\n",
      "  Malignant Epithelial Mesothelioma: 5664\n",
      "  Malignant Glioma: 5665\n",
      "  Malignant Glioma (WHO Grade III or IV): 5666\n",
      "  Malignant Glioma of Brain: 5667\n",
      "  Malignant Gliomas: 5668\n",
      "  Malignant Hemopathy: 5669\n",
      "  Malignant Intracranial Tumors: 5670\n",
      "  Malignant Liver Disease: 5671\n",
      "  Malignant Lymphoma: 5672\n",
      "  Malignant Lymphoma, Stem Cell Type: 5673\n",
      "  Malignant Melanoma: 5674\n",
      "  Malignant Melanoma Stage IV: 5675\n",
      "  Malignant Melanoma, Cancer: 5676\n",
      "  Malignant Melanoma, Metastatic: 5677\n",
      "  Malignant Melanoma, Neoplasms: 5678\n",
      "  Malignant Mesothelioma: 5679\n",
      "  Malignant Middle Cerebral Artery Infarction: 5680\n",
      "  Malignant Neoplasm: 5681\n",
      "  Malignant Neoplasm of Breast: 5682\n",
      "  Malignant Neoplasm of Esophagus: 5683\n",
      "  Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma: 5684\n",
      "  Malignant Neoplasms Brain: 5685\n",
      "  Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic: 5686\n",
      "  Malignant Neoplasms of Brain: 5687\n",
      "  Malignant Neoplasms of Digestive Organs: 5688\n",
      "  Malignant Neoplasms of Female Genital Organs: 5689\n",
      "  Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites: 5690\n",
      "  Malignant Neoplasms of Male Genital Organs: 5691\n",
      "  Malignant Neoplasms of Mesothelial and Soft Tissue: 5692\n",
      "  Malignant Neoplasms of Urinary Tract: 5693\n",
      "  Malignant Ovarian Clear Cell Tumor: 5694\n",
      "  Malignant Ovarian Endometrioid Tumor: 5695\n",
      "  Malignant Ovarian Mixed Epithelial Tumor: 5696\n",
      "  Malignant PEComa (Perivascular Epithelioid Cell Tumors): 5697\n",
      "  Malignant Peripheral Nerve Sheath Tumors: 5698\n",
      "  Malignant Peripheral Nerve Sheath Tumour (MPNST): 5699\n",
      "  Malignant Pleural Effusion: 5700\n",
      "  Malignant Pleural Effusions: 5701\n",
      "  Malignant Pleural Mesothelioma: 5702\n",
      "  Malignant Pleural Mesothelioma (MPM): 5703\n",
      "  Malignant Pleural Mesothelioma, Advanced: 5704\n",
      "  Malignant Rhabdoid Tumors (MRT): 5705\n",
      "  Malignant Solid Neoplasm: 5706\n",
      "  Malignant Solid Tumor: 5707\n",
      "  Malignant Solid Tumors: 5708\n",
      "  Malignant Solid Tumour: 5709\n",
      "  Malignant Thymoma: 5710\n",
      "  Malignant Tumor of Ill-defined Site: 5711\n",
      "  Malignant Tumors: 5712\n",
      "  Malignant and Non-malignant High Risk Diseases: 5713\n",
      "  Malleolus Fracture, Lateral: 5714\n",
      "  Malnourished Children With Watery Diarrhoea: 5715\n",
      "  Malnutrition: 5716\n",
      "  Malnutrition, Child: 5717\n",
      "  Malocclusion: 5718\n",
      "  Mammaplasty: 5719\n",
      "  Mammary Tumor: 5720\n",
      "  Mammographic Breast Density: 5721\n",
      "  Mammographic Density: 5722\n",
      "  Mammoplasty: 5723\n",
      "  Management of Actionable Test Results (ATRs): 5724\n",
      "  Management of Chronic Pain: 5725\n",
      "  Mandibular Injuries: 5726\n",
      "  Mania: 5727\n",
      "  Mantle Cell Lymphoma: 5728\n",
      "  Mantle-Cell Lymphoma: 5729\n",
      "  Marburg Virus Disease: 5730\n",
      "  Marfan Syndrome: 5731\n",
      "  Marginal Zone Lymphoma: 5732\n",
      "  Marijuana Abuse: 5733\n",
      "  Marijuana Dependence: 5734\n",
      "  Marijuana Smoking: 5735\n",
      "  Marijuana Usage: 5736\n",
      "  Marijuana Use: 5737\n",
      "  Marital Relationship: 5738\n",
      "  Masked Hypertension: 5739\n",
      "  Mass Casualty Incident: 5740\n",
      "  Masseter Muscle Prominence: 5741\n",
      "  Mastectomy: 5742\n",
      "  Mastocytosis: 5743\n",
      "  Maternal Behavior: 5744\n",
      "  Maternal Obesity: 5745\n",
      "  Maternal Opioid Use Disorder: 5746\n",
      "  Mature Cataracts: 5747\n",
      "  Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma: 5748\n",
      "  Maxillary Sinusitis: 5749\n",
      "  McCune-Albright Syndrome: 5750\n",
      "  Measles: 5751\n",
      "  Measles Antibody Seroconversion: 5752\n",
      "  Measure of Uptake of XTRA in the Brain: 5753\n",
      "  Mechanical Complication of Intrauterine Device: 5754\n",
      "  Mechanical Heart Valve Recipients: 5755\n",
      "  Mechanical Ventilation: 5756\n",
      "  Mechanical Ventilation Complication: 5757\n",
      "  Mechanically Ventilated ICU Patients: 5758\n",
      "  Mechanically Ventilated Patients: 5759\n",
      "  Mechanically Ventilated and Intubated Subjects: 5760\n",
      "  Meconium Aspiration: 5761\n",
      "  Meconium Aspiration Syndrome: 5762\n",
      "  Mediastinal Neoplasms: 5763\n",
      "  Medical Abortion: 5764\n",
      "  Medical Abortion, Complete or Unspecified, Without Complication: 5765\n",
      "  Medical Oncology: 5766\n",
      "  Medical Patient: 5767\n",
      "  Medical Patients: 5768\n",
      "  Medicaments Substances in Therapeutic Use: 5769\n",
      "  Medication Absorption: 5770\n",
      "  Medication Adherence: 5771\n",
      "  Medication Overuse Headache: 5772\n",
      "  Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: 5773\n",
      "  Medullary Thyroid Cancer: 5774\n",
      "  Medullary Thyroid Carcinoma: 5775\n",
      "  Medulloblastoma: 5776\n",
      "  Medulloblastoma, Childhood: 5777\n",
      "  Megaloblastic Anemia Nos: 5778\n",
      "  Meibomian Gland Dysfunction: 5779\n",
      "  Melanoma: 5780\n",
      "  Melanoma (Skin): 5781\n",
      "  Melanoma Metastatic: 5782\n",
      "  Melanoma With a Breslow's Thickness ≥ 1mm: 5783\n",
      "  Melanoma and Brain Metastases: 5784\n",
      "  Melanoma and Metastatic Colorectal Cancer: 5785\n",
      "  Melanosis: 5786\n",
      "  Melasma: 5787\n",
      "  Melatonin: 5788\n",
      "  Melphalan Autologous Transplant: 5789\n",
      "  Membranoproliferative Glomerulonephritis: 5790\n",
      "  Membranous Nephropathy: 5791\n",
      "  Memory: 5792\n",
      "  Memory Deficit: 5793\n",
      "  Memory Impairment: 5794\n",
      "  Memory Impairment Due to Corticosteroid Use: 5795\n",
      "  Memory, Short-Term: 5796\n",
      "  Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.: 5797\n",
      "  Meniere Disease: 5798\n",
      "  Meniere's Disease: 5799\n",
      "  Meningioma: 5800\n",
      "  Meningitis: 5801\n",
      "  Meningitis Streptococcal: 5802\n",
      "  Meningitis, Bacterial: 5803\n",
      "  Meningitis, Cryptococcal: 5804\n",
      "  Meningitis, Meningococcal: 5805\n",
      "  Meningitis, Meningococcal, Serogroup B: 5806\n",
      "  Meningitis, Tuberculous: 5807\n",
      "  Meningococcal Disease: 5808\n",
      "  Meningococcal Infection: 5809\n",
      "  Meningococcal Infections: 5810\n",
      "  Meningococcal Meningitis: 5811\n",
      "  Meningococcal Serogroup B: 5812\n",
      "  Meningococcal Vaccine: 5813\n",
      "  Meniscus Lesion: 5814\n",
      "  Menopausal Depression: 5815\n",
      "  Menopausal Hot Flushes: 5816\n",
      "  Menopausal Osteoporosis: 5817\n",
      "  Menopausal Symptom Relief: 5818\n",
      "  Menopause: 5819\n",
      "  Menopause Related Conditions: 5820\n",
      "  Menorrhagia: 5821\n",
      "  Mental Acuity: 5822\n",
      "  Mental Disorders: 5823\n",
      "  Mental Disorders Diagnosed in Childhood: 5824\n",
      "  Mental Illness: 5825\n",
      "  Mental Processes: 5826\n",
      "  Mental Retardation: 5827\n",
      "  Merkel Cell Carcinoma: 5828\n",
      "  Merkel Cell Polyomavirus Infection: 5829\n",
      "  Mesenchymal Tumor: 5830\n",
      "  Mesolthelioma: 5831\n",
      "  Mesothelin Positive: 5832\n",
      "  Mesothelioma: 5833\n",
      "  Mesothelioma, Malignant: 5834\n",
      "  Metabolic Acidosis: 5835\n",
      "  Metabolic Cardiovascular Syndrome: 5836\n",
      "  Metabolic Control: 5837\n",
      "  Metabolic Disease: 5838\n",
      "  Metabolic Diseases: 5839\n",
      "  Metabolic Disorders: 5840\n",
      "  Metabolic Processes: 5841\n",
      "  Metabolic Syndrome: 5842\n",
      "  Metabolic Syndrome X: 5843\n",
      "  Metabolic Syndrome x: 5844\n",
      "  Metabolic X Syndrome Dyslipidemia: 5845\n",
      "  Metabolism - Cerebral Energy: 5846\n",
      "  Metabolism and Nutrition Disorder: 5847\n",
      "  Metabolism, Drug: 5848\n",
      "  Metapneumovirus: 5849\n",
      "  Metastases: 5850\n",
      "  Metastases of Central Nervous System: 5851\n",
      "  Metastases, Neoplasm: 5852\n",
      "  Metastasis: 5853\n",
      "  Metastasis to Brain of Unknown Primary: 5854\n",
      "  Metastatic: 5855\n",
      "  Metastatic Adenocarcinoma of the Pancreas: 5856\n",
      "  Metastatic Adult Soft Tissue Sarcoma: 5857\n",
      "  Metastatic Advanced Gastric Cancer: 5858\n",
      "  Metastatic Alveolar Soft Part Sarcoma: 5859\n",
      "  Metastatic Anaplastic Thyroid Cancer: 5860\n",
      "  Metastatic Androgen Independent Prostate Cancer: 5861\n",
      "  Metastatic Basal Cell Carcinoma: 5862\n",
      "  Metastatic Biliary Tract Cancer: 5863\n",
      "  Metastatic Breast Adenocarcinoma: 5864\n",
      "  Metastatic Breast Cancer: 5865\n",
      "  Metastatic Breast Cancer With Bone Involvement: 5866\n",
      "  Metastatic Breast Cancer With Intracranial Metastases: 5867\n",
      "  Metastatic Breastcancer: 5868\n",
      "  Metastatic Cancer: 5869\n",
      "  Metastatic Cancer (Different Solid Tumour Types): 5870\n",
      "  Metastatic Cancer Pancreas: 5871\n",
      "  Metastatic Cancer With Impaired Renal Function: 5872\n",
      "  Metastatic Carcinoma: 5873\n",
      "  Metastatic Carcinoma in the Adrenal Cortex: 5874\n",
      "  Metastatic Carcinoma in the Liver: 5875\n",
      "  Metastatic Carcinoma of the Cervix: 5876\n",
      "  Metastatic Castrate Resistant Prostate Cancer: 5877\n",
      "  Metastatic Castrate- Resistant Prostate Cancer: 5878\n",
      "  Metastatic Castrate-Resistant Prostate Cancer: 5879\n",
      "  Metastatic Castrate-Resistant Prostate Cancer (mCRPC),: 5880\n",
      "  Metastatic Castration Resistant Prostate Cancer: 5881\n",
      "  Metastatic Castration-Resistant Prostate Cancer: 5882\n",
      "  Metastatic Castration-Resistant Prostate Cancer (mCRPC): 5883\n",
      "  Metastatic Castration-resistant Prostate Cancer: 5884\n",
      "  Metastatic Clear Cell Renal Carcinoma: 5885\n",
      "  Metastatic Clear Cell Renal Cell Carcinoma: 5886\n",
      "  Metastatic Colon Cancer: 5887\n",
      "  Metastatic Colorectal Adenocarcinoma: 5888\n",
      "  Metastatic Colorectal Cancer: 5889\n",
      "  Metastatic Colorectal Carcinoma: 5890\n",
      "  Metastatic Cutaneous Melanoma: 5891\n",
      "  Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction: 5892\n",
      "  Metastatic Disease: 5893\n",
      "  Metastatic ER+ Breast Cancer: 5894\n",
      "  Metastatic Epidural Spinal Cord Compression: 5895\n",
      "  Metastatic Gastric Adenocarcinoma: 5896\n",
      "  Metastatic Gastric Cancer: 5897\n",
      "  Metastatic Gastro-esophageal Adenocarcinoma: 5898\n",
      "  Metastatic Gastrointestinal Carcinoid Tumor: 5899\n",
      "  Metastatic HER2-positive Breast Cancer With Brain Metastasis: 5900\n",
      "  Metastatic Head and Neck Squamous Cell Carcinoma: 5901\n",
      "  Metastatic Head-and-neck Squamous-cell Carcinoma: 5902\n",
      "  Metastatic Hepatocellular Carcinoma: 5903\n",
      "  Metastatic Hormone Sensitive Prostate Cancer: 5904\n",
      "  Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer: 5905\n",
      "  Metastatic Hormone-Sensitive Prostate Cancer: 5906\n",
      "  Metastatic Kidney Carcinoma: 5907\n",
      "  Metastatic Leiomyosarcoma: 5908\n",
      "  Metastatic Liver Cancer: 5909\n",
      "  Metastatic Malignant Melanoma: 5910\n",
      "  Metastatic Malignant Melanoma and Renal Cell Carcinoma: 5911\n",
      "  Metastatic Malignant Neoplasm: 5912\n",
      "  Metastatic Malignant Neoplasm in the Bone: 5913\n",
      "  Metastatic Malignant Neoplasm in the Brain: 5914\n",
      "  Metastatic Malignant Neoplasm in the Lung: 5915\n",
      "  Metastatic Malignant Solid Neoplasm: 5916\n",
      "  Metastatic Malignant Uveal Melanoma: 5917\n",
      "  Metastatic Melanoma: 5918\n",
      "  Metastatic Melanoma (Carrying BRAF V600 Mutation): 5919\n",
      "  Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC): 5920\n",
      "  Metastatic Melanoma to the Groin Lymph Nodes: 5921\n",
      "  Metastatic Melanoma, BRAF V600 Mutation Positive: 5922\n",
      "  Metastatic NSCLC: 5923\n",
      "  Metastatic Neoplasm: 5924\n",
      "  Metastatic Non Small Cell Lung Cancer: 5925\n",
      "  Metastatic Non-Small Cell Lung Cancer: 5926\n",
      "  Metastatic Non-hematologic Malignancies: 5927\n",
      "  Metastatic Non-small-cell lunG Cancer: 5928\n",
      "  Metastatic Ocular Melanoma: 5929\n",
      "  Metastatic Osteosarcoma: 5930\n",
      "  Metastatic Ovarian Cancer: 5931\n",
      "  Metastatic Pancreas Cancer: 5932\n",
      "  Metastatic Pancreatic Adenocarcinoma: 5933\n",
      "  Metastatic Pancreatic Cancer: 5934\n",
      "  Metastatic Pancreatic Carcinoma: 5935\n",
      "  Metastatic Pancreatic Ductal Adenocarcinoma: 5936\n",
      "  Metastatic Prostate Cancer: 5937\n",
      "  Metastatic Prostate Carcinoma: 5938\n",
      "  Metastatic Pulmonary Nodules: 5939\n",
      "  Metastatic Renal Cancer: 5940\n",
      "  Metastatic Renal Cell Cancer: 5941\n",
      "  Metastatic Renal Cell Carcinoma: 5942\n",
      "  Metastatic Renal Cell Carcinoma (mRCC): 5943\n",
      "  Metastatic Sarcoma: 5944\n",
      "  Metastatic Solid Malignancies: 5945\n",
      "  Metastatic Solid Tumor Cancer: 5946\n",
      "  Metastatic Solid Tumors: 5947\n",
      "  Metastatic Solid Tumors of Metastatic Disease: 5948\n",
      "  Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies: 5949\n",
      "  Metastatic Solid Tumors.: 5950\n",
      "  Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma: 5951\n",
      "  Metastatic Squamous Non-small Cell Lung Cancer: 5952\n",
      "  Metastatic Thyroid Cancer: 5953\n",
      "  Metastatic Thyroid Papillary Carcinoma: 5954\n",
      "  Metastatic Triple Negative Breast Cancer: 5955\n",
      "  Metastatic Urothelial Cancer: 5956\n",
      "  Metastatic Urothelial Carcinoma: 5957\n",
      "  Metastatic Urothelial Carcinoma (UC): 5958\n",
      "  Metastatic Urothelial Cell Cancer: 5959\n",
      "  Metastatic Uveal Melanoma: 5960\n",
      "  Metastatic and Advanced Solid Tumors: 5961\n",
      "  Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive: 5962\n",
      "  Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: 5963\n",
      "  Metastatic or Incurable Non-small Cell Lung Cancer: 5964\n",
      "  Metastatic or Locally Advanced Unresectable Solid Tumors: 5965\n",
      "  Metastatic or Locally-advanced Unresectable Breast Cancer: 5966\n",
      "  Metastatic or Recurrent Gastric Adenocarcinoma: 5967\n",
      "  Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus: 5968\n",
      "  Metastatic sRCC: 5969\n",
      "  Metastatic, Androgen Independent Prostate Cancer: 5970\n",
      "  Metastatic, Gastric or Gastro-oesophageal Junction, Cancer: 5971\n",
      "  Metastatic, Stage III or Stage IV, Melanoma: 5972\n",
      "  Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours: 5973\n",
      "  Metformin Response: 5974\n",
      "  Methadone-maintenance Subjects: 5975\n",
      "  Methamphetamine: 5976\n",
      "  Methamphetamine Abuse: 5977\n",
      "  Methamphetamine Dependence: 5978\n",
      "  Methamphetamine Metabolism, CYP2D6 Genotype: 5979\n",
      "  Methamphetamine Use Disorder: 5980\n",
      "  Methamphetamine-dependence: 5981\n",
      "  Methemoglobinemia: 5982\n",
      "  Methicillin-Resistant Staphylococcus Aureus: 5983\n",
      "  Methicillin-resistant Staphylococcus Aureus: 5984\n",
      "  Methylmalonic Acidemia (MMA): 5985\n",
      "  Metopic Craniosynostosis: 5986\n",
      "  Metrorrhagia: 5987\n",
      "  Microalbuminuria: 5988\n",
      "  Microcirculation: 5989\n",
      "  Microsatellite Stable Colorectal Cancer: 5990\n",
      "  Microsatellite Unstable Colorectal Cancer: 5991\n",
      "  Microscopic Hematuria: 5992\n",
      "  Microvascular Angina: 5993\n",
      "  Microvascular Coronary Artery Disease: 5994\n",
      "  Midazolam Overdose: 5995\n",
      "  Middle Cerebral Artery Stroke: 5996\n",
      "  Middle Ear Disease: 5997\n",
      "  Middle-ear Function: 5998\n",
      "  Migraine: 5999\n",
      "  Migraine Disorders: 6000\n",
      "  Migraine Headache: 6001\n",
      "  Migraine Headaches: 6002\n",
      "  Migraine With Aura: 6003\n",
      "  Migraine in Children: 6004\n",
      "  Migrainous Headache: 6005\n",
      "  Mild Allergic Rhinitis: 6006\n",
      "  Mild Alzheimer's Disease: 6007\n",
      "  Mild Asthma: 6008\n",
      "  Mild Cognitive Impairment: 6009\n",
      "  Mild Cognitive Impairment (MCI): 6010\n",
      "  Mild Cognitive Impairment Due to Alzheimer's Disease: 6011\n",
      "  Mild Hypertension: 6012\n",
      "  Mild Persistent Asthma: 6013\n",
      "  Mild Traumatic Brain Injury: 6014\n",
      "  Mild or Moderate Surgical Bleeding: 6015\n",
      "  Mild to Moderate Alzheimer's Disease: 6016\n",
      "  Mild to Moderate Atopic Dermatitis: 6017\n",
      "  Mild to Moderate Psoriasis: 6018\n",
      "  Mild to Moderate Ulcerative Colitis: 6019\n",
      "  Mild-Moderate Alzheimer's Disease: 6020\n",
      "  Milk Allergy: 6021\n",
      "  Minimal Change Disease: 6022\n",
      "  Minimal Hepatic Encephalopathy: 6023\n",
      "  Minimal Residual Disease: 6024\n",
      "  Minimally Conscious States Due to Traumatic Brain Injury: 6025\n",
      "  Minor Intra-uterine Abnormalities: 6026\n",
      "  Miscarriage: 6027\n",
      "  Miscarriage in First Trimester: 6028\n",
      "  Misoprostol: 6029\n",
      "  Missed Abortion: 6030\n",
      "  Mitochondrial Diseases: 6031\n",
      "  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): 6032\n",
      "  Mitochondrial Toxicity: 6033\n",
      "  Mitral Leaflet Prolapse: 6034\n",
      "  Mitral Stenosis: 6035\n",
      "  Mitral Valve Insufficiency: 6036\n",
      "  Mitral Valve Prolapse: 6037\n",
      "  Mitral Valve Regurgitation: 6038\n",
      "  Mitral Valve Stenosis: 6039\n",
      "  Mitral Valve Stenosis With Incompetence or Regurgitation: 6040\n",
      "  Mixed Gliomas: 6041\n",
      "  Mixed Hyperlipidemia: 6042\n",
      "  Mixed Hyperlipoproteinemia: 6043\n",
      "  Mixed Lineage Acute Leukemia: 6044\n",
      "  Mixed Urinary Incontinence: 6045\n",
      "  Mobility After Total Knee Arthroplasty: 6046\n",
      "  Mobility Limitation: 6047\n",
      "  Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB): 6048\n",
      "  Moderate Asthma: 6049\n",
      "  Moderate and Severe Plaque Psoriasis: 6050\n",
      "  Moderate and Severe Rheumatoid Arthritis: 6051\n",
      "  Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns: 6052\n",
      "  Moderate or Severe Submental Fullness: 6053\n",
      "  Moderate to Severe Acute Postoperative Pain: 6054\n",
      "  Moderate to Severe Allergic Asthma: 6055\n",
      "  Moderate to Severe Alzheimer: 6056\n",
      "  Moderate to Severe Atopic Dermatitis: 6057\n",
      "  Moderate to Severe Chronic Pain: 6058\n",
      "  Moderate to Severe Chronic Plaque Psoriasis: 6059\n",
      "  Moderate to Severe Convexity of Submental Fat: 6060\n",
      "  Moderate to Severe Cyclic Mastalgia: 6061\n",
      "  Moderate to Severe Hypoxic-ischemic Encephalopathy: 6062\n",
      "  Moderate to Severe Plaque Psoriasis: 6063\n",
      "  Moderate to Severe Primary Dysmenorrhea: 6064\n",
      "  Moderate to Severe Psoriasis: 6065\n",
      "  Moderate to Severe Rheumatoid Arthritis: 6066\n",
      "  Moderate to Severe Ulcerative Colitis: 6067\n",
      "  Moderate to Severe Vasomotor Symptoms in Postmenopausal: 6068\n",
      "  Moderate-severe Pain: 6069\n",
      "  Moderate-to-severe Acute Pain: 6070\n",
      "  Modified Release Oral Formulation: 6071\n",
      "  Mohs Surgery: 6072\n",
      "  Molar Incisor Hypomineralization: 6073\n",
      "  Molecular Mechanisms of Pharmacological Action: 6074\n",
      "  Molluscum Contagiosum: 6075\n",
      "  Molybdenum Cofactor Deficiency Type A: 6076\n",
      "  Molybdenum Cofactor Deficiency, Type A: 6077\n",
      "  Monoclonal B-Cell Lymphocytosis: 6078\n",
      "  Monoclonal Gammopathies: 6079\n",
      "  Monoclonal Gammopathy: 6080\n",
      "  Monoclonal Gammopathy of Undetermined Significance: 6081\n",
      "  Monopolar Depression, Single Episode or Unspecified: 6082\n",
      "  Mood: 6083\n",
      "  Mood Disorder: 6084\n",
      "  Mood Disorders: 6085\n",
      "  Mood Lability: 6086\n",
      "  Morbid Obesity: 6087\n",
      "  Morbidity: 6088\n",
      "  Morning Sickness: 6089\n",
      "  Morphea: 6090\n",
      "  Morphea, Plaque Form: 6091\n",
      "  Morquio's Disease: 6092\n",
      "  Mortality: 6093\n",
      "  Morton's Neuroma: 6094\n",
      "  Motavizumab Administration for a Second Season for RSV Prophylaxis: 6095\n",
      "  Motility Disorder: 6096\n",
      "  Motion Sickness: 6097\n",
      "  Motor Activity: 6098\n",
      "  Motor Condition as Measured by Quantified Scale: 6099\n",
      "  Motor Neuron Disease: 6100\n",
      "  Motor Weakness in Two or Four Limbs: 6101\n",
      "  Mouth Cancer: 6102\n",
      "  Mouth Neoplasms: 6103\n",
      "  Mucinous Adenocarcinoma of the Colon: 6104\n",
      "  Mucinous Adenocarcinoma of the Rectum: 6105\n",
      "  Mucinous Cystic Tumor With Moderate Dysplasia: 6106\n",
      "  Muckle Wells Syndrome: 6107\n",
      "  Mucopolysaccharidosis I: 6108\n",
      "  Mucopolysaccharidosis II: 6109\n",
      "  Mucopolysaccharidosis III, Type B (MPS IIIB): 6110\n",
      "  Mucopolysaccharidosis IIIB: 6111\n",
      "  Mucopolysaccharidosis IVA: 6112\n",
      "  Mucopolysaccharidosis Type 3 B: 6113\n",
      "  Mucopolysaccharidosis Type 7: 6114\n",
      "  Mucopolysaccharidosis Type I: 6115\n",
      "  Mucopolysaccharidosis VI: 6116\n",
      "  Mucormycosis: 6117\n",
      "  Mucosa Associated Lymphoid Tissue (MALT) Lymphoma: 6118\n",
      "  Mucosal Irritation: 6119\n",
      "  Mucosal Lentiginous Melanoma: 6120\n",
      "  Mucosal Melanoma: 6121\n",
      "  Mucositis: 6122\n",
      "  Multi-Drug Resistant Tuberculosis: 6123\n",
      "  Multi-drug Resistant Tuberculosis: 6124\n",
      "  Multidrug Resistant Tuberculosis: 6125\n",
      "  Multinodular Goiter: 6126\n",
      "  Multiple Brain Metastases: 6127\n",
      "  Multiple Micronutrient Deficiencies During Pregnancy: 6128\n",
      "  Multiple Myeloma: 6129\n",
      "  Multiple Myeloma Stage I: 6130\n",
      "  Multiple Myeloma and Plasma Cell Neoplasm: 6131\n",
      "  Multiple Myeloma de Novo Treatment: 6132\n",
      "  Multiple Myeloma in Relapse: 6133\n",
      "  Multiple Myeloma, Relapsed: 6134\n",
      "  Multiple Myeloma-Light Chain Only: 6135\n",
      "  Multiple Organ Failure: 6136\n",
      "  Multiple Sclerosis: 6137\n",
      "  Multiple Sclerosis (MS): 6138\n",
      "  Multiple Sclerosis (MS) - Relapsing-remitting: 6139\n",
      "  Multiple Sclerosis (Relapsing Remitting): 6140\n",
      "  Multiple Sclerosis Relapse: 6141\n",
      "  Multiple Sclerosis, Chronic Progressive: 6142\n",
      "  Multiple Sclerosis, Osteoporosis: 6143\n",
      "  Multiple Sclerosis, Primary Progressive: 6144\n",
      "  Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis: 6145\n",
      "  Multiple Sclerosis, Relapsing Remitting: 6146\n",
      "  Multiple Sclerosis, Relapsing-Remitting: 6147\n",
      "  Multiple Sclerosis, Relapsing-remitting: 6148\n",
      "  Multiple Sclerosis, Secondary Progressive: 6149\n",
      "  Multiple System Atrophy: 6150\n",
      "  Multiple Trauma: 6151\n",
      "  Multivessel Coronary Artery Disease: 6152\n",
      "  Mumps: 6153\n",
      "  Muscle Atrophy: 6154\n",
      "  Muscle Cramps in Amyotrophic Lateral Sclerosis: 6155\n",
      "  Muscle Fiber Atrophy, Type II: 6156\n",
      "  Muscle Function: 6157\n",
      "  Muscle Injury: 6158\n",
      "  Muscle Lesions: 6159\n",
      "  Muscle Oxygenation: 6160\n",
      "  Muscle Pain: 6161\n",
      "  Muscle Soreness: 6162\n",
      "  Muscle Spasticity: 6163\n",
      "  Muscle Spasticity Due to Multiple Sclerosis: 6164\n",
      "  Muscle Strength: 6165\n",
      "  Muscle Tear: 6166\n",
      "  Muscle Wasting: 6167\n",
      "  Muscle Wasting (Atrophy) After Hip Fracture Surgery: 6168\n",
      "  Muscle Weakness: 6169\n",
      "  Muscle-invasive Bladder Cancer: 6170\n",
      "  Muscle-invasive Transitional Cell Carcinoma of the Bladder: 6171\n",
      "  Muscular Atrophy, Spinal: 6172\n",
      "  Muscular Disease: 6173\n",
      "  Muscular Diseases: 6174\n",
      "  Muscular Dystrophies: 6175\n",
      "  Muscular Dystrophy: 6176\n",
      "  Muscular Dystrophy (DMD): 6177\n",
      "  Muscular Dystrophy, Duchenne: 6178\n",
      "  Muscular Dystrophy, Oculopharyngeal: 6179\n",
      "  Muscular Fatigue: 6180\n",
      "  Musculoskeletal Complications: 6181\n",
      "  Musculoskeletal Diseases: 6182\n",
      "  Musculoskeletal Pain: 6183\n",
      "  Myasthenia Gravis: 6184\n",
      "  Myasthenia Gravis Exacerbations: 6185\n",
      "  Myasthenia Gravis, Generalized: 6186\n",
      "  Myasthenia Gravis, MuSK: 6187\n",
      "  Myasthenic Syndromes, Congenital: 6188\n",
      "  Mycobacterium Avium Complex: 6189\n",
      "  Mycobacterium Avium Complex Lung Disease: 6190\n",
      "  Mycobacterium Infections, Nontuberculous: 6191\n",
      "  Mycobacterium Tuberculosis: 6192\n",
      "  Mycoses: 6193\n",
      "  Mycosis Fungoides: 6194\n",
      "  Myelitis, Transverse: 6195\n",
      "  Myeloablative Conditioning: 6196\n",
      "  Myelodysplasia: 6197\n",
      "  Myelodysplastic Syndrome: 6198\n",
      "  Myelodysplastic Syndrome (MDS): 6199\n",
      "  Myelodysplastic Syndrome MDS: 6200\n",
      "  Myelodysplastic Syndrome With Low-grade Lesions: 6201\n",
      "  Myelodysplastic Syndromes: 6202\n",
      "  Myelodysplastic Syndromes (MDS): 6203\n",
      "  Myelodysplastic Syndromes, Myelogenous Leukemia, Acute: 6204\n",
      "  Myelodysplastic and Myeloproliferative Disorders: 6205\n",
      "  Myelofibroses: 6206\n",
      "  Myelofibrosis: 6207\n",
      "  Myelofibrosis (MF): 6208\n",
      "  Myelofibrosis With High Molecular Risk Mutations: 6209\n",
      "  Myelogenous Leukemia: 6210\n",
      "  Myelogenous Leukemia, Acute: 6211\n",
      "  Myelogenous Leukemia, Chronic, Chronic Phase: 6212\n",
      "  Myeloid Leukemia: 6213\n",
      "  Myeloid Leukemia, Chronic: 6214\n",
      "  Myeloid Leukemia, Chronic, Chronic-Phase: 6215\n",
      "  Myeloid Malignancies: 6216\n",
      "  Myeloid Malignancy: 6217\n",
      "  Myeloma: 6218\n",
      "  Myeloma Multiple: 6219\n",
      "  Myeloma, Plasma-Cell: 6220\n",
      "  Myelopathy: 6221\n",
      "  Myeloproliferative Diseases: 6222\n",
      "  Myeloproliferative Disorders: 6223\n",
      "  Myeloproliferative Neoplasm (MPN): 6224\n",
      "  Myeloproliferative Neoplasms: 6225\n",
      "  Myocardial Edema: 6226\n",
      "  Myocardial Fibrosis: 6227\n",
      "  Myocardial Infarct: 6228\n",
      "  Myocardial Infarction: 6229\n",
      "  Myocardial Infarction (MI): 6230\n",
      "  Myocardial Infarction With Non-obstructive Coronary Arteries: 6231\n",
      "  Myocardial Infarction, Anterior Wall: 6232\n",
      "  Myocardial Injury: 6233\n",
      "  Myocardial Ischemia: 6234\n",
      "  Myocardial Perfusion Imaging: 6235\n",
      "  Myocardial Reperfusion Injury: 6236\n",
      "  Myocardial Revascularization: 6237\n",
      "  Myocardial Stunning: 6238\n",
      "  Myocarditis: 6239\n",
      "  Myoclonus: 6240\n",
      "  Myofascial Neck Pain: 6241\n",
      "  Myofascial Pain: 6242\n",
      "  Myofascial Pain Syndrome: 6243\n",
      "  Myofascial Pain Syndromes: 6244\n",
      "  Myoinositol: 6245\n",
      "  Myomectomy: 6246\n",
      "  Myomectomy; Surgical Blood Loss: 6247\n",
      "  Myopathic Conditions: 6248\n",
      "  Myopia: 6249\n",
      "  Myopia, Degenerative: 6250\n",
      "  Myopic Choroidal Neovascularization: 6251\n",
      "  Myopic Macular Degeneration: 6252\n",
      "  Myositis: 6253\n",
      "  Myotonia Congenita: 6254\n",
      "  Myotonic Dystrophy: 6255\n",
      "  Myringotomy: 6256\n",
      "  Myxoid Liposarcoma: 6257\n",
      "  N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma: 6258\n",
      "  N. Meningitidis Carriage: 6259\n",
      "  N/A, as Healthy Volunteers: 6260\n",
      "  NAC: 6261\n",
      "  NAFLD: 6262\n",
      "  NAFLD - Nonalcoholic Fatty Liver Disease: 6263\n",
      "  NASH (Non-alcoholic Steato-hepatitis): 6264\n",
      "  NASH - Nonalcoholic Steatohepatitis: 6265\n",
      "  NASOPHARYNGEAL CARCINOMA: 6266\n",
      "  NF1: 6267\n",
      "  NHL: 6268\n",
      "  NIDDM: 6269\n",
      "  NODULOCYSTIC ACNE: 6270\n",
      "  NOMID: 6271\n",
      "  NON-SMALL CELL LUNG CANCER: 6272\n",
      "  NON-breast HER2+ Malignancies: 6273\n",
      "  NPWT: 6274\n",
      "  NSAID Related Gastric Irritation: 6275\n",
      "  NSAID-induced Gastropathy: 6276\n",
      "  NSCLC: 6277\n",
      "  NSCLC (Non-Small Cell Lung Cancer): 6278\n",
      "  NSCLC (Non-small Cell Lung Carcinoma): 6279\n",
      "  NSCLC Patients With EGFR Activating Mutation: 6280\n",
      "  NSCLC Stage IIIB: 6281\n",
      "  NSCLC Stage IV: 6282\n",
      "  NSCLC, Non Small Cell Lung Cancer: 6283\n",
      "  NSCLC, Recurrent: 6284\n",
      "  NSCLC, Stage IV: 6285\n",
      "  NUT Midline Carcinoma: 6286\n",
      "  NUT Midline Carcinoma (NMC): 6287\n",
      "  Nail Psoriasis: 6288\n",
      "  Narcolepsy: 6289\n",
      "  Narcolepsy With Cataplexy: 6290\n",
      "  Narcotic Abuse: 6291\n",
      "  Narcotic Consumption: 6292\n",
      "  Nasal Alar Collapse, Bilateral: 6293\n",
      "  Nasal Congestion: 6294\n",
      "  Nasal Obstruction: 6295\n",
      "  Nasal Polyposis: 6296\n",
      "  Nasal Polyps: 6297\n",
      "  Nasal Sinus; Inflammation: 6298\n",
      "  Nasal Synechiae: 6299\n",
      "  Nasal Type Extranodal NK/T-Cell Lymphoma: 6300\n",
      "  Nash: 6301\n",
      "  Nasofibroscopy: 6302\n",
      "  Nasolabial Fold: 6303\n",
      "  Nasolabial Folds: 6304\n",
      "  Nasopharyngeal Cancer: 6305\n",
      "  Nasopharyngeal Cancers: 6306\n",
      "  Nasopharyngeal Carcinoma: 6307\n",
      "  Nasopharyngeal Neoplasms: 6308\n",
      "  Nausea: 6309\n",
      "  Nausea and Vomiting: 6310\n",
      "  Nausea and Vomiting, Chemotherapy-Induced: 6311\n",
      "  Necator Americanus Infection: 6312\n",
      "  Neck Pain: 6313\n",
      "  Necrobiosis Lipoidica: 6314\n",
      "  Necrobiosis Lipoidica Diabeticorum: 6315\n",
      "  Necrotizing Enterocolitis: 6316\n",
      "  Necrotizing Enterocolitis of Newborn: 6317\n",
      "  Necrotizing Soft Tissue Infections: 6318\n",
      "  Need for Bowel Preparation: 6319\n",
      "  Needle Phobia: 6320\n",
      "  Negative Symptoms of Schizophrenia: 6321\n",
      "  Negative-Pressure Wound Therapy: 6322\n",
      "  Neisseria Gonorrhoeae: 6323\n",
      "  Neisseria Meningitidis: 6324\n",
      "  Nelson Syndrome: 6325\n",
      "  Neonatal Abstinence Syndrome: 6326\n",
      "  Neonatal Adaptation: 6327\n",
      "  Neonatal Anemia: 6328\n",
      "  Neonatal Asphyxial Encephalopathy: 6329\n",
      "  Neonatal Distress: 6330\n",
      "  Neonatal Encephalopathy: 6331\n",
      "  Neonatal Infection: 6332\n",
      "  Neonatal Post-Hemorrhagic Hydrocephalus: 6333\n",
      "  Neonatal Respiratory Distress Syndrome: 6334\n",
      "  Neonatal SEPSIS: 6335\n",
      "  Neonatal Seizure: 6336\n",
      "  Neonatal Seizures: 6337\n",
      "  Neonatal Sepsis: 6338\n",
      "  Neonatal Tongue-tie: 6339\n",
      "  Neonates on ECMO: 6340\n",
      "  Neoplasm: 6341\n",
      "  Neoplasm Malignant: 6342\n",
      "  Neoplasm Metastases: 6343\n",
      "  Neoplasm Metastasis: 6344\n",
      "  Neoplasm, Prostate: 6345\n",
      "  Neoplasms: 6346\n",
      "  Neoplasms Malignant: 6347\n",
      "  Neoplasms Pancreatic: 6348\n",
      "  Neoplasms by Site: 6349\n",
      "  Neoplasms, Advanced: 6350\n",
      "  Neoplasms, Advanced Solid: 6351\n",
      "  Neoplasms, Breast: 6352\n",
      "  Neoplasms, Colorectal: 6353\n",
      "  Neoplasms, Cystic, Mucinous, and Serous: 6354\n",
      "  Neoplasms, Endometrial: 6355\n",
      "  Neoplasms, Germ Cell and Embryonal: 6356\n",
      "  Neoplasms, Glandular and Epithelial: 6357\n",
      "  Neoplasms, Haematologic: 6358\n",
      "  Neoplasms, Malignant: 6359\n",
      "  Neoplasms, Myelogenous Leukemia, Acute: 6360\n",
      "  Neoplasms, Nerve Tissue: 6361\n",
      "  Neoplasms, Oral: 6362\n",
      "  Neoplasms, Ovarian: 6363\n",
      "  Neoplasms, Pancreatic: 6364\n",
      "  Neoplasms, Prostate: 6365\n",
      "  Neoplasms, Unknown Primary: 6366\n",
      "  Neoplasms,Ovarian: 6367\n",
      "  Neoplasms，Non-Small Cell Lung Cancer: 6368\n",
      "  Neoplastic Disease: 6369\n",
      "  Neoplastic Meningitis: 6370\n",
      "  Neovascular Age Related Macular Degeneration: 6371\n",
      "  Neovascular Age Related Macular Degeneration (AMD): 6372\n",
      "  Neovascular Age-Related Macular Degeneration: 6373\n",
      "  Neovascular Age-related Macular Degeneration: 6374\n",
      "  Neovascular Macular Degeneration: 6375\n",
      "  Neovascularization: 6376\n",
      "  Nephrectomy: 6377\n",
      "  Nephritis, Lupus: 6378\n",
      "  Nephrogenic Fibrosing Dermopathy: 6379\n",
      "  Nephrolithiasis: 6380\n",
      "  Nephrology: 6381\n",
      "  Nephropathy: 6382\n",
      "  Nephrostomy; Complications: 6383\n",
      "  Nephrotic Syndrome: 6384\n",
      "  Nephrotic Syndrome Steroid-Dependent: 6385\n",
      "  Nephrotoxicity: 6386\n",
      "  Nerve Block: 6387\n",
      "  Nerve Compression Syndromes: 6388\n",
      "  Nerve Pain: 6389\n",
      "  Nervous System Diseases: 6390\n",
      "  Nervous System Disorders: 6391\n",
      "  Nervous System Malformations: 6392\n",
      "  Neural Tube Defects: 6393\n",
      "  Neuralgia: 6394\n",
      "  Neuralgia Peripheral: 6395\n",
      "  Neuralgia, Postherpetic: 6396\n",
      "  Neuritis: 6397\n",
      "  Neuroblastoma: 6398\n",
      "  Neuroblastoma Recurrent: 6399\n",
      "  Neurocognitive Decline: 6400\n",
      "  Neurocognitive Disturbance: 6401\n",
      "  Neurocysticercosis: 6402\n",
      "  Neurodegeneration: 6403\n",
      "  Neuroendocrine Cancer: 6404\n",
      "  Neuroendocrine Carcinoma: 6405\n",
      "  Neuroendocrine Carcinoma of Pancreas: 6406\n",
      "  Neuroendocrine Carcinomas: 6407\n",
      "  Neuroendocrine Tumor: 6408\n",
      "  Neuroendocrine Tumors: 6409\n",
      "  Neuroendocrine Tumors in Lung: 6410\n",
      "  Neuroendrocrine Tumors: 6411\n",
      "  Neuroepithelial Tumor: 6412\n",
      "  Neurofibroma: 6413\n",
      "  Neurofibroma, Plexiform: 6414\n",
      "  Neurofibromatoses: 6415\n",
      "  Neurofibromatosis: 6416\n",
      "  Neurofibromatosis 1: 6417\n",
      "  Neurofibromatosis 2: 6418\n",
      "  Neurofibromatosis Type 1: 6419\n",
      "  Neurofibromatosis Type 1 (NF1): 6420\n",
      "  Neurofibromatosis Type 2: 6421\n",
      "  Neurofibromatosis Type I: 6422\n",
      "  Neurogenic Bladder: 6423\n",
      "  Neurogenic Bladder Dysfunction Nos: 6424\n",
      "  Neurogenic Detrusor Overactivity: 6425\n",
      "  Neurogenic Urinary Bladder: 6426\n",
      "  Neuroleptic-Induced Tardive Dyskinesia: 6427\n",
      "  Neuroleptic-Induced Tremor: 6428\n",
      "  Neurological Pathology: 6429\n",
      "  Neurological; Disorder, Nervous System: 6430\n",
      "  Neurologically Impaired: 6431\n",
      "  Neuroma: 6432\n",
      "  Neuromuscular Block: 6433\n",
      "  Neuromuscular Blockade: 6434\n",
      "  Neuromuscular Disease: 6435\n",
      "  Neuromyelitis Optica: 6436\n",
      "  Neuromyelitis Optica Spectrum Disorder: 6437\n",
      "  Neuronal Ceroid Lipofuscinosis: 6438\n",
      "  Neuropathic Back Pain: 6439\n",
      "  Neuropathic Diabetic Foot Ulcers: 6440\n",
      "  Neuropathic Pain: 6441\n",
      "  Neuropathic Pain From Lumbosacral Radiculopathy: 6442\n",
      "  Neuropathic Pain in Cancer: 6443\n",
      "  Neuropathy: 6444\n",
      "  Neurosurgery: 6445\n",
      "  Neurotoxicity: 6446\n",
      "  Neurotrophic Keratitis: 6447\n",
      "  Neurotrophic Keratopathy: 6448\n",
      "  Neutropenia: 6449\n",
      "  Neutropenia, Febrile: 6450\n",
      "  Neutropenia, Severe Chronic: 6451\n",
      "  New Daily Persistent Headache: 6452\n",
      "  New Onset Atrial Fibrillation: 6453\n",
      "  New Onset Diabetes After Transplant: 6454\n",
      "  New Onset Diabetes Mellitus After Renal Transplantation: 6455\n",
      "  New Onset Type 1 Diabetes Mellitus: 6456\n",
      "  New Onset Type-1 Diabetes: 6457\n",
      "  New-onset Type 1 Diabetes Mellitus: 6458\n",
      "  Newborn Hypoxic Ischemic Encephalopathy: 6459\n",
      "  Newly Diagnosed Diffuse Large B-Cell Lymphoma: 6460\n",
      "  Newly Diagnosed Glioblastoma: 6461\n",
      "  Newly Diagnosed High Grade Glioma (HGG): 6462\n",
      "  Newly Diagnosed High-Grade Glioma: 6463\n",
      "  Newly Diagnosed Melanoma Metastases in the Brain and Spine: 6464\n",
      "  Newly Diagnosed Multiple Myeloma: 6465\n",
      "  Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II: 6466\n",
      "  Newly Diagnosed, Multiple Myeloma: 6467\n",
      "  Newly Diagnosed, Previously Untreated Multiple Myeloma: 6468\n",
      "  Nicotine: 6469\n",
      "  Nicotine Addiction: 6470\n",
      "  Nicotine Dependence: 6471\n",
      "  Nicotine Dependence, Cigarettes: 6472\n",
      "  Nicotine Use Disorder: 6473\n",
      "  Nicotine Withdrawal: 6474\n",
      "  Nicotine-free Hookah Smoking: 6475\n",
      "  Niemann-Pick Disease, Type C: 6476\n",
      "  Niemann-Pick Type C Disease: 6477\n",
      "  No Condition, Healthy Females: 6478\n",
      "  No Evidence of Disease: 6479\n",
      "  No Explained Sterility: 6480\n",
      "  Nocturia: 6481\n",
      "  Nocturnal Enuresis: 6482\n",
      "  Nocturnal Hypertension: 6483\n",
      "  Nocturnal Leg Cramps: 6484\n",
      "  Nodal Lymphoma: 6485\n",
      "  Nodding Syndrome: 6486\n",
      "  Node Positive HER2 Negative Breast Cancer: 6487\n",
      "  Nodes, Lung: 6488\n",
      "  Nodular Basal Cell Carcinoma: 6489\n",
      "  Noise-induced Hearing Loss: 6490\n",
      "  Non Alcoholic Fatty Liver Disease: 6491\n",
      "  Non Alcoholic Steatohepatitis: 6492\n",
      "  Non Alcoholic Steatohepatitis (NASH): 6493\n",
      "  Non Arteritic Anterior Ischemic Optic Neuropathy: 6494\n",
      "  Non Castrate Metastatic Prostate Cancer: 6495\n",
      "  Non Cystic Fibrosis Bronchiectasis: 6496\n",
      "  Non Healing Wounds: 6497\n",
      "  Non Hematologic Cancers: 6498\n",
      "  Non Hodgkin Lymphoma: 6499\n",
      "  Non Hodgkin's Lymphoma: 6500\n",
      "  Non Infectious Uveitis: 6501\n",
      "  Non Muscle Invasive Bladder Cancer: 6502\n",
      "  Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma: 6503\n",
      "  Non Proliferative Diabetic Retinopathy: 6504\n",
      "  Non ST Elevation Myocardial Infarction: 6505\n",
      "  Non ST Segment Elevation Acute Coronary Syndrome: 6506\n",
      "  Non ST Segment Elevation Myocardial Infarction: 6507\n",
      "  Non Shockable Out of Hospital Cardiac Arrest: 6508\n",
      "  Non Small Cell Lung Cancer: 6509\n",
      "  Non Small Cell Lung Cancer (NSCLC): 6510\n",
      "  Non Small Cell Lung Cancer Metastatic: 6511\n",
      "  Non Small Cell Lung Cancer Stage IIIB: 6512\n",
      "  Non Small Cell Lung Carcinoma: 6513\n",
      "  Non Small-cell Lung Cancer: 6514\n",
      "  Non Squamous Cell Lung Cancer: 6515\n",
      "  Non Squamous Non Small Cell Lung: 6516\n",
      "  Non Squamous, Non-small-cell Lung Cancer: 6517\n",
      "  Non Union Diaphyseal Fractures: 6518\n",
      "  Non-24 Hour Sleep-Wake Disorder: 6519\n",
      "  Non-Alcoholic Fatty Liver Disease: 6520\n",
      "  Non-Alcoholic Steatohepatitis: 6521\n",
      "  Non-Alcoholic Steatohepatitis (NASH): 6522\n",
      "  Non-Bleeding Peptic Ulcers: 6523\n",
      "  Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas): 6524\n",
      "  Non-Constipation Irritable Bowel Syndrome: 6525\n",
      "  Non-Cystic Fibrosis Bronchiectasis: 6526\n",
      "  Non-Hodgkin Lymphoma: 6527\n",
      "  Non-Hodgkin Lymphomas: 6528\n",
      "  Non-Hodgkin's B-cell Lymphoma: 6529\n",
      "  Non-Hodgkin's Lymphoma: 6530\n",
      "  Non-Hodgkin's Lymphoma (NHL): 6531\n",
      "  Non-Hodgkin's Lymphoma or Hodgkin's Disease: 6532\n",
      "  Non-Hodgkin's Lymphoma,: 6533\n",
      "  Non-Hodgkin's Lymphoma, Solid Cancers: 6534\n",
      "  Non-Hodgkins Lymphoma: 6535\n",
      "  Non-Insulin Dependent Diabetes Mellitus: 6536\n",
      "  Non-Insulin-dependent Diabetes Mellitus: 6537\n",
      "  Non-Malignant Hematologic Disorders: 6538\n",
      "  Non-Metastatic Adenocarcinoma of the Rectum: 6539\n",
      "  Non-Metastatic Prostate Cancer: 6540\n",
      "  Non-Neoplastic Hematologic and Lymphocytic Disorder: 6541\n",
      "  Non-Resectable Cholangiocarcinoma: 6542\n",
      "  Non-ST Elevation Acute Coronary Syndrome: 6543\n",
      "  Non-ST-elevation Acute Coronary Syndrome: 6544\n",
      "  Non-Secretory Plasma Cell Myeloma: 6545\n",
      "  Non-Small Cell Lunch Cancer: 6546\n",
      "  Non-Small Cell Lung Cancer: 6547\n",
      "  Non-Small Cell Lung Cancer (NSCLC): 6548\n",
      "  Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line: 6549\n",
      "  Non-Small Cell Lung Cancer - Completely Resectable: 6550\n",
      "  Non-Small Cell Lung Cancer NSCLC: 6551\n",
      "  Non-Small Cell Lung Cancer and Pleural Mesothelioma: 6552\n",
      "  Non-Small Cell Lung Cancer, Head and Neck Cancer: 6553\n",
      "  Non-Small Cell Lung Cancer, Small Cell Lung Cancer: 6554\n",
      "  Non-Small Cell Lung Carcinoma: 6555\n",
      "  Non-Small-Cell Lung: 6556\n",
      "  Non-Small-Cell Lung Adenocarcinoma: 6557\n",
      "  Non-Small-Cell Lung Cancer: 6558\n",
      "  Non-Small-Cell Lung Cancer Metastatic: 6559\n",
      "  Non-Small-Cell Lung Carcinoma: 6560\n",
      "  Non-Squamous Cell Non-small Cell Lung Cancer: 6561\n",
      "  Non-Squamous Non-Small Cell Lung Cancer: 6562\n",
      "  Non-Squamous Non-Small Cell Lung Cancer (NSCLC): 6563\n",
      "  Non-Tuberculous Mycobacterial Pneumonia: 6564\n",
      "  Non-alcoholic Fatty Liver Disease: 6565\n",
      "  Non-alcoholic Fatty Liver Disease (NAFLD: 6566\n",
      "  Non-alcoholic Fatty Liver Disease (NAFLD): 6567\n",
      "  Non-alcoholic Fatty Liver Disease in Women With PCOS: 6568\n",
      "  Non-alcoholic Steatohepatitis: 6569\n",
      "  Non-alcoholic Steatohepatitis (NASH): 6570\n",
      "  Non-alcoholic Steatohepatitis NASH: 6571\n",
      "  Non-anaemic Patients Undergoing Cardiac Surgery: 6572\n",
      "  Non-cancer Pain: 6573\n",
      "  Non-clear Cell Renal Cell Cancer: 6574\n",
      "  Non-colorectal Cancer: 6575\n",
      "  Non-diabetic Nephropathy: 6576\n",
      "  Non-diabetic Painful Peripheral Polyneuropathy: 6577\n",
      "  Non-erosive Reflux Disease: 6578\n",
      "  Non-functioning Pituitary Adenomas: 6579\n",
      "  Non-healing Soft Tissue Wounds: 6580\n",
      "  Non-hodgkin Lymphoma: 6581\n",
      "  Non-hodgkin Lymphoma,B Cell: 6582\n",
      "  Non-hodgkin's Lymphoma: 6583\n",
      "  Non-hodgkins Lymphoma: 6584\n",
      "  Non-idiopathic Scoliosis: 6585\n",
      "  Non-infectious Anterior Uveitis: 6586\n",
      "  Non-infectious Intermediate and Posterior Uveitis: 6587\n",
      "  Non-infectious Uveitis: 6588\n",
      "  Non-infectious, Non-necrotizing Anterior Scleritis: 6589\n",
      "  Non-inflammatory Joint Disease: 6590\n",
      "  Non-insulin-dependent Diabetes Mellitus: 6591\n",
      "  Non-ischemic Cardiomyopathy: 6592\n",
      "  Non-major Orthopaedic Surgery: 6593\n",
      "  Non-malignant Chronic Pain: 6594\n",
      "  Non-melanoma Skin Cancer: 6595\n",
      "  Non-melanomatous Skin Cancer: 6596\n",
      "  Non-metastatic, Hormone naïve Prostate Cancer: 6597\n",
      "  Non-muscle Invasive Bladder Cancer: 6598\n",
      "  Non-muscle Invasive Bladder Cancer (NMIBC): 6599\n",
      "  Non-myeloid Malignancies: 6600\n",
      "  Non-obstructive Coronary Artery Disease: 6601\n",
      "  Non-organic Loss of Appetite: 6602\n",
      "  Non-radiographic Spondyloarthritis: 6603\n",
      "  Non-relaxing Puborectalis Syndrome: 6604\n",
      "  Non-seminomatous Germ Cell Tumors: 6605\n",
      "  Non-small Cell Lung Cancer: 6606\n",
      "  Non-small Cell Lung Cancer (NSCLC): 6607\n",
      "  Non-small Cell Lung Cancer (NSCLC) Stage III: 6608\n",
      "  Non-small Cell Lung Cancer (NSCLC) With Brain Metastases: 6609\n",
      "  Non-small Cell Lung Cancer (NSCLC), Recurrent: 6610\n",
      "  Non-small Cell Lung Cancer Adenocarcinoma: 6611\n",
      "  Non-small Cell Lung Cancer Metastatic: 6612\n",
      "  Non-small Cell Lung Cancer Stage I: 6613\n",
      "  Non-small Cell Lung Cancer Stage I and II: 6614\n",
      "  Non-small Cell Lung Cancer Stage III: 6615\n",
      "  Non-small Cell Lung Cancer Stage IIIA: 6616\n",
      "  Non-small Cell Lung Cancer Stage IIIB: 6617\n",
      "  Non-small Cell Lung Cancer Stage IIIB/IV: 6618\n",
      "  Non-small Cell Lung Cancer Stage IV: 6619\n",
      "  Non-small Cell Lung Cancer(NSCLC): 6620\n",
      "  Non-small Cell Lung Cancer, Stage III: 6621\n",
      "  Non-small Cell Lung Carcinoma: 6622\n",
      "  Non-small Cell Lung Carcinoma (NSCLC): 6623\n",
      "  Non-small-Cell Lung Carcinoma: 6624\n",
      "  Non-small-cell Lung Cancer: 6625\n",
      "  Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV: 6626\n",
      "  Non-small-cell Lung Cancer With Somatic EGFR Mutations: 6627\n",
      "  Non-specific Abdominal Pain: 6628\n",
      "  Non-squamous Cell Non-Metastatic Non-Small Cell Lung Cancer: 6629\n",
      "  Non-squamous Non-small Cell Lung Cancer: 6630\n",
      "  Non-squamous Non-small Cell Lung Cancer Stage II: 6631\n",
      "  Non-transfusion Dependent Thalassemia: 6632\n",
      "  Non-union Diaphysary Tibial Fractures: 6633\n",
      "  Nonalcoholic Fatty Liver Disease: 6634\n",
      "  Nonalcoholic Fatty Liver Disease (NAFLD): 6635\n",
      "  Nonalcoholic Steatohapatitis: 6636\n",
      "  Nonalcoholic Steatohepatitis: 6637\n",
      "  Nonalcoholic Steatohepatitis (NASH): 6638\n",
      "  Nonalcoholic Steatohepatitis (NASH) With Fibrosis: 6639\n",
      "  Nonallergic Irritant Rhinitis: 6640\n",
      "  Nonarteritic Anterior Ischemic Optic Neuropathy: 6641\n",
      "  Nonconvulsive Electrographic Seizures: 6642\n",
      "  Nonexudative Age Related Macular Degeneration: 6643\n",
      "  Noninfectious Uveitis: 6644\n",
      "  Noninvasive Neurally Adjusted Ventilatory Assist and Pressure Support in Preterm Infants: 6645\n",
      "  Nonproliferative Diabetic Retinopathy: 6646\n",
      "  Nonradiographic Axial Spondylitis, Ankylosing: 6647\n",
      "  Nonrestorative Sleep: 6648\n",
      "  Nonsmall Cell Lung Cancer: 6649\n",
      "  Nonspecific Pain Post Traumatic Injury: 6650\n",
      "  Nonsquamous Nonsmall Cell Neoplasm of Lung: 6651\n",
      "  Nontraumatic Intracerebral Hemorrhage, Multiple Localized: 6652\n",
      "  Nontuberculous Mycobacterial Infection: 6653\n",
      "  Nontuberculous Mycobacterial Lymphadenitis.: 6654\n",
      "  Nontuberculous Mycobacterium Infection: 6655\n",
      "  Nonunion Fracture: 6656\n",
      "  Nonunion Fractures: 6657\n",
      "  Noonan Syndrome: 6658\n",
      "  Normal: 6659\n",
      "  Normal Drug Tolerance: 6660\n",
      "  Normal Healthy: 6661\n",
      "  Normal Healthy Volunteers: 6662\n",
      "  Normal Pressure Hydrocephalus: 6663\n",
      "  Normal Renal Function: 6664\n",
      "  Normal, Healthy Volunteers: 6665\n",
      "  Norovirus: 6666\n",
      "  Norovirus Infection: 6667\n",
      "  Norovirus Infections: 6668\n",
      "  Nosocomial Infection: 6669\n",
      "  Nosocomial Infections: 6670\n",
      "  Notalgia Paresthetica: 6671\n",
      "  Novel 2009 Influenza H1N1: 6672\n",
      "  Nsclc: 6673\n",
      "  Nurse Based Care Management: 6674\n",
      "  Nut Hypersensitivities: 6675\n",
      "  Nutrition Disorders in Old Age: 6676\n",
      "  Nutritional Intervention: 6677\n",
      "  Nutritional Status: 6678\n",
      "  Nystagmus, Congenital: 6679\n",
      "  OSTEOPENIA: 6680\n",
      "  OSTEOSARCOMA: 6681\n",
      "  Obese: 6682\n",
      "  Obese Hypogonadotropic Hypogonadism: 6683\n",
      "  Obesity: 6684\n",
      "  Obesity Hypoventilation Syndrome: 6685\n",
      "  Obesity Prevention: 6686\n",
      "  Obesity Type 2 Diabetes Mellitus: 6687\n",
      "  Obesity and Type 2 Diabetes: 6688\n",
      "  Obesity, Abdominal: 6689\n",
      "  Obesity, Adolescent: 6690\n",
      "  Obesity, Childhood: 6691\n",
      "  Obesity, Morbid: 6692\n",
      "  Obesity; Drug: 6693\n",
      "  Obsessive Compulsive Disorder: 6694\n",
      "  Obsessive-Compulsive Disorder: 6695\n",
      "  Obsessive-compulsive Disorder: 6696\n",
      "  Obsessive-compulsive Disorder (OCD): 6697\n",
      "  Obstetric Complication: 6698\n",
      "  Obstetric Labor, Premature: 6699\n",
      "  Obstetric Labour, Premature: 6700\n",
      "  Obstetric Pain: 6701\n",
      "  Obstetrical Complications From Sedation During Parturition: 6702\n",
      "  Obstetrical Hemorrhage: 6703\n",
      "  Obstructed Defecation Syndrome (ODS): 6704\n",
      "  Obstruction: 6705\n",
      "  Obstruction; Catheter, Infusion Catheter (Vascular): 6706\n",
      "  Obstructive Sleep Apnea: 6707\n",
      "  Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography: 6708\n",
      "  Obstructive Sleep Apnea (OSA): 6709\n",
      "  Obstructive Sleep Apnea Syndrome: 6710\n",
      "  Obstructive Sleep Apnea of Adult: 6711\n",
      "  Obstructive Sleep Apnoea: 6712\n",
      "  Obstructive Sleep Disorder: 6713\n",
      "  Occasional Sleeplessness: 6714\n",
      "  Occult Gastrointestinal Bleeding: 6715\n",
      "  Ocular Discomfort: 6716\n",
      "  Ocular GVHD: 6717\n",
      "  Ocular Graft vs Host Disease: 6718\n",
      "  Ocular Hypertension: 6719\n",
      "  Ocular Hypertension (OHT): 6720\n",
      "  Ocular Infection and Inflammation: 6721\n",
      "  Ocular Inflammation: 6722\n",
      "  Ocular Itching: 6723\n",
      "  Ocular Melanoma: 6724\n",
      "  Ocular Myasthenia Gravis: 6725\n",
      "  Ocular Physiology: 6726\n",
      "  Ocular Toxoplasmosis: 6727\n",
      "  Odontalgia: 6728\n",
      "  Odontogenic Infection: 6729\n",
      "  Odontoid Fractures Type II: 6730\n",
      "  Oesophageal Cancer: 6731\n",
      "  Oesophageal Carcinoma: 6732\n",
      "  Oesophagitis, Eosinophilic: 6733\n",
      "  Oesophago-gastric Cancer: 6734\n",
      "  Office Hysteroscopy and Endometrial Biopsy: 6735\n",
      "  Oily Skin: 6736\n",
      "  Old Myocardial Infarction: 6737\n",
      "  Older Adult Manual Wheelchair Users: 6738\n",
      "  Olfaction Disorders: 6739\n",
      "  Oligoastrocytoma, Mixed: 6740\n",
      "  Oligodendroglioma: 6741\n",
      "  Oligodendroglioma, Adult: 6742\n",
      "  Oligohydramnios: 6743\n",
      "  Oligometastatic Disease: 6744\n",
      "  Omphalitis: 6745\n",
      "  Onchocerciasis: 6746\n",
      "  Oncology: 6747\n",
      "  One or Two Traumatic Vertebral Fractures: 6748\n",
      "  Onset and Duration of a Digital Nerve Block: 6749\n",
      "  Onychomycosis: 6750\n",
      "  Onychomycosis of Toenail: 6751\n",
      "  Onychomycosis/Onycholysis and Tinea Pedis: 6752\n",
      "  Oocyte Donation: 6753\n",
      "  Oophorectomy: 6754\n",
      "  Open Angle Glaucoma: 6755\n",
      "  Open Angle Glaucoma and Cataract: 6756\n",
      "  Open Angle Glaucoma or Ocular Hypertension: 6757\n",
      "  Open Fracture: 6758\n",
      "  Open Thoracotomy: 6759\n",
      "  Open tíbia Fracture With Sub-segmental Bone Loss: 6760\n",
      "  Open-Angle Glaucoma: 6761\n",
      "  Open-angle Glaucoma: 6762\n",
      "  Operable Breast Neoplasms: 6763\n",
      "  Operation Site Bleed: 6764\n",
      "  Operation Time: 6765\n",
      "  Opiate Addiction: 6766\n",
      "  Opiate Dependence: 6767\n",
      "  Opiates: 6768\n",
      "  Opioid Abuse: 6769\n",
      "  Opioid Abuse, Unspecified: 6770\n",
      "  Opioid Analgesia: 6771\n",
      "  Opioid Consumption: 6772\n",
      "  Opioid Dependence: 6773\n",
      "  Opioid Dependency: 6774\n",
      "  Opioid Free Anaesthesia: 6775\n",
      "  Opioid Induced Bowel Dysfunction: 6776\n",
      "  Opioid Induced Swallowing Disorders: 6777\n",
      "  Opioid Overdose: 6778\n",
      "  Opioid Related Disorders: 6779\n",
      "  Opioid Use: 6780\n",
      "  Opioid Use Disorder: 6781\n",
      "  Opioid Use Disorders: 6782\n",
      "  Opioid-Induced Bowel Dysfunction: 6783\n",
      "  Opioid-Induced Constipation: 6784\n",
      "  Opioid-Induced Constipation (OIC): 6785\n",
      "  Opioid-Induced Disorders: 6786\n",
      "  Opioid-Induced Hyperalgesia: 6787\n",
      "  Opioid-Related Disorders: 6788\n",
      "  Opioid-induced Constipation: 6789\n",
      "  Opioid-use Disorder: 6790\n",
      "  Oppositional Defiant Disorder: 6791\n",
      "  Opsoclonus-myoclonus Syndrome: 6792\n",
      "  Optic Atrophy, Hereditary, Leber: 6793\n",
      "  Optic Nerve Diseases: 6794\n",
      "  Optic Nerve Glioma: 6795\n",
      "  Optic Neuritis: 6796\n",
      "  Optic Neuropathy, Ischemic: 6797\n",
      "  Optic, Atrophy, Hereditary, Leber: 6798\n",
      "  Oral Anticoagulation: 6799\n",
      "  Oral Cancer: 6800\n",
      "  Oral Candidiasis: 6801\n",
      "  Oral Cavity Cancer: 6802\n",
      "  Oral Cavity Neoplasm: 6803\n",
      "  Oral Cavity SCC: 6804\n",
      "  Oral Chronic Graft vs Host Disease: 6805\n",
      "  Oral Chronic Graft-Versus-Host Disease: 6806\n",
      "  Oral Complications: 6807\n",
      "  Oral Dystonia: 6808\n",
      "  Oral Erosive Lichen Planus: 6809\n",
      "  Oral Health: 6810\n",
      "  Oral Herpes Simplex: 6811\n",
      "  Oral Leukoplakia: 6812\n",
      "  Oral Lichen Planus: 6813\n",
      "  Oral Mucositis: 6814\n",
      "  Oral Mucositis (Ulcerative) Due to Radiation: 6815\n",
      "  Oral Mucositis in Patients Undergoing HSCT: 6816\n",
      "  Oral Nutritional Supplementation: 6817\n",
      "  Organ Failure, Multiple: 6818\n",
      "  Organ Preservation Solutions: 6819\n",
      "  Organ Transplantation From Brain-dead Donors: 6820\n",
      "  Organ Transplantation, Renal Transplantation: 6821\n",
      "  Organic Cation Transporter 1: 6822\n",
      "  Ornithine Transcarbamylase Deficiency: 6823\n",
      "  Orofacial Pain: 6824\n",
      "  Oropharyngeal Cancer: 6825\n",
      "  Oropharyngeal Candidiasis: 6826\n",
      "  Oropharyngeal Dysphagia: 6827\n",
      "  Oropharyngeal Neoplasms: 6828\n",
      "  Oropharynx Cancer: 6829\n",
      "  Orthognathic Surgery: 6830\n",
      "  Orthomyxoviridae Infection: 6831\n",
      "  Orthopaedic Trauma: 6832\n",
      "  Orthopedic Disorder: 6833\n",
      "  Orthopedic Disorder of Spine: 6834\n",
      "  Orthopedic Procedures: 6835\n",
      "  Orthopedic Trauma Wounds: 6836\n",
      "  Orthopedic/Podiatry Procedures: 6837\n",
      "  Orthopoxviral Disease: 6838\n",
      "  Orthostatic Hypotension: 6839\n",
      "  Orthostatic Intolerance: 6840\n",
      "  Osteo Arthritis Knee: 6841\n",
      "  Osteo Arthritis of the Knee: 6842\n",
      "  Osteoarthritis: 6843\n",
      "  Osteoarthritis Knee Pain: 6844\n",
      "  Osteoarthritis Pain: 6845\n",
      "  Osteoarthritis Pain of the Hip and or Knee: 6846\n",
      "  Osteoarthritis Pain of the Knee: 6847\n",
      "  Osteoarthritis of First Metatarsalphalangeal Joint: 6848\n",
      "  Osteoarthritis of Hip: 6849\n",
      "  Osteoarthritis of Knee: 6850\n",
      "  Osteoarthritis of the Glenohumeral Joint: 6851\n",
      "  Osteoarthritis of the Hand: 6852\n",
      "  Osteoarthritis of the Hip: 6853\n",
      "  Osteoarthritis of the Knee: 6854\n",
      "  Osteoarthritis of the Knee or Hip: 6855\n",
      "  Osteoarthritis of the Lumbar Spine: 6856\n",
      "  Osteoarthritis(Primary): 6857\n",
      "  Osteoarthritis, Degenerative: 6858\n",
      "  Osteoarthritis, Hip: 6859\n",
      "  Osteoarthritis, Knee: 6860\n",
      "  Osteoarthritis, Knee Joint: 6861\n",
      "  Osteoarthritis; Knee: 6862\n",
      "  Osteoarthrosis: 6863\n",
      "  Osteoathritis: 6864\n",
      "  Osteochondritis Dissecans: 6865\n",
      "  Osteogenesis Imperfecta: 6866\n",
      "  Osteogenesis Imperfecta (OI): 6867\n",
      "  Osteoid Osteoma: 6868\n",
      "  Osteomalacia: 6869\n",
      "  Osteomyelitis: 6870\n",
      "  Osteonecrosis: 6871\n",
      "  Osteonecrosis of the Femoral Head: 6872\n",
      "  Osteopenia: 6873\n",
      "  Osteopetrosis: 6874\n",
      "  Osteoporosis: 6875\n",
      "  Osteoporosis Postmenopausal: 6876\n",
      "  Osteoporosis, Age-Related: 6877\n",
      "  Osteoporosis, Osteopenia: 6878\n",
      "  Osteoporosis, Post-Menopausal: 6879\n",
      "  Osteoporosis, Postmenopausal: 6880\n",
      "  Osteoporotic Fractures: 6881\n",
      "  Osteoradionecrosis: 6882\n",
      "  Osteosarcoma: 6883\n",
      "  Osteosarcoma Metastatic: 6884\n",
      "  Ostomy: 6885\n",
      "  Other Abnormal Granulation Tissue Nos: 6886\n",
      "  Other Acute Postoperative Pain: 6887\n",
      "  Other Conditions That May Be A Focus of Clinical Attention: 6888\n",
      "  Other Functional Disturbances Following Cardiac Surgery: 6889\n",
      "  Other Reconstructive Surgery: 6890\n",
      "  Other Skin: 6891\n",
      "  Otitis: 6892\n",
      "  Otitis Externa: 6893\n",
      "  Otitis Media: 6894\n",
      "  Otitis Media With Effusion: 6895\n",
      "  Otitis Media in Patients With Tympanostomy Tubes: 6896\n",
      "  Otitis Media, Serous: 6897\n",
      "  Otitis Media, Suppurative: 6898\n",
      "  Otolaryngeal Cancer: 6899\n",
      "  Otorrhea: 6900\n",
      "  Otosclerosis: 6901\n",
      "  Out of Hospital Cardiac Arrest: 6902\n",
      "  Outpatient Breast Surgery: 6903\n",
      "  Outpatient Surgery: 6904\n",
      "  Ovarian Cancer: 6905\n",
      "  Ovarian Cancer Stage IV: 6906\n",
      "  Ovarian Carcinoma: 6907\n",
      "  Ovarian Carcinoma, Stage 3 or 4: 6908\n",
      "  Ovarian Clear Cell Carcinoma: 6909\n",
      "  Ovarian Clear Cell Cystadenocarcinoma: 6910\n",
      "  Ovarian Diseases: 6911\n",
      "  Ovarian Dysgerminoma: 6912\n",
      "  Ovarian Endometrioid Adenocarcinoma: 6913\n",
      "  Ovarian Function: 6914\n",
      "  Ovarian Hyperstimulation Syndrome: 6915\n",
      "  Ovarian Insufficiency: 6916\n",
      "  Ovarian Neoplasm: 6917\n",
      "  Ovarian Neoplasms: 6918\n",
      "  Ovarian Papillary Serous Carcinoma: 6919\n",
      "  Ovarian Reserve: 6920\n",
      "  Ovarian Response: 6921\n",
      "  Ovarian Serous Tumor: 6922\n",
      "  Ovarian Stimulation: 6923\n",
      "  Ovary Cancer: 6924\n",
      "  Over Weight: 6925\n",
      "  Over-Active Bladder: 6926\n",
      "  Overactive Bladder: 6927\n",
      "  Overactive Bladder (OAB): 6928\n",
      "  Overactive Bladder Syndrome: 6929\n",
      "  Overactive Bladder in Parkinson's Disease: 6930\n",
      "  Overall Survival: 6931\n",
      "  Overall Survival Comparison Between the 2 Arms: 6932\n",
      "  Overdose: 6933\n",
      "  Overweight: 6934\n",
      "  Overweight and Obesity: 6935\n",
      "  Overweight; Hyperlipidemia: 6936\n",
      "  Ovulation: 6937\n",
      "  Ovulation Induction: 6938\n",
      "  Ovulation Inhibition: 6939\n",
      "  Ovulation Suppression: 6940\n",
      "  Oxidative Stress: 6941\n",
      "  Oxygen Saturation: 6942\n",
      "  Oxytocin: 6943\n",
      "  P Acnes Colonization: 6944\n",
      "  PAD: 6945\n",
      "  PAH: 6946\n",
      "  PARAPLEGIA: 6947\n",
      "  PCOS: 6948\n",
      "  PD-1 Antibodies: 6949\n",
      "  PDA: 6950\n",
      "  PGM3: 6951\n",
      "  PICC Placement: 6952\n",
      "  PIK3CA Mutated Advanced Solid Tumors: 6953\n",
      "  PIK3CA-Related Overgrowth: 6954\n",
      "  PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome: 6955\n",
      "  PK Properties Of Gabapentin In Subjects With Impaired Renal Function: 6956\n",
      "  PK in Patients With Various Degrees of Renal Impairment: 6957\n",
      "  PMS: 6958\n",
      "  PNC Vaccine: 6959\n",
      "  POEMS Syndrome: 6960\n",
      "  POLE Exonuclease Mutant Colon Cancer: 6961\n",
      "  PONV: 6962\n",
      "  PPHN: 6963\n",
      "  PPROM: 6964\n",
      "  PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE: 6965\n",
      "  PROSTATE CANCER: 6966\n",
      "  PT-NANBH: 6967\n",
      "  PTCH1 or SMO Activated Solid and Hematologic Tumors: 6968\n",
      "  PTCL: 6969\n",
      "  PTSD: 6970\n",
      "  PTSD and Alcohol Use Disorder: 6971\n",
      "  PVR: 6972\n",
      "  Pachyonychia Congenita: 6973\n",
      "  Paediatric Outpatient Surgery: 6974\n",
      "  Paget's Disease of the Vulva: 6975\n",
      "  Pain: 6976\n",
      "  Pain Acute: 6977\n",
      "  Pain Associated With Fibromyalgia: 6978\n",
      "  Pain Control: 6979\n",
      "  Pain Due to Certain Specified Procedures: 6980\n",
      "  Pain Intractable: 6981\n",
      "  Pain Management: 6982\n",
      "  Pain Management After Breast Biopsy: 6983\n",
      "  Pain Perception: 6984\n",
      "  Pain Postoperative: 6985\n",
      "  Pain Relief: 6986\n",
      "  Pain Relief in Labour: 6987\n",
      "  Pain Teeth: 6988\n",
      "  Pain and Discomfort During Scaling and Root Planning of Patients With: 6989\n",
      "  Pain of Anesthesia at Breast Biopsy: 6990\n",
      "  Pain, Acute: 6991\n",
      "  Pain, Breast: 6992\n",
      "  Pain, Burning: 6993\n",
      "  Pain, Chronic: 6994\n",
      "  Pain, Inflammatory: 6995\n",
      "  Pain, Intractable: 6996\n",
      "  Pain, Neuropathic: 6997\n",
      "  Pain, Perioperative: 6998\n",
      "  Pain, Post Surgical: 6999\n",
      "  Pain, Post-operative: 7000\n",
      "  Pain, Post-surgical: 7001\n",
      "  Pain, Postoperative: 7002\n",
      "  Pain, Referred: 7003\n",
      "  Pain; Bone Neoplasms; Neoplasm Metastasis: 7004\n",
      "  Painful Bladder Syndrome: 7005\n",
      "  Painful Bone Metastases: 7006\n",
      "  Painful Diabetic Neuropathies: 7007\n",
      "  Painful Diabetic Neuropathy: 7008\n",
      "  Painful Diabetic Peripheral Neuropathy (PDPN): 7009\n",
      "  Painful Irreversible Pulpitis: 7010\n",
      "  Painful Lumbar Radiculopathy: 7011\n",
      "  Painful Myelopathy: 7012\n",
      "  Painful Neuropathy: 7013\n",
      "  Painful Osteoporotic Vertebral Compression Fractures (VCF): 7014\n",
      "  Painful Polyneuropathy: 7015\n",
      "  Palliative Care: 7016\n",
      "  Palmar-Plantar Erythrodysesthesia: 7017\n",
      "  Palmo-Plantar Pustular Psoriasis: 7018\n",
      "  Palmoplantar Psoriasis: 7019\n",
      "  Palmoplantar Pustulosis: 7020\n",
      "  Pancreas Adenocarcinoma: 7021\n",
      "  Pancreas Cancer: 7022\n",
      "  Pancreas Neoplasms: 7023\n",
      "  Pancreas, Adenocarcinoma: 7024\n",
      "  Pancreas-Kidney Transplantation: 7025\n",
      "  Pancreatic Adenocarcinoma: 7026\n",
      "  Pancreatic Adenocarcinoma Metastatic: 7027\n",
      "  Pancreatic Adenocarcinoma Non-resectable: 7028\n",
      "  Pancreatic Adenocarcinoma Resectable: 7029\n",
      "  Pancreatic Cancer: 7030\n",
      "  Pancreatic Cancer Non-resectable: 7031\n",
      "  Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection: 7032\n",
      "  Pancreatic Cancer Resectable: 7033\n",
      "  Pancreatic Cancer Stage II: 7034\n",
      "  Pancreatic Cancer, Adult: 7035\n",
      "  Pancreatic Cancer, Metastatic: 7036\n",
      "  Pancreatic Carcinoma: 7037\n",
      "  Pancreatic Carcinoma Metastatic: 7038\n",
      "  Pancreatic Carcinoma Non-resectable: 7039\n",
      "  Pancreatic Carcinoma Stage I: 7040\n",
      "  Pancreatic Cyst: 7041\n",
      "  Pancreatic Ductal Adenocarcinoma: 7042\n",
      "  Pancreatic Ductal Adenocarcinoma (PDAC): 7043\n",
      "  Pancreatic Ductal Carcinoma: 7044\n",
      "  Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis: 7045\n",
      "  Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis: 7046\n",
      "  Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy: 7047\n",
      "  Pancreatic Insufficiency: 7048\n",
      "  Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus: 7049\n",
      "  Pancreatic Metastatic Cancer: 7050\n",
      "  Pancreatic Neoplasm: 7051\n",
      "  Pancreatic Neoplasms: 7052\n",
      "  Pancreatic Neuroendocrine Tumors (pNET): 7053\n",
      "  Pancreatitis: 7054\n",
      "  Pancreatitis, Acute Necrotizing: 7055\n",
      "  Pancreatitis, Chronic: 7056\n",
      "  Pancytopenia Due to Chemotherapy: 7057\n",
      "  Pandas: 7058\n",
      "  Pandemic: 7059\n",
      "  Pandemic H5N1 Influenza: 7060\n",
      "  Pandemic Influenza Vaccine: 7061\n",
      "  Panel Reactive Antibodies: 7062\n",
      "  Panic Disorder: 7063\n",
      "  Pantothenate Kinase-Associated Neurodegeneration: 7064\n",
      "  Papillary Thyroid Cancer: 7065\n",
      "  Papillomavirus Infections: 7066\n",
      "  Papulopustular Rosacea: 7067\n",
      "  Paracetamol: 7068\n",
      "  Paraganglioma: 7069\n",
      "  Parainfluenza: 7070\n",
      "  Paralytic Ileus: 7071\n",
      "  Paranasal Sinus Squamous Cell Carcinoma: 7072\n",
      "  Paranoia: 7073\n",
      "  Paraparesis Spastic Tropical: 7074\n",
      "  Paraphilia: 7075\n",
      "  Parapsoriasis: 7076\n",
      "  Parastomal Hernia: 7077\n",
      "  Parathyroid Disease: 7078\n",
      "  Parathyroid Hormone Suppression Test With Cinacalcet: 7079\n",
      "  Parecoxib: 7080\n",
      "  Parenteral Nutrition: 7081\n",
      "  Parenteral Nutrition (No Primary Condition Studied): 7082\n",
      "  Parenteral Nutrition Associated Cholestasis: 7083\n",
      "  Parenteral Nutrition Associated Liver Disease: 7084\n",
      "  Parenteral Nutrition for Patients With Proven Insufficient Enteral Resorption: 7085\n",
      "  Parenting: 7086\n",
      "  Parkinson: 7087\n",
      "  Parkinson Disease: 7088\n",
      "  Parkinson Disease(PD): 7089\n",
      "  Parkinson Disease, Off Episodes: 7090\n",
      "  Parkinson''s Disease: 7091\n",
      "  Parkinson's Disease: 7092\n",
      "  Parkinson's Disease Dementia: 7093\n",
      "  Parkinson's Disease Psychosis: 7094\n",
      "  Parkinson's Disease With Motor Fluctuations: 7095\n",
      "  Parkinson's Disease With Severe Pain: 7096\n",
      "  Parkinson's Syndrome: 7097\n",
      "  Parkinsonian Syndrome: 7098\n",
      "  Parkinsonism: 7099\n",
      "  Parkinsons's Disease: 7100\n",
      "  Parkinson´s Disease: 7101\n",
      "  Paroxysmal Atrial Fibrillation: 7102\n",
      "  Paroxysmal Nocturnal Hemoglobinuria: 7103\n",
      "  Paroxysmal Nocturnal Hemoglobinuria (PNH): 7104\n",
      "  Paroxysmal Supraventricular Tachycardia: 7105\n",
      "  Paroxysmal Supraventricular Tachycardia (PSVT): 7106\n",
      "  Part 1 - Healthy Volunteers: 7107\n",
      "  Part I (SAD) - Healthy Participants: 7108\n",
      "  Partial Corticotrope Insufficiency: 7109\n",
      "  Partial Epilepsies: 7110\n",
      "  Partial Epilepsy: 7111\n",
      "  Partial Nephrectomy: 7112\n",
      "  Partial Onset Seizures: 7113\n",
      "  Partial Seizure Disorder: 7114\n",
      "  Partial Seizures: 7115\n",
      "  Partial Supraspinatus Tear: 7116\n",
      "  Partial Thickness Wounds: 7117\n",
      "  Partial-onset Seizures: 7118\n",
      "  Participants Less Than 12 Months of Age With RSV Illness: 7119\n",
      "  Partner Assisted Interpersonal Psychotherapy: 7120\n",
      "  Parturients: 7121\n",
      "  Parvovirus B19 Infection: 7122\n",
      "  Patella-Dislocation: 7123\n",
      "  Patellar Tendinopathy: 7124\n",
      "  Patellofemoral Pain Syndrome: 7125\n",
      "  Patent Ductus Arteriosus: 7126\n",
      "  Patent Ductus Arteriosus (PDA): 7127\n",
      "  Patent Foramen Ovale: 7128\n",
      "  Pathogen Resistance: 7129\n",
      "  Pathologic Skin Picking: 7130\n",
      "  Pathological Angiogenesis: 7131\n",
      "  Pathological Gambling: 7132\n",
      "  Patient Diagnosed With OCD and Resistant to SSRI Treatment: 7133\n",
      "  Patient Discharge: 7134\n",
      "  Patient Under Going Colorectal and Stomach Cancer Surgery: 7135\n",
      "  Patient With Hepatic Metastasis: 7136\n",
      "  Patient With Neuropathic Pain: 7137\n",
      "  Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy: 7138\n",
      "  Patients: 7139\n",
      "  Patients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, Lexiscan: 7140\n",
      "  Patients Receiving Fractionated Stereotactic Radiotherapy: 7141\n",
      "  Patients Receiving Mismatched Allogeneic HCT: 7142\n",
      "  Patients Requiring Ambulatory Surgery Under General Anesthesia: 7143\n",
      "  Patients Requiring Diagnostic Gastroscopy With Sedation: 7144\n",
      "  Patients Requiring Home Parenteral Nutrition: 7145\n",
      "  Patients Undergoing Elective Coronary Artery Bypass Graft: 7146\n",
      "  Patients Undergoing Endoscopic Sinus Surgery: 7147\n",
      "  Patients Undergoing Gastrointestinal Endoscopy: 7148\n",
      "  Patients Undergoing High Risk PCI.: 7149\n",
      "  Patients Undergoing a THR: 7150\n",
      "  Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion): 7151\n",
      "  Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2: 7152\n",
      "  Patients Who Have Received Allo-HSCT: 7153\n",
      "  Patients Who Receive Colonoscopy: 7154\n",
      "  Patients With \"ASA 3\" Designation: 7155\n",
      "  Patients With Acute Pancreatitis: 7156\n",
      "  Patients With Acute Stroke: 7157\n",
      "  Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy: 7158\n",
      "  Patients With Cancer: 7159\n",
      "  Patients With Chemotherapy Induced Anemia (CIA): 7160\n",
      "  Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks): 7161\n",
      "  Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated: 7162\n",
      "  Patients With Fungic Infections: 7163\n",
      "  Patients With Gastric Peritoneal Carcinomatosis: 7164\n",
      "  Patients With History of Ischemic Heart Disease With LV Dysfunction Undergoing Noncardiac Surgery: 7165\n",
      "  Patients With Leptomeningeal Disease: 7166\n",
      "  Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening: 7167\n",
      "  Patients With Nasal Polyps: 7168\n",
      "  Patients With Newly Diagnosed Active NISU: 7169\n",
      "  Patients With Residual or Reccurent EGFRvIII+ Glioma: 7170\n",
      "  Patients for In Vitro Fertilization(IVF)Treatment: 7171\n",
      "  Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI: 7172\n",
      "  Peanut Allergy: 7173\n",
      "  Peanut Hypersensitivity: 7174\n",
      "  Pearson Syndrome: 7175\n",
      "  Pectus Excavatum: 7176\n",
      "  Pediatric Acute Myeloblastic Leukemia, Relapsed: 7177\n",
      "  Pediatric Acute Myelogenous Leukemia (AML): 7178\n",
      "  Pediatric Adenotonsillectomy: 7179\n",
      "  Pediatric Bipolar Disorder: 7180\n",
      "  Pediatric Brain Tumor: 7181\n",
      "  Pediatric Brain Tumors: 7182\n",
      "  Pediatric Burns: 7183\n",
      "  Pediatric Cancer: 7184\n",
      "  Pediatric Cancers: 7185\n",
      "  Pediatric Central Nervous System Tumor: 7186\n",
      "  Pediatric Cholestasis: 7187\n",
      "  Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload: 7188\n",
      "  Pediatric Crohn's Disease: 7189\n",
      "  Pediatric Gastroesophageal Reflux Disease: 7190\n",
      "  Pediatric Growth Hormone Deficiency: 7191\n",
      "  Pediatric Hypertension With or Without CKD: 7192\n",
      "  Pediatric Liver Transplantation: 7193\n",
      "  Pediatric Mild Traumatic Brain Injury: 7194\n",
      "  Pediatric Obesity: 7195\n",
      "  Pediatric Perioperative Blood Pressure Management: 7196\n",
      "  Pediatric Plaque Psoriasis: 7197\n",
      "  Pediatric Pulmonary Hypertension: 7198\n",
      "  Pediatric Rigid Bronchoscopy: 7199\n",
      "  Pediatric Solid Tumors: 7200\n",
      "  Pediatric Traumatic Brain Injury: 7201\n",
      "  Pediatrics: 7202\n",
      "  Pediculosis: 7203\n",
      "  Pediculosis Capitis: 7204\n",
      "  Pediculus Humanus Capitis: 7205\n",
      "  Pedophilia: 7206\n",
      "  Peer Review, Research: 7207\n",
      "  Pelizaeus-Merzbacher Disease: 7208\n",
      "  Pelvic Floor Disorders: 7209\n",
      "  Pelvic Floor Muscle Syndrome: 7210\n",
      "  Pelvic Girdle Pain: 7211\n",
      "  Pelvic Organ Prolapse: 7212\n",
      "  Pelvic Pain: 7213\n",
      "  Pelvic Pain Associated With Refractory Endometriosis: 7214\n",
      "  Pelvic Ring Fractures: 7215\n",
      "  Pelvis Pain Chronic: 7216\n",
      "  Pemphigus: 7217\n",
      "  Pemphigus Foliaceus: 7218\n",
      "  Pemphigus Vulgaris: 7219\n",
      "  Penetrating Keratoplasty: 7220\n",
      "  Penicillin Allergy: 7221\n",
      "  Penile Cancer: 7222\n",
      "  Penile Neoplasm: 7223\n",
      "  Penile Squamous Cell Carcinoma: 7224\n",
      "  Penile Squamous Cell Carcinoma (PSCC): 7225\n",
      "  Penile Squamous Cell Carcinoma Stage IV: 7226\n",
      "  Peptic Ulcer: 7227\n",
      "  Peptic Ulcer Disease: 7228\n",
      "  Peptic Ulcer Hemorrhage: 7229\n",
      "  Peptic Ulcer Perforation: 7230\n",
      "  Peptic Ulcer/Erosions: 7231\n",
      "  Peptic Ulcers: 7232\n",
      "  Perceived Social Isolation: 7233\n",
      "  Percutaneous Coronary Intervention: 7234\n",
      "  Percutaneous Electric Nerve Stimulation: 7235\n",
      "  Percutaneous Intervention Via Femoral Artery: 7236\n",
      "  Percutaneous Nephrolithotripsy: 7237\n",
      "  Percutaneous Transluminal Coronary Angioplasty: 7238\n",
      "  Perennial Allergic Rhinitis: 7239\n",
      "  Perennial Allergic Rhinoconjunctivitis: 7240\n",
      "  Perfusion; Complications: 7241\n",
      "  Peri-Implantitis: 7242\n",
      "  Peri-implantitis: 7243\n",
      "  Peri-oral Wrinkles: 7244\n",
      "  Perianal Crohn's Disease: 7245\n",
      "  Perianal Fistula: 7246\n",
      "  Perianal Warts: 7247\n",
      "  Periarthritis: 7248\n",
      "  Pericarditis: 7249\n",
      "  Perimenopausal Depression: 7250\n",
      "  Perimenopausal Disorder: 7251\n",
      "  Perimenopause: 7252\n",
      "  Perinatal Asphyxia: 7253\n",
      "  Perinatal Outcomes: 7254\n",
      "  Perineal Laceration Repair: 7255\n",
      "  Perineal Tear: 7256\n",
      "  Perineal Wound Infection: 7257\n",
      "  Periodic Fever: 7258\n",
      "  Periodic Fevers Syndrome: 7259\n",
      "  Periodontal Bone Loss: 7260\n",
      "  Periodontal Disease: 7261\n",
      "  Periodontal Diseases: 7262\n",
      "  Periodontal Health: 7263\n",
      "  Periodontal Pocket: 7264\n",
      "  Periodontitis: 7265\n",
      "  Periodontitis, Chronic: 7266\n",
      "  Perioperative Bleeding: 7267\n",
      "  Perioperative Hypothermia: 7268\n",
      "  Perioperative Pain: 7269\n",
      "  Perioral Dermatitis: 7270\n",
      "  Peripartum Cardiomyopathy: 7271\n",
      "  Peripheral Arterial Disease: 7272\n",
      "  Peripheral Arterial Disease (PAD): 7273\n",
      "  Peripheral Arterial Diseases: 7274\n",
      "  Peripheral Arterial Occlusive Disease: 7275\n",
      "  Peripheral Artery Disease: 7276\n",
      "  Peripheral Artery Disease (PAD): 7277\n",
      "  Peripheral Artery Disease With Intermittent Claudication: 7278\n",
      "  Peripheral Endovascular Interventions: 7279\n",
      "  Peripheral Lung Lesions: 7280\n",
      "  Peripheral Nerve Block Prolongation: 7281\n",
      "  Peripheral Nerve Discontinuities: 7282\n",
      "  Peripheral Nerve Injuries: 7283\n",
      "  Peripheral Nerve Injury: 7284\n",
      "  Peripheral Nerve Tumors: 7285\n",
      "  Peripheral Neuropathic Pain: 7286\n",
      "  Peripheral Neuropathy: 7287\n",
      "  Peripheral Neuropathy Due to Chemotherapy: 7288\n",
      "  Peripheral Neuropathy Grade 2 or Greater: 7289\n",
      "  Peripheral Neuropathy in Breast Cancer Patient: 7290\n",
      "  Peripheral Neuropathy, Chemotherapy-induced: 7291\n",
      "  Peripheral Nueropathy Pain: 7292\n",
      "  Peripheral Pulmonary Stenosis: 7293\n",
      "  Peripheral Spondylarthritis: 7294\n",
      "  Peripheral T Cell Lymphoma: 7295\n",
      "  Peripheral T-Cell Lymphoma: 7296\n",
      "  Peripheral T-Cell Non-Hodgkin's Lymphoma: 7297\n",
      "  Peripheral T-cell Lymphoma: 7298\n",
      "  Peripheral T-cell Lymphoma (PTCL): 7299\n",
      "  Peripheral T-cell Lymphomas: 7300\n",
      "  Peripheral Vascular Disease: 7301\n",
      "  Peripheral Vascular Diseases: 7302\n",
      "  Peripheral Vein Vasodilation: 7303\n",
      "  Peripheral Venous Catheter Complications: 7304\n",
      "  Peripheral Vertigo.: 7305\n",
      "  Peripheral Vestibular Disease: 7306\n",
      "  Peripherally Inserted Central Catheter: 7307\n",
      "  Peripherally Inserted Central Catheters: 7308\n",
      "  Peritoneal Cancer: 7309\n",
      "  Peritoneal Carcinomatosis: 7310\n",
      "  Peritoneal Dialysis: 7311\n",
      "  Peritoneal Dialysis Patients: 7312\n",
      "  Peritoneal Dialysis-associated Peritonitis: 7313\n",
      "  Peritoneal Malignancies: 7314\n",
      "  Peritoneal Mesothelioma: 7315\n",
      "  Peritoneal Neoplasms: 7316\n",
      "  Peritonitis: 7317\n",
      "  Peritumoral Brain Edema: 7318\n",
      "  Persistence of Varicella Immunity: 7319\n",
      "  Persistence to Enbrel: 7320\n",
      "  Persistent ARDS: 7321\n",
      "  Persistent Asthma: 7322\n",
      "  Persistent Atrial Fibrillation: 7323\n",
      "  Persistent Corneal Epithelial Defects: 7324\n",
      "  Persistent Cough in IPF: 7325\n",
      "  Persistent Diabetic Macular Edema: 7326\n",
      "  Persistent Epithelial Defect: 7327\n",
      "  Persistent Fetal Circulation Syndrome: 7328\n",
      "  Persistent Pain After Inguinal Herniotomy: 7329\n",
      "  Persistent Pregnancy of Unknown Location: 7330\n",
      "  Persistent Pulmonary Hypertension: 7331\n",
      "  Persistent Pulmonary Hypertension of the Newborn: 7332\n",
      "  Persistent or Chronic ITP: 7333\n",
      "  Persistent or Permanent Nonvalvular Atrial Fibrillation: 7334\n",
      "  Pertussis: 7335\n",
      "  Pervasive Development Disorders: 7336\n",
      "  Pervasive Developmental Disorder: 7337\n",
      "  Peutz-Jeghers Syndrome: 7338\n",
      "  Peyronie's Disease: 7339\n",
      "  Ph+ Acute Lymphoblastic Leukemia (Ph+ALL): 7340\n",
      "  Phaeochromocytoma: 7341\n",
      "  Phantom Limb: 7342\n",
      "  Phantom Limb Pain: 7343\n",
      "  Phantom Limb Pain (PLP): 7344\n",
      "  Phantom Pain: 7345\n",
      "  Pharmacodynamic Interaction: 7346\n",
      "  Pharmacodynamics: 7347\n",
      "  Pharmacogenetics of Metformin: 7348\n",
      "  Pharmacokinetic: 7349\n",
      "  Pharmacokinetic Assessments in Healthy Volunteers: 7350\n",
      "  Pharmacokinetic Study: 7351\n",
      "  Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin: 7352\n",
      "  Pharmacokinetics: 7353\n",
      "  Pharmacokinetics Study in de Novo Kidney Transplantation: 7354\n",
      "  Pharmacokinetics of ASP015K: 7355\n",
      "  Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects: 7356\n",
      "  Pharmacokinetics of ASP7657: 7357\n",
      "  Pharmacokinetics of ASP8477: 7358\n",
      "  Pharmacokinetics of ASP9853: 7359\n",
      "  Pharmacokinetics of Avycaz in ICU Patients: 7360\n",
      "  Pharmacokinetics of BAL4815: 7361\n",
      "  Pharmacokinetics of FG-4592: 7362\n",
      "  Pharmacokinetics of Isavuconazole: 7363\n",
      "  Pharmacokinetics of MDV3100: 7364\n",
      "  Pharmacokinetics of Mirabegron: 7365\n",
      "  Pharmacokinetics of Novel Curcumin Formulations: 7366\n",
      "  Pharmacokinetics of YM178: 7367\n",
      "  Pharmacokinetics, Bioavailability: 7368\n",
      "  Pharmacological Action: 7369\n",
      "  Pharmacology: 7370\n",
      "  Pharmacology, Clinical: 7371\n",
      "  Pharmaokinetics: 7372\n",
      "  Pharyngeal Gonococcal Infection: 7373\n",
      "  Pharyngitis: 7374\n",
      "  Pharyngotonsillitis: 7375\n",
      "  Phase 1: 7376\n",
      "  Phase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma: 7377\n",
      "  Phase 1 Sickle Cell: 7378\n",
      "  Phase 1: Pain Management: 7379\n",
      "  Phase I: To Determine the Maximum Tolerated Dose (MTD): 7380\n",
      "  Phenylalanine Hydroxylase Deficiencies: 7381\n",
      "  Phenylketonuria: 7382\n",
      "  Phenylketonuria (PKU): 7383\n",
      "  Phenylketonurias: 7384\n",
      "  Pheochromocytoma: 7385\n",
      "  Philadelphia Chromosome Negative: 7386\n",
      "  Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia: 7387\n",
      "  Philadelphia Chromosome Positive Chronic Myelogenous Leukemia: 7388\n",
      "  Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL: 7389\n",
      "  Philadelphia Positive (Ph+) Chronic Myeloid Leukemia: 7390\n",
      "  Philadelphia Positive Acute Lymphoblastic Leukemia: 7391\n",
      "  Philidelphia Positive Chronic Myeloid Leukaemia: 7392\n",
      "  Phimosis: 7393\n",
      "  Phobia, Social: 7394\n",
      "  Phobic Disorders: 7395\n",
      "  Phonotrauma: 7396\n",
      "  Photo-damage: 7397\n",
      "  Photobiology: 7398\n",
      "  Photodamaged Skin: 7399\n",
      "  Photorefractive Keratectomy: 7400\n",
      "  Photosensitive Epilepsy: 7401\n",
      "  Physical Activity: 7402\n",
      "  Physical Inactivity: 7403\n",
      "  Physician Education: 7404\n",
      "  Physician Well-being: 7405\n",
      "  Physiopathology: 7406\n",
      "  Picky Eating Behaviors: 7407\n",
      "  Pigment Epithelial Detachment: 7408\n",
      "  Pigmentation Disorders: 7409\n",
      "  Pigmented Villonodular Synovitis: 7410\n",
      "  Pilonidal Sinus: 7411\n",
      "  Pituitary Macroadenoma: 7412\n",
      "  Pituitary Tumor: 7413\n",
      "  Pituitary Tumours: 7414\n",
      "  Pityriasis Rubra Pilaris: 7415\n",
      "  Placenta Accreta: 7416\n",
      "  Placenta Previa Complete Centralis: 7417\n",
      "  Placental Insufficiency: 7418\n",
      "  Placental Transfusion: 7419\n",
      "  Plague: 7420\n",
      "  Plantar Fasciitis: 7421\n",
      "  Plantar Fasciosis, Achilles Tendinosis: 7422\n",
      "  Plantar Warts: 7423\n",
      "  Plaque Psoriasis: 7424\n",
      "  Plaque Psoriasis Vulgaris: 7425\n",
      "  Plaque-Type Psoriasis: 7426\n",
      "  Plaque-type Psoriasis: 7427\n",
      "  Plasma Cell Disorder: 7428\n",
      "  Plasma Cell Leukemia: 7429\n",
      "  Plasma Cell Leukemia in Remission: 7430\n",
      "  Plasma Cell Myeloma: 7431\n",
      "  Plasmacytoma: 7432\n",
      "  Plasmodium Falciparum: 7433\n",
      "  Plasmodium Falciparum Infection: 7434\n",
      "  Plasmodium Falciparum Malaria: 7435\n",
      "  Plasmodium Vivax: 7436\n",
      "  Plasmodium Vivax Infection: 7437\n",
      "  Plasmodium Vivax Malaria: 7438\n",
      "  Plastic Bronchitis: 7439\n",
      "  Platelet Aggregation: 7440\n",
      "  Platelet Dysfunction: 7441\n",
      "  Platelet Dysfunction Due to Drugs: 7442\n",
      "  Platelet Reactivity: 7443\n",
      "  Platelet Transfusion Refractoriness (PTR): 7444\n",
      "  Platelet-rich Plasma: 7445\n",
      "  Platinum Resistant Ovarian Cancer: 7446\n",
      "  Platinum Sensitive Ovarian Cancer: 7447\n",
      "  Platinum Sensitive Relapsed Ovarian Cancer: 7448\n",
      "  Platinum-Resistant Fallopian Tube Carcinoma: 7449\n",
      "  Platinum-resistant Ovarian Cancer: 7450\n",
      "  Pleomorphic Adenoma of the Parotid Gland: 7451\n",
      "  Pleural Diseases: 7452\n",
      "  Pleural Effusion: 7453\n",
      "  Pleural Effusion, Malignant: 7454\n",
      "  Pleural Empyema: 7455\n",
      "  Pleural Mesothelioma: 7456\n",
      "  Pleural Mesothelioma Malignant Advanced: 7457\n",
      "  Pleural Metastases: 7458\n",
      "  Plexiform Neurofibroma Associated With Neurofibromatosis Type 1: 7459\n",
      "  Plexiform Neurofibromas: 7460\n",
      "  Pneumococcal Disease: 7461\n",
      "  Pneumococcal Infection: 7462\n",
      "  Pneumococcal Infections: 7463\n",
      "  Pneumococcal Pneumonia: 7464\n",
      "  Pneumococcal Vaccines: 7465\n",
      "  Pneumocystis Carinii Pneumonia: 7466\n",
      "  Pneumonia: 7467\n",
      "  Pneumonia Ventilator Associated: 7468\n",
      "  Pneumonia With Hospitalized Elderly Patient: 7469\n",
      "  Pneumonia, Aspiration: 7470\n",
      "  Pneumonia, Bacterial: 7471\n",
      "  Pneumonia, Interstitial Plasma Cell: 7472\n",
      "  Pneumonia, Pneumococcal: 7473\n",
      "  Pneumonia, Ventilator-Associated: 7474\n",
      "  Pneumonia, Ventilator-associated: 7475\n",
      "  Pneumonia, Viral: 7476\n",
      "  Pneumothorax Iatrogenic Postprocedural: 7477\n",
      "  Poisoning by Inhaled Anaesthetic: 7478\n",
      "  Polio: 7479\n",
      "  Poliomyelitis: 7480\n",
      "  Polyarticular Course Juvenile Idiopathic Arthritis: 7481\n",
      "  Polyarticular-course Juvenile Idiopathic Arthritis (JIA): 7482\n",
      "  Polycystic Kidney Disease: 7483\n",
      "  Polycystic Kidney Diseases: 7484\n",
      "  Polycystic Kidney, Autosomal Dominant: 7485\n",
      "  Polycystic Liver Disease: 7486\n",
      "  Polycystic Ovarian Syndrome: 7487\n",
      "  Polycystic Ovarian Syndrome (PCOS): 7488\n",
      "  Polycystic Ovary Syndrome: 7489\n",
      "  Polycystic Ovary Syndrome (PCOS): 7490\n",
      "  Polycythemia Vera: 7491\n",
      "  Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase: 7492\n",
      "  Polycythemia; Familial: 7493\n",
      "  Polymorphic Light Eruption: 7494\n",
      "  Polymyalgia Rheumatica: 7495\n",
      "  Polymyositis: 7496\n",
      "  Polyneuropathies: 7497\n",
      "  Polyneuropathies and Other Disorders of the Peripheral Nervous System: 7498\n",
      "  Polyneuropathy: 7499\n",
      "  Polyp of Large Intestine: 7500\n",
      "  Polyp of Nasal Sinus: 7501\n",
      "  Polypharmacy: 7502\n",
      "  Polypoidal Choroidal Vasculopathy: 7503\n",
      "  Polypoidal Choroidal Vasculopathy Without Active Polyp: 7504\n",
      "  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: 7505\n",
      "  Polytrauma: 7506\n",
      "  Pompe Disease: 7507\n",
      "  Pompe Disease (Infantile-Onset): 7508\n",
      "  Pompe Disease (Late-onset): 7509\n",
      "  Pontine Glioma: 7510\n",
      "  Poor Graft Function: 7511\n",
      "  Poor Quality Sleep: 7512\n",
      "  Popliteal Nerve Block: 7513\n",
      "  Port Wine Stain: 7514\n",
      "  Port Wine Stains: 7515\n",
      "  Port-Wine Stain: 7516\n",
      "  Port-site Hernia: 7517\n",
      "  Portal Hypertension: 7518\n",
      "  Portal Hypertension Gastropathy: 7519\n",
      "  Portal Hypertension Related to Cirrhosis: 7520\n",
      "  Portal Vein Thrombosis: 7521\n",
      "  Portopulmonary Hypertension: 7522\n",
      "  Positive C-Diff Culture: 7523\n",
      "  Positive Doping Tests in Sports: 7524\n",
      "  Positive Helicobacter Pylori Serology: 7525\n",
      "  Positive Regulation of Oxidative Stress Process: 7526\n",
      "  Positron-Emission Tomography: 7527\n",
      "  Post Acute Coronary Syndrome: 7528\n",
      "  Post Caesarean Analgesia: 7529\n",
      "  Post Cerebral Hemorrhage: 7530\n",
      "  Post Concussion Symptoms: 7531\n",
      "  Post Concussion Syndrome: 7532\n",
      "  Post Gastrectomy State: 7533\n",
      "  Post Herpetic Neuralgia: 7534\n",
      "  Post Laparoscopic Shoulder Pain: 7535\n",
      "  Post Menopausal Osteoporosis: 7536\n",
      "  Post Menopausal, Hormone Receptor Positive Breast Cancer: 7537\n",
      "  Post Operative Analgesia: 7538\n",
      "  Post Operative Blood Loss: 7539\n",
      "  Post Operative Dental Pain: 7540\n",
      "  Post Operative Ileus: 7541\n",
      "  Post Operative Local Anaesthesia: 7542\n",
      "  Post Operative Pain: 7543\n",
      "  Post Operative Pain Control: 7544\n",
      "  Post Operative Pain as Estimated by the Sue of the VAS Score: 7545\n",
      "  Post Operative Surgical Site Infection: 7546\n",
      "  Post Operative Urinary Retention: 7547\n",
      "  Post Partum: 7548\n",
      "  Post Partum Haemorrhage: 7549\n",
      "  Post Partum Hemorrhage: 7550\n",
      "  Post Prandial Distress Syndrome: 7551\n",
      "  Post Surgical Ocular Inflammation and Pain: 7552\n",
      "  Post Surgical Pain: 7553\n",
      "  Post Traumatic Headache: 7554\n",
      "  Post Traumatic Stress Disorder: 7555\n",
      "  Post Traumatic Stress Disorder (PTSD): 7556\n",
      "  Post-Dural Puncture Headache: 7557\n",
      "  Post-ERCP Acute Pancreatitis: 7558\n",
      "  Post-ERCP Acute Pancreatitis.: 7559\n",
      "  Post-ERCP Pancreatitis: 7560\n",
      "  Post-Herpetic Neuralgia: 7561\n",
      "  Post-Lumbar Puncture Headache: 7562\n",
      "  Post-Menopausal Osteoporosis: 7563\n",
      "  Post-Operative Delirium: 7564\n",
      "  Post-Operative Ileus: 7565\n",
      "  Post-Operative Nausea and Vomiting: 7566\n",
      "  Post-Operative Pain: 7567\n",
      "  Post-Transplant Glucocorticoid Induced Diabetes: 7568\n",
      "  Post-Transplant Lymphoproliferative Disorder: 7569\n",
      "  Post-Traumatic Headache: 7570\n",
      "  Post-Traumatic Headaches: 7571\n",
      "  Post-Traumatic Respiratory Failure: 7572\n",
      "  Post-Traumatic Stress Disorder: 7573\n",
      "  Post-Traumatic Stress Disorders: 7574\n",
      "  Post-dural Puncture Headache: 7575\n",
      "  Post-herpetic Neuralgia: 7576\n",
      "  Post-ischemic Stroke: 7577\n",
      "  Post-laminectomy Pain Syndrome: 7578\n",
      "  Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer: 7579\n",
      "  Post-menopausal Period: 7580\n",
      "  Post-menopausal Vasomotor Symptoms: 7581\n",
      "  Post-operation Pain: 7582\n",
      "  Post-operational Pain: 7583\n",
      "  Post-operative Craniotomy Patients: 7584\n",
      "  Post-operative Delirium: 7585\n",
      "  Post-operative Dental Pain: 7586\n",
      "  Post-operative Ileus: 7587\n",
      "  Post-operative Nausea and Vomiting: 7588\n",
      "  Post-operative Pain: 7589\n",
      "  Post-operative Pneumonia: 7590\n",
      "  Post-partum Perineal Pain: 7591\n",
      "  Post-polio Syndrome: 7592\n",
      "  Post-solid Organ Transplant: 7593\n",
      "  Post-stroke Spasticity of the Lower Limb: 7594\n",
      "  Post-surgical Dental Pain: 7595\n",
      "  Post-surgical Inflammation: 7596\n",
      "  Post-surgical Pain: 7597\n",
      "  Post-thoracotomy Pain: 7598\n",
      "  Post-thrombotic Syndrome: 7599\n",
      "  Post-tonsillectomy Pain: 7600\n",
      "  Post-transplant Lymphoproliferative Disorder: 7601\n",
      "  Post-transplantation Lymphoproliferative Disorder: 7602\n",
      "  Post-traumatic Osteoarthritis of the Knee: 7603\n",
      "  Post-traumatic Stress Disorder: 7604\n",
      "  PostTraumatic Stress Disorder: 7605\n",
      "  Postdural Puncture Headache: 7606\n",
      "  Posterior Blepharoconjunctivitis: 7607\n",
      "  Posterior Cervical Decompression and Fusion: 7608\n",
      "  Posterior Fossa Tumor: 7609\n",
      "  Posterior Tibial Tendon Dysfunction: 7610\n",
      "  Posterior Uveitis: 7611\n",
      "  Posterolateral Thoracotomy: 7612\n",
      "  Posthepatitic Cirrhosis: 7613\n",
      "  Postherpetic Neuralgia: 7614\n",
      "  Postherpetic Neuralgia ( PHN ): 7615\n",
      "  Postinflammatory Hyperpigmentation: 7616\n",
      "  Postmenopausal: 7617\n",
      "  Postmenopausal Disorder: 7618\n",
      "  Postmenopausal Osteoporosis: 7619\n",
      "  Postmenopausal Symptoms: 7620\n",
      "  Postmenopausal Syndrome: 7621\n",
      "  Postmenopausal Women: 7622\n",
      "  Postmenopausal Women With Advanced Breast Cancer: 7623\n",
      "  Postmenopause: 7624\n",
      "  Postnasal Drainage: 7625\n",
      "  Postop Adult ICU Patients: 7626\n",
      "  Postoperative: 7627\n",
      "  Postoperative Acute Kidney Injury After Off-pump Coronary Artery Bypass Graft: 7628\n",
      "  Postoperative Adhesion: 7629\n",
      "  Postoperative Anaemia: 7630\n",
      "  Postoperative Analgesia: 7631\n",
      "  Postoperative Atrial Fibrillation: 7632\n",
      "  Postoperative Cardiac Complication: 7633\n",
      "  Postoperative Cognitive Dysfunction: 7634\n",
      "  Postoperative Complications: 7635\n",
      "  Postoperative Confusion: 7636\n",
      "  Postoperative Delirium: 7637\n",
      "  Postoperative Ecchymosis: 7638\n",
      "  Postoperative Hemorrhage: 7639\n",
      "  Postoperative Hyperalgesia: 7640\n",
      "  Postoperative Hypoxemia: 7641\n",
      "  Postoperative Ileus: 7642\n",
      "  Postoperative Infection: 7643\n",
      "  Postoperative Morbidity: 7644\n",
      "  Postoperative Nausea and Vomiting: 7645\n",
      "  Postoperative Pain: 7646\n",
      "  Postoperative Pain After Ambulatory Surgery: 7647\n",
      "  Postoperative Pain After Breast Reconstruction With Abdominal Flap: 7648\n",
      "  Postoperative Pain Management: 7649\n",
      "  Postoperative Pain Management After Total Hip Arthroplasty: 7650\n",
      "  Postoperative Pain in Infants: 7651\n",
      "  Postoperative Residual Curarization: 7652\n",
      "  Postoperative Sedation: 7653\n",
      "  Postoperative Supraventricular Tachyarrythmia: 7654\n",
      "  Postoperative Thromboembolism: 7655\n",
      "  Postoperative Urinary Retention: 7656\n",
      "  Postoperative Wound Infection-deep: 7657\n",
      "  Postoperative; Dysfunction Following Cardiac Surgery: 7658\n",
      "  Postpancreatectomy Hyperglycemia: 7659\n",
      "  Postpartum: 7660\n",
      "  Postpartum Anemia: 7661\n",
      "  Postpartum Depression: 7662\n",
      "  Postpartum Depressive Disorder: 7663\n",
      "  Postpartum Haemorrhage: 7664\n",
      "  Postpartum Hemorrhage: 7665\n",
      "  Postpartum Hemorrhage (Primary): 7666\n",
      "  Postpoliomyelitis Syndrome: 7667\n",
      "  Postprandial Fatigue: 7668\n",
      "  Postsurgical Pain: 7669\n",
      "  Postsurgical Pain Due to Third Molar Extraction: 7670\n",
      "  Postthoracotomy Pain: 7671\n",
      "  Posttraumatic Stress Disorder: 7672\n",
      "  Posttraumatic Stress Disorder (PTSD): 7673\n",
      "  Posttraumatic Stress Disorders: 7674\n",
      "  Postural Orthostatic Tachycardia Syndrome: 7675\n",
      "  Postural Orthostatic Tachycardia Syndrome (POTS): 7676\n",
      "  Postural Tachycardia Syndrome: 7677\n",
      "  Postural Tachycardia Syndrome (POTS): 7678\n",
      "  Pouchitis: 7679\n",
      "  Poverty: 7680\n",
      "  Power Wheelchair: 7681\n",
      "  Prader Willi Syndrome: 7682\n",
      "  Prader-Willi Syndrome: 7683\n",
      "  Prader-willi Syndrome: 7684\n",
      "  Pre-Diabetes: 7685\n",
      "  Pre-Eclampsia: 7686\n",
      "  Pre-Frail or Frail State: 7687\n",
      "  Pre-diabetes: 7688\n",
      "  Pre-eclampsia: 7689\n",
      "  Pre-hypertension: 7690\n",
      "  Pre-operative Pediatric Anxiety: 7691\n",
      "  PreDiabetes: 7692\n",
      "  PreTerm Birth: 7693\n",
      "  Preanesthetic Medication: 7694\n",
      "  Prebiotics: 7695\n",
      "  Precancerous Condition: 7696\n",
      "  Precancerous/Nonmalignant Condition: 7697\n",
      "  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: 7698\n",
      "  Precursor Cell Lymphoblastic Leukemia-Lymphoma: 7699\n",
      "  Prediabetes: 7700\n",
      "  Prediabetic State: 7701\n",
      "  Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain: 7702\n",
      "  Predicted Tauopathies, Including: 7703\n",
      "  Preeclampsia: 7704\n",
      "  Preeclampsia Severe: 7705\n",
      "  Preeclampsia With Severe Features: 7706\n",
      "  Pregabalin on Catheter Related Bladder Discomfort: 7707\n",
      "  Pregnancy: 7708\n",
      "  Pregnancy Complicated by Low Implantation: 7709\n",
      "  Pregnancy Complicated by Malaria as Antepartum Condition: 7710\n",
      "  Pregnancy Complications: 7711\n",
      "  Pregnancy Prevention: 7712\n",
      "  Pregnancy Related: 7713\n",
      "  Pregnancy Toxemia: 7714\n",
      "  Pregnancy, Unwanted: 7715\n",
      "  Pregnant Women Who Test Positive for Bacterial Vaginosis: 7716\n",
      "  Prehypertension: 7717\n",
      "  Preimplantation Gentic Screening (PGS): 7718\n",
      "  Preleukemia: 7719\n",
      "  Premature Birth: 7720\n",
      "  Premature Birth of Newborn: 7721\n",
      "  Premature Ejaculation: 7722\n",
      "  Premature Infant: 7723\n",
      "  Premature Infants: 7724\n",
      "  Premature Ovarian Failure: 7725\n",
      "  Prematurity: 7726\n",
      "  Prematurity, Respiratory Distress Syndrome,Hypoxemia: 7727\n",
      "  Prematurity; Extreme: 7728\n",
      "  Premedication: 7729\n",
      "  Premenopausal Breast Cancer: 7730\n",
      "  Premenstrual Syndrome: 7731\n",
      "  Preneoplastic Conditions: 7732\n",
      "  Presbyopia: 7733\n",
      "  Prescription Opioid Dependence: 7734\n",
      "  Pressure Ulcer: 7735\n",
      "  Pressure Ulcers: 7736\n",
      "  Preterm Birth: 7737\n",
      "  Preterm Delivery: 7738\n",
      "  Preterm Delivery.: 7739\n",
      "  Preterm Infants: 7740\n",
      "  Preterm Labor: 7741\n",
      "  Preterm Labor With Intact Membranes: 7742\n",
      "  Preterm Neonates: 7743\n",
      "  Preterm Preeclampsia: 7744\n",
      "  Preterm Premature Rupture of Membranes (PPROM): 7745\n",
      "  Preterm Premature Ruptured Membranes: 7746\n",
      "  Prevention: 7747\n",
      "  Prevention of Acute Rejection After Kidney Transplantation: 7748\n",
      "  Prevention of Anemia: 7749\n",
      "  Prevention of Drug Abuse and Dependency: 7750\n",
      "  Prevention of Ebola Infection: 7751\n",
      "  Prevention of Growth Restriction: 7752\n",
      "  Prevention of Meningococcal Infection: 7753\n",
      "  Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC: 7754\n",
      "  Prevention of Postoperative Ileus: 7755\n",
      "  Prevention of Surgical Site Infections: 7756\n",
      "  Preventive Medicine: 7757\n",
      "  Previous Incision: 7758\n",
      "  Previous Vka Treatment: 7759\n",
      "  Previously Treated Advanced Colorectal Cancer: 7760\n",
      "  Previously Treated Myelodysplastic Syndromes: 7761\n",
      "  Previously Treated Non Small Cell Lung Cancer: 7762\n",
      "  Previously Treated PH + CML: 7763\n",
      "  Previously Untreated Pancreatic Ductal Adenocarcinoma: 7764\n",
      "  Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer: 7765\n",
      "  Priapism: 7766\n",
      "  Primacy Immune Thrombocytopenia: 7767\n",
      "  Primary Achalasia: 7768\n",
      "  Primary Advanced Carcinoma of the Oral Cavity or Oropharynx: 7769\n",
      "  Primary Amyloidosis of Light Chain Type: 7770\n",
      "  Primary Arteriovenous Fistula Failure: 7771\n",
      "  Primary Biliary Cholangitis: 7772\n",
      "  Primary Biliary Cholangitis (PBC): 7773\n",
      "  Primary Biliary Cirrhosis: 7774\n",
      "  Primary Biliary Cirrhosis (PBC): 7775\n",
      "  Primary Breast Cancer: 7776\n",
      "  Primary Central Nervous System Lymphoma: 7777\n",
      "  Primary Central Nervous System Non-Hodgkin Lymphoma: 7778\n",
      "  Primary Ciliary Dyskinesia: 7779\n",
      "  Primary Disease: 7780\n",
      "  Primary Dyslipidemia: 7781\n",
      "  Primary Dysmenorrhea: 7782\n",
      "  Primary Fibromyalgia: 7783\n",
      "  Primary Focal Hyperhidrosis of the Hands: 7784\n",
      "  Primary Focal Segmental Glomerulosclerosis: 7785\n",
      "  Primary Four Repeat Tauopathies (4RT): 7786\n",
      "  Primary Generalized (Osteo)Arthritis: 7787\n",
      "  Primary Glioblastoma Multiforme: 7788\n",
      "  Primary Graft Dysfunction: 7789\n",
      "  Primary Heart Transplant: 7790\n",
      "  Primary Hepatocellular Carcinoma: 7791\n",
      "  Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women: 7792\n",
      "  Primary Hypercholesterolaemia: 7793\n",
      "  Primary Hypercholesterolemia: 7794\n",
      "  Primary Hyperlipidemia and Mixed Dyslipidemia: 7795\n",
      "  Primary Hyperlipidemia or Mixed Dyslipidemia: 7796\n",
      "  Primary Hyperoxaluria: 7797\n",
      "  Primary Hyperoxaluria Type 1: 7798\n",
      "  Primary Hyperoxaluria Type I: 7799\n",
      "  Primary Hyperparathyroidism: 7800\n",
      "  Primary Hypertension: 7801\n",
      "  Primary Hypophosphatemic Rickets: 7802\n",
      "  Primary IgA Nephropathy: 7803\n",
      "  Primary Immune Deficiency: 7804\n",
      "  Primary Immune Deficiency Disorder: 7805\n",
      "  Primary Immune Deficiency Disorders: 7806\n",
      "  Primary Immunodeficiency: 7807\n",
      "  Primary Immunodeficiency (PID): 7808\n",
      "  Primary Immunodeficiency Diseases: 7809\n",
      "  Primary Immunodeficiency Diseases (PID): 7810\n",
      "  Primary Insomnia: 7811\n",
      "  Primary Liver Cancer: 7812\n",
      "  Primary Lymphedema: 7813\n",
      "  Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts): 7814\n",
      "  Primary Mediastinal Large B Cell Lymphoma: 7815\n",
      "  Primary Mitochondrial Disease: 7816\n",
      "  Primary Mitochondrial Myopathy: 7817\n",
      "  Primary Myelofibrosis: 7818\n",
      "  Primary Myelofibrosis (PMF): 7819\n",
      "  Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis: 7820\n",
      "  Primary Nocturnal Enuresis: 7821\n",
      "  Primary Open Angle Glaucoma: 7822\n",
      "  Primary Open Angle Glaucoma (POAG): 7823\n",
      "  Primary Open-Angle Glaucoma: 7824\n",
      "  Primary Open-angle Glaucoma: 7825\n",
      "  Primary Open-angle Glaucoma (POAG): 7826\n",
      "  Primary Open-angle Glaucoma and Ocular Hypertension: 7827\n",
      "  Primary Ovarian Cancer: 7828\n",
      "  Primary Ovarian Insufficiency: 7829\n",
      "  Primary Percutaneous Coronary Intervention: 7830\n",
      "  Primary Peritoneal Cancer: 7831\n",
      "  Primary Peritoneal Carcinoma: 7832\n",
      "  Primary Peritoneal Cavity Cancer: 7833\n",
      "  Primary Progressive Aphasia With Suspected Alzheimer's Disease: 7834\n",
      "  Primary Progressive Multiple Sclerosis: 7835\n",
      "  Primary Refractory Neuroblastoma: 7836\n",
      "  Primary Renal Allograft Candidate: 7837\n",
      "  Primary Sclerosing Cholangitis: 7838\n",
      "  Primary Sclerosing Cholangitis (PSC): 7839\n",
      "  Primary Sjogren's Syndrome: 7840\n",
      "  Primary Sjögren's Syndrome: 7841\n",
      "  Primary Systemic (AL) Amyloidosis: 7842\n",
      "  Primary Systemic Amyloidosis: 7843\n",
      "  Primary Tauopathies: 7844\n",
      "  Primary Total Knee Arthroplasty: 7845\n",
      "  Primary Tumor: 7846\n",
      "  Primary or Secondary Hypogonadism: 7847\n",
      "  Primitive Neuroectodermal Tumor: 7848\n",
      "  Pro-inflammatory Activity: 7849\n",
      "  Problematic AOD Use: 7850\n",
      "  Procedural Anxiety: 7851\n",
      "  Procedural Sedation: 7852\n",
      "  Proctitis: 7853\n",
      "  Proctitis, Ulcerative: 7854\n",
      "  Prodromal Schizophrenia: 7855\n",
      "  Progeria: 7856\n",
      "  Progression Free Survival of the Treatment: 7857\n",
      "  Progression-free Survival: 7858\n",
      "  Progressive Familial Intrahepatic Cholestasis (PFIC): 7859\n",
      "  Progressive Keratoconus: 7860\n",
      "  Progressive Multifocal Leukoencephalopathy: 7861\n",
      "  Progressive Multiple Sclerosis: 7862\n",
      "  Progressive Solid Malignancies: 7863\n",
      "  Progressive Supranuclear Palsy: 7864\n",
      "  Progressive Supranuclear Palsy (PSP): 7865\n",
      "  Proliferative Diabetic Retinopathy: 7866\n",
      "  Proliferative Diabetic Retinopathy (PDR): 7867\n",
      "  Proliferative Thyroid Disease: 7868\n",
      "  Proliferative Vitreoretinopathy: 7869\n",
      "  Prolonged Labor: 7870\n",
      "  Prolonged Post-traumatic Stress Disorder: 7871\n",
      "  Prolonged Pregnancy: 7872\n",
      "  Prolonged QTc Interval: 7873\n",
      "  Prolymphocytic Leukemia: 7874\n",
      "  Prophylaxis Pneumococcal Vaccine: 7875\n",
      "  Prophylaxis for the Measles Infection: 7876\n",
      "  Prophylaxis of Venous Thromboembolic Events: 7877\n",
      "  Prophylaxis of Venous Thromboembolism: 7878\n",
      "  Prophylaxis: Influenza: 7879\n",
      "  Propionic Acidemia: 7880\n",
      "  Propofol: 7881\n",
      "  Prostate: 7882\n",
      "  Prostate Adenocarcinoma: 7883\n",
      "  Prostate Adenocarcinoma Without Neuroendocrine Differentiation: 7884\n",
      "  Prostate Cancer: 7885\n",
      "  Prostate Cancer Adenocarcinoma: 7886\n",
      "  Prostate Cancer Metastatic: 7887\n",
      "  Prostate Cancer Metastatic Castration Resistant: 7888\n",
      "  Prostate Cancer Non-Metastatic: 7889\n",
      "  Prostate Cancer Patients: 7890\n",
      "  Prostate Cancer Patients Undergoing Radical Prostatectomy: 7891\n",
      "  Prostate Cancer Recurrent: 7892\n",
      "  Prostate Cancer With Intermediate Risk: 7893\n",
      "  Prostate Cancer.: 7894\n",
      "  Prostate Cancers: 7895\n",
      "  Prostate Carcinoma: 7896\n",
      "  Prostate Carcinoma Metastatic to the Bone: 7897\n",
      "  Prostate Disease: 7898\n",
      "  Prostate Infections: 7899\n",
      "  Prostate Neoplasm: 7900\n",
      "  Prostate Neoplasms: 7901\n",
      "  Prostatectomy: 7902\n",
      "  Prostatic Cancer, Castration-Resistant: 7903\n",
      "  Prostatic Diseases: 7904\n",
      "  Prostatic Hyperplasia: 7905\n",
      "  Prostatic Neoplasm: 7906\n",
      "  Prostatic Neoplasms: 7907\n",
      "  Prostatic Neoplasms, Castration-Resistant: 7908\n",
      "  Prostatitis: 7909\n",
      "  Prostheses and Implants: 7910\n",
      "  Prosthesis Loosening: 7911\n",
      "  Prosthetic Fixation After Cementless Total Hip Arthroplasty: 7912\n",
      "  Prosthetic Joint Infection: 7913\n",
      "  Prosthetic Joint Infections: 7914\n",
      "  Prosthetic Joint Infections of Hip: 7915\n",
      "  Protective Lung Ventilation Using:: 7916\n",
      "  Protein Losing Enteropathy: 7917\n",
      "  Protein-Energy Malnutrition: 7918\n",
      "  Proteinuria: 7919\n",
      "  Proteinuric Kidney Disease: 7920\n",
      "  Prothrombin Complex Factor Deficiency: 7921\n",
      "  Proximal Humerus Fractures (to be Managed Non-operatively): 7922\n",
      "  Proximal Tibia Fracture: 7923\n",
      "  Pruritis: 7924\n",
      "  Pruritus: 7925\n",
      "  Pruritus, Atopic Dermatitis: 7926\n",
      "  Pseudoachondroplasia: 7927\n",
      "  Pseudoarthrosis: 7928\n",
      "  Pseudobulbar Affect (Involuntary Laughing and/or Crying): 7929\n",
      "  Pseudofolliculitis Barbae: 7930\n",
      "  Pseudohypoparathyroidism Type 1a: 7931\n",
      "  Pseudomembranous Colitis: 7932\n",
      "  Pseudomonas Aeruginosa Infection: 7933\n",
      "  Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization: 7934\n",
      "  Pseudoxanthoma Elasticum: 7935\n",
      "  Psoriasis: 7936\n",
      "  Psoriasis Vulgaris: 7937\n",
      "  Psoriasis of Scalp: 7938\n",
      "  Psoriasis, Moderate to Severe: 7939\n",
      "  Psoriasis, Plaque-type Psoriasis: 7940\n",
      "  Psoriasis, Skin or Nails: 7941\n",
      "  Psoriatic Arthritis: 7942\n",
      "  Psoriatic Nails: 7943\n",
      "  Psychiatric Diseases: 7944\n",
      "  Psychiatric Illness: 7945\n",
      "  Psychologic Manipulation: 7946\n",
      "  Psychological Distress: 7947\n",
      "  Psychological Stress: 7948\n",
      "  Psychomotor Agitation: 7949\n",
      "  Psychosis: 7950\n",
      "  Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type: 7951\n",
      "  Psychosis, Schizophrenia: 7952\n",
      "  Psychosocial: 7953\n",
      "  Psychosocial Stress: 7954\n",
      "  Psychotic Depression: 7955\n",
      "  Psychotic Disorder: 7956\n",
      "  Psychotic Disorders: 7957\n",
      "  Pterygia: 7958\n",
      "  Pterygium: 7959\n",
      "  Pterygium of Conjunctiva and Cornea: 7960\n",
      "  Ptosis, Eyelid: 7961\n",
      "  Puberty, Precocious: 7962\n",
      "  Pulmonary Alveolar Proteinosis, Autoimmune: 7963\n",
      "  Pulmonary Arterial Hypertension: 7964\n",
      "  Pulmonary Arterial Hypertension (PAH): 7965\n",
      "  Pulmonary Arterial Hypertension, Children: 7966\n",
      "  Pulmonary Arterial Hypertention: 7967\n",
      "  Pulmonary Artery Hypertension: 7968\n",
      "  Pulmonary Aspergillosis - Invasive: 7969\n",
      "  Pulmonary Aspiration of Gastric Contents: 7970\n",
      "  Pulmonary Cancer: 7971\n",
      "  Pulmonary Coin Lesion: 7972\n",
      "  Pulmonary Complications: 7973\n",
      "  Pulmonary Disease: 7974\n",
      "  Pulmonary Disease, Chronic Obstructive: 7975\n",
      "  Pulmonary Diseases: 7976\n",
      "  Pulmonary Edema: 7977\n",
      "  Pulmonary Embolism: 7978\n",
      "  Pulmonary Embolism and Thrombosis: 7979\n",
      "  Pulmonary Emphysema: 7980\n",
      "  Pulmonary Fibrosis: 7981\n",
      "  Pulmonary Fibrosis Secondary to Systemic Sclerosis: 7982\n",
      "  Pulmonary Function; Newborn, Abnormal: 7983\n",
      "  Pulmonary Hypertension: 7984\n",
      "  Pulmonary Hypertension Associated With Connective Tissue Disease: 7985\n",
      "  Pulmonary Hypertension Associated With HFpEF: 7986\n",
      "  Pulmonary Hypertension Associated With Sickle Cell Disease: 7987\n",
      "  Pulmonary Hypertensive Crisis: 7988\n",
      "  Pulmonary Insufficiency: 7989\n",
      "  Pulmonary Lymphangioleiomyomatosis: 7990\n",
      "  Pulmonary Metastatic Osteosarcoma (pOS): 7991\n",
      "  Pulmonary Non-tuberculous Mycobacterial Lung Disease: 7992\n",
      "  Pulmonary Sarcoidosis: 7993\n",
      "  Pulmonary Surgical Procedures: 7994\n",
      "  Pulmonary Tuberculoses: 7995\n",
      "  Pulmonary Tuberculosis: 7996\n",
      "  Pulmonary Tuberculosis (TB): 7997\n",
      "  Pulmonary Valve Insufficiency: 7998\n",
      "  Pulmonary Vascular Disease: 7999\n",
      "  Pulmonary Ventilation: 8000\n",
      "  Pulpotomy: 8001\n",
      "  Pure Red Cell Aplasia: 8002\n",
      "  Purpura: 8003\n",
      "  Purpura, Thrombocytopaenic, Idiopathic: 8004\n",
      "  Purpura, Thrombocytopenic, Idiopathic: 8005\n",
      "  Purpura, Thrombotic Thrombocytopenic: 8006\n",
      "  Pustular Psoriasis: 8007\n",
      "  Pustulosis of Palms and Soles: 8008\n",
      "  Pyelonephritis: 8009\n",
      "  Pyelonephritis Acute: 8010\n",
      "  Pyoderma: 8011\n",
      "  Pyoderma Gangrenosum: 8012\n",
      "  Pyrexia: 8013\n",
      "  Pyromania: 8014\n",
      "  Pyruvate Kinase Deficiency: 8015\n",
      "  Q Fever: 8016\n",
      "  Quad Atrophy: 8017\n",
      "  Quality of Life: 8018\n",
      "  Quality of Recovery: 8019\n",
      "  RAS Peptide Profile in Healthy Volunteers: 8020\n",
      "  RECTAL CANCER: 8021\n",
      "  RECTAL NEOPLASMS: 8022\n",
      "  RECURRENT GLIOBLASTOMA: 8023\n",
      "  REM Sleep Behavior Disorder: 8024\n",
      "  RHEUMATOID ARTHRITIS: 8025\n",
      "  RLS: 8026\n",
      "  RNA Virus Infections: 8027\n",
      "  RSD (Reflex Sympathetic Dystrophy): 8028\n",
      "  RSV Bronchiolitis: 8029\n",
      "  RSV Infection: 8030\n",
      "  Rabies: 8031\n",
      "  Rabies Infection: 8032\n",
      "  Rabies Vaccine Allergy: 8033\n",
      "  Rabies Virus: 8034\n",
      "  Radial Artery Injury at Wrist and Hand Level: 8035\n",
      "  Radiation Dermatitis: 8036\n",
      "  Radiation Exposure: 8037\n",
      "  Radiation Injuries: 8038\n",
      "  Radiation Proctitis: 8039\n",
      "  Radiation Protection: 8040\n",
      "  Radiation Retinopathy: 8041\n",
      "  Radiation-induced Oesophagitis: 8042\n",
      "  Radiation-induced Xerostomia: 8043\n",
      "  Radicular Pain: 8044\n",
      "  Radiodermatitis: 8045\n",
      "  Radionecrosis: 8046\n",
      "  Radiotherapy: 8047\n",
      "  Radiotherapy Induced Mucositis: 8048\n",
      "  Radius Fracture: 8049\n",
      "  Radius Fractures: 8050\n",
      "  Rapid Sequence Induction Intubation: 8051\n",
      "  Rapid Sequence Intubation: 8052\n",
      "  Rash: 8053\n",
      "  Rash Due to Epidermal Growth Factor Receptor Inhibitors: 8054\n",
      "  Raynaud Phenomenon: 8055\n",
      "  Raynaud Phenomenon Secondary to Systemic Sclerosis: 8056\n",
      "  Raynaud's Disease: 8057\n",
      "  Raynaud's Phenomenon: 8058\n",
      "  Raynaud's Phenomenon Secondary to Connective Tissue Disease: 8059\n",
      "  Reading Comprehension: 8060\n",
      "  Rebel Neuropathic Pains: 8061\n",
      "  Recalcitrant Cutaneous Warts: 8062\n",
      "  Recalcitrant Wet Age-related Macular Degeneration: 8063\n",
      "  Recessive Dystrophic Epidermolysis Bullosa: 8064\n",
      "  Recovery Following Cholecystectomy: 8065\n",
      "  Recovery Following Partial Medial Meniscectomy: 8066\n",
      "  Recovery Management Checkup (RMC): 8067\n",
      "  Recreational CNS Depressant Use: 8068\n",
      "  Rectal Adenocarcinoma: 8069\n",
      "  Rectal Cancer: 8070\n",
      "  Rectal Cancer Dukes B, Dukes C: 8071\n",
      "  Rectal Cancer, Adenocarcinoma: 8072\n",
      "  Rectal Fistula: 8073\n",
      "  Rectal Hyposensitivity: 8074\n",
      "  Rectal Mucinous Adenocarcinoma: 8075\n",
      "  Rectal Neoplasm Carcinoma in Situ Adenocarcinoma: 8076\n",
      "  Rectal Neoplasms: 8077\n",
      "  Rectal Neoplasms Malignant: 8078\n",
      "  Rectal Tumors: 8079\n",
      "  Rectal Tumour: 8080\n",
      "  Recurrent Acute Myeloid Leukemia: 8081\n",
      "  Recurrent Adenoid Cystic Carcinoma of the Salivary Glands: 8082\n",
      "  Recurrent Adrenocortical Carcinoma: 8083\n",
      "  Recurrent Adult Acute Lymphoblastic Leukemia: 8084\n",
      "  Recurrent Adult Acute Myeloid Leukemia: 8085\n",
      "  Recurrent Adult Burkitt Lymphoma: 8086\n",
      "  Recurrent Adult Diffuse Large Cell Lymphoma: 8087\n",
      "  Recurrent Adult Soft Tissue Sarcoma: 8088\n",
      "  Recurrent Anaplastic Large Cell Lymphoma: 8089\n",
      "  Recurrent Aphthous Stomatitis: 8090\n",
      "  Recurrent B Acute Lymphoblastic Leukemia: 8091\n",
      "  Recurrent B-Cell Non-Hodgkin Lymphoma: 8092\n",
      "  Recurrent Bacterial Vaginosis: 8093\n",
      "  Recurrent Bladder Cancer: 8094\n",
      "  Recurrent Bladder Carcinoma: 8095\n",
      "  Recurrent Bladder Urothelial Carcinoma: 8096\n",
      "  Recurrent Brain Tumors: 8097\n",
      "  Recurrent Breast Cancer: 8098\n",
      "  Recurrent C. Difficile Infection: 8099\n",
      "  Recurrent Central Nervous System Lymphoma: 8100\n",
      "  Recurrent Central Nervous System Neoplasm: 8101\n",
      "  Recurrent Cervical Cancer: 8102\n",
      "  Recurrent Childhood Anaplastic Astrocytoma: 8103\n",
      "  Recurrent Childhood Medulloblastoma: 8104\n",
      "  Recurrent Chronic Lymphocytic Leukemia: 8105\n",
      "  Recurrent Clostridium Difficile Infection: 8106\n",
      "  Recurrent Colon Cancer: 8107\n",
      "  Recurrent Colon Carcinoma: 8108\n",
      "  Recurrent Colorectal Carcinoma: 8109\n",
      "  Recurrent Condyloma: 8110\n",
      "  Recurrent Crying Spells: 8111\n",
      "  Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma: 8112\n",
      "  Recurrent Diffuse Large B-Cell Lymphoma: 8113\n",
      "  Recurrent Disease: 8114\n",
      "  Recurrent Endometrial Carcinoma: 8115\n",
      "  Recurrent Epithelial Cancer of Ovary: 8116\n",
      "  Recurrent Epithelial Ovarian Cancer: 8117\n",
      "  Recurrent Fallopian Tube Cancer: 8118\n",
      "  Recurrent Fallopian Tube Carcinoma: 8119\n",
      "  Recurrent Follicular Lymphoma: 8120\n",
      "  Recurrent Genital Herpes: 8121\n",
      "  Recurrent Genital Herpes (RGH): 8122\n",
      "  Recurrent Glioblastoma: 8123\n",
      "  Recurrent Glioblastoma Multiforme: 8124\n",
      "  Recurrent Glioblastoma Multiforme (GBM): 8125\n",
      "  Recurrent Glioblastoma or Other Glioma Subtypes: 8126\n",
      "  Recurrent Glioma: 8127\n",
      "  Recurrent Grade 1 Follicular Lymphoma: 8128\n",
      "  Recurrent Gynecological Cancer: 8129\n",
      "  Recurrent Head and Neck Cancer: 8130\n",
      "  Recurrent Head and Neck Carcinoma: 8131\n",
      "  Recurrent Head and Neck Squamous Cell Carcinoma: 8132\n",
      "  Recurrent Hepatitis C: 8133\n",
      "  Recurrent Hepatocellular Carcinoma: 8134\n",
      "  Recurrent Herpes Simplex Labialis: 8135\n",
      "  Recurrent Hodgkin Lymphoma: 8136\n",
      "  Recurrent Hypopharyngeal Squamous Cell Carcinoma: 8137\n",
      "  Recurrent IDHwt Gliomas With FGFR3-TACC3 Fusion: 8138\n",
      "  Recurrent Implantation Failure: 8139\n",
      "  Recurrent Large Cell Lung Carcinoma: 8140\n",
      "  Recurrent Laryngeal Squamous Cell Carcinoma: 8141\n",
      "  Recurrent Lung Non-Small Cell Carcinoma: 8142\n",
      "  Recurrent Major Depressive Disorder With Atypical Features: 8143\n",
      "  Recurrent Malignant Glioma: 8144\n",
      "  Recurrent Malignant Gliomas: 8145\n",
      "  Recurrent Malignant Mesothelioma: 8146\n",
      "  Recurrent Melanoma: 8147\n",
      "  Recurrent Meningiomas: 8148\n",
      "  Recurrent Merkel Cell Carcinoma: 8149\n",
      "  Recurrent Metastatic Squamous Neck Cancer With Occult Primary: 8150\n",
      "  Recurrent Miscarriage: 8151\n",
      "  Recurrent Nasopharyngeal Carcinoma: 8152\n",
      "  Recurrent Nasopharynx Carcinoma: 8153\n",
      "  Recurrent Neuroblastoma: 8154\n",
      "  Recurrent Neuroendocrine Tumor: 8155\n",
      "  Recurrent Non Small Cell Lung Cancer: 8156\n",
      "  Recurrent Non-Small Cell Lung Cancer: 8157\n",
      "  Recurrent Non-Small Cell Lung Carcinoma: 8158\n",
      "  Recurrent Non-small Cell Lung Cancer: 8159\n",
      "  Recurrent Ovarian Cancer: 8160\n",
      "  Recurrent Ovarian Carcinoma: 8161\n",
      "  Recurrent Ovarian Epithelial Cancer: 8162\n",
      "  Recurrent Pancreatic Carcinoma: 8163\n",
      "  Recurrent Pediatric ALL: 8164\n",
      "  Recurrent Pericarditis: 8165\n",
      "  Recurrent Plasma Cell Myeloma: 8166\n",
      "  Recurrent Platinum-resistant Ovarian Cancer: 8167\n",
      "  Recurrent Pleural Malignant Mesothelioma: 8168\n",
      "  Recurrent Pregnancy Loss: 8169\n",
      "  Recurrent Prostate Cancer: 8170\n",
      "  Recurrent Prostate Carcinoma: 8171\n",
      "  Recurrent Renal Cell Cancer: 8172\n",
      "  Recurrent Respiratory Papillomatosis: 8173\n",
      "  Recurrent Salivary Gland Cancer: 8174\n",
      "  Recurrent Skin Cancer: 8175\n",
      "  Recurrent Skin Carcinoma: 8176\n",
      "  Recurrent Small Cell Lung Cancer: 8177\n",
      "  Recurrent Small Cell Lung Carcinoma: 8178\n",
      "  Recurrent Small Lymphocytic Lymphoma: 8179\n",
      "  Recurrent Solid Tumor: 8180\n",
      "  Recurrent Squamous Cell Carcinoma of the Head or Neck: 8181\n",
      "  Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity: 8182\n",
      "  Recurrent Squamous Cell Carcinoma of the Nasopharynx: 8183\n",
      "  Recurrent Squamous Cell Lung Carcinoma: 8184\n",
      "  Recurrent Thyroid Cancer: 8185\n",
      "  Recurrent Tonsillitis: 8186\n",
      "  Recurrent Tuberculosis: 8187\n",
      "  Recurrent Upper-Respiratory Tract Infections: 8188\n",
      "  Recurrent Urinary Tract Infection: 8189\n",
      "  Recurrent Urinary Tract Infections in Women: 8190\n",
      "  Recurrent Uterine Corpus Sarcoma: 8191\n",
      "  Recurrent Uterine Sarcoma: 8192\n",
      "  Recurrent Vestibulopathy: 8193\n",
      "  Recurrent and Metastatic Endometrial Cancer: 8194\n",
      "  Recurrent and Metastatic Nasopharyngeal Carcinoma: 8195\n",
      "  Recurrent or Metastatic Colorectal Cancer: 8196\n",
      "  Recurrent or Metastatic NPC: 8197\n",
      "  Recurrent or Progressive Malignant Glioma: 8198\n",
      "  Recurrent or Refractory Pediatric Ependymoma: 8199\n",
      "  Recurrent/ Metastatic Endometrial Carcinoma: 8200\n",
      "  Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck: 8201\n",
      "  Recurrent/Refractory Glioblastoma: 8202\n",
      "  Red Blood Cell Transfusion: 8203\n",
      "  Reduction in Hypertrophic Skin Scarring: 8204\n",
      "  Refeeding Syndrome: 8205\n",
      "  Reflux: 8206\n",
      "  Reflux Esophagitis: 8207\n",
      "  Reflux Oesophagitis: 8208\n",
      "  Refractive Assessment: 8209\n",
      "  Refractive Disorders: 8210\n",
      "  Refractive Error: 8211\n",
      "  Refractive Error - Myopia: 8212\n",
      "  Refractory Acute Myeloid Leukemia: 8213\n",
      "  Refractory Aggressive Non-Hodgkin's Lymphoma: 8214\n",
      "  Refractory Angina: 8215\n",
      "  Refractory Brain Tumors: 8216\n",
      "  Refractory Cancer: 8217\n",
      "  Refractory Chronic Lymphocytic Leukemia: 8218\n",
      "  Refractory Epilepsy: 8219\n",
      "  Refractory Germ Cell Tumors Expressing EGRF: 8220\n",
      "  Refractory Hematologic Cancer: 8221\n",
      "  Refractory Hemochromatosis Rheumatism: 8222\n",
      "  Refractory Hodgkin Lymphoma: 8223\n",
      "  Refractory Hypertension: 8224\n",
      "  Refractory Leukemia: 8225\n",
      "  Refractory Low-grade Gliomas: 8226\n",
      "  Refractory Major Depressive Disorder: 8227\n",
      "  Refractory Malignancies: 8228\n",
      "  Refractory Multiple Myeloma: 8229\n",
      "  Refractory Nasopharyngeal Carcinoma: 8230\n",
      "  Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites: 8231\n",
      "  Refractory Partial Onset Seizures: 8232\n",
      "  Refractory Partial Seizures: 8233\n",
      "  Refractory Peripheral T-Cell Lymphoma: 8234\n",
      "  Refractory Plasma Cell Myeloma: 8235\n",
      "  Refractory Reflux Esophagitis: 8236\n",
      "  Refractory Solid Tumor: 8237\n",
      "  Refractory Solid Tumors: 8238\n",
      "  Refractory Viral Infections: 8239\n",
      "  Refractory or Recurrent Ascites: 8240\n",
      "  Refractory or Recurrent Hypermutated Malignancies: 8241\n",
      "  Refractory or Relapsed Solid Tumors: 8242\n",
      "  Refractory/Relapsed Indolent Non-Hodgkin Lymphoma: 8243\n",
      "  Regional Citrate Anticoagulation (RCA): 8244\n",
      "  Relapse Rate of a Major Depressive Episode: 8245\n",
      "  Relapse Remitting Multiple Sclerosis: 8246\n",
      "  Relapse/Refractory Multiple Myeloma: 8247\n",
      "  Relapsed / Recurrent Germ Cell Tumors: 8248\n",
      "  Relapsed AML: 8249\n",
      "  Relapsed Acute Leukemia: 8250\n",
      "  Relapsed Acute Lymphoblastic Leukemia: 8251\n",
      "  Relapsed Acute Myelogenous Leukemia: 8252\n",
      "  Relapsed B-Cell Non-Hodgkin Lymphoma: 8253\n",
      "  Relapsed Bladder Cancer: 8254\n",
      "  Relapsed Breast Cancer: 8255\n",
      "  Relapsed Cutaneous T Cell Lymphom: 8256\n",
      "  Relapsed Diffuse Large B-Cell Lymphoma: 8257\n",
      "  Relapsed Epithelial Ovarian Cancer: 8258\n",
      "  Relapsed Ewing Sarcoma: 8259\n",
      "  Relapsed Follicular Lymphoma: 8260\n",
      "  Relapsed Hodgkin Lymphoma: 8261\n",
      "  Relapsed Lymphoblastic Leukemia: 8262\n",
      "  Relapsed Lymphomas: 8263\n",
      "  Relapsed Malignant Mesothelioma: 8264\n",
      "  Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer: 8265\n",
      "  Relapsed Multiple Myeloma: 8266\n",
      "  Relapsed Peripheral T-Cell Lymphoma: 8267\n",
      "  Relapsed Solid Tumor: 8268\n",
      "  Relapsed T-Cell Acute Lymphoblastic Leukemia: 8269\n",
      "  Relapsed and Refractory Aggressive B- and T-cell Lymphomas: 8270\n",
      "  Relapsed and Refractory Multiple Myeloma: 8271\n",
      "  Relapsed and/or Refractory Multiple Myeloma: 8272\n",
      "  Relapsed and/or Relapsed-refractory Multiple Myeloma: 8273\n",
      "  Relapsed or Refractory Acute Lymphoblastic Leukemia: 8274\n",
      "  Relapsed or Refractory Acute Myeloid Leukemia: 8275\n",
      "  Relapsed or Refractory Acute Myeloid Leukemia (AML): 8276\n",
      "  Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia: 8277\n",
      "  Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma: 8278\n",
      "  Relapsed or Refractory Chronic Lymphocytic Leukemia: 8279\n",
      "  Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): 8280\n",
      "  Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL): 8281\n",
      "  Relapsed or Refractory Lymphoproliferative Malignancies: 8282\n",
      "  Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS): 8283\n",
      "  Relapsed or Refractory Multiple Myeloma: 8284\n",
      "  Relapsed or Refractory Solid Tumors: 8285\n",
      "  Relapsed or Refractory Solid Tumors or Lymphoma in Children: 8286\n",
      "  Relapsed or Refractory Systemic Light Chain Amyloidosis: 8287\n",
      "  Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia: 8288\n",
      "  Relapsed/ Refractory Multiple Myeloma: 8289\n",
      "  Relapsed/Refractory AML: 8290\n",
      "  Relapsed/Refractory Acute Myeloid Leukemia: 8291\n",
      "  Relapsed/Refractory Acute Myeloid Leukemia (AML): 8292\n",
      "  Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia: 8293\n",
      "  Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma: 8294\n",
      "  Relapsed/Refractory FLT3-mutated AML: 8295\n",
      "  Relapsed/Refractory Follicular Non-Hodgkin Lymphoma: 8296\n",
      "  Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma: 8297\n",
      "  Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas: 8298\n",
      "  Relapsed/Refractory Large B-cell Lymphoma: 8299\n",
      "  Relapsed/Refractory Leukemia: 8300\n",
      "  Relapsed/Refractory Leukemias: 8301\n",
      "  Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma: 8302\n",
      "  Relapsed/Refractory Multiple Myeloma: 8303\n",
      "  Relapsed/Refractory Non-Hodgkin's Lymphoma: 8304\n",
      "  Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma: 8305\n",
      "  Relapsed/Refractory Solid Tumor Malignancies or Lymphoma: 8306\n",
      "  Relapsed/Refractory Solid Tumors/Hematological Malignancies: 8307\n",
      "  Relapsing Multiple Sclerorsis: 8308\n",
      "  Relapsing Multiple Sclerosis: 8309\n",
      "  Relapsing Polychondritis: 8310\n",
      "  Relapsing Remitting Multiple Sclerosis: 8311\n",
      "  Relapsing Remitting Multiple Sclerosis (RRMS): 8312\n",
      "  Relapsing Remitting Multiple Sclerosis RRMS: 8313\n",
      "  Relapsing-Remitting Multiple Sclerosis: 8314\n",
      "  Relapsing-Remitting Multiple Sclerosis (RRMS): 8315\n",
      "  Relapsing-remitting Multiple Sclerosis: 8316\n",
      "  Relapsing-remitting Multiple Sclerosis (RRMS): 8317\n",
      "  Relative Bioavailability: 8318\n",
      "  Renal Anaemia: 8319\n",
      "  Renal Artery Obstruction: 8320\n",
      "  Renal Artery Stenosis: 8321\n",
      "  Renal Calculi: 8322\n",
      "  Renal Calculus: 8323\n",
      "  Renal Cancer: 8324\n",
      "  Renal Cancer Cell: 8325\n",
      "  Renal Cancers: 8326\n",
      "  Renal Cell Adenocarcinoma: 8327\n",
      "  Renal Cell Cancer: 8328\n",
      "  Renal Cell Cancer Metastatic: 8329\n",
      "  Renal Cell Carcinoma: 8330\n",
      "  Renal Cell Carcinoma (RCC): 8331\n",
      "  Renal Cell Carcinoma, Metastatic: 8332\n",
      "  Renal Clear Cell Carcinoma: 8333\n",
      "  Renal Colic: 8334\n",
      "  Renal Denervation: 8335\n",
      "  Renal Dialysis: 8336\n",
      "  Renal Disease: 8337\n",
      "  Renal Dysfunction: 8338\n",
      "  Renal Failure: 8339\n",
      "  Renal Failure Chronic: 8340\n",
      "  Renal Failure Chronic Requiring Hemodialysis: 8341\n",
      "  Renal Failure, Chronic: 8342\n",
      "  Renal Failure, End Stage: 8343\n",
      "  Renal Function: 8344\n",
      "  Renal Function Disorder: 8345\n",
      "  Renal Impairment: 8346\n",
      "  Renal Impairment in Hepatorenal Syndrome: 8347\n",
      "  Renal Insufficiency: 8348\n",
      "  Renal Insufficiency, Acute: 8349\n",
      "  Renal Insufficiency, Chronic: 8350\n",
      "  Renal Malignant Tumor: 8351\n",
      "  Renal Replacement Therapies: 8352\n",
      "  Renal Transplant: 8353\n",
      "  Renal Transplant Donor of Left Kidney: 8354\n",
      "  Renal Transplant Infection: 8355\n",
      "  Renal Transplant Osteodystrophy: 8356\n",
      "  Renal Transplant Patients at High-risk for Skin Cancer: 8357\n",
      "  Renal Transplant Recipients: 8358\n",
      "  Renal Transplant Rejection: 8359\n",
      "  Renal Transplantation: 8360\n",
      "  Renin Angiotensin: 8361\n",
      "  Repeated Embryo Implantation Failure: 8362\n",
      "  Reproductive Endocrinology: 8363\n",
      "  Reproductive Techniques, Assisted: 8364\n",
      "  Requiring Subclavian Vein Cannulation: 8365\n",
      "  Resectable Biliary Tract Cancer: 8366\n",
      "  Resectable Esophageal Cancer: 8367\n",
      "  Resectable Pancreatic Cancer: 8368\n",
      "  Resectable Pancreatic Carcinoma: 8369\n",
      "  Resectable Rectal Cancer Clinical Stage II and III: 8370\n",
      "  Resectable, Non-functioning Pituitary Adenoma: 8371\n",
      "  Residual Disease: 8372\n",
      "  Residual Neuromuscular Blockade: 8373\n",
      "  Resistant Hypertension: 8374\n",
      "  Resistant Hypertension in Kidney Transplant Patients: 8375\n",
      "  Resistant Vascular Ulcers: 8376\n",
      "  Respiration: 8377\n",
      "  Respiration Disorders: 8378\n",
      "  Respiration, Artificial: 8379\n",
      "  Respiratory Device Comfort: 8380\n",
      "  Respiratory Disorders: 8381\n",
      "  Respiratory Distress: 8382\n",
      "  Respiratory Distress Syndrome: 8383\n",
      "  Respiratory Distress Syndrome (& [Hyaline Membrane Disease]): 8384\n",
      "  Respiratory Distress Syndrome (RDS): 8385\n",
      "  Respiratory Distress Syndrome, Adult: 8386\n",
      "  Respiratory Distress Syndrome, Newborn: 8387\n",
      "  Respiratory Distress Syndrome,Adult: 8388\n",
      "  Respiratory Failure: 8389\n",
      "  Respiratory Infections, Acute: 8390\n",
      "  Respiratory Insufficiency: 8391\n",
      "  Respiratory Insufficiency Syndrome of Newborn: 8392\n",
      "  Respiratory Insufficiency of Prematurity: 8393\n",
      "  Respiratory Syncytial Virus: 8394\n",
      "  Respiratory Syncytial Virus (RSV): 8395\n",
      "  Respiratory Syncytial Virus Infections: 8396\n",
      "  Respiratory Syncytial Virus Lower Respiratory Tract Infection: 8397\n",
      "  Respiratory Syncytial Viruses: 8398\n",
      "  Respiratory Tract Diseases: 8399\n",
      "  Respiratory Tract Infection: 8400\n",
      "  Respiratory Tract Infections: 8401\n",
      "  Response Rate: 8402\n",
      "  Response of Viral Infection to Woodsmoke: 8403\n",
      "  Responses to Infant Immunisations: 8404\n",
      "  Restless Leg Disorder: 8405\n",
      "  Restless Leg Syndrome: 8406\n",
      "  Restless Legs Syndrome: 8407\n",
      "  Restless Legs Syndrome (RLS): 8408\n",
      "  Restrictive Burn Scars: 8409\n",
      "  Restrictive Burn Scars of Joint Area: 8410\n",
      "  Restrictive Chronic Lung Allograft Dysfunction: 8411\n",
      "  Restrictive Scar Contracture: 8412\n",
      "  Resuscitation: 8413\n",
      "  Retained Fetal Lung Fluid: 8414\n",
      "  Retina: 8415\n",
      "  Retinal Anomalies: 8416\n",
      "  Retinal Artery Occlusion: 8417\n",
      "  Retinal Detachment: 8418\n",
      "  Retinal Disease: 8419\n",
      "  Retinal Diseases: 8420\n",
      "  Retinal Hemorrhage: 8421\n",
      "  Retinal Ischemia: 8422\n",
      "  Retinal Vein Occlusion: 8423\n",
      "  Retinitis: 8424\n",
      "  Retinitis Pigmentosa: 8425\n",
      "  Retinoblastoma: 8426\n",
      "  Retinopathy: 8427\n",
      "  Retinopathy of Prematurity: 8428\n",
      "  Retinopathy of Prematurity (ROP): 8429\n",
      "  Rett Syndrome: 8430\n",
      "  Reversal of Anticoagulant Treatment: 8431\n",
      "  Reversible Cerebral Vasoconstriction Syndrome: 8432\n",
      "  Revision Surgery of Total Hip Arthroplasty: 8433\n",
      "  Rhabdoid Neoplasm of CNS: 8434\n",
      "  Rhabdomyolysis: 8435\n",
      "  Rhabdomyosarcoma: 8436\n",
      "  Rhegmatogenous Macula-off Retinal Detachment: 8437\n",
      "  Rhegmatogenous Retinal Detachment: 8438\n",
      "  Rhegmatogenous Retinal Detachment - Macula Off: 8439\n",
      "  Rheumatic Heart Disease: 8440\n",
      "  Rheumatoid Arthritis: 8441\n",
      "  Rheumatoid Arthritis (RA): 8442\n",
      "  Rheumatoid Arthritis RA: 8443\n",
      "  Rheumatoid Arthritis, DMARD-naive and Early Disease Patients: 8444\n",
      "  Rheumatoid Arthritis, Juvenile: 8445\n",
      "  Rheumatoid and Osteoarthritis: 8446\n",
      "  Rheumatologic Conditions (JRA,Lupus): 8447\n",
      "  Rhinitis: 8448\n",
      "  Rhinitis Allergic: 8449\n",
      "  Rhinitis, Allergic: 8450\n",
      "  Rhinitis, Allergic, Perennial: 8451\n",
      "  Rhinitis, Allergic, Perennial and Seasonal: 8452\n",
      "  Rhinitis, Allergic, Seasonal: 8453\n",
      "  Rhinoconjunctivitis: 8454\n",
      "  Rhinosinusitis: 8455\n",
      "  Rhinovirus: 8456\n",
      "  Rib Fracture Multiple: 8457\n",
      "  Rib Fractures: 8458\n",
      "  Richter Syndrome: 8459\n",
      "  Richter's Syndrome: 8460\n",
      "  Richter's Transformation: 8461\n",
      "  Ricin Poisoning: 8462\n",
      "  Rift Valley Fever: 8463\n",
      "  Right Ventricular Infarction: 8464\n",
      "  Right to Left Shunt: 8465\n",
      "  Risk Behavior: 8466\n",
      "  Risk Factors for or a Diagnosis of Osteoporosis: 8467\n",
      "  Risk of Bone Fracture Occurrences: 8468\n",
      "  Root Canal Therapy: 8469\n",
      "  Rosacea: 8470\n",
      "  Rotator Cuff: 8471\n",
      "  Rotator Cuff Injury: 8472\n",
      "  Rotator Cuff Repair of the Shoulder: 8473\n",
      "  Rotator Cuff Syndrome: 8474\n",
      "  Rotator Cuff Tear: 8475\n",
      "  Rotator Cuff Tear Arthropathy: 8476\n",
      "  Rotator Cuff Tendinopathy: 8477\n",
      "  Rotator Cuff/Shoulder Structure and Function: 8478\n",
      "  Rotavirus: 8479\n",
      "  Rotavirus Disease: 8480\n",
      "  Rotavirus Gastroenteritis: 8481\n",
      "  Rotavirus Infection: 8482\n",
      "  Rotavirus Infections: 8483\n",
      "  Rotavirus Vaccine: 8484\n",
      "  Rsv Bronchiolitis: 8485\n",
      "  Rubella: 8486\n",
      "  Rumination: 8487\n",
      "  Rupture of Anterior Cruciate Ligament: 8488\n",
      "  Rupture of Posterior Cruciate Ligament: 8489\n",
      "  Ruptured Cerebral Aneurysm: 8490\n",
      "  SARS: 8491\n",
      "  SC Disease: 8492\n",
      "  SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors: 8493\n",
      "  SGLT-2 Inhibitors: 8494\n",
      "  SI Joint Pain: 8495\n",
      "  SLE: 8496\n",
      "  SLE Glomerulonephritis Syndrome, WHO Class V: 8497\n",
      "  SMA: 8498\n",
      "  SMALL CELL LUNG CARCINOMA: 8499\n",
      "  SMD: 8500\n",
      "  SPONDYLOARTHRITIS: 8501\n",
      "  SRP: 8502\n",
      "  ST Elevation Acute Myocardial Infarction: 8503\n",
      "  ST Elevation Myocardial Infarction: 8504\n",
      "  ST Elevation Myocardial Infarction (STEMI): 8505\n",
      "  ST Segment Elevated Myocardial Infarction: 8506\n",
      "  ST Segment Elevation Myocardial Infarction: 8507\n",
      "  ST Segment Elevation Myocardial Infarction (STEMI): 8508\n",
      "  ST-Elevation Myocardial Infarction: 8509\n",
      "  ST-Segment Elevation Myocardial Infarction: 8510\n",
      "  ST-Segment Elevation Myocardial Infraction: 8511\n",
      "  ST-elevation MI: 8512\n",
      "  ST-elevation Myocardial Infarction: 8513\n",
      "  ST-segment Elevation Myocardial Infarction: 8514\n",
      "  STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER: 8515\n",
      "  STEMI: 8516\n",
      "  STEMI - ST Elevation Myocardial Infarction: 8517\n",
      "  Sacro Iliac Joint Pain: 8518\n",
      "  Sacro-Iliac Spondylosis: 8519\n",
      "  Safety: 8520\n",
      "  Safety After Oral Intake: 8521\n",
      "  Safety Issues: 8522\n",
      "  Safety and Efficacy: 8523\n",
      "  Safety and Efficacy of Sedation Medications: 8524\n",
      "  Safety and Tolerability: 8525\n",
      "  Safety and Tolerability in Healthy Volunteers: 8526\n",
      "  Safety of ASP2151: 8527\n",
      "  Safety of Long Acting Beta Agnoists: 8528\n",
      "  Safety/Effacy: 8529\n",
      "  Salivary Bacteria Levels: 8530\n",
      "  Salivary Gland Cancer: 8531\n",
      "  Salivary Gland Cancers: 8532\n",
      "  Salivary Gland Dysfunction: 8533\n",
      "  Salivary Gland Malignancy: 8534\n",
      "  Salivary Gland Squamous Cell Carcinoma: 8535\n",
      "  Sanfilippo Syndrome: 8536\n",
      "  Sanfilippo Syndrome Type A (MPS IIIA): 8537\n",
      "  Saphenous Vein Graft Atherosclerosis: 8538\n",
      "  Saphenous Vein Graft Disease: 8539\n",
      "  Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID: 8540\n",
      "  Sarcoid-associated Uveitis: 8541\n",
      "  Sarcoidosis: 8542\n",
      "  Sarcoidosis; Antimycobacterial Therapy: 8543\n",
      "  Sarcoma: 8544\n",
      "  Sarcoma, Ewing: 8545\n",
      "  Sarcoma, Kaposi: 8546\n",
      "  Sarcoma, Soft Tissue: 8547\n",
      "  Sarcoma, Soft-tissue: 8548\n",
      "  Sarcoma, Synovial: 8549\n",
      "  Sarcopenia: 8550\n",
      "  Scalp Psoriasis: 8551\n",
      "  Scaphoid Bone: 8552\n",
      "  Scaphoid Fracture: 8553\n",
      "  Scar: 8554\n",
      "  Scar Formation: 8555\n",
      "  Scar Improvement: 8556\n",
      "  Scar Prevention: 8557\n",
      "  Scarring: 8558\n",
      "  Scheduled Cesarean Sections: 8559\n",
      "  Schistosoma Hematobium Infection: 8560\n",
      "  Schistosomiasis: 8561\n",
      "  Schistosomiasis Mansoni: 8562\n",
      "  Schizoaffective Disorder: 8563\n",
      "  Schizophrenia: 8564\n",
      "  Schizophrenia (Recent-onset): 8565\n",
      "  Schizophrenia Spectrum and Other Psychotic Disorders: 8566\n",
      "  Schizophrenia With Impulsivity: 8567\n",
      "  Schizophrenia and Disorders With Psychotic Features: 8568\n",
      "  Schizophrenia and Related Disorders: 8569\n",
      "  Schizophrenia and Schizophrenia Spectrum Psychosis: 8570\n",
      "  Schizophrenia, Acute Episode: 8571\n",
      "  Schizophrenia, Cerebellar Ataxia: 8572\n",
      "  Schizophrenia, Schizoaffective Disorder: 8573\n",
      "  Schizophrenia; Negative Type: 8574\n",
      "  Schizophrenias: 8575\n",
      "  Schizophrenic Disorder: 8576\n",
      "  Schizophrenic Disorders: 8577\n",
      "  Schizophreniform Disorder: 8578\n",
      "  Schizotypal Personality Disorder: 8579\n",
      "  Schnitzler Syndrome: 8580\n",
      "  Sciatica: 8581\n",
      "  Scleritis: 8582\n",
      "  Scleroderma: 8583\n",
      "  Scleroderma Disease: 8584\n",
      "  Scleroderma, Localized: 8585\n",
      "  Scleroderma, Systemic: 8586\n",
      "  Sclerosing Cholangitis: 8587\n",
      "  Scoliosis: 8588\n",
      "  Scorpion Envenomation: 8589\n",
      "  Scorpion Sting: 8590\n",
      "  Screening Colonoscopy: 8591\n",
      "  Screening Colonoscopy for Low Risk Subjects: 8592\n",
      "  Screening of Colonic Polyps: 8593\n",
      "  Scrotal Pain: 8594\n",
      "  Seasonal Affective Disorder: 8595\n",
      "  Seasonal Affective Disorder (SAD): 8596\n",
      "  Seasonal Affective Rhinitis: 8597\n",
      "  Seasonal Allergic Conjunctivitis to Ragweed: 8598\n",
      "  Seasonal Allergic Rhinitis: 8599\n",
      "  Seasonal Allergic Rhinitis (SAR): 8600\n",
      "  Seasonal Allergic Rhinoconjunctivitis: 8601\n",
      "  Seasonal Influenza: 8602\n",
      "  Seborrheic Dermatitis: 8603\n",
      "  Seborrheic Dermatitis on the Face: 8604\n",
      "  Second Degree Burn Less Than 5%TBSA: 8605\n",
      "  Second Trimester Abortion: 8606\n",
      "  Second Trimester Labor Induction: 8607\n",
      "  Second or Third Degree Burns: 8608\n",
      "  Secondary Amenorrhea: 8609\n",
      "  Secondary Hyperoxaluria: 8610\n",
      "  Secondary Hyperparathyroidism: 8611\n",
      "  Secondary Hyperparathyroidism Due to Renal Causes: 8612\n",
      "  Secondary Hypogonadism: 8613\n",
      "  Secondary Hypothyroidism: 8614\n",
      "  Secondary Immune Deficiency Disorder: 8615\n",
      "  Secondary Lymphedema: 8616\n",
      "  Secondary Malignant Neoplasm of Bone: 8617\n",
      "  Secondary Osteoporosis: 8618\n",
      "  Secondary Progressive Multiple Sclerosis: 8619\n",
      "  Secondary Progressive Multiple Sclerosis (SPMS): 8620\n",
      "  Secondhand Smoke Exposure: 8621\n",
      "  Secretion Removal Above ETT Cuff: 8622\n",
      "  Secretory Diarrhea: 8623\n",
      "  Sedation: 8624\n",
      "  Sedation During Bronchoscopy: 8625\n",
      "  Sedation During Spinal Anesthesia: 8626\n",
      "  Sedation in Intensive Care: 8627\n",
      "  Sedentary Lifestyle: 8628\n",
      "  Sedentary Subjects: 8629\n",
      "  Segmental Overgrowth Syndrome: 8630\n",
      "  Seizure Disorder Generalized Tonic Clonic: 8631\n",
      "  Seizure Disorder, Partial: 8632\n",
      "  Seizure, Absence: 8633\n",
      "  Seizure, Alcohol Related: 8634\n",
      "  Seizure, Epileptic: 8635\n",
      "  Seizures: 8636\n",
      "  Select Advanced Solid Tumors: 8637\n",
      "  Selenoprotein N-related Myopathy: 8638\n",
      "  Self-identified Problematic Caffeine Use: 8639\n",
      "  Self-injurious Behavior: 8640\n",
      "  Seminoma: 8641\n",
      "  Sensitivity (Hyper); Gastrointestinal: 8642\n",
      "  Sensorineural Hearing Loss: 8643\n",
      "  Separation Anxiety Disorder: 8644\n",
      "  Sepsis: 8645\n",
      "  Sepsis Affecting Skin: 8646\n",
      "  Sepsis Newborn: 8647\n",
      "  Sepsis and Coagulopathy: 8648\n",
      "  Sepsis, Severe: 8649\n",
      "  Septic Abortion: 8650\n",
      "  Septic Shock: 8651\n",
      "  Sequelae of Perinatal Brain Injury: 8652\n",
      "  Sequelae of Viral Hepatitis: 8653\n",
      "  Serious Bacterial Infection: 8654\n",
      "  Serious Systemic Infections: 8655\n",
      "  Serologically Active Adult Systemic Lupus Erythematosus: 8656\n",
      "  Seroma: 8657\n",
      "  Seronegative Spondyloarthropathies: 8658\n",
      "  Seropositive RA: 8659\n",
      "  Severe Acute Alcoholic Hepatitis: 8660\n",
      "  Severe Acute Decompensated Alcoholic Hepatitis: 8661\n",
      "  Severe Acute Malnutrition: 8662\n",
      "  Severe Alcoholic Hepatitis: 8663\n",
      "  Severe Alzheimer's Disease: 8664\n",
      "  Severe Aplastic Anemia: 8665\n",
      "  Severe Asthma: 8666\n",
      "  Severe Caner Pain: 8667\n",
      "  Severe Chronic Neutropenia: 8668\n",
      "  Severe Chronic Pain: 8669\n",
      "  Severe Combined Immunodeficiency: 8670\n",
      "  Severe Combined Immunodeficiency Disease: 8671\n",
      "  Severe Combined Immunodeficiency Due to ADA Deficiency: 8672\n",
      "  Severe Compressive Ulnar Nerve Neuropathy (McGowan Grade III): 8673\n",
      "  Severe Diabetic Retinopathy: 8674\n",
      "  Severe Eosinophilic Asthma: 8675\n",
      "  Severe Haemophilia A: 8676\n",
      "  Severe Hemophilia A: 8677\n",
      "  Severe Hemophilia B: 8678\n",
      "  Severe Hepatic Impairment: 8679\n",
      "  Severe Hypertension: 8680\n",
      "  Severe Hypertriglyceridemia: 8681\n",
      "  Severe Hypoxic-ischemic Encephalopathy: 8682\n",
      "  Severe IgE-mediated Asthma: 8683\n",
      "  Severe Nonproliferative: 8684\n",
      "  Severe Osteoarthritis of the Knee: 8685\n",
      "  Severe Persistent Asthma: 8686\n",
      "  Severe Prednisone Dependent Eosinophilic Asthma: 8687\n",
      "  Severe Preeclampsia: 8688\n",
      "  Severe Renal Impairment: 8689\n",
      "  Severe Seborrheic Dermatitis: 8690\n",
      "  Severe Sepsis: 8691\n",
      "  Severe Sepsis With Septic Shock: 8692\n",
      "  Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit: 8693\n",
      "  Severe Stroke With Affected Arm Motor Function: 8694\n",
      "  Severe Sudden Sensorineural Hearing Loss: 8695\n",
      "  Severe Thermal Injury, Greater Than 20% TBSA: 8696\n",
      "  Severe Thrombocytopenia: 8697\n",
      "  Severe Trauma Brain Injury: 8698\n",
      "  Severe Trauma Patients: 8699\n",
      "  Severe Traumatic Pain: 8700\n",
      "  Severe Tricuspid Regurgitation: 8701\n",
      "  Sexual Active Women: 8702\n",
      "  Sexual Assault: 8703\n",
      "  Sexual Dysfunction: 8704\n",
      "  Sexual Dysfunction, Physiological: 8705\n",
      "  Sexual Dysfunctions, Psychological: 8706\n",
      "  Sexual Pain Disorders: 8707\n",
      "  Sexually Transmitted Diseases: 8708\n",
      "  Sezary Syndrome: 8709\n",
      "  Shift-Work Sleep Disorder: 8710\n",
      "  Shigella: 8711\n",
      "  Shigella Sonnei Dysenteries: 8712\n",
      "  Shigellosis: 8713\n",
      "  Shingles: 8714\n",
      "  Shock: 8715\n",
      "  Shock, Cardiogenic: 8716\n",
      "  Shock, Hemorrhagic: 8717\n",
      "  Shock, Septic: 8718\n",
      "  Shock, Traumatic: 8719\n",
      "  Shock,Hemorrhagic: 8720\n",
      "  Shockable Out of Hospital Cardiac Arrest: 8721\n",
      "  Short Bowel Syndrome: 8722\n",
      "  Short Cervix: 8723\n",
      "  Short Duration Lower Limb Surgery Via Spinal Anaesthesia: 8724\n",
      "  Short Stature: 8725\n",
      "  Short Stature Born Small for Gestational Age (SGA): 8726\n",
      "  Short-term Insomnia: 8727\n",
      "  Shoulder Arthroplasty: 8728\n",
      "  Shoulder Arthroscopy: 8729\n",
      "  Shoulder Fracture: 8730\n",
      "  Shoulder Fractures: 8731\n",
      "  Shoulder Hand Syndrome: 8732\n",
      "  Shoulder Impingement: 8733\n",
      "  Shoulder Impingement Syndrome: 8734\n",
      "  Shoulder Injury: 8735\n",
      "  Shoulder Musculoskeletal Disorders: 8736\n",
      "  Shoulder Pain: 8737\n",
      "  Shoulder Symptoms After Lymph Node Dissection: 8738\n",
      "  Shy-Drager Syndrome: 8739\n",
      "  Sialorrhea: 8740\n",
      "  Sialorrhea Secondary to Parkinson's Disease: 8741\n",
      "  Sick Sinus Syndrome: 8742\n",
      "  Sickle Cell Anemia: 8743\n",
      "  Sickle Cell Crisis: 8744\n",
      "  Sickle Cell Disease: 8745\n",
      "  Sickle Cell Disease and Thalassemia: 8746\n",
      "  Signs and Symptoms: 8747\n",
      "  Signs and Symptoms, Digestive: 8748\n",
      "  Simultaneous Kidney and Pancreas Transplantation: 8749\n",
      "  Single Level Posterolateral Spinal Fusion: 8750\n",
      "  Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale): 8751\n",
      "  Single Ventricle: 8752\n",
      "  Single-ventricle: 8753\n",
      "  Sinus Thrombosis, Intracranial: 8754\n",
      "  Sinusitis: 8755\n",
      "  Sinusitis, Acute: 8756\n",
      "  Sjogren's Syndrome: 8757\n",
      "  Sjogrens Disease: 8758\n",
      "  Sjögren's Syndrome: 8759\n",
      "  Sjögren-Larsson Syndrome: 8760\n",
      "  Skeletal Muscle Changes After Crt: 8761\n",
      "  Skeletal Muscle Mitochondrial Dysfunction in the Elderly: 8762\n",
      "  Skill Development of Staff: 8763\n",
      "  Skin Abnormalities: 8764\n",
      "  Skin Aging: 8765\n",
      "  Skin Alterations Associated With Atopic Dermatitis: 8766\n",
      "  Skin Basal Cell Carcinoma: 8767\n",
      "  Skin Burn Degree Second: 8768\n",
      "  Skin Cancer: 8769\n",
      "  Skin Care: 8770\n",
      "  Skin Diseases: 8771\n",
      "  Skin Diseases, Infectious: 8772\n",
      "  Skin Fibrosis: 8773\n",
      "  Skin Flora Bacterial Reduction Post-product Application: 8774\n",
      "  Skin Flora Contamination: 8775\n",
      "  Skin Graft Complications: 8776\n",
      "  Skin Infection: 8777\n",
      "  Skin Infections: 8778\n",
      "  Skin Infections, Bacterial: 8779\n",
      "  Skin Irritation: 8780\n",
      "  Skin Lesions: 8781\n",
      "  Skin Manifestations: 8782\n",
      "  Skin Rash: 8783\n",
      "  Skin Roughness: 8784\n",
      "  Skin Structures and Soft Tissue Infections: 8785\n",
      "  Skin Transplantation: 8786\n",
      "  Skin Ulcer: 8787\n",
      "  Skin Ulcer Venous Stasis Chronic: 8788\n",
      "  Skin Ulcers: 8789\n",
      "  Skin Whitening: 8790\n",
      "  Skin and Subcutaneous Tissue Bacterial Infections: 8791\n",
      "  Skin/Soft Tissue Infections: 8792\n",
      "  Skull Defects: 8793\n",
      "  Sleep: 8794\n",
      "  Sleep Apnea: 8795\n",
      "  Sleep Apnea Syndromes: 8796\n",
      "  Sleep Apnea, Central: 8797\n",
      "  Sleep Apnea, Obstructive: 8798\n",
      "  Sleep Apnea, Obstructive; Post-Traumatic Stress Disorders: 8799\n",
      "  Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT): 8800\n",
      "  Sleep Deprivation: 8801\n",
      "  Sleep Disorder: 8802\n",
      "  Sleep Disorder (Healthy Volunteers): 8803\n",
      "  Sleep Disordered Breathing: 8804\n",
      "  Sleep Disorders: 8805\n",
      "  Sleep Disorders, Circadian Rhythm: 8806\n",
      "  Sleep Disturbance: 8807\n",
      "  Sleep Initiation and Maintenance Disorders: 8808\n",
      "  Sleep Problems: 8809\n",
      "  Sleep Quality: 8810\n",
      "  Sleep-Disordered Breathing: 8811\n",
      "  Small Bowel Carcinoid Tumor: 8812\n",
      "  Small Bowel Obstruction: 8813\n",
      "  Small Cell Lung Cancer: 8814\n",
      "  Small Cell Lung Cancer ( SCLC ): 8815\n",
      "  Small Cell Lung Cancer (SCLC): 8816\n",
      "  Small Cell Lung Cancer Extensive Stage: 8817\n",
      "  Small Cell Lung Cancer Recurrent: 8818\n",
      "  Small Cell Lung Cancer and Breast Cancer: 8819\n",
      "  Small Cell Lung Cancer and Other Solid Tumors: 8820\n",
      "  Small Cell Lung Carcinoma: 8821\n",
      "  Small Cell Lung Carcinoma, Extensive Disease: 8822\n",
      "  Small Cell Prostate Cancer: 8823\n",
      "  Small Fiber Neuropathy: 8824\n",
      "  Small Intestinal Bacterial Overgrowth: 8825\n",
      "  Small Intestine Cancer: 8826\n",
      "  Small Renal Mass: 8827\n",
      "  Small for Gestational Age: 8828\n",
      "  Small-Cell Lung Cancer: 8829\n",
      "  Small-cell Lung Cancer: 8830\n",
      "  Smallpox: 8831\n",
      "  Smiling: 8832\n",
      "  Smith-Lemli-Opitz Syndrome: 8833\n",
      "  Smokeless Tobacco Use: 8834\n",
      "  Smokers: 8835\n",
      "  Smoking: 8836\n",
      "  Smoking Addiction: 8837\n",
      "  Smoking Behavior: 8838\n",
      "  Smoking Cessation: 8839\n",
      "  Smoking Dependence: 8840\n",
      "  Smoking, Cigarette: 8841\n",
      "  Smoking, Tobacco: 8842\n",
      "  Smoldering Multiple Myeloma: 8843\n",
      "  Snake Bite: 8844\n",
      "  Snake Bites: 8845\n",
      "  Snake Envenomation: 8846\n",
      "  Sneddon-Wilkinson: 8847\n",
      "  Snoring: 8848\n",
      "  Social Anxiety Disorder: 8849\n",
      "  Social Behavior: 8850\n",
      "  Social Behaviour: 8851\n",
      "  Social Cognition: 8852\n",
      "  Social Phobia: 8853\n",
      "  Social Psychology: 8854\n",
      "  Socioemotional Aging: 8855\n",
      "  Soft Tissue Infections: 8856\n",
      "  Soft Tissue Injuries of the Shoulder: 8857\n",
      "  Soft Tissue Sarcoma: 8858\n",
      "  Soft Tissue Sarcoma Adult: 8859\n",
      "  Soft Tissue Sarcoma of Members: 8860\n",
      "  Soft Tissue Sarcoma of the Extremities: 8861\n",
      "  Soft Tissue Sarcomas: 8862\n",
      "  Soft Tissue Tumors: 8863\n",
      "  Soft-tissue Sarcoma: 8864\n",
      "  Solar Lentigines: 8865\n",
      "  Solar Urticaria: 8866\n",
      "  Solid Cancer: 8867\n",
      "  Solid Cancer Metastatic Disease: 8868\n",
      "  Solid Cancers: 8869\n",
      "  Solid Malignancies: 8870\n",
      "  Solid Malignancies, With or Without Lung Metastases: 8871\n",
      "  Solid Neoplasm: 8872\n",
      "  Solid Organ Cancers: 8873\n",
      "  Solid Tumor: 8874\n",
      "  Solid Tumor Cancer: 8875\n",
      "  Solid Tumor Cancers: 8876\n",
      "  Solid Tumor Malignancies: 8877\n",
      "  Solid Tumor Malignancy: 8878\n",
      "  Solid Tumor Regardless of Localization and Stage: 8879\n",
      "  Solid Tumor, Adult: 8880\n",
      "  Solid Tumor, Unspecified, Adult: 8881\n",
      "  Solid Tumors: 8882\n",
      "  Solid Tumors (Phase 1): 8883\n",
      "  Solid Tumors Harboring NTRK Fusion: 8884\n",
      "  Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations: 8885\n",
      "  Solid Tumors Induced by Prior Radiation Exposure: 8886\n",
      "  Solid Tumors That Overexpress HER2 (HER2 Positive): 8887\n",
      "  Solid Tumors and Advanced Endometrial Cancer: 8888\n",
      "  Solid Tumors and Hematologic Malignancy: 8889\n",
      "  Solid Tumors and Lymphomas: 8890\n",
      "  Solid Tumors for Phase Ib: 8891\n",
      "  Solid Tumour: 8892\n",
      "  Solid Tumours: 8893\n",
      "  Solitary Bone Plasmacytoma: 8894\n",
      "  Solitary Fibrous Tumors: 8895\n",
      "  Solitary Pulmonary Nodule: 8896\n",
      "  Somatization Disorder: 8897\n",
      "  Somatoform Disorders: 8898\n",
      "  Sore Throat: 8899\n",
      "  Spasmodic Torticollis: 8900\n",
      "  Spasms, Infantile: 8901\n",
      "  Spastic Equinovarus Foot: 8902\n",
      "  Spasticity: 8903\n",
      "  Spasticity Due to Cerebral Palsy: 8904\n",
      "  Spasticity Due to Multiple Sclerosis: 8905\n",
      "  Spatial Neglect: 8906\n",
      "  Specific Advanced Solid Tumors: 8907\n",
      "  Specific Phobia: 8908\n",
      "  Speech Sound Disorders: 8909\n",
      "  Sperm DNA Fragmentation: 8910\n",
      "  Sperm Quality: 8911\n",
      "  Sphincter of Oddi Dysfunction: 8912\n",
      "  Spinal Anesthesia: 8913\n",
      "  Spinal Cord Compression: 8914\n",
      "  Spinal Cord Injured, Tetraplegia: 8915\n",
      "  Spinal Cord Injuries: 8916\n",
      "  Spinal Cord Injury: 8917\n",
      "  Spinal Cord Injury (SCI): 8918\n",
      "  Spinal Cord Trauma: 8919\n",
      "  Spinal Diseases: 8920\n",
      "  Spinal Disorders: 8921\n",
      "  Spinal Fusion: 8922\n",
      "  Spinal Fusion Acquired: 8923\n",
      "  Spinal Induced Hypotension in Cesarean Delivery: 8924\n",
      "  Spinal Induced Shivering: 8925\n",
      "  Spinal Injury: 8926\n",
      "  Spinal Muscular Atrophy: 8927\n",
      "  Spinal Muscular Atrophy (SMA): 8928\n",
      "  Spinal Muscular Atrophy Type 3: 8929\n",
      "  Spinal Muscular Atrophy Type I: 8930\n",
      "  Spinal Muscular Atrophy Type II: 8931\n",
      "  Spinal Neoplasms: 8932\n",
      "  Spinal Stenosis: 8933\n",
      "  Spinal Trauma With Neurological Deficit: 8934\n",
      "  Spinal-induced Hypotension: 8935\n",
      "  Spinocerebellar Ataxia Type 3: 8936\n",
      "  Spinocerebellar Degeneration: 8937\n",
      "  Splenic Artery Aneurysm: 8938\n",
      "  Split Thickness Skin Graft: 8939\n",
      "  Spondylarthropathies: 8940\n",
      "  Spondylitis, Ankylosing: 8941\n",
      "  Spondyloarthritis: 8942\n",
      "  Spondyloarthropathy: 8943\n",
      "  Spondylolisthesis: 8944\n",
      "  Spontaneous Bacterial Peritonitis: 8945\n",
      "  Spontaneous Pneumothorax: 8946\n",
      "  Sporadic Amyotrophic Lateral Sclerosis: 8947\n",
      "  Sporadic Angiomyolipomas (AMLs): 8948\n",
      "  Sporadic Inclusion Body Myositis: 8949\n",
      "  Sporadic Superficial and Nodular Skin Basal Cell Carcinomas: 8950\n",
      "  Sports Concussion: 8951\n",
      "  Spouse Abuse: 8952\n",
      "  Sprain: 8953\n",
      "  Squamous Carcinoma of Esophagus: 8954\n",
      "  Squamous Cell Cancer: 8955\n",
      "  Squamous Cell Cancer of the Head and Neck: 8956\n",
      "  Squamous Cell Carcinoma: 8957\n",
      "  Squamous Cell Carcinoma Head and Neck: 8958\n",
      "  Squamous Cell Carcinoma Of The Head And Neck: 8959\n",
      "  Squamous Cell Carcinoma of Anal Canal: 8960\n",
      "  Squamous Cell Carcinoma of Cervix: 8961\n",
      "  Squamous Cell Carcinoma of Esophagus: 8962\n",
      "  Squamous Cell Carcinoma of Head and Neck: 8963\n",
      "  Squamous Cell Carcinoma of Head and Neck (SCCHN): 8964\n",
      "  Squamous Cell Carcinoma of Nasopharynx: 8965\n",
      "  Squamous Cell Carcinoma of the Head and Neck: 8966\n",
      "  Squamous Cell Carcinoma of the Head and Neck (SCCHN): 8967\n",
      "  Squamous Cell Carcinoma of the Head and Neck Cancer: 8968\n",
      "  Squamous Cell Carcinoma of the Head and Neck T1/2N0-2: 8969\n",
      "  Squamous Cell Carcinoma of the Hypopharynx: 8970\n",
      "  Squamous Cell Carcinoma of the Hypopharynx Stage III: 8971\n",
      "  Squamous Cell Carcinoma of the Larynx: 8972\n",
      "  Squamous Cell Carcinoma of the Lung: 8973\n",
      "  Squamous Cell Carcinoma of the Oral Cavity: 8974\n",
      "  Squamous Cell Carcinoma of the Oropharynx: 8975\n",
      "  Squamous Cell Carcinoma of the Penis: 8976\n",
      "  Squamous Cell Carcinoma of the Skin: 8977\n",
      "  Squamous Cell Carcinoma, Head And Neck: 8978\n",
      "  Squamous Cell Head and Neck Carcinoma: 8979\n",
      "  Squamous Cell Lung Cancer: 8980\n",
      "  Squamous Cell Non-small Cell Lung Cancer: 8981\n",
      "  Squamous Cell Skin Carcinoma: 8982\n",
      "  Squamous Non Small Cell Lung Cancer: 8983\n",
      "  Squamous Non-Small Cell Lung Cancer: 8984\n",
      "  Squamous Non-small Cell Lung Cancer: 8985\n",
      "  Squamous-cell Non-small Cell Lung Cancer: 8986\n",
      "  Stable Angina: 8987\n",
      "  Stable Angina Pectoris: 8988\n",
      "  Stable Asthma: 8989\n",
      "  Stable Atherothrombotic Disease: 8990\n",
      "  Stable COPD Patients: 8991\n",
      "  Stable Coronary Artery Disease: 8992\n",
      "  Stable Coronary Artery Disease Undergoing PCI: 8993\n",
      "  Stable Coronary Heart Disease: 8994\n",
      "  Stable Coronary Heart Disease (CHD): 8995\n",
      "  Stable Coronary Syndrome: 8996\n",
      "  Stable Plaque Psoriasis: 8997\n",
      "  Stable Renal Transplant Recipients: 8998\n",
      "  Stable Vitiligo: 8999\n",
      "  Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7: 9000\n",
      "  Stage 0 Breast Carcinoma: 9001\n",
      "  Stage 1 Hypertension: 9002\n",
      "  Stage 2 Pulmonary Sarcoidosis: 9003\n",
      "  Stage 2 Systolic Hypertension: 9004\n",
      "  Stage 3 Chronic Kidney Disease: 9005\n",
      "  Stage 4 Cancer: 9006\n",
      "  Stage 5 Chronic Kidney Disease (CKD): 9007\n",
      "  Stage I Bladder Cancer AJCC v8: 9008\n",
      "  Stage I Breast Cancer: 9009\n",
      "  Stage I Breast Cancer AJCC v7: 9010\n",
      "  Stage I Gallbladder Cancer AJCC v8: 9011\n",
      "  Stage I Hypopharyngeal Squamous Cell Carcinoma: 9012\n",
      "  Stage I Mantle Cell Lymphoma: 9013\n",
      "  Stage I Multiple Myeloma: 9014\n",
      "  Stage I Non-Small Cell Lung Cancer: 9015\n",
      "  Stage I Oral Cavity Squamous Cell Carcinoma: 9016\n",
      "  Stage I Prostate Adenocarcinoma: 9017\n",
      "  Stage I Prostate Cancer: 9018\n",
      "  Stage I Uterine Sarcoma AJCC v7: 9019\n",
      "  Stage IA Breast Cancer: 9020\n",
      "  Stage IA Non-Small Cell Lung Carcinoma: 9021\n",
      "  Stage IA Non-small Cell Lung Cancer: 9022\n",
      "  Stage IA Pancreatic Cancer: 9023\n",
      "  Stage IB Esophageal Adenocarcinoma: 9024\n",
      "  Stage IB Melanoma: 9025\n",
      "  Stage IB2 Cervical Cancer: 9026\n",
      "  Stage II Adult Soft Tissue Sarcoma: 9027\n",
      "  Stage II Breast Cancer: 9028\n",
      "  Stage II Fallopian Tube Cancer AJCC v8: 9029\n",
      "  Stage II Hypertension: 9030\n",
      "  Stage II Multiple Myeloma: 9031\n",
      "  Stage II Prostate Adenocarcinoma: 9032\n",
      "  Stage II Rectal Cancer: 9033\n",
      "  Stage IIA Skin Melanoma: 9034\n",
      "  Stage IIB Esophageal Cancer AJCC v7: 9035\n",
      "  Stage III (IIIB or IIIC) Colon Cancer: 9036\n",
      "  Stage III Adult Soft Tissue Sarcoma: 9037\n",
      "  Stage III Bladder Cancer: 9038\n",
      "  Stage III Breast Cancer: 9039\n",
      "  Stage III Chronic Lymphocytic Leukemia: 9040\n",
      "  Stage III Cutaneous Melanoma AJCC v7: 9041\n",
      "  Stage III Diffuse Large B-Cell Lymphoma: 9042\n",
      "  Stage III Fallopian Tube Cancer: 9043\n",
      "  Stage III Fallopian Tube Cancer AJCC v7: 9044\n",
      "  Stage III Gastric Cancer: 9045\n",
      "  Stage III Grade 1 Follicular Lymphoma: 9046\n",
      "  Stage III Intrahepatic Cholangiocarcinoma: 9047\n",
      "  Stage III Intrahepatic Cholangiocarcinoma AJCC v7: 9048\n",
      "  Stage III Melanoma: 9049\n",
      "  Stage III Non-Small Cell Lung Cancer AJCC v7: 9050\n",
      "  Stage III Non-small Cell Lung Cancer: 9051\n",
      "  Stage III Ovarian Cancer: 9052\n",
      "  Stage III Prostate Adenocarcinoma AJCC v7: 9053\n",
      "  Stage III Prostate Cancer: 9054\n",
      "  Stage III Squamous Cell Carcinoma of the Hypopharynx: 9055\n",
      "  Stage III Squamous Cell Carcinoma of the Oropharynx: 9056\n",
      "  Stage III or IV Melanoma: 9057\n",
      "  Stage III or Stage IV Melanoma: 9058\n",
      "  Stage IIIA Fallopian Tube Cancer: 9059\n",
      "  Stage IIIA Lung Non-Small Cell Cancer AJCC v7: 9060\n",
      "  Stage IIIA Non-Small Cell Lung Cancer: 9061\n",
      "  Stage IIIA Non-small Cell Lung Cancer: 9062\n",
      "  Stage IIIA Skin Melanoma: 9063\n",
      "  Stage IIIA Uveal Melanoma: 9064\n",
      "  Stage IIIB Melanoma: 9065\n",
      "  Stage IIIB Merkel Cell Carcinoma: 9066\n",
      "  Stage IIIB Non-Small Cell Lung Cancer: 9067\n",
      "  Stage IIIB Non-Small Cell Lung Cancer AJCC v7: 9068\n",
      "  Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion: 9069\n",
      "  Stage IIIB or IV Non-Small Cell Lung Cancer: 9070\n",
      "  Stage IIIB-C Melanoma: 9071\n",
      "  Stage IIIC Skin Melanoma: 9072\n",
      "  Stage IIIb Non-small Cell Lung Cancer: 9073\n",
      "  Stage IV (Metastatic) Breast Cancer: 9074\n",
      "  Stage IV Adrenocortical Carcinoma: 9075\n",
      "  Stage IV Bladder Cancer: 9076\n",
      "  Stage IV Breast Cancer: 9077\n",
      "  Stage IV Colon Cancer: 9078\n",
      "  Stage IV Colorectal Cancer: 9079\n",
      "  Stage IV EGFR Mutated Non-Small Cell Lung Cancer: 9080\n",
      "  Stage IV Esophageal Squamous Cell Carcinoma: 9081\n",
      "  Stage IV Fallopian Tube Cancer AJCC v6 and v7: 9082\n",
      "  Stage IV Kidney Cancer: 9083\n",
      "  Stage IV Lung Cancer: 9084\n",
      "  Stage IV Melanoma: 9085\n",
      "  Stage IV NSCLC: 9086\n",
      "  Stage IV Nasopharyngeal Carcinoma: 9087\n",
      "  Stage IV Non-Small Cell Lung Cancer: 9088\n",
      "  Stage IV Non-small Cell Lung Cancer: 9089\n",
      "  Stage IV Pancreatic Cancer: 9090\n",
      "  Stage IV Prostate Cancer: 9091\n",
      "  Stage IV Resectable Melanoma: 9092\n",
      "  Stage IV Small Cell Lung Cancer: 9093\n",
      "  Stage IVA Colorectal Cancer: 9094\n",
      "  Stage-Ⅱ Colorectal Cancer: 9095\n",
      "  Stages II-III Breast Cancer: 9096\n",
      "  Staphylococcal Infection: 9097\n",
      "  Staphylococcal Infections: 9098\n",
      "  Staphylococcal Skin Infection: 9099\n",
      "  Staphylococcal Skin Infections: 9100\n",
      "  Staphylococcal Vaccine: 9101\n",
      "  Staphylococcus: 9102\n",
      "  Staphylococcus Aureus: 9103\n",
      "  Staphylococcus Aureus Bacteraemia: 9104\n",
      "  Staphylococcus Aureus Bacteremia: 9105\n",
      "  Staphylococcus Aureus Pneumonia: 9106\n",
      "  Staphylococcus Aureus Skin Infection: 9107\n",
      "  Stargardt's Disease: 9108\n",
      "  Stargardt's Macular Dystrophy: 9109\n",
      "  Startle Response: 9110\n",
      "  Starvation: 9111\n",
      "  Stasis Ulcer: 9112\n",
      "  Statin Adverse Reaction: 9113\n",
      "  Statin Pharmacokinetics Pre and Post Gastric Bypass Surgery: 9114\n",
      "  Statin-associated Myalgia: 9115\n",
      "  Status Asthmaticus: 9116\n",
      "  Status Epilepticus: 9117\n",
      "  Status Epilepticus, Non-Convulsive: 9118\n",
      "  Steatorrhea: 9119\n",
      "  Stem Cell Transplant Complications: 9120\n",
      "  Stem Cell Transplant Patients: 9121\n",
      "  Stem Cell Transplantation: 9122\n",
      "  Stem Cells: 9123\n",
      "  Stenosis: 9124\n",
      "  Sternum Wound Infection: 9125\n",
      "  Steroid Refractory Acute Graft Versus Host Disease: 9126\n",
      "  Steroid and/or Prednisone Dependent Asthma: 9127\n",
      "  Steroid-Resistant Nephrotic Syndrome: 9128\n",
      "  Steroid-refractory Acute Graft-versus-Host Disease: 9129\n",
      "  Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation: 9130\n",
      "  Stevens-Johnson Syndrome: 9131\n",
      "  Stiff-Person Syndrome: 9132\n",
      "  Still's Disease, Adult-Onset: 9133\n",
      "  Stimulant Use & Co-occuring Opioid Use Disorders: 9134\n",
      "  Stomach (Gastric) Cancer: 9135\n",
      "  Stomach Cancer: 9136\n",
      "  Stomach Neoplasm: 9137\n",
      "  Stomach Neoplasms: 9138\n",
      "  Stomach Ulcer: 9139\n",
      "  Stomatitis: 9140\n",
      "  Strabismus: 9141\n",
      "  Street-crossing Ability: 9142\n",
      "  Streptococcal Infections: 9143\n",
      "  Streptococcus Pneumoniae: 9144\n",
      "  Stress: 9145\n",
      "  Stress Disorder: 9146\n",
      "  Stress Disorder, Post-Traumatic: 9147\n",
      "  Stress Disorders, Post Traumatic: 9148\n",
      "  Stress Disorders, Post-Traumatic: 9149\n",
      "  Stress Disorders, Posttraumatic: 9150\n",
      "  Stress Fracture Foot: 9151\n",
      "  Stress Hyperglycemia: 9152\n",
      "  Stress Urinary Incontinence: 9153\n",
      "  Striae Distensae: 9154\n",
      "  Stroke: 9155\n",
      "  Stroke Prevention in Patients With Atrial Fibrillation: 9156\n",
      "  Stroke, Acute: 9157\n",
      "  Stroke, Ischemic: 9158\n",
      "  Stroke, Not Specified as Hemorrhage or Infarction: 9159\n",
      "  Strongyloides Stercoralis Infection: 9160\n",
      "  Stunting: 9161\n",
      "  Sturge Weber Syndrome: 9162\n",
      "  Sturge- Weber Syndrome: 9163\n",
      "  Stuttering: 9164\n",
      "  Sub-optimal Vitamin D Status: 9165\n",
      "  Subacute Cutaneous Lupus Erythematosus: 9166\n",
      "  Subarachnoid Aneurysm Hemorrhage: 9167\n",
      "  Subarachnoid Cysticercosis: 9168\n",
      "  Subarachnoid Haemorrhage (SAH): 9169\n",
      "  Subarachnoid Hemorrhage: 9170\n",
      "  Subarachnoid Hemorrhage, Aneurysmal: 9171\n",
      "  Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation: 9172\n",
      "  Subclinical Hypercortisolism: 9173\n",
      "  Subclinical hypothyroïdism: 9174\n",
      "  Subcutaneous Abdominal Fat: 9175\n",
      "  Subcutaneous Adipose Tissue Reduction: 9176\n",
      "  Subfertility: 9177\n",
      "  Subfoveal Choroidal Neovascularization: 9178\n",
      "  Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD: 9179\n",
      "  Subjective Cognitive Decline: 9180\n",
      "  Subjective Tinnitus: 9181\n",
      "  Subjects Had Unipolar, Non-psychotic Major Depression: 9182\n",
      "  Subjects Referred to CT-examination of the Abdomen: 9183\n",
      "  Subjects Requesting and Requiring an Open Rhinoplasty: 9184\n",
      "  Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy: 9185\n",
      "  Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation): 9186\n",
      "  Subjects Undergoing Cataract Surgery and Insertion of IOL: 9187\n",
      "  Subjects With NSCLC With an EGFR Activating Mutation: 9188\n",
      "  Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC: 9189\n",
      "  Subjects With Varying Degrees of Renal Insufficiency and: 9190\n",
      "  Submacular Vascularized Pigment Epithelial Detachments: 9191\n",
      "  Substance Abuse: 9192\n",
      "  Substance Abuse Treatment for Adults: 9193\n",
      "  Substance Dependence: 9194\n",
      "  Substance Use: 9195\n",
      "  Substance Use Disorder: 9196\n",
      "  Substance Use Disorders: 9197\n",
      "  Substance Withdrawal Syndrome: 9198\n",
      "  Substance-Related Disorders: 9199\n",
      "  Substance-related Disorders: 9200\n",
      "  Sudden Cardiac Death: 9201\n",
      "  Sudden Deafness: 9202\n",
      "  Sudden Sensorineural Hearing Loss (SSNHL): 9203\n",
      "  Sugar Intake: 9204\n",
      "  Suicidal Ideation: 9205\n",
      "  Suicide: 9206\n",
      "  Suicide, Attempted: 9207\n",
      "  Sun Protection: 9208\n",
      "  Sun-induced Wrinkles: 9209\n",
      "  Sunburn: 9210\n",
      "  Superficial Basal Cell Carcinoma: 9211\n",
      "  Superficial Esophageal Cancer: 9212\n",
      "  Superficial Partial Thickness Burn: 9213\n",
      "  Superficial Surgical Site Infection: 9214\n",
      "  Superficial Venous Insufficiency, Varicose Veins: 9215\n",
      "  Supplementation: 9216\n",
      "  Suppression of Ovulation: 9217\n",
      "  Supracondylar Fractures: 9218\n",
      "  Supracondylar Humerus Fracture: 9219\n",
      "  Supranuclear Palsy, Progressive: 9220\n",
      "  Supratentorial Malignant Brain Tumor: 9221\n",
      "  Supratentorial Neoplasms, Malignant: 9222\n",
      "  Supratentorial Newly Diagnosed Inoperable Gliobastoma: 9223\n",
      "  Supraventricular Tachycardia: 9224\n",
      "  Surgery: 9225\n",
      "  Surgery of Right Upper Extremity: 9226\n",
      "  Surgery, Colorectal: 9227\n",
      "  Surgery, Hand: 9228\n",
      "  Surgical Adhesions: 9229\n",
      "  Surgical Anesthesia: 9230\n",
      "  Surgical Bleeding: 9231\n",
      "  Surgical Incisions: 9232\n",
      "  Surgical Pathology of the Leg or the Foot.: 9233\n",
      "  Surgical Release of Ai Pulley Trigger Finger: 9234\n",
      "  Surgical Site Infection: 9235\n",
      "  Surgical Site Infections: 9236\n",
      "  Surgical Skin Preparation: 9237\n",
      "  Surgical Wound Dehiscence: 9238\n",
      "  Surgical Wound Infection: 9239\n",
      "  Suspected Appendicitis: 9240\n",
      "  Suspected Biliary Obstruction: 9241\n",
      "  Suspected Heparin-Induced Thrombocytopenia: 9242\n",
      "  Suspected Pulmonary Embolism: 9243\n",
      "  Swallowing Dysfunction: 9244\n",
      "  Swine-Origin Influenza A H1N1 Virus: 9245\n",
      "  Sympathetic Nerve Activity: 9246\n",
      "  Symptomatic Anemia: 9247\n",
      "  Symptomatic Atrial Fibrillation: 9248\n",
      "  Symptomatic Cervical Disc Disease: 9249\n",
      "  Symptomatic Diabetic Peripheral Polyneuropathy: 9250\n",
      "  Symptomatic Femoro-popliteal Chronic Total Occlusion: 9251\n",
      "  Symptomatic Haemorrhoidal Disease Requiring Surgical Management: 9252\n",
      "  Symptomatic Hip Osteoarthritis: 9253\n",
      "  Symptomatic Irreversible Pulpitis: 9254\n",
      "  Symptomatic Musculoskeletal Diseases: 9255\n",
      "  Symptomatic Neurogenic Orthostatic Hypotension: 9256\n",
      "  Symptomatic Neurogenic Orthostatic Hypotension (NOH): 9257\n",
      "  Symptomatic Osteoarthritis of the Knee: 9258\n",
      "  Symptomatic Paroxysmal Atrial Fibrillation: 9259\n",
      "  Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases: 9260\n",
      "  Symptomatic or Large Uterine Fibroids: 9261\n",
      "  Symptoms of Inhalational Anthrax: 9262\n",
      "  Syndrome X: 9263\n",
      "  Syndrome of Inappropriate ADH-secretion: 9264\n",
      "  Syndromic Ichthyoses: 9265\n",
      "  Synovial Sarcoma: 9266\n",
      "  Syphilis: 9267\n",
      "  Systemic Anaplastic Large-Cell Lymphoma: 9268\n",
      "  Systemic Inflammation: 9269\n",
      "  Systemic Inflammatory Response Syndrome: 9270\n",
      "  Systemic Juvenile Idiopathic Arthritis: 9271\n",
      "  Systemic Lupus: 9272\n",
      "  Systemic Lupus Erythematosus: 9273\n",
      "  Systemic Lupus Erythematosus (SLE): 9274\n",
      "  Systemic Lupus Erythematosus Arthritis: 9275\n",
      "  Systemic Lupus Erythematosus Nephritis: 9276\n",
      "  Systemic Lupus Erythematosus, Lupus Nephritis: 9277\n",
      "  Systemic Mastocytosis: 9278\n",
      "  Systemic Mastocytosis, Aggressive (ASM): 9279\n",
      "  Systemic Scleroderma: 9280\n",
      "  Systemic Sclerosis: 9281\n",
      "  Systemic Sclerosis (Scleroderma): 9282\n",
      "  Systemic Sclerosis Patients With Digital Ulcers: 9283\n",
      "  Systemic Sclerosis, Scleroderma: 9284\n",
      "  Systemic Sclerosis-Associated PAH: 9285\n",
      "  Systemic Sclerosis-associated Interstitial Lung Disease: 9286\n",
      "  Systemic-Onset Juvenile Idiopathic Arthritis: 9287\n",
      "  Systolic Heart Failure: 9288\n",
      "  T Cell Leukemia, Adult: 9289\n",
      "  T Cell Non-Hodgkin Lymphoma: 9290\n",
      "  T-Acute Lymphoblastic Leukemia: 9291\n",
      "  T-Cell Large Granular Lymphocytic Leukemia: 9292\n",
      "  T-Cell Lymphoma: 9293\n",
      "  T-Cell Lymphoma Relapsed: 9294\n",
      "  T-cell Lymphoma: 9295\n",
      "  T-cell Non-Hodgkin Lymphoma: 9296\n",
      "  T-cell Non-Hodgkin's Lymphoma: 9297\n",
      "  T-cell Type Acute Leukemia-Precursor: 9298\n",
      "  T-cell-prolymphocytic Leukemia: 9299\n",
      "  T1DM: 9300\n",
      "  T2DM (Type 2 Diabetes Mellitus): 9301\n",
      "  T2DM With NAFLD: 9302\n",
      "  TAKAYASU ARTERITIS: 9303\n",
      "  TB: 9304\n",
      "  TBI: 9305\n",
      "  TBI (Traumatic Brain Injury): 9306\n",
      "  TBI-Traumatic Brain Injury: 9307\n",
      "  THoracotomy: 9308\n",
      "  TIA: 9309\n",
      "  TMD: 9310\n",
      "  TNF-receptor Associated Periodic Syndromes (TRAPS): 9311\n",
      "  TOBACCO USE CESSATION: 9312\n",
      "  TSC1: 9313\n",
      "  TTR-mediated Amyloidosis: 9314\n",
      "  TYpe 2 Diabetes Mellitus: 9315\n",
      "  Tachyarrhythmia: 9316\n",
      "  Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients: 9317\n",
      "  Takayasu's Arteritis: 9318\n",
      "  Takotsubo Cardiomyopathy: 9319\n",
      "  Talus Osteochondral Defect: 9320\n",
      "  Tardive Dyskinesia: 9321\n",
      "  Taste Disorder, Primary, Sweet: 9322\n",
      "  Taste, Altered: 9323\n",
      "  Tear Film Thickness: 9324\n",
      "  Teeth, Endodontically-Treated: 9325\n",
      "  Telangiectasia: 9326\n",
      "  Telangiectasia, Hereditary Hemorrhagic: 9327\n",
      "  Telangiectasis: 9328\n",
      "  Temporal Lobe Epilepsy: 9329\n",
      "  Temporomandibular Disorder: 9330\n",
      "  Temporomandibular Disorders: 9331\n",
      "  Temporomandibular Joint: 9332\n",
      "  Temporomandibular Joint Disorders: 9333\n",
      "  Temporomandibular Joint Dysfunction: 9334\n",
      "  Tendinitis: 9335\n",
      "  Tendinopathy: 9336\n",
      "  Tendinosis: 9337\n",
      "  Tendonitis: 9338\n",
      "  Tenia Solium Infection: 9339\n",
      "  Tennis Elbow: 9340\n",
      "  Tenosynovitis: 9341\n",
      "  Tension-Type Headache: 9342\n",
      "  Tension-type Headache: 9343\n",
      "  Tensional-type Headache: 9344\n",
      "  Teriflunomide Elimination: 9345\n",
      "  Termed Pregnancy With Indications for Labor Induction.: 9346\n",
      "  Terminal Liver Disease: 9347\n",
      "  Termination of Pregnancy: 9348\n",
      "  Tertiary Prevention in Colon Cancer: 9349\n",
      "  Testicular Cancer: 9350\n",
      "  Testicular Neoplasms: 9351\n",
      "  Testosterone Deficiency: 9352\n",
      "  Tetanus: 9353\n",
      "  Tetralogy of Fallot: 9354\n",
      "  Thalassemia: 9355\n",
      "  Thalassemia (Transfusion Delendent): 9356\n",
      "  Thalassemia Major With Severe Transfusional Iron Overload: 9357\n",
      "  Thalassemia Majors (Beta-Thalassemia Major): 9358\n",
      "  The Effect of LCFA on Nutrient Absorption: 9359\n",
      "  The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm: 9360\n",
      "  The Methodology Assessment of Glucose Dependent Insulin Secretion: 9361\n",
      "  The Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter Removal: 9362\n",
      "  The Primary Outcome of This Study Will be the Rate of Endometritis: 9363\n",
      "  Therapeutic Equivalency: 9364\n",
      "  Therapy: 9365\n",
      "  Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome: 9366\n",
      "  Therapy-resistant Depression: 9367\n",
      "  Thermal Burns: 9368\n",
      "  Thermal Hyperalgesia: 9369\n",
      "  Thermal Imaging, Neonatal Pneumonia, Tachypnea: 9370\n",
      "  Thermal Injury: 9371\n",
      "  Thermal Injury Pain: 9372\n",
      "  Third Degree Burns: 9373\n",
      "  Third Molar: 9374\n",
      "  Third Molar Extraction: 9375\n",
      "  Third Stage of Labor: 9376\n",
      "  Third Stage of Labour: 9377\n",
      "  Thoracic: 9378\n",
      "  Thoracic Aortic Aneurysms: 9379\n",
      "  Thoracic Diseases: 9380\n",
      "  Thoracic Neoplasm: 9381\n",
      "  Thoracic Paravertebral Blocks: 9382\n",
      "  Thoracic Sarcomas: 9383\n",
      "  Thoracic Surgery: 9384\n",
      "  Thoracic Surgery, Video-assisted: 9385\n",
      "  Thoracoabdominal Aortic Aneurysms: 9386\n",
      "  Thoracotomy: 9387\n",
      "  Thoracotomy Surgery: 9388\n",
      "  Threatened Abortion in First Trimester: 9389\n",
      "  Threatened Preterm Labor: 9390\n",
      "  Throat Disorder: 9391\n",
      "  Thrombin Inhibition: 9392\n",
      "  Thrombocytopaenia: 9393\n",
      "  Thrombocytopenia: 9394\n",
      "  Thrombocytosis: 9395\n",
      "  Thromboembolism: 9396\n",
      "  Thrombophilia Due to Acquired Antithrombin III Deficiency: 9397\n",
      "  Thrombosis: 9398\n",
      "  Thrombosis Portal Vein: 9399\n",
      "  Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL): 9400\n",
      "  Thrombotic Disorders: 9401\n",
      "  Thrombotic Microangiopathies: 9402\n",
      "  Thrombotic Microangiopathy: 9403\n",
      "  Thrombotic Thrombocytopenic Purpura: 9404\n",
      "  Thrombotic Thrombocytopenic Purpura (TTP): 9405\n",
      "  Thymic Carcinoma: 9406\n",
      "  Thymoma: 9407\n",
      "  Thymoma and Thymic Carcinoma: 9408\n",
      "  Thyroid: 9409\n",
      "  Thyroid Associated Ophthalmopathies: 9410\n",
      "  Thyroid Cancer: 9411\n",
      "  Thyroid Carcinoma: 9412\n",
      "  Thyroid Carcinoma, Anaplastic: 9413\n",
      "  Thyroid Disease: 9414\n",
      "  Thyroid Dysfunction: 9415\n",
      "  Thyroid Eye Disease: 9416\n",
      "  Thyroid Gland Carcinoma: 9417\n",
      "  Thyroid Neoplasm: 9418\n",
      "  Thyroid Neoplasms: 9419\n",
      "  Thyroid-Associated Ophthalmopathy: 9420\n",
      "  Thyroid-associated Ophthalmopathy: 9421\n",
      "  Thyroidectomy: 9422\n",
      "  Tibial Delayed Healing: 9423\n",
      "  Tibial Fractures: 9424\n",
      "  Tibial Plateau Fracture: 9425\n",
      "  Tick-Borne Encephalitis: 9426\n",
      "  Tick-borne Encephalitis: 9427\n",
      "  Time to Progression: 9428\n",
      "  Time-trial Performance: 9429\n",
      "  Tinea: 9430\n",
      "  Tinea Capitis: 9431\n",
      "  Tinea Cruris: 9432\n",
      "  Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied: 9433\n",
      "  Tinea Pedis: 9434\n",
      "  Tinnitus: 9435\n",
      "  Tinnitus, Subjective: 9436\n",
      "  Tissue Adhesions: 9437\n",
      "  Tissue Plasminogen Activator: 9438\n",
      "  To Assess the Tissular and Plasma Kinetics of Ertapenem: 9439\n",
      "  To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients: 9440\n",
      "  To Determine Bioequivalence Under Fasting Conditions: 9441\n",
      "  To Determine Bioequivalence Under Fed Conditions: 9442\n",
      "  Tobacco Abstinence Syndrome: 9443\n",
      "  Tobacco Abuse: 9444\n",
      "  Tobacco Cessation: 9445\n",
      "  Tobacco Dependence: 9446\n",
      "  Tobacco Smoking: 9447\n",
      "  Tobacco Toxicant Exposure: 9448\n",
      "  Tobacco Use: 9449\n",
      "  Tobacco Use Cessation: 9450\n",
      "  Tobacco Use Disorder: 9451\n",
      "  Tolerance: 9452\n",
      "  Tongue Cancer: 9453\n",
      "  Tonsillectomy: 9454\n",
      "  Tonsillectomy With or Without Adenoidectomy: 9455\n",
      "  Tonsillitis: 9456\n",
      "  Tooth Erosion: 9457\n",
      "  Tooth Extraction: 9458\n",
      "  Tooth Extraction Status Nos: 9459\n",
      "  Tooth Loss: 9460\n",
      "  Tooth Lost: 9461\n",
      "  Toothache: 9462\n",
      "  Topical Antisepsis: 9463\n",
      "  Torn Meniscus: 9464\n",
      "  Torsades de Pointes: 9465\n",
      "  Torticollis: 9466\n",
      "  Total Hip Arthroplasty: 9467\n",
      "  Total Hip Replacement: 9468\n",
      "  Total Hip Replacement Surgery: 9469\n",
      "  Total Hip Replacement System: 9470\n",
      "  Total Knee Arthroplasty: 9471\n",
      "  Total Knee Replacement: 9472\n",
      "  Total Knee and Total Hip Arthroplasty: 9473\n",
      "  Total Parenteral Nutrition-induced Cholestasis: 9474\n",
      "  Total Thyroidectomy: 9475\n",
      "  Tourette Disorder: 9476\n",
      "  Tourette Syndrome: 9477\n",
      "  Tourette's Disorder (TD): 9478\n",
      "  Tourette's Syndrome: 9479\n",
      "  Tourettes Syndrome: 9480\n",
      "  Tourniquet-induced Pain: 9481\n",
      "  Toxic Epidermal Necrolysis: 9482\n",
      "  Toxic Nodular Goitre: 9483\n",
      "  Toxic Shock Syndrome: 9484\n",
      "  Toxic-Shock Syndrome: 9485\n",
      "  Toxicity: 9486\n",
      "  Toxoplasmosis, Cerebral: 9487\n",
      "  Tracheal Intubation: 9488\n",
      "  Tracheal Stenosis: 9489\n",
      "  Tracheoesopharyngeal Fistula: 9490\n",
      "  Tracheostomy: 9491\n",
      "  Tracheostomy Infection: 9492\n",
      "  Trachoma: 9493\n",
      "  Tranexamic Acid: 9494\n",
      "  Transcatheter Aortic Valve Replacement: 9495\n",
      "  Transcranial Direct Current Stimulation: 9496\n",
      "  Transformed Migraine: 9497\n",
      "  Transfusion Reaction: 9498\n",
      "  Transfusion Transmitted Babesiosis: 9499\n",
      "  Transfusion-dependent β-thalassemia Patients: 9500\n",
      "  Transfusional Iron Overload: 9501\n",
      "  Transhumeral Amputation: 9502\n",
      "  Transient Hypothyroxinemia: 9503\n",
      "  Transient Hypothyroxinemia of Prematurity (THOP): 9504\n",
      "  Transient Insomnia: 9505\n",
      "  Transient Ischemic Attack: 9506\n",
      "  Transient Ischemic Attack (TIA): 9507\n",
      "  Transient Ischemic Attacks: 9508\n",
      "  Transient Neurologic Syndrome: 9509\n",
      "  Transient Severe Arterial Phase Motion: 9510\n",
      "  Transitional Cell Carcinoma: 9511\n",
      "  Transitional Cell Carcinoma of Bladder: 9512\n",
      "  Transitional Cell Carcinoma of the Bladder: 9513\n",
      "  Transplant Associated Microangiopathy TAM: 9514\n",
      "  Transplant Glomerulopathy: 9515\n",
      "  Transplant-Related Cancer: 9516\n",
      "  Transplant-Related Hematologic Malignancy: 9517\n",
      "  Transplant; Failure, Kidney: 9518\n",
      "  Transplantation: 9519\n",
      "  Transplantation Infection: 9520\n",
      "  Transplantation, Kidney: 9521\n",
      "  Transplantation, Liver: 9522\n",
      "  Transplants and Implants: 9523\n",
      "  Transthyretin (TTR)-Mediated Amyloidosis: 9524\n",
      "  Transverse Myelitis: 9525\n",
      "  Trauma: 9526\n",
      "  Trauma-related Wound: 9527\n",
      "  Trauma/Injury Problem: 9528\n",
      "  Traumatic Brain Injuries: 9529\n",
      "  Traumatic Brain Injury: 9530\n",
      "  Traumatic Brain Injury With Brief Loss of Consciousness: 9531\n",
      "  Traumatic Encephalopathies, Chronic: 9532\n",
      "  Traumatic Femur Fracture: 9533\n",
      "  Traumatic Hemorrhage: 9534\n",
      "  Traumatic Injury of the Spinal Cord: 9535\n",
      "  Traumatic Vaginal Delivery: 9536\n",
      "  Traumatic; Lesion: 9537\n",
      "  Traveler's Diarrhea: 9538\n",
      "  Travelers' Diarrhea: 9539\n",
      "  Treatment: 9540\n",
      "  Treatment Refusal: 9541\n",
      "  Treatment Resistant Depression: 9542\n",
      "  Treatment Resistant Depressive Disorder: 9543\n",
      "  Treatment Resistant Major Depressive Disorder: 9544\n",
      "  Treatment for Metastatic or Locally Advanced Cervical Cancer: 9545\n",
      "  Treatment of Acute Zika Virus Infection: 9546\n",
      "  Treatment of H. Pylori Infection: 9547\n",
      "  Treatment of Iron Deficiency Anemia in Pregnancy: 9548\n",
      "  Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis: 9549\n",
      "  Treatment- Resistant Bipolar Disorder: 9550\n",
      "  Treatment-Related Cancer: 9551\n",
      "  Treatment-Resistant Depression: 9552\n",
      "  Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB: 9553\n",
      "  Treatment-resistant Depression: 9554\n",
      "  Treatment-resistant Schizophrenia: 9555\n",
      "  Tremor: 9556\n",
      "  Trichomoniasis: 9557\n",
      "  Trichotillomania: 9558\n",
      "  Tricuspid Regurgitation: 9559\n",
      "  Trigeminal Neuralgia: 9560\n",
      "  Trigeminal Neuralgia (Burchiel Type I): 9561\n",
      "  Trigeminal Neuralgia (TN): 9562\n",
      "  Trigger Finger: 9563\n",
      "  Trigger Finger Disorder: 9564\n",
      "  Triple Negative Breast Cancer: 9565\n",
      "  Triple Negative Breast Cancer (TNBC): 9566\n",
      "  Triple Negative Breast Neoplasms: 9567\n",
      "  Triple Negative Locally Advanced Non-resectable Breast Cancer: 9568\n",
      "  Triple Negative Metastatic Breast Cancer: 9569\n",
      "  Triple-Negative Breast Cancer: 9570\n",
      "  Triple-Negative Breast Neoplasms: 9571\n",
      "  Triple-negative Breast Cancer: 9572\n",
      "  Trypanosomiasis: 9573\n",
      "  Trypanosomiasis, African: 9574\n",
      "  Tube Feeding: 9575\n",
      "  Tuberculosis: 9576\n",
      "  Tuberculosis Infection: 9577\n",
      "  Tuberculosis Multi Drug Resistant Active: 9578\n",
      "  Tuberculosis, MDR: 9579\n",
      "  Tuberculosis, Meningeal: 9580\n",
      "  Tuberculosis, Multidrug Resistant: 9581\n",
      "  Tuberculosis, Multidrug-Resistant: 9582\n",
      "  Tuberculosis, Pulmonary: 9583\n",
      "  Tuberculous Meningitis: 9584\n",
      "  Tuberous Sclerosis: 9585\n",
      "  Tuberous Sclerosis Complex: 9586\n",
      "  Tubular Breast Cancer Stage II: 9587\n",
      "  Tularemia: 9588\n",
      "  Tumor: 9589\n",
      "  Tumor Lysis Syndrome: 9590\n",
      "  Tumor With Alterations of the FGF-R: 9591\n",
      "  Tumor of Ear, Nose and Throat: 9592\n",
      "  Tumor or Lymphoma: 9593\n",
      "  Tumor, Brain: 9594\n",
      "  Tumor, Solid: 9595\n",
      "  Tumor-Induced Osteomalacia: 9596\n",
      "  Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome: 9597\n",
      "  Tumors: 9598\n",
      "  Tumors With Aberrations in ALK: 9599\n",
      "  Tumors With Aberrations in ALK or ROS1: 9600\n",
      "  Tumors of the Central Nervous System: 9601\n",
      "  Tumors, Breast: 9602\n",
      "  Tumors, Central Nervous System: 9603\n",
      "  Turner Syndrome: 9604\n",
      "  Turner's Syndrome: 9605\n",
      "  Tympanic Membrane Perforation: 9606\n",
      "  Type 1 Diabetes: 9607\n",
      "  Type 1 Diabetes Mellitus: 9608\n",
      "  Type 1 Diabetes Mellitus With Hypoglycemia: 9609\n",
      "  Type 1 Gaucher Disease: 9610\n",
      "  Type 1 Hyperlipoproteinemia: 9611\n",
      "  Type 2 Diabetes: 9612\n",
      "  Type 2 Diabetes Mellitus: 9613\n",
      "  Type 2 Diabetes Mellitus (T2DM): 9614\n",
      "  Type 2 Diabetes Mellitus Related Endothelial Dysfunction: 9615\n",
      "  Type 2 Diabetes Mellitus With Diabetic Nephropathy: 9616\n",
      "  Type 2 Diabetes Mellitus With Features of Insulin Resistance: 9617\n",
      "  Type 2 Diabetes Mellitus and Microalbuminuria: 9618\n",
      "  Type 2 Diabetes Mellitus(T2DM): 9619\n",
      "  Type 2 Diabetic Nephropathy: 9620\n",
      "  Type 2 Diabets Mellitus: 9621\n",
      "  Type 3 Choroidal Neovascularization: 9622\n",
      "  Type I Diabetes: 9623\n",
      "  Type I Diabetes Mellitus: 9624\n",
      "  Type I Hypersensitivity: 9625\n",
      "  Type I-Allergy: 9626\n",
      "  Type II Diabetes: 9627\n",
      "  Type II Diabetes Mellitus: 9628\n",
      "  Type IV Pressure Ulcers: 9629\n",
      "  Type One Diabetes: 9630\n",
      "  Type-2 Diabetes Mellitus: 9631\n",
      "  Type1 Diabetes: 9632\n",
      "  Type1 Diabetes Mellitus: 9633\n",
      "  Type1diabetes: 9634\n",
      "  Type2 Diabetes: 9635\n",
      "  Type2 Diabetes Mellitus: 9636\n",
      "  Typhoid Fever: 9637\n",
      "  Typhoid and Paratyphoid Fevers: 9638\n",
      "  URTICARIA: 9639\n",
      "  UTERINE MYOMAS: 9640\n",
      "  Ulcer: 9641\n",
      "  Ulcerated Cutaneous Metastases: 9642\n",
      "  Ulcerative Colitis: 9643\n",
      "  Ulcerative Colitis (UC): 9644\n",
      "  Ulcerative Colitis, Active Moderate: 9645\n",
      "  Ulcus Cruris: 9646\n",
      "  Ultrasonography: 9647\n",
      "  Ultrasound: 9648\n",
      "  Umbilical Cord Blood: 9649\n",
      "  Umbilical Cord Blood Transplant: 9650\n",
      "  Umbilical Hernia: 9651\n",
      "  Uncomplicated Acute Cholecystitis: 9652\n",
      "  Uncomplicated Cholelithiasis: 9653\n",
      "  Uncomplicated Falciparum Malaria: 9654\n",
      "  Uncomplicated Plasmodium Knowlesi Malaria: 9655\n",
      "  Uncontrolled Intraocular Pressure: 9656\n",
      "  Uncontrolled Postoperative Pain: 9657\n",
      "  Underdosing of Skeletal Muscle Relaxants for Laparotomy: 9658\n",
      "  Undesired Intrauterine Pregnancy: 9659\n",
      "  Unexplained Infertility: 9660\n",
      "  Unicompartmental Knee Replacement: 9661\n",
      "  Unilateral Cataract Extraction: 9662\n",
      "  Unilateral Cleft Lip: 9663\n",
      "  Unilateral Inguinal Hernia: 9664\n",
      "  Unilateral Knee Arthroplasty: 9665\n",
      "  Unilateral Limbal Stem Cell Insufficiency: 9666\n",
      "  Unipolar Depression: 9667\n",
      "  Unipolar Major Depression: 9668\n",
      "  Unknown Primary Carcinoma: 9669\n",
      "  Unknown Primary Tumors: 9670\n",
      "  Unplanned Caesarean Section: 9671\n",
      "  Unplanned Use of Health Care Services: 9672\n",
      "  Unrecognized Condition: 9673\n",
      "  Unrecognized Condition: Mature B or T-cell Neoplasm: 9674\n",
      "  Unresectable Hepatocellular Carcinoma: 9675\n",
      "  Unresectable Hepatocellular Carcinoma (HCC): 9676\n",
      "  Unresectable Intrahepatic Cholangiocarcinoma: 9677\n",
      "  Unresectable Liver Metastasis of Colorectal Cancer: 9678\n",
      "  Unresectable Malignant Neoplasm: 9679\n",
      "  Unresectable Metastatic Colo-rectal Cancer: 9680\n",
      "  Unresectable Metastatic Colorectal Cancer: 9681\n",
      "  Unresectable Pancreatic Carcinoma: 9682\n",
      "  Unresectable Stage III or Stage IV Melanoma: 9683\n",
      "  Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST): 9684\n",
      "  Unresectable or Metastatic Melanoma: 9685\n",
      "  Unresectable or Metastatic Solid Tumors: 9686\n",
      "  Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction: 9687\n",
      "  Unruptured Wide-neck Intracranial Aneurysms: 9688\n",
      "  Unsafe Sex: 9689\n",
      "  Unspecified Adult Solid Tumor: 9690\n",
      "  Unspecified Adult Solid Tumor - Protocol Specific: 9691\n",
      "  Unspecified Adult Solid Tumor, Protocol Specific: 9692\n",
      "  Unspecified Childhood Solid Tumor, Protocol Specific: 9693\n",
      "  Unstable Angina: 9694\n",
      "  Unstable Angina Pectoris: 9695\n",
      "  Untreated Adult Acute Myeloid Leukemia: 9696\n",
      "  Untreated Childhood Medulloblastoma: 9697\n",
      "  Untreated Metastatic Colorectal Cancer: 9698\n",
      "  Upper Airway Obstruction: 9699\n",
      "  Upper GI Bleeding: 9700\n",
      "  Upper GI Cancer: 9701\n",
      "  Upper Gastrointestinal Bleeding: 9702\n",
      "  Upper Gastrointestinal Disease,Ulcers: 9703\n",
      "  Upper Gastrointestinal Mucosal Damage: 9704\n",
      "  Upper Limb Spasticity: 9705\n",
      "  Upper Respiratory Infection: 9706\n",
      "  Upper Respiratory Infections: 9707\n",
      "  Upper Respiratory Tract Infection: 9708\n",
      "  Upper Respiratory Tract Infections: 9709\n",
      "  Urea Cycle Disorder: 9710\n",
      "  Urea Cycle Disorders: 9711\n",
      "  Urea Cycle Disorders, Inborn: 9712\n",
      "  Uremia: 9713\n",
      "  Uremic Pruritus: 9714\n",
      "  Uremic Pruritus in Hemodialysis Patients: 9715\n",
      "  Uremic Xerosis: 9716\n",
      "  Ureteral Calculi: 9717\n",
      "  Ureteral Calculi, Hyperalgic, Not Complicated: 9718\n",
      "  Ureteral Calculus: 9719\n",
      "  Ureteral Patency: 9720\n",
      "  Ureteral Stent Discomfort: 9721\n",
      "  Ureterolithiasis: 9722\n",
      "  Urethra Injury: 9723\n",
      "  Urethral Stricture Disease: 9724\n",
      "  Urethritis: 9725\n",
      "  Urge Urinary Incontinence: 9726\n",
      "  Urinary Bladder Cancer: 9727\n",
      "  Urinary Bladder Diseases: 9728\n",
      "  Urinary Bladder Neoplasm: 9729\n",
      "  Urinary Bladder Neoplasms: 9730\n",
      "  Urinary Bladder Overactive: 9731\n",
      "  Urinary Bladder, Neurogenic: 9732\n",
      "  Urinary Bladder, Overactive: 9733\n",
      "  Urinary Calculi: 9734\n",
      "  Urinary Catheterization: 9735\n",
      "  Urinary Frequency/Urgency: 9736\n",
      "  Urinary Incontinence: 9737\n",
      "  Urinary Incontinence , Stress: 9738\n",
      "  Urinary Incontinence Mixed (Stress and Urge): 9739\n",
      "  Urinary Incontinence, Stress: 9740\n",
      "  Urinary Incontinence, Urge: 9741\n",
      "  Urinary Infection: 9742\n",
      "  Urinary Retention: 9743\n",
      "  Urinary Retention Postoperative: 9744\n",
      "  Urinary Stress Incontinence: 9745\n",
      "  Urinary Tract Cancer: 9746\n",
      "  Urinary Tract Infection: 9747\n",
      "  Urinary Tract Infection Complicated: 9748\n",
      "  Urinary Tract Infection Symptomatic: 9749\n",
      "  Urinary Tract Infections: 9750\n",
      "  Urinary Tract Problem: 9751\n",
      "  Urinary Urge: 9752\n",
      "  Urinary Urge Incontinence: 9753\n",
      "  Urination Disorders: 9754\n",
      "  Urolithiasis: 9755\n",
      "  Urologic Diseases: 9756\n",
      "  Urologic Injuries: 9757\n",
      "  Urologic Malignancies: 9758\n",
      "  Urologic Neoplasms: 9759\n",
      "  Urological: 9760\n",
      "  Urothelial Cancer: 9761\n",
      "  Urothelial Carcinoma: 9762\n",
      "  Urticaria: 9763\n",
      "  Urticaria Chronic: 9764\n",
      "  Usher Syndrome: 9765\n",
      "  Usual Type Vulval Intraepithelial Neoplasia (uVIN): 9766\n",
      "  Uterine Atony: 9767\n",
      "  Uterine Cancer: 9768\n",
      "  Uterine Cervical Cancer: 9769\n",
      "  Uterine Cervical Dysplasia: 9770\n",
      "  Uterine Cervical Neoplasms: 9771\n",
      "  Uterine Fibroid: 9772\n",
      "  Uterine Fibroids: 9773\n",
      "  Uterine Fibroids and Heavy Menstrual Bleeding: 9774\n",
      "  Uterine Leiomyoma: 9775\n",
      "  Uterine Leiomyosarcoma: 9776\n",
      "  Uterine Myoma: 9777\n",
      "  Uterine Myomas: 9778\n",
      "  Uterine Neoplasms: 9779\n",
      "  Uterine Scar: 9780\n",
      "  Uterine Synechiae After Scraping for Natural Miscarriage: 9781\n",
      "  Uveal Melanoma: 9782\n",
      "  Uveitic Macular Edema: 9783\n",
      "  Uveitis: 9784\n",
      "  Uveitis Affecting the Posterior Segment: 9785\n",
      "  Uveitis, Anterior: 9786\n",
      "  Uveitis, Posterior: 9787\n",
      "  Uveitis; Posterior, Disorder: 9788\n",
      "  V600-mutated BRAF Unresectable Melanoma: 9789\n",
      "  VA Drug Interactions: 9790\n",
      "  VARICOSE VEINS: 9791\n",
      "  VHL Gene Mutation: 9792\n",
      "  VTE Prophylaxis: 9793\n",
      "  Vaccination: 9794\n",
      "  Vaccination Adverse Events: 9795\n",
      "  Vaccines: 9796\n",
      "  Vaccines, Pneumococcal: 9797\n",
      "  Vaccines, Pneumococcal Conjugate Vaccine: 9798\n",
      "  Vaginal Atrophy: 9799\n",
      "  Vaginal Atrophy in Breast Cancer Patients: 9800\n",
      "  Vaginal Delivery: 9801\n",
      "  Vaginal Dryness: 9802\n",
      "  Vaginal Health: 9803\n",
      "  Vaginal Hysterectomy: 9804\n",
      "  Vaginal Infection: 9805\n",
      "  Vaginal Prolapse: 9806\n",
      "  Vaginal Vault Prolapse: 9807\n",
      "  Vaginitis Bacterial: 9808\n",
      "  Vaginitis Gardnerella: 9809\n",
      "  Vaginosis, Bacterial: 9810\n",
      "  Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging: 9811\n",
      "  Valve Surgery: 9812\n",
      "  Valvular Heart Disease: 9813\n",
      "  Valvular Surgery: 9814\n",
      "  Vancomycin Resistant Enterococcal Colonization: 9815\n",
      "  Varenicline and the Blunting of Cocaine Cues: 9816\n",
      "  Variceal Bleeding: 9817\n",
      "  Varicella: 9818\n",
      "  Varicella Zoster: 9819\n",
      "  Varicocele: 9820\n",
      "  Varicose Ulcer: 9821\n",
      "  Varicose Veins: 9822\n",
      "  Various Advanced Cancer: 9823\n",
      "  Vascular Access Complication: 9824\n",
      "  Vascular Calcification: 9825\n",
      "  Vascular Dementia: 9826\n",
      "  Vascular Disease: 9827\n",
      "  Vascular Disease, Peripheral: 9828\n",
      "  Vascular Diseases: 9829\n",
      "  Vascular Headaches: 9830\n",
      "  Vascular Lesions: 9831\n",
      "  Vascular Resistance: 9832\n",
      "  Vascular Stiffness: 9833\n",
      "  Vascular System Injuries: 9834\n",
      "  Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot): 9835\n",
      "  Vasculitis: 9836\n",
      "  Vasculogenic Erectile Dysfunction: 9837\n",
      "  Vaso-occlusive Crisis: 9838\n",
      "  Vasoconstriction: 9839\n",
      "  Vasomotor Symptoms: 9840\n",
      "  Vasomotor Symptoms (VMS): 9841\n",
      "  Vasomotor Symptoms; Hot Flashes: 9842\n",
      "  Vasoplegia: 9843\n",
      "  Vasoplegic Syndrome: 9844\n",
      "  Vasospasm: 9845\n",
      "  Velo-cardio-facial Syndrome: 9846\n",
      "  Venezuelan Equine Encephalitis: 9847\n",
      "  Venom Allergy: 9848\n",
      "  Venous Disease Classification (CEAP): C2 or C3: 9849\n",
      "  Venous Hypertension Ulcers: 9850\n",
      "  Venous Insufficiency: 9851\n",
      "  Venous Leg Ulcer: 9852\n",
      "  Venous Leg Ulcers: 9853\n",
      "  Venous Reflux: 9854\n",
      "  Venous Stasis Ulcer: 9855\n",
      "  Venous Stasis Ulcers: 9856\n",
      "  Venous Thromboembolism: 9857\n",
      "  Venous Thromboembolism (VTE): 9858\n",
      "  Venous Thrombosis: 9859\n",
      "  Venous Ulcer: 9860\n",
      "  Venous Ulcers: 9861\n",
      "  Ventilation, Mechanical: 9862\n",
      "  Ventilator Adverse Event: 9863\n",
      "  Ventilator Associated Pneumonia: 9864\n",
      "  Ventilator Weaning: 9865\n",
      "  Ventilator-Associated Pneumonia: 9866\n",
      "  Ventilator-Associated Pneumonia (VAP): 9867\n",
      "  Ventilator-Induced Lung Injury: 9868\n",
      "  Ventilator-associated Pneumonia: 9869\n",
      "  Ventral Hernia: 9870\n",
      "  Ventricular Arrhythmia: 9871\n",
      "  Ventricular Function: 9872\n",
      "  Ventricular Premature Complexes: 9873\n",
      "  Ventricular Tachycardia: 9874\n",
      "  Verifying the Correct Position of Intravenous Catheters: 9875\n",
      "  Vernal Keratoconjunctivitis: 9876\n",
      "  Vertebral Compression Fracture: 9877\n",
      "  Vertebral Osteomyelitis: 9878\n",
      "  Vertigo: 9879\n",
      "  Very High Risk Neuroblastoma: 9880\n",
      "  Very Low Birth Weight Infant: 9881\n",
      "  Very Low Birth Weight Preterms: 9882\n",
      "  Vestibular Diseases: 9883\n",
      "  Vestibular Dizziness: 9884\n",
      "  Vestibular Migraine: 9885\n",
      "  Vestibular Schwannoma: 9886\n",
      "  Vestibulodynia: 9887\n",
      "  Vibrio Cholerae: 9888\n",
      "  Video Assisted Thoracoscopic Surgery: 9889\n",
      "  Vincristine Induced Neuropathy: 9890\n",
      "  Violence: 9891\n",
      "  Violent Aggressive Behavior: 9892\n",
      "  Viral Bronchiolitis: 9893\n",
      "  Viral Disease: 9894\n",
      "  Viral Hepatitis C: 9895\n",
      "  Viral Infection: 9896\n",
      "  Viral Upper Respiratory Tract Infection: 9897\n",
      "  Viruria: 9898\n",
      "  Virus: 9899\n",
      "  Virus Disease: 9900\n",
      "  Virus Diseases: 9901\n",
      "  Virus-HIV: 9902\n",
      "  Visceral Artery Aneurysms: 9903\n",
      "  Visceral Hypersensitivity: 9904\n",
      "  Visceral Leishmaniasis: 9905\n",
      "  Vision Disorders: 9906\n",
      "  Visual Acuity: 9907\n",
      "  Visual Acuity Reduced Transiently: 9908\n",
      "  Visual Impairment: 9909\n",
      "  Visual Impairment Due to Diabetic Macular Edema: 9910\n",
      "  Visual Outcomes: 9911\n",
      "  Vitamin B12 Deficiency: 9912\n",
      "  Vitamin D Deficiency: 9913\n",
      "  Vitamin D3 Deficiency: 9914\n",
      "  Vitamin d Deficiency: 9915\n",
      "  Vitiligo: 9916\n",
      "  Vitrectomy: 9917\n",
      "  Vitreomacular Attachment: 9918\n",
      "  Vitreomacular Traction: 9919\n",
      "  Vitreoretinal Traction Syndrome: 9920\n",
      "  Vitreous Hemorrhage: 9921\n",
      "  Vivax Malaria: 9922\n",
      "  Vocal Cord Paralysis Unilateral: 9923\n",
      "  Vocal Fold Nodules: 9924\n",
      "  Vogt Koyanagi Harada Disease: 9925\n",
      "  Voiding Cystourethrogram (VCUG): 9926\n",
      "  Volunteers: 9927\n",
      "  Volunteers on Chronic, Stable Antipsychotic Regimens: 9928\n",
      "  Vomiting: 9929\n",
      "  Vomiting Postoperative: 9930\n",
      "  Von Hippel-Lindau Syndrome: 9931\n",
      "  Von Willebrand Disease: 9932\n",
      "  Von Willebrand Diseases: 9933\n",
      "  Voriconazole: 9934\n",
      "  Vulvar Atrophy: 9935\n",
      "  Vulvar Cancer: 9936\n",
      "  Vulvar Lichen Sclerosus: 9937\n",
      "  Vulvar Vestibulitis: 9938\n",
      "  Vulvodynia: 9939\n",
      "  Vulvovaginal Atrophy: 9940\n",
      "  Vulvovaginal Candidiases: 9941\n",
      "  Vulvovaginal Candidiasis: 9942\n",
      "  Waldenstrom Macroglobulinemia: 9943\n",
      "  Waldenstrom's Macroglobulinemia: 9944\n",
      "  Waldenström Macroglobulinemia: 9945\n",
      "  Waldenström's Macroglobulinemia: 9946\n",
      "  Waning Donor Chimerism: 9947\n",
      "  Warfarin: 9948\n",
      "  Warm Autoimmune Hemolytic Anemia: 9949\n",
      "  Wart, Genital: 9950\n",
      "  Warts: 9951\n",
      "  Wasting: 9952\n",
      "  We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.: 9953\n",
      "  Weaning of Mechanical Ventilation: 9954\n",
      "  Wegener's Granulomatosis: 9955\n",
      "  Wegeners Granulomatosis: 9956\n",
      "  Weight: 9957\n",
      "  Weight Gain: 9958\n",
      "  Weight Gain Preterm: 9959\n",
      "  Weight Loss: 9960\n",
      "  Weight Maintenance: 9961\n",
      "  Weight Regain Post Bariatric Surgery: 9962\n",
      "  Weight-bearing Deficits: 9963\n",
      "  West Nile Fever: 9964\n",
      "  West Nile Fever Encephalitis: 9965\n",
      "  West Nile Neuroinvasive Disease: 9966\n",
      "  West Nile Viral Infection: 9967\n",
      "  West Nile Virus: 9968\n",
      "  Wet Age Related Macular Degeneration: 9969\n",
      "  Wet Age-Related Macular Degeneration: 9970\n",
      "  Wet Age-related Macular Degeneration: 9971\n",
      "  Wet Age-related Macular Degeneration (Wet AMD): 9972\n",
      "  Wet Macular Degeneration: 9973\n",
      "  Wheelchair Users: 9974\n",
      "  Wheeze: 9975\n",
      "  Wheezing: 9976\n",
      "  Wheezy Bronchitis: 9977\n",
      "  Whiplash: 9978\n",
      "  Whiplash Injuries: 9979\n",
      "  White Spot Lesion: 9980\n",
      "  Whole Cell Pertussis: 9981\n",
      "  Whooping Cough: 9982\n",
      "  Wide Neck Intracranial Aneurysms: 9983\n",
      "  Wild Type BRAF Stage IV Melanoma: 9984\n",
      "  Wilms Tumor: 9985\n",
      "  Wilson Disease: 9986\n",
      "  Wiskott-Aldrich Syndrome: 9987\n",
      "  Withdrawal Syndrome: 9988\n",
      "  Women Diagnosed With Cancer: 9989\n",
      "  Women With Fertility Disorder: 9990\n",
      "  Wound: 9991\n",
      "  Wound Care: 9992\n",
      "  Wound Complication: 9993\n",
      "  Wound Complications: 9994\n",
      "  Wound Heal: 9995\n",
      "  Wound Healing: 9996\n",
      "  Wound Healing Disturbance of: 9997\n",
      "  Wound Infection: 9998\n",
      "  Wound Infections: 9999\n",
      "  Wound of Skin: 10000\n",
      "  Wounds: 10001\n",
      "  Wounds and Injuries: 10002\n",
      "  Wrinkle: 10003\n",
      "  Wrinkles: 10004\n",
      "  X-Linked Adrenoleukodystrophy: 10005\n",
      "  X-Linked Hypophosphatemia: 10006\n",
      "  X-linked Adrenoleukodystrophy: 10007\n",
      "  X-linked Hypophosphatemia: 10008\n",
      "  Xerostomia: 10009\n",
      "  Xerostomia Due to Radiotherapy (Disorder): 10010\n",
      "  Yaws: 10011\n",
      "  Yellow Fever: 10012\n",
      "  Young Healthy Adults: 10013\n",
      "  ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease: 10014\n",
      "  Zika Virus: 10015\n",
      "  Zika Virus Infection: 10016\n",
      "  Zinc Deficiency: 10017\n",
      "  Zollinger-Ellison Syndrome: 10018\n",
      "  a Single-Dose of Etoricoxib: 10019\n",
      "  brca1 Mutation Carrier: 10020\n",
      "  c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM: 10021\n",
      "  cKIT-positive Solid Tumors: 10022\n",
      "  cMET-dysregulated Advanced Solid Tumors: 10023\n",
      "  in Vitro Fertilization: 10024\n",
      "  neurofibromatosis1 (NF1): 10025\n",
      "  pCR Rate: 10026\n",
      "  rrCLL: 10027\n",
      "  the Influence of Oropharyngeal Leak Pressure and Sealing Between the Mask and Vocal Cord During Changing Patient's Head and Neck Position: 10028\n",
      "  β-thalassemia Major: 10029\n",
      "\n",
      "Mapping for column 'intervention_type':\n",
      "  BEHAVIORAL: 0\n",
      "  BIOLOGICAL: 1\n",
      "  COMBINATION_PRODUCT: 2\n",
      "  DEVICE: 3\n",
      "  DIAGNOSTIC_TEST: 4\n",
      "  DIETARY_SUPPLEMENT: 5\n",
      "  DRUG: 6\n",
      "  GENETIC: 7\n",
      "  OTHER: 8\n",
      "  PROCEDURE: 9\n",
      "  RADIATION: 10\n",
      "\n",
      "Mapping for column 'study_design':\n",
      "  NON_RANDOMIZED: 0\n",
      "  RANDOMIZED: 1\n",
      "  UNKNOWN: 2\n",
      "\n",
      "Mapping for column 'sponsor_type':\n",
      "  AMBIG: 0\n",
      "  FED: 1\n",
      "  INDIV: 2\n",
      "  INDUSTRY: 3\n",
      "  NETWORK: 4\n",
      "  NIH: 5\n",
      "  OTHER: 6\n",
      "  OTHER_GOV: 7\n",
      "  UNKNOWN: 8\n",
      "\n",
      "Mapping for column 'gender':\n",
      "  ALL: 0\n",
      "  FEMALE: 1\n",
      "  MALE: 2\n",
      "\n",
      "Mapping for column 'location':\n",
      "  (FG) Puglia: 0\n",
      "  (sp): 1\n",
      "  *CS: 2\n",
      "  14166: 3\n",
      "  388-1 Pungnap-2dong, Songpa-gu: 4\n",
      "  7, Chung-Shan S. Road: 5\n",
      "  A Coruna: 6\n",
      "  A Coruña: 7\n",
      "  A.P: 8\n",
      "  AG: 9\n",
      "  AL: 10\n",
      "  AN: 11\n",
      "  AP: 12\n",
      "  APO Ae: 13\n",
      "  AR: 14\n",
      "  AV: 15\n",
      "  Aarhus: 16\n",
      "  Aarhus C: 17\n",
      "  Abbaseya: 18\n",
      "  Abbasseia: 19\n",
      "  Aberdeen: 20\n",
      "  Aberdeenshire: 21\n",
      "  Abington: 22\n",
      "  Abruzzo: 23\n",
      "  Accra: 24\n",
      "  Achaia: 25\n",
      "  Acre: 26\n",
      "  Ahmedabad: 27\n",
      "  Aichi: 28\n",
      "  Aichi Pref.: 29\n",
      "  Aisne: 30\n",
      "  Ajayonco@hotmail.com: 31\n",
      "  Akershus: 32\n",
      "  Akita: 33\n",
      "  Al Manial, Cairo, Egypt: 34\n",
      "  Al Qahirah: 35\n",
      "  Al-dakahliya: 36\n",
      "  Alabama: 37\n",
      "  Alabang: 38\n",
      "  Alaska: 39\n",
      "  Alava: 40\n",
      "  Alberta: 41\n",
      "  Alem 349, Ezeiza, Provincia de Buenos Aires: 42\n",
      "  Alexandria Governorate: 43\n",
      "  Alicante: 44\n",
      "  Almanial: 45\n",
      "  Alpes Maritimes: 46\n",
      "  Alpes de Haute provence: 47\n",
      "  Alpes-Maritimes: 48\n",
      "  Alsace: 49\n",
      "  Altindag: 50\n",
      "  Amazonas: 51\n",
      "  Amhara: 52\n",
      "  An Hui: 53\n",
      "  Anamdong 5-ga, Seongbuk-gu: 54\n",
      "  Ancona: 55\n",
      "  Andalucia: 56\n",
      "  Andalucía: 57\n",
      "  Andhra Pradesh: 58\n",
      "  Andhrapradesh: 59\n",
      "  Andria-Barletta-Trani: 60\n",
      "  Angus: 61\n",
      "  Anhui: 62\n",
      "  Ansan-si: 63\n",
      "  Antioquia: 64\n",
      "  Antwerp: 65\n",
      "  Antwerpen: 66\n",
      "  Aomori: 67\n",
      "  Aquitaine: 68\n",
      "  Araba: 69\n",
      "  Aracaju: 70\n",
      "  Aravaca: 71\n",
      "  Ardennes: 72\n",
      "  Argau: 73\n",
      "  Arizona: 74\n",
      "  Arkansas: 75\n",
      "  Arua District: 76\n",
      "  Asanbyeongwon-gil, songpa-gu: 77\n",
      "  Asante Akim North District: 78\n",
      "  Ascoli Piceno: 79\n",
      "  Ashanti: 80\n",
      "  Ashanti Region: 81\n",
      "  Assiut Governorate: 82\n",
      "  Assiut governorate: 83\n",
      "  Assuit: 84\n",
      "  Asturias: 85\n",
      "  Asyut: 86\n",
      "  Asyut Governorate: 87\n",
      "  Atacora: 88\n",
      "  Athens: 89\n",
      "  Attica: 90\n",
      "  Attika: 91\n",
      "  Attiki: 92\n",
      "  Auckland: 93\n",
      "  Australian Capital Territory: 94\n",
      "  Auvergne: 95\n",
      "  Auvergne-Rhône-Alpes: 96\n",
      "  Avellino: 97\n",
      "  Avon: 98\n",
      "  Ayrshire: 99\n",
      "  BA: 100\n",
      "  BAR: 101\n",
      "  BC - British Columbia: 102\n",
      "  BE: 103\n",
      "  BG: 104\n",
      "  BKK: 105\n",
      "  BL: 106\n",
      "  BN: 107\n",
      "  BO: 108\n",
      "  BS: 109\n",
      "  BW: 110\n",
      "  Baaden-Wuerttemberg: 111\n",
      "  Bad Krozingen: 112\n",
      "  Badajoz: 113\n",
      "  Baden Wuerttemberg: 114\n",
      "  Baden Würtemberg: 115\n",
      "  Baden Württemberg: 116\n",
      "  Baden-W.: 117\n",
      "  Baden-Wuertemberg: 118\n",
      "  Baden-Wuerttemberg: 119\n",
      "  Baden-Würrtemberg: 120\n",
      "  Baden-Würtemberg: 121\n",
      "  Baden-Württemberg: 122\n",
      "  Bagamoyo District: 123\n",
      "  Bagmati Zone: 124\n",
      "  Bahia: 125\n",
      "  Bahia State: 126\n",
      "  Bahçelievler: 127\n",
      "  Bahía: 128\n",
      "  Baja California: 129\n",
      "  Bakırkoy: 130\n",
      "  Baldingerstraße: 131\n",
      "  Baleares: 132\n",
      "  Balearic Island: 133\n",
      "  Bali: 134\n",
      "  Balkh: 135\n",
      "  Baluchistan: 136\n",
      "  Bangkok: 137\n",
      "  Banglore: 138\n",
      "  Banpo-daero Seocho-gu: 139\n",
      "  Baranya Megye: 140\n",
      "  Barcelona: 141\n",
      "  Barcelone: 142\n",
      "  Bari: 143\n",
      "  Bas Rhin: 144\n",
      "  Basel Stadt: 145\n",
      "  Basel-Stadt: 146\n",
      "  Baselstadt: 147\n",
      "  Basse-normandie: 148\n",
      "  Bavaria: 149\n",
      "  Bayern: 150\n",
      "  Beijing: 151\n",
      "  Bellariastrasse 38: 152\n",
      "  Ben Gurion: 153\n",
      "  Bergamo: 154\n",
      "  Berkshire: 155\n",
      "  Bern: 156\n",
      "  Bihar: 157\n",
      "  Bilbao: 158\n",
      "  Biomedicum: 159\n",
      "  Bispebjerg: 160\n",
      "  Bizakaia: 161\n",
      "  Bizkaia: 162\n",
      "  Blegdamsvej: 163\n",
      "  Blekinge: 164\n",
      "  Bloemfontein: 165\n",
      "  Bogotá D.C.: 166\n",
      "  Bordeaux: 167\n",
      "  Bornova: 168\n",
      "  Bouche Du Rhône: 169\n",
      "  Bouches Du Rhône: 170\n",
      "  Boulevard Georges Besnier: 171\n",
      "  Brabant: 172\n",
      "  Brabant Wallon: 173\n",
      "  Brandenburg: 174\n",
      "  Brescia: 175\n",
      "  Bretagne: 176\n",
      "  Brisbane, QLD: 177\n",
      "  British Columbia: 178\n",
      "  Brittany: 179\n",
      "  Brussel: 180\n",
      "  Brussel Hoofdstedelijk Gewest: 181\n",
      "  Brussels: 182\n",
      "  Brussels Hoofdstedelijk Gewest: 183\n",
      "  Bruxelles: 184\n",
      "  Bruxelles-Capitale: 185\n",
      "  Buckinghamshire: 186\n",
      "  Buenos Aires: 187\n",
      "  Bundang-gu: 188\n",
      "  Bupyeong 6-dong, Bupyeong-gu,: 189\n",
      "  Bupyoung-gu, Incheon: 190\n",
      "  Burgenland: 191\n",
      "  Burgundy: 192\n",
      "  Busan: 193\n",
      "  Busanjin-gu: 194\n",
      "  Busanjin-gu Gaegum-dong: 195\n",
      "  Bydgoszcz: 196\n",
      "  CE: 197\n",
      "  CF: 198\n",
      "  CH: 199\n",
      "  CH - 6853 Ligornetto: 200\n",
      "  CL: 201\n",
      "  CT: 202\n",
      "  Caba: 203\n",
      "  Cabo Delgado: 204\n",
      "  Cadiz: 205\n",
      "  Cairo: 206\n",
      "  Calabria: 207\n",
      "  California: 208\n",
      "  Calvados: 209\n",
      "  Cambridge: 210\n",
      "  Cambridgeshire: 211\n",
      "  Cambs: 212\n",
      "  Campania: 213\n",
      "  Canarias: 214\n",
      "  Canary Islands: 215\n",
      "  Cankaya: 216\n",
      "  Cantabria: 217\n",
      "  Canton St. Gall: 218\n",
      "  Canton of Geneva: 219\n",
      "  Cape Town: 220\n",
      "  Capital: 221\n",
      "  Capital Region: 222\n",
      "  Capital Region Of Denmark: 223\n",
      "  Capital Region of Denmark: 224\n",
      "  Cardiff: 225\n",
      "  Carinthia: 226\n",
      "  Castilla-La Mancha: 227\n",
      "  Castle hill hosp: 228\n",
      "  Catalonia: 229\n",
      "  Catalunya: 230\n",
      "  Cataluña: 231\n",
      "  Catania: 232\n",
      "  Catanzaro, CZ: 233\n",
      "  Catanzaro, CZ, Italy: 234\n",
      "  Cavite: 235\n",
      "  Ceara: 236\n",
      "  Ceará: 237\n",
      "  Cedex: 238\n",
      "  Cedex 09: 239\n",
      "  Cedex 19: 240\n",
      "  Central: 241\n",
      "  Central Java: 242\n",
      "  Centre: 243\n",
      "  Chaidari: 244\n",
      "  Chandpur: 245\n",
      "  Changhua Country: 246\n",
      "  Chantaburi: 247\n",
      "  Chengdu: 248\n",
      "  Chenni: 249\n",
      "  Cheon-nam: 250\n",
      "  Cheshire: 251\n",
      "  Chiang Mai: 252\n",
      "  Chiapas: 253\n",
      "  Chiayi Hsien: 254\n",
      "  Chiba: 255\n",
      "  Chiba-Ken: 256\n",
      "  Chiba-prefecture: 257\n",
      "  Chieti: 258\n",
      "  Chisinau: 259\n",
      "  Chon Buri: 260\n",
      "  Chongchungdo: 261\n",
      "  Chongno-gu: 262\n",
      "  Chongno-gu, 28 Yongon-dong: 263\n",
      "  Chongqing: 264\n",
      "  Chonnam: 265\n",
      "  Choong-Chung-Do: 266\n",
      "  Choongnam: 267\n",
      "  Chungbuk: 268\n",
      "  Chungcheonbuk-do: 269\n",
      "  Chungcheongbuk-do: 270\n",
      "  Chungcheongbul-do: 271\n",
      "  Chungcheongnam-do: 272\n",
      "  Chungnam: 273\n",
      "  Chuo-ku: 274\n",
      "  Ciudad Auton. de Buenos Aires: 275\n",
      "  Ciudad Autónoma de Buenos Aires: 276\n",
      "  Ciudad De México: 277\n",
      "  Co Galway: 278\n",
      "  Co Waterford: 279\n",
      "  Co. Cork: 280\n",
      "  Co. Dublin: 281\n",
      "  Coast: 282\n",
      "  Colorado: 283\n",
      "  Comunidad Valenciana: 284\n",
      "  Connacht: 285\n",
      "  Connecticut: 286\n",
      "  Copebhagen: 287\n",
      "  Copenhagen: 288\n",
      "  Copenhagen NV: 289\n",
      "  Copenhagen OE: 290\n",
      "  Copenhagen Ø: 291\n",
      "  Cornwall: 292\n",
      "  Coronado (S.Romão E S. Mamede): 293\n",
      "  County Antrim: 294\n",
      "  County Derry: 295\n",
      "  Coyoacan: 296\n",
      "  Creta: 297\n",
      "  Crete: 298\n",
      "  Csongrad: 299\n",
      "  Cundinamarca: 300\n",
      "  Czech: 301\n",
      "  Czech Republic: 302\n",
      "  Czechosłowacka 8/10: 303\n",
      "  Cádiz: 304\n",
      "  Cádiz.: 305\n",
      "  Côte d'Or: 306\n",
      "  D: 307\n",
      "  D. F: 308\n",
      "  D. F.: 309\n",
      "  D.F: 310\n",
      "  D.F. Mexico: 311\n",
      "  D.f.: 312\n",
      "  DF: 313\n",
      "  DI Yogyakarta: 314\n",
      "  DK: 315\n",
      "  DKI Jakarta: 316\n",
      "  Daechon: 317\n",
      "  Dahak-ro: 318\n",
      "  Dakahalia: 319\n",
      "  Dakahlia: 320\n",
      "  Danmark: 321\n",
      "  De Pintelaan 185: 322\n",
      "  Delaware: 323\n",
      "  Delhi: 324\n",
      "  Derbyshire: 325\n",
      "  Devon: 326\n",
      "  Devon,: 327\n",
      "  District of Columbia: 328\n",
      "  Distrito Federal: 329\n",
      "  Dong dae sin-dong, Seo-gu: 330\n",
      "  Donggu, Jebongro: 331\n",
      "  Dorset: 332\n",
      "  Down: 333\n",
      "  Drente: 334\n",
      "  Dresden: 335\n",
      "  Dublin 4: 336\n",
      "  Dwazulu Natal: 337\n",
      "  ES - Espírito Santo: 338\n",
      "  East Java: 339\n",
      "  East Lancashire: 340\n",
      "  East Sussex: 341\n",
      "  East Yorkshire: 342\n",
      "  East azarbaijan: 343\n",
      "  East-Flanders: 344\n",
      "  East-Flandres: 345\n",
      "  East-Kazakhstan Region: 346\n",
      "  Eastern: 347\n",
      "  Eastern Blacksea: 348\n",
      "  Eastern Cape: 349\n",
      "  Eastern Hararage: 350\n",
      "  Eastern Region: 351\n",
      "  Edegem: 352\n",
      "  Ehime: 353\n",
      "  Ehime-Ken: 354\n",
      "  Eiveniu str. 2: 355\n",
      "  El Qalubia: 356\n",
      "  El Qaluobia: 357\n",
      "  El Qualyobia: 358\n",
      "  Elqalopia: 359\n",
      "  Emilia Romagna: 360\n",
      "  Emilia-Romagna: 361\n",
      "  England: 362\n",
      "  Epirus: 363\n",
      "  Equateur: 364\n",
      "  Esbjerg N: 365\n",
      "  Espirito Santo: 366\n",
      "  Espírito Santo: 367\n",
      "  Essex: 368\n",
      "  Estado De México: 369\n",
      "  Estado de Mexico C.P.: 370\n",
      "  Estado-de-Mexico: 371\n",
      "  Ezor Hashfela: 372\n",
      "  FC: 373\n",
      "  FG: 374\n",
      "  FI: 375\n",
      "  Faiyum Governorate: 376\n",
      "  Fajara: 377\n",
      "  Fars: 378\n",
      "  Federal District: 379\n",
      "  Federal Teritory: 380\n",
      "  Federal Territory: 381\n",
      "  Ferrara: 382\n",
      "  Fife: 383\n",
      "  Firenze: 384\n",
      "  Flanders: 385\n",
      "  Flevoland: 386\n",
      "  Florence: 387\n",
      "  Florida: 388\n",
      "  Foggia: 389\n",
      "  Forlì - Cesena: 390\n",
      "  Fr: 391\n",
      "  Framlington Place: 392\n",
      "  Franconia: 393\n",
      "  Frederiksberg: 394\n",
      "  Frederiksberg C: 395\n",
      "  Free State: 396\n",
      "  Friesland: 397\n",
      "  Friuli Venezia Giulia: 398\n",
      "  Fujian: 399\n",
      "  Fukuoka: 400\n",
      "  Fukuoka-ken: 401\n",
      "  Fukuoka-prefecture: 402\n",
      "  Fukushima: 403\n",
      "  Funen: 404\n",
      "  Fyn: 405\n",
      "  GE: 406\n",
      "  GO: 407\n",
      "  GR: 408\n",
      "  Gabrovo: 409\n",
      "  Galicia: 410\n",
      "  Gangnam: 411\n",
      "  Gangnam Gu: 412\n",
      "  Gangnam-Gu: 413\n",
      "  Gangwon-do: 414\n",
      "  Gansu: 415\n",
      "  Gard: 416\n",
      "  Gauteng: 417\n",
      "  Gedaref: 418\n",
      "  Gedarif: 419\n",
      "  Gelderland: 420\n",
      "  Georgia: 421\n",
      "  Gizella telep: 422\n",
      "  Gjettum: 423\n",
      "  Glamorgan: 424\n",
      "  Glostrup: 425\n",
      "  Gloucestershire: 426\n",
      "  Goias: 427\n",
      "  Goiás: 428\n",
      "  Gojan1-dong/Danwon-gu: 429\n",
      "  Golestan: 430\n",
      "  Golnik: 431\n",
      "  Gorizia: 432\n",
      "  Goyang-si, Gyeonggi-do: 433\n",
      "  Graubuenden: 434\n",
      "  Greater London: 435\n",
      "  Greater Manchester: 436\n",
      "  Grosseto: 437\n",
      "  Guadeloupe: 438\n",
      "  Guanajuato: 439\n",
      "  Guang-Dong: 440\n",
      "  Guangdong: 441\n",
      "  Guangxi: 442\n",
      "  Guangxi Autonomous Region: 443\n",
      "  Guangzhou: 444\n",
      "  Guateng: 445\n",
      "  Guilan: 446\n",
      "  Guipuzcoa: 447\n",
      "  Guipuzcua: 448\n",
      "  Guishan Dist: 449\n",
      "  Gujarat: 450\n",
      "  Gujarat,: 451\n",
      "  Gujrat: 452\n",
      "  Gujurat: 453\n",
      "  Gunma: 454\n",
      "  Guro-gu: 455\n",
      "  Guro-ku, Seoul: 456\n",
      "  Gyenggi: 457\n",
      "  Gyeong-gi: 458\n",
      "  GyeongGi: 459\n",
      "  Gyeonggi: 460\n",
      "  Gyeonggi Do: 461\n",
      "  Gyeonggi-Do: 462\n",
      "  Gyeonggi-do: 463\n",
      "  Gyeonggido: 464\n",
      "  Gyeongsang Namdo: 465\n",
      "  Gyeongsang-Nam-Do: 466\n",
      "  Gyeongsangnam-do: 467\n",
      "  Gyeongsangnamdo: 468\n",
      "  Gyounggi: 469\n",
      "  Gyunggi: 470\n",
      "  Gyunggi-do: 471\n",
      "  HH: 472\n",
      "  HK: 473\n",
      "  HUS: 474\n",
      "  Hainaut: 475\n",
      "  Hajdú-Bihar: 476\n",
      "  Hakata: 477\n",
      "  Hamerkaz: 478\n",
      "  Hammersmith: 479\n",
      "  Hampshire: 480\n",
      "  Hants: 481\n",
      "  Haryana: 482\n",
      "  Hasharon: 483\n",
      "  Hasharon Area: 484\n",
      "  Haute Garonne: 485\n",
      "  Haute Normandie: 486\n",
      "  Haute-Garonne: 487\n",
      "  Hauts Bassins-houet: 488\n",
      "  Hauts de Seine: 489\n",
      "  Hauts-de-Seine: 490\n",
      "  Havana: 491\n",
      "  Hawaii: 492\n",
      "  Hebei: 493\n",
      "  Heilongjiang: 494\n",
      "  Hellerup: 495\n",
      "  Henan: 496\n",
      "  Herestraat 49: 497\n",
      "  Herlev: 498\n",
      "  Hermosillo: 499\n",
      "  Hesse: 500\n",
      "  Hessen: 501\n",
      "  Hessia: 502\n",
      "  Hidalgo: 503\n",
      "  Hiroshima: 504\n",
      "  Hiroshima-ken: 505\n",
      "  Hksar: 506\n",
      "  Hoa Binh: 507\n",
      "  Hobrovej 18-22: 508\n",
      "  Hokkaido: 509\n",
      "  Hokkaidou: 510\n",
      "  Hong Kong: 511\n",
      "  Hong Kong Island: 512\n",
      "  Hong Kong SAR: 513\n",
      "  Hordaland: 514\n",
      "  Hormozgan: 515\n",
      "  Hovedstaden: 516\n",
      "  Hubei: 517\n",
      "  Huddinge: 518\n",
      "  Hunan: 519\n",
      "  Hvidovre: 520\n",
      "  Hyderabad: 521\n",
      "  Hyogo: 522\n",
      "  Hyogo-Pref.: 523\n",
      "  Häme: 524\n",
      "  Hôpital cardiologique: 525\n",
      "  IV: 526\n",
      "  Ibaragi: 527\n",
      "  Ibaraki: 528\n",
      "  Idaho: 529\n",
      "  Ile De France: 530\n",
      "  Ile de France: 531\n",
      "  Ile-de-France: 532\n",
      "  Ile-de-france: 533\n",
      "  Illinois: 534\n",
      "  Indiana: 535\n",
      "  International/Other: 536\n",
      "  Iowa: 537\n",
      "  Ipoh, Perak: 538\n",
      "  Irwon-Dong, Gangnam-Gu: 539\n",
      "  Isere: 540\n",
      "  Isfahan: 541\n",
      "  Ishikawa: 542\n",
      "  Islas Baleares: 543\n",
      "  Islas Canarias: 544\n",
      "  Istanbul: 545\n",
      "  Isère: 546\n",
      "  Italia: 547\n",
      "  Italy/Bologna: 548\n",
      "  Italy/GE: 549\n",
      "  Izmir: 550\n",
      "  Jaen: 551\n",
      "  Jakarta: 552\n",
      "  Jalisco: 553\n",
      "  Jammu & Kashmir: 554\n",
      "  Jammu and kashmir: 555\n",
      "  Jankovcova: 556\n",
      "  Jaén: 557\n",
      "  Jeju Special Self-Governing Province: 558\n",
      "  Jeolla Namdo: 559\n",
      "  Jeollabuk-do: 560\n",
      "  Jeollabukdo: 561\n",
      "  Jeollanam-do: 562\n",
      "  Jeollanamdo: 563\n",
      "  Jeonbuk: 564\n",
      "  Jeonnam: 565\n",
      "  Jette: 566\n",
      "  Jiangsu: 567\n",
      "  Jiangxi: 568\n",
      "  Jihomoravsky Kraj: 569\n",
      "  Jihomoravský Kraj: 570\n",
      "  Jilin: 571\n",
      "  Jin-Gu: 572\n",
      "  Johannesburg: 573\n",
      "  Johor: 574\n",
      "  Johor Bahru: 575\n",
      "  Jongno-Gu: 576\n",
      "  Jung-gu: 577\n",
      "  Jutland: 578\n",
      "  Jylland: 579\n",
      "  Kagawa: 580\n",
      "  Kagoshima: 581\n",
      "  Kagoshima-ken: 582\n",
      "  Kagoshima-prefecture: 583\n",
      "  Kailali: 584\n",
      "  Kanagawa: 585\n",
      "  Kanchanaburi: 586\n",
      "  Kangwon-do: 587\n",
      "  Kansai: 588\n",
      "  Kansas: 589\n",
      "  Kanto: 590\n",
      "  Kanton Zürich: 591\n",
      "  Karnataka: 592\n",
      "  Karonga District: 593\n",
      "  Kasr el Aini: 594\n",
      "  Katanga: 595\n",
      "  Kec.oren: 596\n",
      "  Kelantan: 597\n",
      "  Kempten: 598\n",
      "  Kent: 599\n",
      "  Kentucky: 600\n",
      "  Kerala: 601\n",
      "  Khon Kaen: 602\n",
      "  KhonKaen: 603\n",
      "  Khonkaen: 604\n",
      "  Khorasan: 605\n",
      "  Khorasan Razavi: 606\n",
      "  Khorasane Razavi: 607\n",
      "  Kigali: 608\n",
      "  Kigoma: 609\n",
      "  Kilimanjaro: 610\n",
      "  Kingston 7: 611\n",
      "  Kinshasa province: 612\n",
      "  Kisumu: 613\n",
      "  Kobe-shi: 614\n",
      "  Korea: 615\n",
      "  Korea, Gyeonggi-do: 616\n",
      "  Koshi: 617\n",
      "  Krankenhausstrase 12: 618\n",
      "  Krasnodarskiy Kray: 619\n",
      "  Kresimirova 42: 620\n",
      "  Králové: 621\n",
      "  Kuala Lumpur: 622\n",
      "  Kujawsko-Pomorskie: 623\n",
      "  Kwa-Zulu Natal: 624\n",
      "  KwaZulu Natal: 625\n",
      "  KwaZulu-Natal: 626\n",
      "  KwaZulu-Natal,: 627\n",
      "  Kwara: 628\n",
      "  Kyeonggi-do: 629\n",
      "  Kyonggi-do: 630\n",
      "  Kyunggi Province: 631\n",
      "  Kyungkido: 632\n",
      "  København Ø: 633\n",
      "  LC: 634\n",
      "  La: 635\n",
      "  La Coruña: 636\n",
      "  La Habana: 637\n",
      "  La Réunion: 638\n",
      "  Lagos: 639\n",
      "  Lagos State: 640\n",
      "  Lanarkshire: 641\n",
      "  Lancashire: 642\n",
      "  Las Palmas: 643\n",
      "  Latina: 644\n",
      "  Lazio: 645\n",
      "  Le Kremlin-Bicêtre: 646\n",
      "  Lecce: 647\n",
      "  Leicestershire: 648\n",
      "  Liaoning: 649\n",
      "  Liege: 650\n",
      "  Liguria: 651\n",
      "  Limburg: 652\n",
      "  Limerick: 653\n",
      "  Limoges: 654\n",
      "  Liège: 655\n",
      "  Loei Province: 656\n",
      "  Loire Atlantique: 657\n",
      "  Lombardia: 658\n",
      "  Lombardy: 659\n",
      "  London: 660\n",
      "  London SW17 0RE: 661\n",
      "  Loreto: 662\n",
      "  Los Ríos: 663\n",
      "  Lothian: 664\n",
      "  Louisiana: 665\n",
      "  Louvain: 666\n",
      "  Lower Austria: 667\n",
      "  Lower Galilee: 668\n",
      "  Lower Saxonia: 669\n",
      "  Lower Saxony: 670\n",
      "  Lubelskie: 671\n",
      "  Lucerne: 672\n",
      "  Lugano: 673\n",
      "  MB: 674\n",
      "  ME: 675\n",
      "  MG: 676\n",
      "  MI: 677\n",
      "  MV: 678\n",
      "  Madang and East Sepik Province: 679\n",
      "  Madri: 680\n",
      "  Madrid: 681\n",
      "  Maferinyah: 682\n",
      "  Maharashtr: 683\n",
      "  Maharashtra: 684\n",
      "  Maharastra: 685\n",
      "  Maidstone: 686\n",
      "  Maine: 687\n",
      "  Makkah Western: 688\n",
      "  Malaga: 689\n",
      "  Malmö: 690\n",
      "  Manchester: 691\n",
      "  Manial: 692\n",
      "  Manitoba: 693\n",
      "  Manyara: 694\n",
      "  Maradi: 695\n",
      "  Maranhao: 696\n",
      "  Maranhão: 697\n",
      "  Marne: 698\n",
      "  Marseille Cedex 09: 699\n",
      "  Martinique: 700\n",
      "  Maryland: 701\n",
      "  Massachusetts: 702\n",
      "  Mato Grosso: 703\n",
      "  Mato Grosso Do Sul: 704\n",
      "  Mazandaran: 705\n",
      "  Mazowieckie: 706\n",
      "  Mecklenburg Vorpommern: 707\n",
      "  Mecklenburg-Vorpommern: 708\n",
      "  Melbourne: 709\n",
      "  Menoufia: 710\n",
      "  Merseyside: 711\n",
      "  Met: 712\n",
      "  Metro Manila: 713\n",
      "  Metropolitan: 714\n",
      "  Metropolitan Region: 715\n",
      "  Metropolitana: 716\n",
      "  Mexico DF: 717\n",
      "  Mi: 718\n",
      "  Miaoli: 719\n",
      "  Michigan: 720\n",
      "  Michoacán: 721\n",
      "  Mid Galmorgan: 722\n",
      "  Middlesex: 723\n",
      "  Midi-Pyrénées: 724\n",
      "  Midlothian: 725\n",
      "  Mie: 726\n",
      "  Milan: 727\n",
      "  Milano: 728\n",
      "  Minas Gerais: 729\n",
      "  Minas Gerais/Belo Horizonte: 730\n",
      "  Minnesota: 731\n",
      "  Mississippi: 732\n",
      "  Missouri: 733\n",
      "  Miyagi: 734\n",
      "  Monstir: 735\n",
      "  Montana: 736\n",
      "  Montebello: 737\n",
      "  MonzaBrianza: 738\n",
      "  Morane Saulnier: 739\n",
      "  Moravian-Silesian Region: 740\n",
      "  Morelos: 741\n",
      "  Moscow Region: 742\n",
      "  Moscow region: 743\n",
      "  Mount Scopus: 744\n",
      "  Mowbray: 745\n",
      "  Moyen Ogooué: 746\n",
      "  Muheza: 747\n",
      "  Murcia: 748\n",
      "  Murillo: 749\n",
      "  N Brabant: 750\n",
      "  N Kivu: 751\n",
      "  N-H: 752\n",
      "  N.t.: 753\n",
      "  N/A = Not Applicable: 754\n",
      "  NCR: 755\n",
      "  NH: 756\n",
      "  NRW: 757\n",
      "  NW: 758\n",
      "  Nagano: 759\n",
      "  Namur: 760\n",
      "  Nangarha: 761\n",
      "  Nantes Cedex 1: 762\n",
      "  Narino: 763\n",
      "  Nariño: 764\n",
      "  Nasr City: 765\n",
      "  National Capital Region: 766\n",
      "  Navarra: 767\n",
      "  Navarre: 768\n",
      "  Nebraska: 769\n",
      "  Negev: 770\n",
      "  Nehu District: 771\n",
      "  Nesttun: 772\n",
      "  Nevada: 773\n",
      "  New Brunswick: 774\n",
      "  New Hampshire: 775\n",
      "  New Jersey: 776\n",
      "  New Mexico: 777\n",
      "  New South Wales: 778\n",
      "  New Taipei: 779\n",
      "  New Territories: 780\n",
      "  New Territories, Hong Kong: 781\n",
      "  New York: 782\n",
      "  New ireland province: 783\n",
      "  Newfoundland and Labrador: 784\n",
      "  Nezam Abad: 785\n",
      "  Nicosia: 786\n",
      "  Niedersachsen: 787\n",
      "  Niger: 788\n",
      "  Non US: 789\n",
      "  Non-US/Canada: 790\n",
      "  Noord Brabant: 791\n",
      "  Noord Holland: 792\n",
      "  Noord-Brabant: 793\n",
      "  Noord-Holland: 794\n",
      "  Nord Pas de Calais: 795\n",
      "  Nord-Rhein Westfahlen: 796\n",
      "  Nord-Trøndelag: 797\n",
      "  Nordrhein: 798\n",
      "  Nordrhein-Westfalen: 799\n",
      "  Norfolk: 800\n",
      "  Norrland: 801\n",
      "  North: 802\n",
      "  North Bank Region: 803\n",
      "  North Carolina: 804\n",
      "  North Dakota: 805\n",
      "  North Holland: 806\n",
      "  North Island: 807\n",
      "  North Rhine Westphalia: 808\n",
      "  North Rhine-Westphalia: 809\n",
      "  North-Holland: 810\n",
      "  North-Rhine Westfalia: 811\n",
      "  North-Rhine-Westphalia: 812\n",
      "  Northern Ireland: 813\n",
      "  Northern Jutland: 814\n",
      "  Northern Savo: 815\n",
      "  Northern Territory: 816\n",
      "  Not In US/Canada: 817\n",
      "  Nottingham: 818\n",
      "  Nottinghamshire: 819\n",
      "  Notts: 820\n",
      "  Nova Scotia: 821\n",
      "  Nowon-Gu: 822\n",
      "  Nowon-gu: 823\n",
      "  Nuevo Leon: 824\n",
      "  Nuevo León: 825\n",
      "  Nyanza: 826\n",
      "  Nyanza Province: 827\n",
      "  OYO State: 828\n",
      "  OYS: 829\n",
      "  Oberösterreich: 830\n",
      "  Odense C: 831\n",
      "  Ohio: 832\n",
      "  Okayama: 833\n",
      "  Okinawa: 834\n",
      "  Oklahoma: 835\n",
      "  Old Cairo: 836\n",
      "  Ontario: 837\n",
      "  Oost-Vlaanderen: 838\n",
      "  Orbassano: 839\n",
      "  Ordu: 840\n",
      "  Oregon: 841\n",
      "  Oromia: 842\n",
      "  Osaka: 843\n",
      "  Osaka prefecture: 844\n",
      "  Osterreich: 845\n",
      "  Ostfold: 846\n",
      "  Otago: 847\n",
      "  Overijssel: 848\n",
      "  Oxfordshire: 849\n",
      "  Oxon: 850\n",
      "  Oxons: 851\n",
      "  Oyo: 852\n",
      "  P.O.Box 22660: 853\n",
      "  P.O.Box 6661: 854\n",
      "  PD: 855\n",
      "  PE: 856\n",
      "  PIaui: 857\n",
      "  PR: 858\n",
      "  PV: 859\n",
      "  PZ: 860\n",
      "  Paca: 861\n",
      "  Palpa: 862\n",
      "  Para: 863\n",
      "  Paraiba: 864\n",
      "  Parana: 865\n",
      "  Paraná: 866\n",
      "  Paraíba: 867\n",
      "  Paris: 868\n",
      "  Paris Area: 869\n",
      "  Paris Cedex 14: 870\n",
      "  Paris Cedex 18: 871\n",
      "  Pathumthani: 872\n",
      "  Patras: 873\n",
      "  Pays de la Loire: 874\n",
      "  Pei-Tou District: 875\n",
      "  Penang: 876\n",
      "  Pennsylvania: 877\n",
      "  Pernambuco: 878\n",
      "  Pesaro Urbino: 879\n",
      "  Piauí: 880\n",
      "  Picardie: 881\n",
      "  Piedmont: 882\n",
      "  Pirkanmaa: 883\n",
      "  Please Select: 884\n",
      "  Please Select...: 885\n",
      "  Please select: 886\n",
      "  Pondicherry UT: 887\n",
      "  Pontevedra: 888\n",
      "  Pordenone: 889\n",
      "  Poruba: 890\n",
      "  Potenza: 891\n",
      "  Praha: 892\n",
      "  Pratumthanee: 893\n",
      "  Prefecture: 894\n",
      "  Pringy: 895\n",
      "  Prov. de Buenos Aires: 896\n",
      "  Province 1: 897\n",
      "  Puducherry: 898\n",
      "  Punjab: 899\n",
      "  Pusan: 900\n",
      "  Pyrénées-Atlantiques: 901\n",
      "  Qalubiya: 902\n",
      "  Qalyubiya: 903\n",
      "  Qinghai: 904\n",
      "  Quang Tri: 905\n",
      "  Quebec: 906\n",
      "  Queensland: 907\n",
      "  Québec, Canada: 908\n",
      "  RE: 909\n",
      "  RGS: 910\n",
      "  RJ: 911\n",
      "  RM: 912\n",
      "  RS: 913\n",
      "  RUS: 914\n",
      "  Rajasthan: 915\n",
      "  Ramat Gan: 916\n",
      "  Reg. Metropolitana: 917\n",
      "  Region: 918\n",
      "  Region Hovedstaden: 919\n",
      "  Region Metropolitana: 920\n",
      "  Region Midjylland: 921\n",
      "  Region Midt: 922\n",
      "  Region Midtjylland: 923\n",
      "  Region Nordjylland: 924\n",
      "  Region Zealand: 925\n",
      "  Regione Sicilia: 926\n",
      "  Región Metro De Santiago: 927\n",
      "  Región Metropolitana: 928\n",
      "  Región metropolitana: 929\n",
      "  Republic of Korea: 930\n",
      "  Republic of South Africa: 931\n",
      "  Reykjavik: 932\n",
      "  Reykjavík: 933\n",
      "  Rheinland-Pfalz: 934\n",
      "  Rhode Island: 935\n",
      "  Rhone Alpes: 936\n",
      "  Rhone-alpes: 937\n",
      "  Rio De Janeiro: 938\n",
      "  Rio Grande Do Norte: 939\n",
      "  Rio Grande Do Sul: 940\n",
      "  Rio Grande do Norte: 941\n",
      "  Rio Grande do Sul: 942\n",
      "  Rio de Janeiro: 943\n",
      "  Rogaland: 944\n",
      "  Ruddington: 945\n",
      "  Rufiji: 946\n",
      "  Russia: 947\n",
      "  Réunion: 948\n",
      "  S/c de Tenerife: 949\n",
      "  SAO Paulo: 950\n",
      "  SAR: 951\n",
      "  SE: 952\n",
      "  SLL: 953\n",
      "  SP: 954\n",
      "  SUD: 955\n",
      "  Saarland: 956\n",
      "  Sabah: 957\n",
      "  Sabragamuwa: 958\n",
      "  Sachsen: 959\n",
      "  Sachsen-Anhalt: 960\n",
      "  Saint Denis: 961\n",
      "  Saitama: 962\n",
      "  San Jose: 963\n",
      "  San Salvador: 964\n",
      "  San Sebastian: 965\n",
      "  Santa Catarina: 966\n",
      "  Santa Fe: 967\n",
      "  Santander: 968\n",
      "  Santo Domingo: 969\n",
      "  Sanxia Dist: 970\n",
      "  Sao Paulo: 971\n",
      "  Sao Paulo SP: 972\n",
      "  Sarawak: 973\n",
      "  Saskatchewan: 974\n",
      "  Saxonia-Anhalt: 975\n",
      "  Saxony: 976\n",
      "  Saxony-Anhalt: 977\n",
      "  Schleswig Holstein: 978\n",
      "  Schleswig-Holstein: 979\n",
      "  Scotland: 980\n",
      "  Seine Maritime: 981\n",
      "  Seine Saint Denis: 982\n",
      "  Seine maritime: 983\n",
      "  Seine-Saint-Denis: 984\n",
      "  Seine-saint-denis: 985\n",
      "  Selangor: 986\n",
      "  Select A State: 987\n",
      "  Seodaemun: 988\n",
      "  Seodaemun-gu: 989\n",
      "  Seongnam-si, Bundang-gu: 990\n",
      "  Seoul: 991\n",
      "  Seoul Metropolitan: 992\n",
      "  Seoul, Gangnam-gu: 993\n",
      "  Seoul, Korea, Republic Of: 994\n",
      "  Sergipe: 995\n",
      "  Seville: 996\n",
      "  Sha Tin New Territories: 997\n",
      "  Shaanxi: 998\n",
      "  Shandong: 999\n",
      "  Shanghai: 1000\n",
      "  Shanxi: 1001\n",
      "  Shatin: 1002\n",
      "  Shebin El-kom: 1003\n",
      "  Shiga: 1004\n",
      "  Shinagawa-ku: 1005\n",
      "  Shizuoka: 1006\n",
      "  Siberia: 1007\n",
      "  Sichuan: 1008\n",
      "  Sicily: 1009\n",
      "  Sigmund-Freud Str. 25: 1010\n",
      "  Sind: 1011\n",
      "  Sindh: 1012\n",
      "  Sjaelland: 1013\n",
      "  Skane: 1014\n",
      "  Skåne: 1015\n",
      "  Sofia-Grad: 1016\n",
      "  Somerset: 1017\n",
      "  Songkhla: 1018\n",
      "  Songkla: 1019\n",
      "  Songpa-gu: 1020\n",
      "  Sor-Trondelag: 1021\n",
      "  Sout Australi: 1022\n",
      "  South Australia: 1023\n",
      "  South Carolina: 1024\n",
      "  South Dakota: 1025\n",
      "  South Glamorgan: 1026\n",
      "  South Holland: 1027\n",
      "  South Yorkshire: 1028\n",
      "  South-Holland: 1029\n",
      "  Southern Nationality: 1030\n",
      "  Spain/ Baleares: 1031\n",
      "  Spain/Madrid: 1032\n",
      "  Special Province of Yogyakarta: 1033\n",
      "  Srinagar Kashmir: 1034\n",
      "  St George's University of London: 1035\n",
      "  St. Gall: 1036\n",
      "  Stavropol: 1037\n",
      "  Steiemark: 1038\n",
      "  Steiermark: 1039\n",
      "  Stockholm: 1040\n",
      "  Strelna: 1041\n",
      "  Strovolos: 1042\n",
      "  Styria: 1043\n",
      "  Suedring 15: 1044\n",
      "  Sumida-ku: 1045\n",
      "  Sunsari: 1046\n",
      "  Surrey: 1047\n",
      "  Sussex: 1048\n",
      "  Syddanmark: 1049\n",
      "  SÃO Paulo: 1050\n",
      "  São Paulo: 1051\n",
      "  Sør-Trøndelag: 1052\n",
      "  TO: 1053\n",
      "  TS: 1054\n",
      "  Tahoua: 1055\n",
      "  Tainan: 1056\n",
      "  Taipei county: 1057\n",
      "  Taiwan: 1058\n",
      "  Taiwan ROC: 1059\n",
      "  Tak: 1060\n",
      "  Tak province: 1061\n",
      "  Takatsu-ku: 1062\n",
      "  Tamil Nadu: 1063\n",
      "  Tamil nadu: 1064\n",
      "  Tamilnadu: 1065\n",
      "  Tampere: 1066\n",
      "  Tanga Region: 1067\n",
      "  Tanga and Kilimanjaro: 1068\n",
      "  Taoyuan: 1069\n",
      "  Taoyuan County: 1070\n",
      "  Tarragona: 1071\n",
      "  Tasmania: 1072\n",
      "  Tatarstan: 1073\n",
      "  Tayside: 1074\n",
      "  Tayside, Scotland: 1075\n",
      "  Tbilisi: 1076\n",
      "  Tel Hashomer: 1077\n",
      "  Telemark: 1078\n",
      "  Tennessee: 1079\n",
      "  Texas: 1080\n",
      "  The Netherlands: 1081\n",
      "  Thessalia: 1082\n",
      "  Thessaly: 1083\n",
      "  Thüringen: 1084\n",
      "  Tianjin: 1085\n",
      "  Ticino: 1086\n",
      "  Timis: 1087\n",
      "  Tirol: 1088\n",
      "  Tlalpan: 1089\n",
      "  To: 1090\n",
      "  Tocantins: 1091\n",
      "  Tochigi: 1092\n",
      "  Tokyo: 1093\n",
      "  Torino: 1094\n",
      "  Toulouse Cedex: 1095\n",
      "  Trinidad: 1096\n",
      "  Trondheim: 1097\n",
      "  Tucuman: 1098\n",
      "  Turin: 1099\n",
      "  Tuscany: 1100\n",
      "  Tydfill: 1101\n",
      "  Tyne & Wear: 1102\n",
      "  Tyne And Wear: 1103\n",
      "  Tyne and Wear: 1104\n",
      "  Tyrol: 1105\n",
      "  U.T: 1106\n",
      "  UK: 1107\n",
      "  UP: 1108\n",
      "  Udine: 1109\n",
      "  Ul. Bobrzyńskiego 14,: 1110\n",
      "  Upper Austria: 1111\n",
      "  Upper Silesia: 1112\n",
      "  Uppsala county: 1113\n",
      "  Urb Ingenieria: 1114\n",
      "  Utah: 1115\n",
      "  Utrecht: 1116\n",
      "  Uttar Pradesh: 1117\n",
      "  Uusimaa: 1118\n",
      "  VAud: 1119\n",
      "  VD: 1120\n",
      "  VI: 1121\n",
      "  Val De Marne: 1122\n",
      "  Val de Marne: 1123\n",
      "  Valencia: 1124\n",
      "  Valle: 1125\n",
      "  Valle Del Cauca: 1126\n",
      "  Valle del Cauca: 1127\n",
      "  Vastra Gotaland: 1128\n",
      "  Vastra Gotalandsregionen: 1129\n",
      "  Vaud: 1130\n",
      "  Vaud (VD): 1131\n",
      "  Veneto: 1132\n",
      "  Vermont: 1133\n",
      "  Vest-Agder: 1134\n",
      "  Vestfold: 1135\n",
      "  Via F.A. Giorgioli, 14: 1136\n",
      "  Victoria: 1137\n",
      "  Vinh Long Province: 1138\n",
      "  Virginia: 1139\n",
      "  Vizcaya: 1140\n",
      "  Vlaams Brabant: 1141\n",
      "  Vlaams-Brabant: 1142\n",
      "  Vlaanderen: 1143\n",
      "  Vojvodina: 1144\n",
      "  Värmland: 1145\n",
      "  Västerbotten: 1146\n",
      "  Wakayama Prefecture: 1147\n",
      "  Wakiso: 1148\n",
      "  Wales: 1149\n",
      "  Warwickshire: 1150\n",
      "  Washington: 1151\n",
      "  Wegenerstraße: 1152\n",
      "  West Bank: 1153\n",
      "  West Bengal: 1154\n",
      "  West Dumbartonshire: 1155\n",
      "  West Java: 1156\n",
      "  West Midlands: 1157\n",
      "  West Virginia: 1158\n",
      "  West Yorkshire: 1159\n",
      "  West-Azerbaijan: 1160\n",
      "  Western Australia: 1161\n",
      "  Western Cape: 1162\n",
      "  Western Province: 1163\n",
      "  Westfalen-Lippe: 1164\n",
      "  Wielkopolska: 1165\n",
      "  Wilayah Persekutuan: 1166\n",
      "  Wilrijk: 1167\n",
      "  Wirral: 1168\n",
      "  Wisconsin: 1169\n",
      "  Xinhua Township: 1170\n",
      "  Xinjiang: 1171\n",
      "  Yahşihan: 1172\n",
      "  Yaroslavl Region: 1173\n",
      "  Yonsei-ro Seodaemun-gu: 1174\n",
      "  Yonsei-ro, Seodaemun-gu 50-1: 1175\n",
      "  Yorkshire: 1176\n",
      "  Yumbe District: 1177\n",
      "  Yunnan: 1178\n",
      "  Z-Holland: 1179\n",
      "  ZH: 1180\n",
      "  Zacatecas, México DF: 1181\n",
      "  Zagreb: 1182\n",
      "  Zamalek: 1183\n",
      "  Zhejiang: 1184\n",
      "  Zuid Holland: 1185\n",
      "  Zuid Limburg: 1186\n",
      "  Zuid-Holland: 1187\n",
      "  Zurich: 1188\n",
      "  chu ANGERS: 1189\n",
      "  ile de la Reunion: 1190\n",
      "  other: 1191\n",
      "  the Meteropolis of Seoul: 1192\n",
      "  Østerbro: 1193\n",
      "  Şişli: 1194\n",
      "  Şişli/Nişantaşı: 1195\n",
      "  Вâlе: 1196\n",
      "  اسيوط: 1197\n",
      "\n",
      "Mapping for column 'masking':\n",
      "  DOUBLE: 0\n",
      "  NONE: 1\n",
      "  QUADRUPLE: 2\n",
      "  SINGLE: 3\n",
      "  TRIPLE: 4\n",
      "\n"
     ]
    }
   ],
   "source": [
    "categorical_cols = [\n",
    "    'phase', 'condition', 'intervention_type', 'study_design',\n",
    "    'sponsor_type', 'gender', 'location', 'masking'\n",
    "]\n",
    "\n",
    "# Dictionaries to store the mapping for each column\n",
    "label_mappings = {}\n",
    "\n",
    "for col in categorical_cols:\n",
    "    # Get unique values and sort them for consistent mapping\n",
    "    unique_vals = sorted(df_balanced[col].unique())\n",
    "    mapping = {val: idx for idx, val in enumerate(unique_vals)}\n",
    "    # Save mapping\n",
    "    label_mappings[col] = mapping\n",
    "    # Apply mapping to the column\n",
    "    df_balanced[col + '_encoded'] = df_balanced[col].map(mapping)\n",
    "\n",
    "# Display the mapping for each column\n",
    "for col, mapping in label_mappings.items():\n",
    "    print(f\"Mapping for column '{col}':\")\n",
    "    for k, v in mapping.items():\n",
    "        print(f\"  {k}: {v}\")\n",
    "    print()\n",
    "\n",
    "# Now df has new columns like 'phase_encoded', 'condition_encoded', etc.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "e278cc75",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>phase</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>study_design</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>gender</th>\n",
       "      <th>location</th>\n",
       "      <th>masking</th>\n",
       "      <th>duration</th>\n",
       "      <th>final_status</th>\n",
       "      <th>phase_encoded</th>\n",
       "      <th>condition_encoded</th>\n",
       "      <th>intervention_type_encoded</th>\n",
       "      <th>study_design_encoded</th>\n",
       "      <th>sponsor_type_encoded</th>\n",
       "      <th>gender_encoded</th>\n",
       "      <th>location_encoded</th>\n",
       "      <th>masking_encoded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>PHASE3</td>\n",
       "      <td>Vulvovaginal Atrophy</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>550.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Alabama</td>\n",
       "      <td>TRIPLE</td>\n",
       "      <td>222.0</td>\n",
       "      <td>1</td>\n",
       "      <td>5</td>\n",
       "      <td>9940</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>37</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>PHASE2</td>\n",
       "      <td>Borderline Ovarian Serous Tumor</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>52.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>California</td>\n",
       "      <td>NONE</td>\n",
       "      <td>4715.0</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>1409</td>\n",
       "      <td>8</td>\n",
       "      <td>2</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>208</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Actinic Keratosis (AK)</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>502.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>ALL</td>\n",
       "      <td>other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>427.0</td>\n",
       "      <td>1</td>\n",
       "      <td>6</td>\n",
       "      <td>157</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>0</td>\n",
       "      <td>1191</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Health</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>56.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>MALE</td>\n",
       "      <td>D</td>\n",
       "      <td>TRIPLE</td>\n",
       "      <td>62.0</td>\n",
       "      <td>1</td>\n",
       "      <td>6</td>\n",
       "      <td>4047</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>6</td>\n",
       "      <td>2</td>\n",
       "      <td>307</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Chronic Kidney Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>OTHER_GOV</td>\n",
       "      <td>75.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Sao Paulo</td>\n",
       "      <td>DOUBLE</td>\n",
       "      <td>974.0</td>\n",
       "      <td>1</td>\n",
       "      <td>6</td>\n",
       "      <td>2079</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>7</td>\n",
       "      <td>0</td>\n",
       "      <td>971</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    phase                        condition intervention_type study_design  \\\n",
       "0  PHASE3             Vulvovaginal Atrophy              DRUG   RANDOMIZED   \n",
       "1  PHASE2  Borderline Ovarian Serous Tumor             OTHER      UNKNOWN   \n",
       "2  PHASE4           Actinic Keratosis (AK)              DRUG   RANDOMIZED   \n",
       "3  PHASE4                           Health              DRUG   RANDOMIZED   \n",
       "4  PHASE4           Chronic Kidney Disease              DRUG   RANDOMIZED   \n",
       "\n",
       "  sponsor_type  enrollment enrollment_type  gender    location masking  \\\n",
       "0     INDUSTRY       550.0          ACTUAL  FEMALE     Alabama  TRIPLE   \n",
       "1        OTHER        52.0          ACTUAL  FEMALE  California    NONE   \n",
       "2     INDUSTRY       502.0          ACTUAL     ALL       other    NONE   \n",
       "3        OTHER        56.0          ACTUAL    MALE           D  TRIPLE   \n",
       "4    OTHER_GOV        75.0          ACTUAL     ALL   Sao Paulo  DOUBLE   \n",
       "\n",
       "   duration  final_status  phase_encoded  condition_encoded  \\\n",
       "0     222.0             1              5               9940   \n",
       "1    4715.0             1              3               1409   \n",
       "2     427.0             1              6                157   \n",
       "3      62.0             1              6               4047   \n",
       "4     974.0             1              6               2079   \n",
       "\n",
       "   intervention_type_encoded  study_design_encoded  sponsor_type_encoded  \\\n",
       "0                          6                     1                     3   \n",
       "1                          8                     2                     6   \n",
       "2                          6                     1                     3   \n",
       "3                          6                     1                     6   \n",
       "4                          6                     1                     7   \n",
       "\n",
       "   gender_encoded  location_encoded  masking_encoded  \n",
       "0               1                37                4  \n",
       "1               1               208                1  \n",
       "2               0              1191                1  \n",
       "3               2               307                4  \n",
       "4               0               971                0  "
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_balanced.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "5216467f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.preprocessing import StandardScaler\n",
    "\n",
    "# Select the columns to standardize\n",
    "scaler = StandardScaler()\n",
    "df_balanced[['enrollment_standardized', 'duration_standardized']] = scaler.fit_transform(df_balanced[['enrollment', 'duration']])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "79a3db0e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>phase</th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>study_design</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>gender</th>\n",
       "      <th>location</th>\n",
       "      <th>masking</th>\n",
       "      <th>...</th>\n",
       "      <th>phase_encoded</th>\n",
       "      <th>condition_encoded</th>\n",
       "      <th>intervention_type_encoded</th>\n",
       "      <th>study_design_encoded</th>\n",
       "      <th>sponsor_type_encoded</th>\n",
       "      <th>gender_encoded</th>\n",
       "      <th>location_encoded</th>\n",
       "      <th>masking_encoded</th>\n",
       "      <th>enrollment_standardized</th>\n",
       "      <th>duration_standardized</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>PHASE3</td>\n",
       "      <td>Vulvovaginal Atrophy</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>550.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>Alabama</td>\n",
       "      <td>TRIPLE</td>\n",
       "      <td>...</td>\n",
       "      <td>5</td>\n",
       "      <td>9940</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>37</td>\n",
       "      <td>4</td>\n",
       "      <td>0.209566</td>\n",
       "      <td>-0.920511</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>PHASE2</td>\n",
       "      <td>Borderline Ovarian Serous Tumor</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>52.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>California</td>\n",
       "      <td>NONE</td>\n",
       "      <td>...</td>\n",
       "      <td>3</td>\n",
       "      <td>1409</td>\n",
       "      <td>8</td>\n",
       "      <td>2</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>208</td>\n",
       "      <td>1</td>\n",
       "      <td>-0.075062</td>\n",
       "      <td>4.004219</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Actinic Keratosis (AK)</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>502.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>ALL</td>\n",
       "      <td>other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>...</td>\n",
       "      <td>6</td>\n",
       "      <td>157</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>0</td>\n",
       "      <td>1191</td>\n",
       "      <td>1</td>\n",
       "      <td>0.182132</td>\n",
       "      <td>-0.695812</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Health</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>56.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>MALE</td>\n",
       "      <td>D</td>\n",
       "      <td>TRIPLE</td>\n",
       "      <td>...</td>\n",
       "      <td>6</td>\n",
       "      <td>4047</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>6</td>\n",
       "      <td>2</td>\n",
       "      <td>307</td>\n",
       "      <td>4</td>\n",
       "      <td>-0.072776</td>\n",
       "      <td>-1.095885</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Chronic Kidney Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>OTHER_GOV</td>\n",
       "      <td>75.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>ALL</td>\n",
       "      <td>Sao Paulo</td>\n",
       "      <td>DOUBLE</td>\n",
       "      <td>...</td>\n",
       "      <td>6</td>\n",
       "      <td>2079</td>\n",
       "      <td>6</td>\n",
       "      <td>1</td>\n",
       "      <td>7</td>\n",
       "      <td>0</td>\n",
       "      <td>971</td>\n",
       "      <td>0</td>\n",
       "      <td>-0.061917</td>\n",
       "      <td>-0.096251</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    phase                        condition intervention_type study_design  \\\n",
       "0  PHASE3             Vulvovaginal Atrophy              DRUG   RANDOMIZED   \n",
       "1  PHASE2  Borderline Ovarian Serous Tumor             OTHER      UNKNOWN   \n",
       "2  PHASE4           Actinic Keratosis (AK)              DRUG   RANDOMIZED   \n",
       "3  PHASE4                           Health              DRUG   RANDOMIZED   \n",
       "4  PHASE4           Chronic Kidney Disease              DRUG   RANDOMIZED   \n",
       "\n",
       "  sponsor_type  enrollment enrollment_type  gender    location masking  ...  \\\n",
       "0     INDUSTRY       550.0          ACTUAL  FEMALE     Alabama  TRIPLE  ...   \n",
       "1        OTHER        52.0          ACTUAL  FEMALE  California    NONE  ...   \n",
       "2     INDUSTRY       502.0          ACTUAL     ALL       other    NONE  ...   \n",
       "3        OTHER        56.0          ACTUAL    MALE           D  TRIPLE  ...   \n",
       "4    OTHER_GOV        75.0          ACTUAL     ALL   Sao Paulo  DOUBLE  ...   \n",
       "\n",
       "   phase_encoded  condition_encoded  intervention_type_encoded  \\\n",
       "0              5               9940                          6   \n",
       "1              3               1409                          8   \n",
       "2              6                157                          6   \n",
       "3              6               4047                          6   \n",
       "4              6               2079                          6   \n",
       "\n",
       "   study_design_encoded  sponsor_type_encoded  gender_encoded  \\\n",
       "0                     1                     3               1   \n",
       "1                     2                     6               1   \n",
       "2                     1                     3               0   \n",
       "3                     1                     6               2   \n",
       "4                     1                     7               0   \n",
       "\n",
       "   location_encoded  masking_encoded  enrollment_standardized  \\\n",
       "0                37                4                 0.209566   \n",
       "1               208                1                -0.075062   \n",
       "2              1191                1                 0.182132   \n",
       "3               307                4                -0.072776   \n",
       "4               971                0                -0.061917   \n",
       "\n",
       "   duration_standardized  \n",
       "0              -0.920511  \n",
       "1               4.004219  \n",
       "2              -0.695812  \n",
       "3              -1.095885  \n",
       "4              -0.096251  \n",
       "\n",
       "[5 rows x 22 columns]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_balanced.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "eeea5ab7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 40216 entries, 0 to 40215\n",
      "Data columns (total 22 columns):\n",
      " #   Column                     Non-Null Count  Dtype  \n",
      "---  ------                     --------------  -----  \n",
      " 0   phase                      40216 non-null  object \n",
      " 1   condition                  40216 non-null  object \n",
      " 2   intervention_type          40216 non-null  object \n",
      " 3   study_design               40216 non-null  object \n",
      " 4   sponsor_type               40216 non-null  object \n",
      " 5   enrollment                 40216 non-null  float64\n",
      " 6   enrollment_type            38792 non-null  object \n",
      " 7   gender                     40216 non-null  object \n",
      " 8   location                   40216 non-null  object \n",
      " 9   masking                    40216 non-null  object \n",
      " 10  duration                   40216 non-null  float64\n",
      " 11  final_status               40216 non-null  int64  \n",
      " 12  phase_encoded              40216 non-null  int64  \n",
      " 13  condition_encoded          40216 non-null  int64  \n",
      " 14  intervention_type_encoded  40216 non-null  int64  \n",
      " 15  study_design_encoded       40216 non-null  int64  \n",
      " 16  sponsor_type_encoded       40216 non-null  int64  \n",
      " 17  gender_encoded             40216 non-null  int64  \n",
      " 18  location_encoded           40216 non-null  int64  \n",
      " 19  masking_encoded            40216 non-null  int64  \n",
      " 20  enrollment_standardized    40216 non-null  float64\n",
      " 21  duration_standardized      40216 non-null  float64\n",
      "dtypes: float64(4), int64(9), object(9)\n",
      "memory usage: 6.8+ MB\n"
     ]
    }
   ],
   "source": [
    "df_balanced.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "23f39f9b",
   "metadata": {},
   "outputs": [],
   "source": [
    "columns_to_drop = [\n",
    "    'phase', 'condition', 'intervention_type', 'study_design',\n",
    "    'sponsor_type', 'enrollment_standardized', 'gender', 'location', 'masking', 'duration_standardized'\n",
    "]\n",
    "\n",
    "df_balanced = df_balanced.drop(columns=columns_to_drop)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "52d49b71",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 40216 entries, 0 to 40215\n",
      "Data columns (total 12 columns):\n",
      " #   Column                     Non-Null Count  Dtype  \n",
      "---  ------                     --------------  -----  \n",
      " 0   enrollment                 40216 non-null  float64\n",
      " 1   enrollment_type            38792 non-null  object \n",
      " 2   duration                   40216 non-null  float64\n",
      " 3   final_status               40216 non-null  int64  \n",
      " 4   phase_encoded              40216 non-null  int64  \n",
      " 5   condition_encoded          40216 non-null  int64  \n",
      " 6   intervention_type_encoded  40216 non-null  int64  \n",
      " 7   study_design_encoded       40216 non-null  int64  \n",
      " 8   sponsor_type_encoded       40216 non-null  int64  \n",
      " 9   gender_encoded             40216 non-null  int64  \n",
      " 10  location_encoded           40216 non-null  int64  \n",
      " 11  masking_encoded            40216 non-null  int64  \n",
      "dtypes: float64(2), int64(9), object(1)\n",
      "memory usage: 3.7+ MB\n"
     ]
    }
   ],
   "source": [
    "df_balanced.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "b0f706c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Get a list of columns, excluding 'final_status'\n",
    "cols = [col for col in df_balanced.columns if col != 'final_status']\n",
    "# Add 'final_status' at the end\n",
    "cols.append('final_status')\n",
    "# Reorder the DataFrame\n",
    "df_balanced = df_balanced[cols]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "ce1a0d0e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_balanced.to_csv('trainable.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "2e8e5486",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "final_status\n",
       "0    20216\n",
       "1    20000\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_balanced['final_status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fc064dca",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
